data_2do0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2do0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.807 0.337 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.9 138.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 245' ' ' ILE . 72.1 t80 -97.0 116.39 29.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.457 ' CG1' HD13 ' A' ' 210' ' ' LEU . 13.5 t -104.32 132.85 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.73 166.45 22.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 61.83 50.82 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.457 HD13 ' CG1' ' A' ' 207' ' ' VAL . 42.7 mt -102.36 157.97 16.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.52 136.55 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -48.2 -44.81 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.425 ' NZ ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -57.41 -36.58 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.42 117.77 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -114.18 168.71 12.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -50.8 -25.33 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.71 -64.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.403 ' O ' ' CG2' ' A' ' 222' ' ' VAL . 34.6 tptt -57.62 -51.15 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.7 tp -49.24 -54.97 14.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -59.58 -52.9 63.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -50.67 -40.73 54.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.54 HG12 ' CE2' ' A' ' 263' ' ' PHE . 29.0 t -66.87 -52.1 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.5 m-85 -60.83 -16.14 37.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.7 t -56.22 -19.3 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.2 mtp -61.69 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -48.57 -37.58 18.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 174.46 -159.8 28.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.2 t -88.03 126.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 93.1 t -84.87 101.99 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.532 ' CG2' ' CD ' ' A' ' 251' ' ' GLU . 45.3 t -59.57 -44.0 92.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.6 ttp85 -141.11 120.43 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -125.2 130.53 52.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -162.89 166.01 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.32 148.61 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.884 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.434 ' CG2' ' CZ ' ' A' ' 206' ' ' PHE . 53.3 mt -132.61 129.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.142 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.87 176.99 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.4 p -139.35 132.78 30.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.71 135.02 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 230' ' ' VAL . 58.0 m -124.24 115.6 21.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 71.4 m-85 -87.7 -175.45 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.532 ' CD ' ' CG2' ' A' ' 230' ' ' VAL . 24.0 mm-40 -90.23 -53.63 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -114.18 146.58 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 93.4 p -50.33 -45.28 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.3 mm -46.53 -56.46 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -56.46 -48.4 77.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.06 -50.5 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.77 -54.78 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -44.94 -54.89 6.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -53.18 -58.65 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 75.6 mt -41.73 -42.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 30.0 t -76.17 -65.74 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -20.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.1 m-85 -104.99 -19.98 13.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 110.16 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.5 84.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.69 130.56 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.96 100.07 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.1 tp -107.22 122.73 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 56.52 43.49 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.3 t0 62.38 28.97 17.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -147.09 125.68 6.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 135.17 29.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 33.3 mtm -99.33 153.19 19.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -119.21 100.72 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.25 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -120.56 144.86 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 7.9 mtt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.818 0.342 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.464 HG12 ' CG1' ' A' ' 260' ' ' ILE . 31.7 m -115.11 132.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -97.0 124.27 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.93 138.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -145.66 164.8 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 t30 67.82 42.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.8 161.78 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 212' ' ' TYR . 44.2 t0 -82.24 133.45 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.482 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 16.8 m-85 -48.08 -29.48 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -72.02 -40.38 68.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 76.8 t -58.22 141.15 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -141.8 166.17 26.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 217' ' ' LYS . 19.4 p-90 -39.68 -48.39 2.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.528 ' N ' ' CG ' ' A' ' 216' ' ' TRP . 35.5 mttm -47.58 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -61.0 -49.34 77.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.425 HD22 ' CG2' ' A' ' 248' ' ' VAL . 9.6 tp -46.47 -48.01 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -68.05 -44.78 75.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.68 -44.39 77.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.543 HG13 ' CE2' ' A' ' 263' ' ' PHE . 21.4 t -72.48 -52.99 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.551 ' CE2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -56.9 -32.17 65.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.4 t -48.51 -21.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' MET . . . . . 0.425 ' O ' ' C ' ' A' ' 226' ' ' ALA . 29.1 mtm -57.66 -65.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 225' ' ' MET . . . -35.85 -50.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.15 -104.41 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.09 119.28 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 54.2 t -77.74 96.02 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 250' ' ' PHE . 60.8 t -54.17 -44.79 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -151.64 117.24 5.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 233' ' ' ASP . . . -115.92 135.39 54.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 232' ' ' ALA . 36.3 m-20 -164.25 161.88 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 34.0 mm -113.23 150.08 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 41.5 mt -123.51 123.05 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 111.167 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.22 174.14 20.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.7 p -138.58 143.96 39.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.551 HG21 ' CE2' ' A' ' 223' ' ' PHE . 57.5 t -137.69 151.0 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 m -131.06 113.34 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 71.3 m-85 -88.73 172.42 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.2 -58.75 3.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -124.5 157.51 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.0 t -49.36 -48.3 46.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.2 mm -38.9 -68.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -52.02 -48.28 64.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -48.6 -52.85 20.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 45.3 t -54.77 -51.25 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -46.35 -47.5 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -65.92 -58.75 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.464 ' CG1' HG12 ' A' ' 205' ' ' VAL . 82.2 mt -41.23 -44.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.6 m -76.81 -65.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -46.71 -21.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.543 ' CE2' HG13 ' A' ' 222' ' ' VAL . 4.4 m-85 -103.73 -29.34 11.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t-20 -56.02 111.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.99 82.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -73.84 130.4 39.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.35 100.95 13.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 tp -108.71 122.28 46.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 58.22 37.39 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.5 28.64 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -145.68 117.77 5.13 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 123.58 10.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.728 2.286 . . . . 0.0 112.313 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 42.7 mtm -83.36 157.32 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . 0.465 ' C ' ' CD2' ' A' ' 274' ' ' HIS . 3.8 t-160 -119.92 100.72 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.53 126.43 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -145.37 144.22 30.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.41 ' CG ' HD11 ' A' ' 260' ' ' ILE . 8.0 mtt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.833 0.349 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 248' ' ' VAL . 22.1 m -103.73 133.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.501 ' CE1' HG21 ' A' ' 245' ' ' ILE . 86.9 t80 -98.32 106.64 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.77 133.65 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.01 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.06 53.44 2.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.64 158.77 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -87.89 130.6 34.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.14 -23.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -69.09 -40.25 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.419 ' CG2' HD21 ' A' ' 268' ' ' LEU . 92.4 t -61.53 119.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.57 162.74 12.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 68.2 p-90 -43.65 -49.19 7.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.496 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 6.9 ptpt -53.75 -54.79 33.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.433 ' N ' ' CG ' ' A' ' 217' ' ' LYS . 0.7 OUTLIER -53.49 -59.89 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.57 HD13 ' CE1' ' A' ' 223' ' ' PHE . 23.5 tp -46.55 -47.29 19.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -60.03 -55.5 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -53.0 -58.18 7.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.563 HG13 ' CZ ' ' A' ' 263' ' ' PHE . 38.4 t -51.67 -41.15 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.57 ' CE1' HD13 ' A' ' 219' ' ' LEU . 3.6 m-85 -70.06 -28.88 65.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 t -42.38 -27.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 50.7 mtp -51.19 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.93 -57.06 4.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -164.79 -157.39 9.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.9 t -92.36 107.91 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.75 100.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 249' ' ' THR . 89.1 t -55.81 -46.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.138 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -144.05 122.06 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -117.07 127.15 53.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -152.86 153.94 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 46.0 mm -119.03 128.47 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.501 HG21 ' CE1' ' A' ' 206' ' ' PHE . 40.7 mt -132.97 136.27 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.148 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 174.54 18.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 68.4 p -142.24 131.07 22.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 223' ' ' PHE . 70.7 t -127.85 129.36 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 230' ' ' VAL . 33.4 m -110.79 112.4 24.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 61.8 m-85 -88.46 173.3 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.15 -55.29 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.93 159.56 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 51.1 p -52.63 -47.65 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.5 mm -42.61 -61.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -54.6 -47.52 73.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.54 -56.31 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.0 t -51.8 -44.41 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -53.9 -46.89 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -70.8 -45.89 63.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.4 mt -49.71 -48.95 20.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 13.0 m -72.49 -54.19 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mtt -55.13 -22.49 17.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 222' ' ' VAL . 22.1 m-85 -104.8 -16.2 14.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -63.81 110.5 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.03 86.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -71.16 132.63 45.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.7 mt -85.79 100.1 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.419 HD21 ' CG2' ' A' ' 214' ' ' VAL . 15.6 tp -107.64 122.33 46.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 58.36 38.68 25.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 67.08 27.53 8.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -144.49 125.66 7.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 121.19 7.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.363 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 55.6 mtm -83.85 152.9 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -118.34 101.13 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 5.7 t -107.49 114.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -133.44 144.63 49.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.808 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 23.1 m -112.12 135.16 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -97.07 114.7 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.458 ' CG1' HD22 ' A' ' 210' ' ' LEU . 14.2 t -99.56 138.19 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.76 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 m120 62.51 41.88 9.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.458 HD22 ' CG1' ' A' ' 207' ' ' VAL . 53.5 mt -91.35 149.34 21.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 214' ' ' VAL . 6.7 t70 -78.76 136.17 37.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -43.24 -31.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.84 -39.76 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 211' ' ' ASP . 94.6 t -54.05 111.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.04 170.55 16.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.489 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 52.6 p-90 -57.97 -32.49 67.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.489 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 8.9 mmtp -68.47 -52.38 33.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -62.77 -41.52 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.47 -58.77 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -52.9 -58.6 6.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -49.66 -58.89 4.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.95 -40.17 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.523 ' CE2' HG22 ' A' ' 248' ' ' VAL . 3.3 m-85 -72.37 -17.07 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.1 t -58.32 -19.38 34.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 26.3 mtm -57.39 -67.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -40.26 -42.08 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.404 ' C ' HG22 ' A' ' 228' ' ' VAL . . . -178.32 -103.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.404 HG22 ' C ' ' A' ' 227' ' ' GLY . 61.5 t -144.12 117.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.429 ' CG1' HG11 ' A' ' 248' ' ' VAL . 39.7 t -75.62 102.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 249' ' ' THR . 79.0 t -50.69 -44.39 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.43 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 8.0 ptp180 -159.38 122.76 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -108.1 135.01 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -139.72 151.39 45.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.89 125.87 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.96 179.867 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 61.2 mt -132.83 126.31 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.369 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.35 167.31 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 56.3 p -139.94 128.68 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 223' ' ' PHE . 36.0 t -124.63 140.5 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 230' ' ' VAL . 15.5 m -121.12 117.89 28.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.77 -176.74 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -83.19 -55.82 4.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -128.96 162.15 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 93.7 p -52.75 -48.24 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.1 mm -37.48 -62.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.39 -41.88 90.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.85 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.88 -49.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -48.49 -42.17 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -75.99 -49.56 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.427 HD11 ' CG ' ' A' ' 277' ' ' MET . 42.8 mt -51.98 -41.4 31.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.2 t -76.68 -50.77 12.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 30.1 mtt -60.04 -21.66 61.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -104.51 -22.15 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.6 110.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.9 84.11 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -72.66 123.46 23.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.893 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.78 105.88 14.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.06 121.93 45.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 58.76 35.11 24.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.62 27.74 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 33.5 mtp85 -142.9 119.51 6.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.722 . . . . 0.0 110.819 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.09 3.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.368 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 59.8 mtm -72.14 159.25 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -125.63 103.56 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.8 110.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.084 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -124.59 142.18 51.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.427 ' CG ' HD11 ' A' ' 260' ' ' ILE . 15.0 mtt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.824 0.345 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.99 137.23 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.411 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 85.5 t80 -98.97 118.46 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.26 134.34 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -137.49 171.91 13.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 m120 60.09 41.53 17.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.0 mt -90.05 155.41 19.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 214' ' ' VAL . 3.3 t70 -67.3 160.76 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -77.71 -33.82 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 65.8 mttt -85.53 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 215' ' ' GLY . 47.6 t -108.91 164.2 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.444 ' N ' ' CG1' ' A' ' 214' ' ' VAL . . . -151.2 148.71 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -40.45 -35.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -66.56 -56.36 11.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -51.22 -44.16 61.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -69.4 -62.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -44.4 -42.28 6.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 27.1 t -70.29 -43.26 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.2 m-85 -69.19 -15.73 63.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -59.38 -13.21 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.0 mtp -67.5 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 259' ' ' ALA . . . -46.26 -47.39 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.1 -141.44 3.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 50.1 t -105.51 114.68 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.11 101.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.177 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.02 -43.69 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.421 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 17.5 ptt180 -160.58 119.8 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -108.44 135.24 50.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 159.3 42.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 48.7 mm -119.31 144.04 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 36.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.874 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.411 HG21 ' CZ ' ' A' ' 206' ' ' PHE . 51.8 mt -131.33 126.18 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.26 175.27 20.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 p -143.48 138.47 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.435 HG12 ' CE1' ' A' ' 250' ' ' PHE . 44.1 t -135.19 143.51 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.421 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 89.2 m -124.4 123.74 40.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.435 ' CE1' HG12 ' A' ' 248' ' ' VAL . 74.2 m-85 -97.62 175.5 6.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -60.15 2.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -109.49 142.58 40.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.7 p -47.82 -43.24 27.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 mm -46.88 -57.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.44 -49.79 75.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -51.32 -48.03 62.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.6 -53.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -46.07 -46.92 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.419 ' HB3' ' CB ' ' A' ' 226' ' ' ALA . . . -64.4 -50.55 67.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.405 ' HA ' ' CG1' ' A' ' 275' ' ' VAL . 96.6 mt -47.53 -50.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 264' ' ' ASN . 15.8 m -72.22 -61.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.8 mmt -45.17 -24.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -104.43 -19.36 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 261' ' ' SER . 10.9 t30 -60.35 113.0 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.54 6.65 89.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.553 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.95 126.17 28.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.88 0.371 . . . . 0.0 110.93 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.56 100.16 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.0 tp -106.05 121.13 43.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.959 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 59.03 37.76 24.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 68.55 26.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -143.67 124.48 7.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 63.2 mtm -84.51 145.36 28.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -109.79 99.25 8.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 4.0 t -109.04 124.66 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 277' ' ' MET . 1.6 ttpm? -149.09 160.55 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 9.4 mmt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.4 m -124.99 139.69 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -100.32 127.35 46.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 45.9 t -116.54 130.51 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.72 170.68 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.67 50.84 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 50.3 mt -100.03 159.95 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 214' ' ' VAL . 25.5 t0 -86.16 131.54 34.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -44.82 -23.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -75.73 -39.54 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 211' ' ' ASP . 70.1 t -59.74 112.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -109.83 172.84 16.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -51.19 -28.94 12.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' A' ' 221' ' ' GLU . 45.0 mttp -67.78 -52.94 31.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.442 ' HD2' ' CG2' ' A' ' 222' ' ' VAL . 19.5 tptm -65.38 -50.48 65.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 12.5 tp -49.91 -53.42 26.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -62.21 -61.79 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 217' ' ' LYS . 0.4 OUTLIER -43.15 -56.63 3.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.442 ' CG2' ' HD2' ' A' ' 218' ' ' LYS . 46.2 t -56.0 -46.94 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.3 m-85 -63.13 -14.84 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.4 t -59.18 -13.91 8.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 41.7 mtp -69.08 -60.71 2.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -44.93 -52.56 8.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.51 -127.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 68.0 t -114.78 119.88 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 248' ' ' VAL . 84.6 t -81.59 98.65 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.1 t -51.45 -43.74 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.35 117.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -108.3 153.38 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -167.73 167.1 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.403 ' CD1' HD21 ' A' ' 219' ' ' LEU . 16.3 mm -126.2 133.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.873 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.68 129.81 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.15 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.69 166.38 24.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 48.2 p -135.8 140.68 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.407 ' CG1' HG12 ' A' ' 229' ' ' VAL . 2.8 t -134.73 143.91 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.1 m -120.96 121.7 38.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -95.34 -176.32 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.83 -53.22 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -134.76 159.29 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 91.9 p -48.86 -36.98 18.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 30.8 mm -47.32 -63.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -58.75 -44.43 90.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.73 -54.55 22.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.72 -49.13 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.164 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -48.32 -47.31 36.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -69.23 -55.09 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 95.2 mt -45.74 -43.37 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -77.6 -59.93 2.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.4 mmt -51.06 -22.81 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.46 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 3.5 m-85 -103.07 -21.0 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -55.33 113.33 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.05 82.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -70.56 127.12 31.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.65 101.37 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.15 124.64 51.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 57.31 32.73 22.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 72.13 31.45 1.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -144.85 120.72 6.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.592 0.71 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 118.46 5.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.704 2.27 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 55.7 mtm -79.87 147.07 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -113.5 99.03 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.8 t -107.65 127.0 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.8 tttm -149.54 159.53 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 11.0 mtt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.841 0.353 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.45 145.5 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.46 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 87.3 t80 -102.58 118.51 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -122.76 167.91 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.35 51.69 8.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.95 163.23 13.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 214' ' ' VAL . 1.7 t0 -80.75 118.14 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -41.27 -41.88 2.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -61.0 -37.45 82.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 211' ' ' ASP . 53.3 t -55.72 151.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -135.26 172.44 22.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.407 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 30.3 p-90 -57.09 -39.72 75.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.407 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 5.3 mtpm? -62.84 -48.49 78.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.407 ' NZ ' HG23 ' A' ' 222' ' ' VAL . 0.5 OUTLIER -63.81 -48.83 75.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.462 HD22 ' CG2' ' A' ' 248' ' ' VAL . 11.2 tp -55.88 -52.55 63.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -59.06 -60.26 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.24 -45.27 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.407 HG23 ' NZ ' ' A' ' 218' ' ' LYS . 85.9 t -69.21 -51.95 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.503 ' CD2' HG23 ' A' ' 248' ' ' VAL . 3.2 m-85 -56.76 -12.86 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.2 t -57.46 -12.23 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.3 mtm -65.31 -66.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.421 ' HB2' ' N ' ' A' ' 259' ' ' ALA . . . -48.83 -39.96 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.073 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 176.65 -171.78 44.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.4 122.16 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 232' ' ' ALA . 94.3 t -79.0 103.66 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.44 -39.31 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -148.62 120.3 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.422 ' CB ' HG13 ' A' ' 229' ' ' VAL . . . -124.98 135.48 52.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.69 167.54 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.64 133.51 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.912 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.46 HG21 ' CZ ' ' A' ' 206' ' ' PHE . 47.7 mt -127.71 124.31 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.78 176.33 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.494 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 57.6 p -142.8 136.73 29.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 223' ' ' PHE . 45.9 t -127.17 139.88 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.442 ' N ' HG11 ' A' ' 248' ' ' VAL . 91.6 m -123.21 111.06 16.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.183 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.565 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 91.0 m-85 -86.62 -175.25 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.49 -49.36 8.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -132.29 156.71 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 16.7 t -48.71 -52.81 21.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 27.9 mm -37.67 -62.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.137 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -53.77 -48.47 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.61 -60.69 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 95.7 t -42.87 -56.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -47.87 -52.29 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.421 ' N ' ' HB2' ' A' ' 226' ' ' ALA . . . -58.88 -42.86 90.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.503 ' O ' ' CB ' ' A' ' 264' ' ' ASN . 48.7 mt -62.62 -59.61 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.1 m -54.29 -42.81 70.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -69.85 -67.17 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.471 ' CE2' ' HA ' ' A' ' 223' ' ' PHE . 41.9 m-85 -57.47 -14.02 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.0 OUTLIER -65.34 110.56 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.57 81.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -69.89 146.03 51.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.97 102.43 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.76 123.52 50.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.434 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 12.1 m-85 56.2 40.61 29.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.5 t70 64.21 30.99 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -147.08 123.25 5.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.566 0.698 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 124.45 11.11 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.363 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 61.0 mtm -85.86 153.07 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -117.35 99.85 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.82 124.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 277' ' ' MET . 22.2 tttm -142.64 157.57 44.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.4 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 7.9 mtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.921 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.84 0.352 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.403 HG12 ' CG1' ' A' ' 260' ' ' ILE . 15.7 m -126.08 148.39 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -104.06 111.67 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.2 t -101.75 138.11 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.158 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.6 170.09 16.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.12 54.43 3.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.04 148.95 30.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.83 141.49 44.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -51.41 -19.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -75.25 -42.48 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 41.5 t -60.74 109.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.5 13.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.448 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 42.1 p-90 -48.24 -34.88 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 99.1 mttt -60.15 -57.25 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -64.31 -57.73 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 22.8 tp -38.69 -49.57 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -67.25 -48.19 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.93 -32.11 60.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 263' ' ' PHE . 38.8 t -78.0 -43.59 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -66.42 -21.28 66.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -51.57 -19.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 7.9 mtm -65.67 -59.67 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.13 -45.35 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 178.81 -162.94 30.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.94 122.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 78.6 t -78.44 101.0 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 249' ' ' THR . 77.0 t -52.59 -42.08 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.419 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 29.2 ptt180 -163.81 117.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.61 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -166.59 172.95 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 23.5 mm -129.51 119.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.868 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 40.8 mt -112.04 128.85 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 111.159 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.8 168.28 21.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.4 p -139.01 135.77 34.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 35.0 t -130.47 139.31 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.8 m -120.8 115.81 23.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 80.8 m-85 -88.83 178.59 6.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -80.75 -55.23 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -117.81 145.03 44.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 83.8 p -47.06 -45.51 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -42.4 -62.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -55.63 -49.18 73.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.05 -49.79 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.3 -53.6 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -45.59 -42.95 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -66.57 -52.21 47.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.448 ' CD1' ' HG2' ' A' ' 277' ' ' MET . 75.8 mt -48.88 -48.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.5 m -71.96 -58.88 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 85.6 mmm -51.83 -24.49 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 222' ' ' VAL . 20.8 m-85 -102.05 -15.08 16.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.52 111.93 4.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.25 90.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -70.73 125.9 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.03 101.88 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.3 tp -108.6 123.7 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 58.72 39.25 24.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.7 26.65 9.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -145.54 124.61 6.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 0.0 110.836 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 119.49 6.43 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 59.7 mtm -80.5 154.91 27.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -119.95 108.81 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.411 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.7 t -116.79 122.31 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -131.72 147.95 52.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.448 ' HG2' ' CD1' ' A' ' 260' ' ' ILE . 3.4 mtp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.821 0.344 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.77 137.26 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.521 ' CE1' HG22 ' A' ' 245' ' ' ILE . 67.6 t80 -99.73 123.52 44.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 66.4 t -112.8 128.42 69.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' A' ' 206' ' ' PHE . . . -132.07 167.55 19.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.4 t30 68.43 45.52 1.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 34.0 mt -104.31 133.84 48.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.47 ' OD2' ' CD2' ' A' ' 269' ' ' PHE . 0.5 OUTLIER -67.5 145.74 54.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -47.63 -33.75 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -58.02 -35.24 70.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.411 HG22 ' CG ' ' A' ' 211' ' ' ASP . 46.4 t -56.06 117.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -117.97 146.6 18.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.532 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 32.0 p-90 -35.44 -45.11 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.532 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 32.7 mtpt -55.92 -60.03 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 219' ' ' LEU . 15.9 tptm -54.19 -65.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 218' ' ' LYS . 14.3 tp -35.23 -58.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.42 -49.67 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.32 -20.9 12.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' A' ' 263' ' ' PHE . 89.1 t -91.34 -45.5 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.513 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.4 m-85 -64.58 -15.99 61.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 42.3 p -58.51 -15.28 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 29.4 mtm -66.42 -55.47 15.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.68 -41.0 80.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.24 -161.67 30.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.52 108.48 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 55.6 t -69.54 104.72 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 53.8 t -50.69 -46.46 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.437 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 0.2 OUTLIER -153.58 122.96 6.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.407 ' C ' ' OD1' ' A' ' 233' ' ' ASP . . . -117.73 133.42 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 232' ' ' ALA . 2.0 m-20 -161.17 167.17 26.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.7 138.56 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.521 HG22 ' CE1' ' A' ' 206' ' ' PHE . 67.4 mt -137.03 128.62 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.136 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.69 170.36 18.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.5 p -138.43 138.23 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.9 151.34 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.437 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 15.6 m -133.48 118.89 18.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -88.82 175.98 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.11 -55.93 4.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.02 155.9 35.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 254' ' ' ILE . 69.0 p -51.67 -50.82 59.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 253' ' ' SER . 14.4 mm -36.39 -62.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -57.41 -45.96 84.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.3 49.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.07 -54.09 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -44.82 -43.01 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -72.45 -53.27 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.0 mt -42.68 -46.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.8 m -76.85 -63.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.0 mmm -45.89 -24.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 3.6 m-85 -100.3 -30.77 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -55.13 111.15 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.07 14.01 77.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -77.08 127.87 33.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.1 mt -85.83 99.94 11.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.67 125.34 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.47 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 25.8 m-85 58.86 33.95 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 70.35 28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -146.85 124.58 5.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.613 0.721 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 126.2 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.413 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 41.7 mtm -86.54 151.37 23.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -115.87 102.29 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.55 124.47 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 158.71 43.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 11.3 mtt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.467 HG11 ' CG1' ' A' ' 260' ' ' ILE . 31.9 m -112.03 134.15 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -95.02 112.27 23.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.3 t -101.18 129.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -135.94 161.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.2 t30 67.54 47.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 46.1 mt -99.96 146.79 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -74.26 137.69 43.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -45.16 -36.43 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -59.97 -43.41 95.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.82 121.88 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -122.12 161.65 16.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.519 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.51 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 56.7 p-90 -35.53 -48.53 0.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.51 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 4.5 ptpt -50.85 -62.66 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 219' ' ' LEU . 18.5 tptp -50.93 -66.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.9 tp -35.43 -42.98 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -69.85 -64.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -42.98 -38.83 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 69.8 t -74.72 -39.83 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.123 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.1 m-85 -73.72 -10.33 59.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.6 t -62.31 -23.48 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.9 mtm -59.98 -61.53 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.58 -54.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.117 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.97 -144.65 4.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -99.54 114.85 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.444 HG12 ' CB ' ' A' ' 232' ' ' ALA . 42.2 t -78.82 103.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 249' ' ' THR . 40.3 t -50.87 -37.04 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.416 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 39.2 ptt85 -168.56 118.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.444 ' CB ' HG12 ' A' ' 229' ' ' VAL . . . -114.37 142.78 45.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -169.66 168.62 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.413 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.5 mm -116.52 141.8 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 36.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.7 mt -132.43 125.44 53.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.164 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.38 168.15 21.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 52.5 p -132.54 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.112 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.432 ' HB ' ' CG2' ' A' ' 205' ' ' VAL . 63.0 t -134.54 138.65 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 230' ' ' VAL . 28.7 m -119.37 117.98 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.47 -178.83 5.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.23 -52.71 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.57 156.32 44.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 17.3 t -48.59 -49.83 35.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.4 mm -39.14 -64.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -53.59 -45.25 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.49 -56.39 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.2 t -50.28 -55.35 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -44.03 -51.58 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 263' ' ' PHE . . . -65.3 -50.8 64.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.467 ' CG1' HG11 ' A' ' 205' ' ' VAL . 84.7 mt -46.85 -52.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.4 m -72.48 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 53.4 mmm -46.61 -24.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 259' ' ' ALA . 26.2 m-85 -103.3 -23.36 13.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.13 110.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.68 89.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -69.98 130.56 42.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.09 100.99 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.6 tp -109.4 121.96 46.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 59.34 41.95 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.44 ' O ' ' CG ' ' A' ' 270' ' ' ASP . 19.6 t70 63.39 24.97 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.28 125.34 7.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 138.19 37.05 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 32.9 mtm -97.39 152.91 18.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -115.74 99.17 7.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.5 t -112.93 118.45 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -139.11 146.14 40.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 24.4 mtt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.39 150.73 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -106.68 122.05 45.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.32 124.37 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -124.21 167.87 13.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 62.16 50.98 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.39 146.35 28.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.88 145.43 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.86 -26.63 36.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.03 -37.51 72.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.07 110.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.126 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -103.88 175.04 22.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.488 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 12.4 p-90 -57.13 -32.68 66.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.488 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 30.3 mmtt -66.43 -56.41 11.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -59.11 -56.42 22.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -46.45 -51.26 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.65 -67.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -38.73 -49.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.405 HG13 ' CE1' ' A' ' 263' ' ' PHE . 23.8 t -59.66 -45.61 94.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.2 -14.39 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 t -55.64 -22.99 25.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.3 mtm -57.32 -63.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 259' ' ' ALA . . . -41.46 -50.03 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.13 -106.28 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 45.6 t -139.99 112.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.15 103.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 249' ' ' THR . 65.6 t -51.46 -37.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.407 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.2 ptm180 -168.16 121.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -107.73 151.03 26.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.36 161.36 30.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.34 126.37 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.941 179.861 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 72.1 mt -136.22 139.29 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 80.8 p -144.69 145.14 31.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.1 t -133.89 130.41 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.3 m -106.72 121.22 43.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 42.9 m-85 -96.06 177.89 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 3.6 mm-40 -76.8 -55.74 5.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -131.09 155.59 46.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.7 p -47.99 -32.18 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.66 -67.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.45 -43.33 75.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.54 -49.72 67.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 62.6 t -57.26 -53.15 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -48.24 -44.63 33.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 226' ' ' ALA . . . -66.77 -62.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 277' ' ' MET . 78.2 mt -40.8 -39.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.7 t -78.97 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 34.9 mtp -49.93 -21.39 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.405 ' CE1' HG13 ' A' ' 222' ' ' VAL . 41.9 m-85 -103.89 -21.97 13.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -55.58 111.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.72 18.21 71.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -78.39 125.16 28.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.46 101.66 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.6 tp -111.12 124.88 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 59.42 31.74 21.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 73.46 28.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -144.9 126.84 7.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 117.26 4.98 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 0.0 112.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 47.3 mtm -78.07 150.72 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -117.33 104.37 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.6 t -114.29 119.9 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 277' ' ' MET . 11.4 ttmt -136.55 157.22 47.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.436 ' HG2' ' CD1' ' A' ' 260' ' ' ILE . 3.9 mtt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.819 0.342 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.0 138.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.185 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.435 ' CZ ' ' CG2' ' A' ' 245' ' ' ILE . 83.0 t80 -105.6 123.42 47.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.64 141.83 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 167.63 21.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 272' ' ' PRO . 62.7 t30 62.81 50.54 3.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.7 mt -104.16 158.51 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -77.16 133.65 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -50.61 -34.59 26.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.925 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -64.75 -35.86 82.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.59 139.68 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.16 21.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.421 ' CD2' ' C ' ' A' ' 216' ' ' TRP . 1.9 p-90 -44.54 -39.59 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 216' ' ' TRP . 57.6 mttt -60.42 -55.56 32.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -56.85 -57.69 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.4 tp -48.36 -52.58 21.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.5 -59.95 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -43.35 -44.96 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' A' ' 263' ' ' PHE . 16.9 t -64.57 -52.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.7 m-85 -56.08 -18.51 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -52.19 -20.3 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 15.7 mtp -61.61 -62.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.84 33.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 170.93 -144.99 8.64 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.64 130.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.2 t -84.84 97.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.79 -42.78 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -153.7 116.99 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -118.4 141.22 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -164.59 171.69 14.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 16.7 mm -127.23 135.68 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.922 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.526 -0.229 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.435 ' CG2' ' CZ ' ' A' ' 206' ' ' PHE . 32.7 mt -135.25 125.41 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.848 0.356 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.49 176.3 19.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.0 p -148.56 141.97 25.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.166 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.49 156.03 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 92.0 m -128.73 109.76 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.454 ' CZ ' ' CB ' ' A' ' 259' ' ' ALA . 64.8 m-85 -83.85 -178.37 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.87 -51.22 7.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.14 158.16 44.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 96.8 p -44.83 -50.99 9.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -38.79 -67.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.27 -43.71 53.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.72 1.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 44.4 t -43.31 -49.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.22 -41.12 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.454 ' CB ' ' CZ ' ' A' ' 250' ' ' PHE . . . -71.51 -55.38 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 264' ' ' ASN . 65.2 mt -50.13 -38.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 36.6 m -79.62 -53.81 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 15.1 mmt -58.78 -22.1 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.0 m-85 -103.69 -23.19 13.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t30 -58.81 110.5 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.59 88.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.13 131.31 42.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.08 100.03 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.414 ' CD2' ' SD ' ' A' ' 273' ' ' MET . 9.1 tp -106.77 121.84 45.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 57.78 43.67 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.45 ' O ' ' CG ' ' A' ' 270' ' ' ASP . 22.9 t70 62.53 26.39 15.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -146.98 126.98 6.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.642 0.734 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 209' ' ' ASN . 53.7 Cg_endo -69.66 131.8 22.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' MET . . . . . 0.414 ' SD ' ' CD2' ' A' ' 268' ' ' LEU . 19.2 mtm -95.43 143.19 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -107.36 100.25 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.9 t -109.06 124.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -146.93 127.5 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.788 0.328 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.21 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -97.34 117.32 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.6 t -108.02 132.31 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.146 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.91 167.31 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 71.46 32.6 2.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.85 156.81 19.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.67 176.23 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -85.03 -30.23 24.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.74 33.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 81.4 t -107.27 128.83 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -126.26 152.91 18.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -40.3 -33.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -60.1 -53.37 58.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.429 ' HD2' ' CG2' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -63.71 -50.41 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.433 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 17.9 tp -51.25 -56.43 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . 0.447 ' CE ' ' HB1' ' A' ' 232' ' ' ALA . 22.8 ttmt -60.57 -55.8 29.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 224' ' ' SER . 26.9 mm-40 -46.95 -59.97 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.525 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 51.1 t -56.13 -51.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.508 ' CD2' HG21 ' A' ' 248' ' ' VAL . 4.2 m-85 -59.61 -13.98 11.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 5.4 t -58.53 -22.15 54.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.3 mtm -55.4 -62.07 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 250' ' ' PHE . . . -49.59 -55.96 11.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.62 -150.43 6.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.01 96.6 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.419 HG13 ' CB ' ' A' ' 232' ' ' ALA . 87.6 t -50.48 96.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 249' ' ' THR . 55.6 t -52.79 -50.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -139.62 119.82 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.447 ' HB1' ' CE ' ' A' ' 220' ' ' LYS . . . -126.64 133.19 51.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.437 ' CG ' ' C ' ' A' ' 232' ' ' ALA . 0.4 OUTLIER -163.14 165.3 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 4.6 mm -124.39 151.33 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.916 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 83.5 mt -137.52 132.91 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.79 171.65 24.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.544 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.4 p -134.37 139.97 45.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 223' ' ' PHE . 72.3 t -138.6 128.29 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.13 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 230' ' ' VAL . 94.0 m -111.79 123.11 49.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 226' ' ' ALA . 66.4 m-85 -96.7 175.51 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -69.96 -57.29 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.98 162.67 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.963 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.57 -38.42 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.6 mm -47.24 -66.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.79 -43.56 72.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.38 67.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 65.5 t -60.34 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.156 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -48.96 -43.88 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -68.36 -59.67 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.076 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.459 ' HA ' ' CG1' ' A' ' 275' ' ' VAL . 33.4 mt -43.99 -42.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.4 m -76.27 -60.66 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -50.14 -23.36 2.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.886 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.525 ' CZ ' HG11 ' A' ' 222' ' ' VAL . 3.6 m-85 -102.46 -22.8 13.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.63 111.38 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.95 17.87 71.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -77.21 122.5 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.5 mt -81.21 99.98 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.1 tp -108.55 122.01 46.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.21 43.6 20.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.438 ' O ' ' CG ' ' A' ' 270' ' ' ASP . 24.0 t0 63.24 25.45 14.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.74 125.22 8.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 126.55 13.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.54 155.93 20.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -121.14 101.12 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.459 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.7 t -111.56 117.8 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.7 tttm -136.81 157.6 46.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.405 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 14.0 mtt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.802 0.334 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 24.2 m -111.97 142.65 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -99.06 117.19 33.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.1 t -107.89 130.16 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -135.23 170.87 15.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 62.19 50.06 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 51.4 mt -101.41 158.78 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -67.88 174.42 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -92.46 -6.22 50.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.556 ' HD2' ' CE1' ' A' ' 269' ' ' PHE . 10.1 ptpt -111.51 31.58 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.9 t -108.5 132.25 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.62 158.53 15.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 35.1 p-90 -45.82 -31.39 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.435 ' CD ' HG22 ' A' ' 222' ' ' VAL . 2.5 tmtp? -63.13 -50.84 68.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.8 tp -59.39 -38.99 81.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -69.35 -64.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 222' ' ' VAL . 12.0 pt-20 -44.32 -40.91 5.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.442 ' N ' ' HG3' ' A' ' 221' ' ' GLU . 89.6 t -66.89 -52.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.538 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.2 m-85 -61.64 -14.01 27.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.5 t -52.03 -25.06 7.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.0 mtm -57.62 -64.25 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.76 -48.16 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -179.3 -154.65 13.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.81 127.05 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.38 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.42 HG13 ' CB ' ' A' ' 232' ' ' ALA . 73.5 t -84.54 99.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -148.54 118.97 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 229' ' ' VAL . . . -119.83 142.24 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -165.88 169.36 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 44.3 mm -129.53 132.91 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 44.4 mt -135.78 126.27 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.133 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.19 168.65 20.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.52 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 73.5 p -138.32 145.49 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 t -139.1 155.25 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.1 m -129.76 115.48 17.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -89.01 -177.62 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.89 -55.68 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -129.29 158.58 38.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 14.8 p -51.08 -34.14 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -49.37 -68.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.37 -43.39 75.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.25 -46.6 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 76.2 t -63.26 -48.67 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -47.96 -49.49 30.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.32 -60.06 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 74.8 mt -39.9 -38.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.092 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 m -82.0 -64.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -48.46 -19.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.538 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.9 m-85 -104.81 -25.33 12.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.05 112.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.48 11.97 79.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.39 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.927 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.1 mt -79.91 99.87 7.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.422 ' CD2' ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -106.72 123.25 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . 0.556 ' CE1' ' HD2' ' A' ' 213' ' ' LYS . 9.2 m-85 60.03 37.43 21.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 68.79 24.97 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.94 127.13 8.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 120.29 7.09 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' MET . . . . . 0.422 ' SD ' ' CD2' ' A' ' 268' ' ' LEU . 35.3 mtm -80.88 151.91 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -115.89 105.73 13.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.71 125.73 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.159 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -144.7 157.33 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 7.9 mmt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.49 143.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -100.37 113.26 25.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.33 135.04 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.88 165.46 27.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 t30 63.29 49.99 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 42.1 mt -100.85 162.91 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.11 132.57 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -44.06 -44.3 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -56.42 -40.17 74.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.2 t -51.91 123.58 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 218' ' ' LYS . . . -121.5 158.39 16.24 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.456 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 25.1 p-90 -38.89 -32.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.456 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 22.5 mtpp -72.35 -47.85 46.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.411 ' HD3' ' CG2' ' A' ' 222' ' ' VAL . 3.1 tmtt? -66.2 -49.64 66.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.3 tp -56.38 -50.84 70.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -66.55 -35.04 79.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.66 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.424 HG11 ' CE2' ' A' ' 263' ' ' PHE . 38.4 t -83.79 -49.13 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.134 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -59.1 -26.38 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.5 t -46.01 -24.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.1 mtm -57.91 -65.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.27 -42.34 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.92 -160.74 28.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.9 123.53 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.66 98.76 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 76.1 t -54.6 -48.07 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -136.55 123.28 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -126.28 128.98 47.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -163.56 163.87 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 19.3 mm -122.73 148.1 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 28.6 mt -132.01 123.08 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.123 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.46 169.5 15.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.1 p -135.33 135.47 40.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.81 143.48 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 24.5 m -126.54 117.6 23.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -88.08 -177.91 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.47 -48.39 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -132.92 155.7 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.3 p -49.14 -46.0 44.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 23.8 mm -41.02 -60.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.43 -42.02 90.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.0 -54.2 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.74 -49.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -47.92 -48.29 31.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.93 -58.28 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.425 ' HA ' ' CG1' ' A' ' 275' ' ' VAL . 80.3 mt -41.36 -46.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.2 m -77.09 -62.22 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 49.7 mmm -47.62 -21.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.424 ' CE2' HG11 ' A' ' 222' ' ' VAL . 4.6 m-85 -104.58 -30.64 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -50.52 115.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.98 16.56 76.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -81.58 121.28 26.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.8 100.63 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.6 tp -108.87 123.14 48.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 59.23 31.56 21.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 74.08 28.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -145.19 121.78 6.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 115.43 4.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 58.8 mtm -73.95 153.53 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -118.01 100.3 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.425 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.2 t -109.96 113.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 277' ' ' MET . 1.8 tppp? -124.1 157.6 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.457 ' N ' ' HG3' ' A' ' 276' ' ' LYS . 24.0 mtp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.06 130.38 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.114 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -95.32 118.58 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 80.8 t -106.31 140.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.82 163.51 32.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 65.66 43.37 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 mt -92.77 149.01 21.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 3.3 t70 -60.12 162.89 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.415 ' N ' ' CG ' ' A' ' 211' ' ' ASP . 19.1 m-85 -79.12 -34.32 43.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.479 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 20.8 mtpp -82.99 37.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -110.02 157.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.131 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.414 ' N ' HG11 ' A' ' 214' ' ' VAL . . . -150.53 155.98 26.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -46.99 -33.43 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.4 -44.83 77.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -56.49 12.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.4 tp -49.94 -61.25 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -50.25 -58.19 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -44.12 -39.89 4.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.549 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 20.0 t -73.73 -46.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.502 ' CE2' HG23 ' A' ' 248' ' ' VAL . 3.2 m-85 -59.65 -20.05 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.3 t -53.22 -22.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.846 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 11.0 mtm -62.93 -61.64 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -50.85 -52.98 36.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.082 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -176.2 -160.26 23.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 67.9 t -79.32 124.84 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 0.0 111.1 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.47 96.0 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.79 -45.57 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -139.84 121.26 15.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -125.92 124.12 40.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 35.5 mm -124.17 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 48.5 mt -132.81 132.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.099 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.69 176.99 18.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p -151.82 127.26 10.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.502 HG23 ' CE2' ' A' ' 223' ' ' PHE . 33.0 t -130.16 154.67 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.157 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 79.3 m -131.17 120.49 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 76.9 m-85 -87.55 -177.77 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.28 -55.03 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -111.35 143.55 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.8 p -48.31 -43.81 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.23 -60.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.03 -48.22 67.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.87 -53.34 19.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.153 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.33 -55.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -41.39 -56.99 2.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -57.08 -47.03 82.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 264' ' ' ASN . 73.1 mt -53.69 -56.83 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.8 t -64.68 -58.98 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -47.0 -57.96 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.549 ' CZ ' HG11 ' A' ' 222' ' ' VAL . 23.4 m-85 -65.66 -40.35 92.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 0.5 OUTLIER -45.04 114.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.43 19.93 67.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 263' ' ' PHE . 12.4 tt0 -87.9 124.73 33.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -79.4 99.99 7.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.7 tp -108.75 120.68 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 60.11 35.03 21.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 72.04 25.04 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -144.56 122.48 6.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 125.62 12.37 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 58.7 mtm -85.31 151.88 23.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -119.04 101.01 7.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 14.3 t -114.01 127.2 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 277' ' ' MET . 7.5 ttmm -143.32 159.98 41.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' MET . . . . . 0.435 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 8.9 mtp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.72 144.06 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -101.05 125.31 47.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.1 t -115.85 127.04 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -134.73 171.68 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.0 36.37 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 44.3 mt -89.16 144.94 25.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -63.44 142.28 58.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -57.49 -27.28 62.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -74.03 -34.57 64.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.55 133.32 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.14 158.17 22.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 46.3 p-90 -36.35 -33.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 24.9 mtpt -62.51 -53.15 58.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -67.06 -52.64 39.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.92 -40.52 14.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -76.0 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -46.07 -33.88 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.19 -58.72 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.464 ' CD2' HG23 ' A' ' 248' ' ' VAL . 3.2 m-85 -52.06 -19.48 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.1 t -53.55 -15.74 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 30.6 mtm -65.53 -63.19 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.95 32.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -174.37 -136.28 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.437 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.99 117.67 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 232' ' ' ALA . 77.5 t -72.34 97.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 92.9 t -53.66 -52.85 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -142.66 117.86 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.448 ' CB ' HG12 ' A' ' 229' ' ' VAL . . . -118.65 143.13 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.89 158.0 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.831 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 26.7 mm -119.59 127.39 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 91.9 mt -136.0 131.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.87 0.367 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -138.33 175.44 21.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.3 p -138.39 145.6 41.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.799 0.333 . . . . 0.0 111.156 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 223' ' ' PHE . 82.9 t -135.91 137.17 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 77.4 m -115.24 114.06 24.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 73.6 m-85 -88.2 169.78 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.416 ' HG2' ' CG2' ' A' ' 230' ' ' VAL . 14.6 mm-40 -75.74 -55.41 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -123.61 154.5 39.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 68.5 p -49.72 -47.69 50.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 35.1 mm -41.2 -63.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -54.33 -45.67 72.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.63 -49.82 64.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.19 -60.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -39.96 -50.54 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -61.63 -59.37 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.8 mt -42.49 -48.35 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 264' ' ' ASN . 7.0 m -73.36 -65.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.3 mmt -45.39 -22.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -103.82 -21.47 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 261' ' ' SER . 5.9 t30 -61.78 111.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.52 8.53 86.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -76.39 130.68 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -88.23 107.92 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.8 tp -114.37 123.58 49.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 60.3 32.28 20.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 74.18 25.94 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -147.07 127.8 7.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.865 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 130.57 19.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 48.3 mtm -91.46 132.82 35.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -96.76 105.31 17.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.69 127.33 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -149.54 150.87 32.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 28.8 mtt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.84 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.791 0.329 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 m -120.15 134.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -95.42 118.26 31.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.6 t -105.38 138.65 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.64 155.99 46.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 74.85 45.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 76.2 mt -99.56 134.82 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -57.57 162.51 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -72.05 -25.3 61.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -70.58 -42.88 70.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.43 139.48 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -141.3 159.9 26.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.505 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 16.6 p-90 -36.61 -33.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.359 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.505 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 9.9 mtpm? -68.23 -61.06 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -56.19 -54.24 47.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.454 HD22 ' CG2' ' A' ' 248' ' ' VAL . 13.9 tp -47.29 -58.07 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -49.96 -63.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -41.94 -42.86 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 263' ' ' PHE . 69.8 t -67.61 -51.17 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -59.73 -28.19 67.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.3 t -45.46 -28.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.832 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 34.5 mtp -51.99 -68.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.67 -56.46 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.91 -170.95 31.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.46 104.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.45 99.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.411 HG23 ' C ' ' A' ' 250' ' ' PHE . 83.1 t -50.09 -50.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.1 ptm180 -153.45 117.44 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -108.53 146.32 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.136 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -165.04 172.09 13.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 49.2 mm -125.25 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 70.5 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 46.9 mt -124.99 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 111.147 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.98 166.79 24.55 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.6 p -136.24 143.84 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 223' ' ' PHE . 85.3 t -140.47 134.56 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 22.3 m -114.19 111.72 22.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -87.39 174.87 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -68.6 -60.01 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -127.2 162.67 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.7 p -51.77 -46.6 64.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.8 mm -40.34 -68.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -52.31 -44.83 65.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.476 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.21 -56.9 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 60.0 t -52.29 -45.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -52.74 -42.58 65.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -72.78 -50.27 25.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 72.0 mt -44.7 -52.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.3 m -72.22 -62.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 18.6 mmt -44.79 -23.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.549 ' CE1' HG12 ' A' ' 222' ' ' VAL . 22.9 m-85 -102.72 -28.02 12.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.44 ' OD1' ' C ' ' A' ' 264' ' ' ASN . 19.7 t-20 -56.42 111.05 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.57 11.49 84.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -74.53 128.31 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.42 102.38 10.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.2 tp -112.02 121.64 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 56.77 41.66 27.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.44 ' O ' ' CG ' ' A' ' 270' ' ' ASP . 28.8 t70 63.26 29.51 15.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -147.02 121.46 5.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.601 0.715 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 123.78 10.43 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.289 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 46.1 mtm -85.47 158.2 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -121.68 100.57 7.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.84 128.67 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -144.31 154.97 43.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 13.9 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.895 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 260' ' ' ILE . 20.1 m -109.4 139.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.513 ' CZ ' HG23 ' A' ' 245' ' ' ILE . 71.8 t80 -99.73 117.05 33.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.65 135.44 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.86 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.94 41.66 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.5 mt -89.25 166.61 13.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.55 139.14 31.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -51.65 -41.68 61.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.02 -33.88 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.04 132.5 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.68 164.75 23.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.492 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.6 p-90 -36.26 -31.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 215' ' ' GLY . 32.1 mttm -60.43 -69.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 219' ' ' LEU . 16.3 mmmt -54.11 -58.16 8.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.554 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 16.2 tp -36.94 -56.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . 0.452 ' HG3' ' CB ' ' A' ' 232' ' ' ALA . 6.8 ttpt -61.1 -67.22 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 224' ' ' SER . 6.3 mm-40 -41.16 -67.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 25.0 t -43.84 -49.08 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.8 m-85 -63.31 -26.14 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 8.2 t -46.45 -23.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 16.3 mtm -55.14 -66.53 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.436 ' HB3' ' N ' ' A' ' 259' ' ' ALA . . . -38.39 -50.84 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.31 -112.94 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.8 t -129.78 110.45 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.436 HG11 ' CG1' ' A' ' 248' ' ' VAL . 49.1 t -70.92 96.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 251' ' ' GLU . 98.3 t -50.05 -49.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.453 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 6.6 ptp85 -151.22 122.4 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.452 ' CB ' ' HG3' ' A' ' 220' ' ' LYS . . . -111.96 151.16 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -169.84 160.47 8.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.46 ' CD1' HD23 ' A' ' 219' ' ' LEU . 49.3 mm -120.01 128.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.875 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.513 HG23 ' CZ ' ' A' ' 206' ' ' PHE . 47.4 mt -122.37 126.1 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.53 165.91 19.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.3 p -137.45 140.1 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.436 ' CG1' HG11 ' A' ' 229' ' ' VAL . 61.1 t -138.16 146.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.453 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 17.9 m -123.18 111.96 17.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 38.5 m-85 -86.17 165.88 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.451 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 0.7 OUTLIER -52.79 -52.63 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -143.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 254' ' ' ILE . 8.9 t -48.23 -54.21 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.5 mm -35.98 -68.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.159 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -48.71 -46.84 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.77 -60.86 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 94.5 t -42.88 -53.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -47.92 -56.82 6.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.436 ' N ' ' HB3' ' A' ' 226' ' ' ALA . . . -58.54 -55.4 35.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.445 ' HA ' ' CG1' ' A' ' 275' ' ' VAL . 91.7 mt -40.65 -58.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 264' ' ' ASN . 46.4 t -68.71 -61.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.8 mtt -44.42 -22.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -103.88 -26.71 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 264' ' ' ASN . 0.2 OUTLIER -52.34 116.73 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.51 82.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . 0.463 ' OE1' ' N ' ' A' ' 267' ' ' LEU . 6.3 tp-100 -78.24 130.15 35.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . 0.463 ' N ' ' OE1' ' A' ' 266' ' ' GLN . 13.0 mt -87.68 100.37 12.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.1 123.81 49.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 59.89 32.23 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.1 26.78 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -145.32 129.01 8.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 126.57 13.49 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' MET . . . . . 0.451 ' HE2' ' CG ' ' A' ' 266' ' ' GLN . 36.6 mtm -84.17 143.43 29.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -109.87 99.26 8.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.5 t -109.43 131.1 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -151.65 155.07 37.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 9.1 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.849 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 62.3 m . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.81 134.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.35 120.82 35.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 210' ' ' LEU . 49.1 t -109.93 139.72 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.09 165.23 27.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 38.5 t30 62.78 46.43 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.405 ' CD2' HG11 ' A' ' 207' ' ' VAL . 30.8 mt -95.74 149.09 21.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.65 138.47 53.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -50.5 -39.96 49.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -61.26 -41.48 96.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.93 131.48 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -131.93 161.88 23.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -43.36 -34.63 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -62.3 -59.44 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -60.37 -57.18 13.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.4 tp -44.67 -55.86 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -56.04 -52.11 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.16 -58.08 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 71.2 t -52.89 -40.09 34.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.15 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.545 ' CE2' HG22 ' A' ' 248' ' ' VAL . 3.7 m-85 -69.04 -32.62 72.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.3 m -40.65 -25.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 223' ' ' PHE . 51.8 mtp -54.77 -66.31 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.4 -48.62 26.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.59 -165.14 28.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.04 107.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.14 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.83 104.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -42.74 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.072 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -144.42 120.31 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -122.65 133.4 54.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.104 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -164.68 167.69 18.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.82 142.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 75.7 mt -135.95 125.73 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.122 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.21 176.31 19.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.4 p -144.82 136.33 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.129 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.545 HG22 ' CE2' ' A' ' 223' ' ' PHE . 39.3 t -129.22 149.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.2 m -129.17 117.13 20.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.498 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 70.9 m-85 -91.22 -175.2 4.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.87 -54.78 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -129.37 163.63 25.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.5 p -53.91 -41.67 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.8 mm -46.13 -65.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.11 -45.09 68.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.28 -59.17 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -48.24 -56.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.169 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -44.06 -45.92 8.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.36 60.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 95.3 mt -48.88 -52.82 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 m -69.75 -63.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -42.58 -38.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -88.21 -26.81 22.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -55.2 109.94 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.62 14.63 75.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -77.06 131.27 38.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.4 mt -88.7 103.02 15.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -110.3 122.21 47.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 59.25 34.07 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 71.53 27.49 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -144.48 117.74 5.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 119.86 6.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 47.5 mtm -79.15 163.17 25.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -126.66 100.65 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 129.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -146.23 145.83 30.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.5 mtt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.85 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.7 t -51.17 148.54 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.4 t -46.94 -62.34 1.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.2 79.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -60.02 126.15 26.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.2 p -128.99 163.89 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -167.76 136.59 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -169.8 169.4 8.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 pp -170.19 175.24 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -119.49 92.75 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.41 85.04 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 129.21 69.47 0.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -75.57 79.94 2.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.9 mt -119.91 177.93 4.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 105.5 178.7 23.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 86.1 p -119.44 -38.65 2.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 97.5 m -40.79 139.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.9 138.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 245' ' ' ILE . 72.1 t80 -97.0 116.39 29.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.457 ' CG1' HD13 ' A' ' 210' ' ' LEU . 13.5 t -104.32 132.85 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.73 166.45 22.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 61.83 50.82 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.457 HD13 ' CG1' ' A' ' 207' ' ' VAL . 42.7 mt -102.36 157.97 16.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.52 136.55 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -48.2 -44.81 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.425 ' NZ ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -57.41 -36.58 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 88.9 t -58.42 117.77 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -114.18 168.71 12.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -50.8 -25.33 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.71 -64.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.403 ' O ' ' CG2' ' A' ' 222' ' ' VAL . 34.6 tptt -57.62 -51.15 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.7 tp -49.24 -54.97 14.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -59.58 -52.9 63.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -50.67 -40.73 54.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.54 HG12 ' CE2' ' A' ' 263' ' ' PHE . 29.0 t -66.87 -52.1 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.5 m-85 -60.83 -16.14 37.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.7 t -56.22 -19.3 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.2 mtp -61.69 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -48.57 -37.58 18.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 174.46 -159.8 28.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.2 t -88.03 126.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 93.1 t -84.87 101.99 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.532 ' CG2' ' CD ' ' A' ' 251' ' ' GLU . 45.3 t -59.57 -44.0 92.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.6 ttp85 -141.11 120.43 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -125.2 130.53 52.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -162.89 166.01 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.32 148.61 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.55 132.46 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 36.6 mp0 -120.41 164.59 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -115.85 178.76 4.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -40.06 -55.57 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.79 -40.43 55.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 114.27 -34.35 4.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -70.14 129.65 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.792 0.33 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 m -50.66 134.64 24.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -92.89 28.58 2.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 72.16 29.77 66.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.457 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.434 ' CG2' ' CZ ' ' A' ' 206' ' ' PHE . 53.3 mt -132.61 129.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.142 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.87 176.99 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.4 p -139.35 132.78 30.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.71 135.02 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 230' ' ' VAL . 58.0 m -124.24 115.6 21.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 71.4 m-85 -87.7 -175.45 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.532 ' CD ' ' CG2' ' A' ' 230' ' ' VAL . 24.0 mm-40 -90.23 -53.63 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -114.18 146.58 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 93.4 p -50.33 -45.28 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.3 mm -46.53 -56.46 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -56.46 -48.4 77.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.06 -50.5 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.77 -54.78 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -44.94 -54.89 6.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -53.18 -58.65 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 75.6 mt -41.73 -42.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 30.0 t -76.17 -65.74 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -20.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.1 m-85 -104.99 -19.98 13.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 110.16 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.5 84.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.69 130.56 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.96 100.07 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.1 tp -107.22 122.73 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 56.52 43.49 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.3 t0 62.38 28.97 17.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -147.09 125.68 6.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 135.17 29.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 33.3 mtm -99.33 153.19 19.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -119.21 100.72 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.25 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -120.56 144.86 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 7.9 mtt -55.82 134.07 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.8 162.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.68 -55.38 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -65.15 99.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -94.35 81.92 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.468 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -69.2 140.74 90.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.558 0.694 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.468 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.5 Cg_endo -69.77 179.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.341 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -128.84 36.02 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 41.66 42.25 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -133.02 98.7 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -174.18 131.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.64 143.07 36.49 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.653 0.74 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 148.59 65.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 96.07 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -125.0 109.86 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -126.62 138.17 31.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.656 0.741 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 93.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.362 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . 0.451 ' CD ' ' O ' ' A' ' 294' ' ' GLN . 0.0 OUTLIER -139.81 112.83 8.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -139.9 124.69 18.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.6 t -168.27 134.49 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 163.83 66.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 85.96 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 96.9 p -147.04 115.36 6.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.5 p -161.53 112.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 m -151.47 125.78 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.7 p -112.04 170.39 8.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.3 -125.99 1.47 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.9 m 49.3 30.12 3.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 110.862 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 53.4 p -104.52 119.46 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.48 111.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.71 169.3 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 pp -166.85 157.14 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -126.87 115.49 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.15 108.5 14.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.129 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.2 105.74 3.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.0 mtp85 -77.15 147.31 36.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 110.894 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 17.9 tp -47.53 96.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 152.3 109.51 0.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.3 m -101.22 46.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.6 m -93.31 136.71 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.464 HG12 ' CG1' ' A' ' 260' ' ' ILE . 31.7 m -115.11 132.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -97.0 124.27 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.93 138.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -145.66 164.8 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 t30 67.82 42.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.8 161.78 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 212' ' ' TYR . 44.2 t0 -82.24 133.45 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.482 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 16.8 m-85 -48.08 -29.48 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -72.02 -40.38 68.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 76.8 t -58.22 141.15 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -141.8 166.17 26.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 217' ' ' LYS . 19.4 p-90 -39.68 -48.39 2.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.528 ' N ' ' CG ' ' A' ' 216' ' ' TRP . 35.5 mttm -47.58 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -61.0 -49.34 77.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.425 HD22 ' CG2' ' A' ' 248' ' ' VAL . 9.6 tp -46.47 -48.01 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -68.05 -44.78 75.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.68 -44.39 77.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.543 HG13 ' CE2' ' A' ' 263' ' ' PHE . 21.4 t -72.48 -52.99 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.551 ' CE2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -56.9 -32.17 65.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.4 t -48.51 -21.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' MET . . . . . 0.425 ' O ' ' C ' ' A' ' 226' ' ' ALA . 29.1 mtm -57.66 -65.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 225' ' ' MET . . . -35.85 -50.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.15 -104.41 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.09 119.28 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 54.2 t -77.74 96.02 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 250' ' ' PHE . 60.8 t -54.17 -44.79 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -151.64 117.24 5.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 233' ' ' ASP . . . -115.92 135.39 54.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 232' ' ' ALA . 36.3 m-20 -164.25 161.88 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 34.0 mm -113.23 150.08 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.56 124.54 35.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -135.67 156.31 49.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 179.8 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -44.98 -51.58 9.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -60.59 -56.98 14.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.89 39.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -100.04 131.51 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.323 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.7 m -90.29 120.58 31.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.11 71.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 41.5 mt -123.51 123.05 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 111.167 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.22 174.14 20.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.7 p -138.58 143.96 39.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.551 HG21 ' CE2' ' A' ' 223' ' ' PHE . 57.5 t -137.69 151.0 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 m -131.06 113.34 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 71.3 m-85 -88.73 172.42 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.2 -58.75 3.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -124.5 157.51 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.0 t -49.36 -48.3 46.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.2 mm -38.9 -68.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -52.02 -48.28 64.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -48.6 -52.85 20.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 45.3 t -54.77 -51.25 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -46.35 -47.5 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -65.92 -58.75 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.464 ' CG1' HG12 ' A' ' 205' ' ' VAL . 82.2 mt -41.23 -44.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.6 m -76.81 -65.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -46.71 -21.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.543 ' CE2' HG13 ' A' ' 222' ' ' VAL . 4.4 m-85 -103.73 -29.34 11.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t-20 -56.02 111.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.99 82.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -73.84 130.4 39.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.35 100.95 13.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 tp -108.71 122.28 46.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 58.22 37.39 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.5 28.64 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -145.68 117.77 5.13 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 123.58 10.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.728 2.286 . . . . 0.0 112.313 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 42.7 mtm -83.36 157.32 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . 0.465 ' C ' ' CD2' ' A' ' 274' ' ' HIS . 3.8 t-160 -119.92 100.72 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.53 126.43 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -145.37 144.22 30.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.41 ' CG ' HD11 ' A' ' 260' ' ' ILE . 8.0 mtt -54.96 126.21 23.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -88.89 162.33 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -113.6 96.23 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -104.15 98.75 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -92.62 86.26 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.471 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -139.64 140.82 26.13 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.471 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.7 Cg_endo -69.8 115.65 4.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -117.66 119.33 34.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 85.59 1.55 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.454 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -94.34 157.37 16.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.5 p90 -145.82 123.41 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -124.69 80.46 61.92 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.612 0.72 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 147.51 63.39 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.375 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 110.92 2.67 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.12 164.3 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -127.38 80.42 71.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.03 67.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.632 2.221 . . . . 0.0 112.387 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -135.96 123.73 22.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.76 111.25 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -163.06 151.17 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 168.1 83.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 146.51 60.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.8 p -112.64 145.73 39.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.6 t -174.82 152.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t -140.39 173.65 11.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.341 . . . . 0.0 110.863 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.1 t -127.0 169.35 13.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 192' ' ' SER . . . -170.18 -98.6 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.5 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 191' ' ' GLY . 36.9 p 34.73 43.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.87 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 p -82.32 150.06 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -155.06 139.98 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.77 172.96 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.3 168.07 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -130.2 112.95 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -134.36 176.68 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.5 59.86 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' A' ' 200' ' ' ARG . 1.2 mpp_? -97.9 178.98 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 110.818 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.26 142.12 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -158.94 -148.84 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.7 p -125.4 0.99 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.8 m -98.41 120.93 39.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.164 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 248' ' ' VAL . 22.1 m -103.73 133.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.501 ' CE1' HG21 ' A' ' 245' ' ' ILE . 86.9 t80 -98.32 106.64 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.77 133.65 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.01 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.06 53.44 2.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.64 158.77 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -87.89 130.6 34.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.14 -23.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -69.09 -40.25 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.419 ' CG2' HD21 ' A' ' 268' ' ' LEU . 92.4 t -61.53 119.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.57 162.74 12.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 68.2 p-90 -43.65 -49.19 7.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.496 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 6.9 ptpt -53.75 -54.79 33.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.433 ' N ' ' CG ' ' A' ' 217' ' ' LYS . 0.7 OUTLIER -53.49 -59.89 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.57 HD13 ' CE1' ' A' ' 223' ' ' PHE . 23.5 tp -46.55 -47.29 19.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -60.03 -55.5 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -53.0 -58.18 7.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.563 HG13 ' CZ ' ' A' ' 263' ' ' PHE . 38.4 t -51.67 -41.15 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.57 ' CE1' HD13 ' A' ' 219' ' ' LEU . 3.6 m-85 -70.06 -28.88 65.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 t -42.38 -27.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 50.7 mtp -51.19 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.93 -57.06 4.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -164.79 -157.39 9.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.9 t -92.36 107.91 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.75 100.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 249' ' ' THR . 89.1 t -55.81 -46.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.138 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -144.05 122.06 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -117.07 127.15 53.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -152.86 153.94 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 46.0 mm -119.03 128.47 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 58.6 mt -61.58 122.21 14.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.4 171.64 14.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -93.5 163.36 13.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -41.11 -47.9 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.95 -44.49 92.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.17 23.73 1.93 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.54 151.51 23.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.4 p -79.24 130.42 35.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 -31.29 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.95 9.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.501 HG21 ' CE1' ' A' ' 206' ' ' PHE . 40.7 mt -132.97 136.27 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.148 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 174.54 18.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 68.4 p -142.24 131.07 22.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 223' ' ' PHE . 70.7 t -127.85 129.36 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 230' ' ' VAL . 33.4 m -110.79 112.4 24.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 61.8 m-85 -88.46 173.3 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.15 -55.29 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.93 159.56 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 51.1 p -52.63 -47.65 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.5 mm -42.61 -61.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -54.6 -47.52 73.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.54 -56.31 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.0 t -51.8 -44.41 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -53.9 -46.89 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -70.8 -45.89 63.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.4 mt -49.71 -48.95 20.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 13.0 m -72.49 -54.19 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mtt -55.13 -22.49 17.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 222' ' ' VAL . 22.1 m-85 -104.8 -16.2 14.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -63.81 110.5 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.03 86.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -71.16 132.63 45.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.7 mt -85.79 100.1 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.419 HD21 ' CG2' ' A' ' 214' ' ' VAL . 15.6 tp -107.64 122.33 46.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 58.36 38.68 25.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 67.08 27.53 8.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -144.49 125.66 7.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 121.19 7.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.363 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 55.6 mtm -83.85 152.9 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -118.34 101.13 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 5.7 t -107.49 114.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -133.44 144.63 49.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 12.0 mtt -58.89 139.2 56.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.36 170.87 10.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.816 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.17 -48.85 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -111.64 88.69 2.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -124.31 36.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.051 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.466 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.7 tp -163.96 140.76 5.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.645 0.736 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.6 Cg_endo -69.69 150.09 68.19 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.67 2.246 . . . . 0.0 112.363 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -82.4 85.64 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.69 111.7 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.534 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -133.63 124.05 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -155.12 126.07 7.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.516 ' CG ' ' HD2' ' A' ' 289' ' ' PRO . 3.9 t80 -130.56 140.54 38.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.691 0.758 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 288' ' ' PHE . 53.5 Cg_endo -69.78 149.22 66.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.336 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 174.69 9.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.0 105.23 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -75.67 143.54 75.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.598 0.713 . . . . 0.0 110.848 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.44 19.35 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.732 2.288 . . . . 0.0 112.328 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -107.15 134.0 50.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -120.78 111.95 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.2 t -146.3 131.3 18.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.8 -158.4 13.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 2.6 3.41 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.664 2.242 . . . . 0.0 112.318 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.6 t -40.6 -34.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 t -150.69 109.14 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.449 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 t -164.36 171.69 14.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.3 t -74.49 -45.37 46.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.65 145.01 11.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -89.08 139.26 30.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.8 m -45.62 -45.21 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 71.6 53.62 9.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.81 167.07 16.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.075 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 pp -171.07 169.07 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.44 -49.45 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.09 178.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.32 -74.15 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -102.46 -40.31 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.42 88.36 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -179.81 86.5 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 36.0 m -116.64 52.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.866 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.4 m -100.99 134.78 43.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 23.1 m -112.12 135.16 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -97.07 114.7 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.458 ' CG1' HD22 ' A' ' 210' ' ' LEU . 14.2 t -99.56 138.19 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.76 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 m120 62.51 41.88 9.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.458 HD22 ' CG1' ' A' ' 207' ' ' VAL . 53.5 mt -91.35 149.34 21.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 214' ' ' VAL . 6.7 t70 -78.76 136.17 37.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -43.24 -31.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.84 -39.76 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 211' ' ' ASP . 94.6 t -54.05 111.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.04 170.55 16.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.489 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 52.6 p-90 -57.97 -32.49 67.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.489 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 8.9 mmtp -68.47 -52.38 33.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -62.77 -41.52 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.47 -58.77 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -52.9 -58.6 6.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -49.66 -58.89 4.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.95 -40.17 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.523 ' CE2' HG22 ' A' ' 248' ' ' VAL . 3.3 m-85 -72.37 -17.07 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.1 t -58.32 -19.38 34.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 26.3 mtm -57.39 -67.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -40.26 -42.08 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.404 ' C ' HG22 ' A' ' 228' ' ' VAL . . . -178.32 -103.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.404 HG22 ' C ' ' A' ' 227' ' ' GLY . 61.5 t -144.12 117.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.429 ' CG1' HG11 ' A' ' 248' ' ' VAL . 39.7 t -75.62 102.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 249' ' ' THR . 79.0 t -50.69 -44.39 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.43 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 8.0 ptp180 -159.38 122.76 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -108.1 135.01 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -139.72 151.39 45.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.89 125.87 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.96 124.23 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.96 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -121.31 167.4 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 240' ' ' GLY . 3.3 t70 -88.52 162.09 16.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 237' ' ' ASP . 5.0 mtpm? -34.41 -58.64 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.96 -43.28 60.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 237' ' ' ASP . . . 119.08 15.64 5.56 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.414 ' HA ' ' NZ ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -89.28 167.99 12.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.898 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.4 m -71.66 146.21 48.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 -23.32 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 101.85 18.47 17.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 61.2 mt -132.83 126.31 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.369 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.35 167.31 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 56.3 p -139.94 128.68 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 223' ' ' PHE . 36.0 t -124.63 140.5 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 230' ' ' VAL . 15.5 m -121.12 117.89 28.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.77 -176.74 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -83.19 -55.82 4.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -128.96 162.15 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 93.7 p -52.75 -48.24 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.1 mm -37.48 -62.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.39 -41.88 90.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.85 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.88 -49.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -48.49 -42.17 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -75.99 -49.56 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.427 HD11 ' CG ' ' A' ' 277' ' ' MET . 42.8 mt -51.98 -41.4 31.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.2 t -76.68 -50.77 12.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 30.1 mtt -60.04 -21.66 61.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -104.51 -22.15 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.6 110.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.9 84.11 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -72.66 123.46 23.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.893 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.78 105.88 14.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.06 121.93 45.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 58.76 35.11 24.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.62 27.74 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 33.5 mtp85 -142.9 119.51 6.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.722 . . . . 0.0 110.819 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.09 3.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.368 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 59.8 mtm -72.14 159.25 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -125.63 103.56 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.8 110.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.084 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -124.59 142.18 51.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.427 ' CG ' HD11 ' A' ' 260' ' ' ILE . 15.0 mtt -56.88 137.95 54.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.08 147.04 52.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -89.85 -54.96 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 280' ' ' ARG . 2.1 ptm85 -131.95 128.13 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -129.57 44.93 2.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 4.0 tp -126.45 133.47 25.02 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -39.59 -40.35 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.74 150.44 0.31 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.81 35.27 2.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.366 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.66 39.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -115.33 81.32 8.29 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 157.59 59.99 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.369 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 100.04 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.08 150.33 41.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -101.59 149.38 36.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -24.66 29.45 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.707 2.271 . . . . 0.0 112.354 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -76.35 146.55 38.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -78.88 151.41 31.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 29.5 t -59.32 -42.02 90.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.02 154.95 16.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -13.27 34.39 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.655 2.237 . . . . 0.0 112.333 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 3.7 t -49.55 -62.29 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.0 m -76.63 97.67 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 89.8 p -157.03 161.91 39.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.823 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.0 t -133.97 152.84 52.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.07 122.24 1.43 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.3 m -118.5 168.61 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.2 t -123.38 -55.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 104.16 95.25 2.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.65 141.93 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.64 150.18 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -109.06 158.0 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.02 163.75 27.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -126.69 156.14 19.91 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -119.31 -41.39 2.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 110.865 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.4 tt -65.82 125.85 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 146.49 165.08 11.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 204' ' ' THR . 89.2 p -107.04 -47.51 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 110.836 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 203' ' ' SER . 0.5 OUTLIER -34.61 114.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.99 137.23 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.411 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 85.5 t80 -98.97 118.46 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.26 134.34 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -137.49 171.91 13.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 m120 60.09 41.53 17.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.0 mt -90.05 155.41 19.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 214' ' ' VAL . 3.3 t70 -67.3 160.76 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -77.71 -33.82 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 65.8 mttt -85.53 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 215' ' ' GLY . 47.6 t -108.91 164.2 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.444 ' N ' ' CG1' ' A' ' 214' ' ' VAL . . . -151.2 148.71 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -40.45 -35.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -66.56 -56.36 11.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -51.22 -44.16 61.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -69.4 -62.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -44.4 -42.28 6.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 27.1 t -70.29 -43.26 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.2 m-85 -69.19 -15.73 63.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -59.38 -13.21 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.0 mtp -67.5 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 259' ' ' ALA . . . -46.26 -47.39 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.1 -141.44 3.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 50.1 t -105.51 114.68 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.11 101.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.177 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.02 -43.69 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.421 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 17.5 ptt180 -160.58 119.8 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -108.44 135.24 50.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 159.3 42.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 48.7 mm -119.31 144.04 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 36.8 mt -80.55 107.53 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -142.42 144.72 33.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 239' ' ' ASP . 3.0 p30 -61.92 160.77 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 237' ' ' ASP . 0.1 OUTLIER -35.78 -30.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 237' ' ' ASP . 27.8 m-20 -67.16 -57.29 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 127.02 31.22 0.76 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -96.41 128.09 43.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.1 m -91.37 118.28 30.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -93.17 35.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 68.47 25.05 75.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.458 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.411 HG21 ' CZ ' ' A' ' 206' ' ' PHE . 51.8 mt -131.33 126.18 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.26 175.27 20.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 p -143.48 138.47 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.435 HG12 ' CE1' ' A' ' 250' ' ' PHE . 44.1 t -135.19 143.51 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.421 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 89.2 m -124.4 123.74 40.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.435 ' CE1' HG12 ' A' ' 248' ' ' VAL . 74.2 m-85 -97.62 175.5 6.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -60.15 2.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -109.49 142.58 40.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.7 p -47.82 -43.24 27.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 mm -46.88 -57.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.44 -49.79 75.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -51.32 -48.03 62.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.6 -53.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -46.07 -46.92 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.419 ' HB3' ' CB ' ' A' ' 226' ' ' ALA . . . -64.4 -50.55 67.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.405 ' HA ' ' CG1' ' A' ' 275' ' ' VAL . 96.6 mt -47.53 -50.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 264' ' ' ASN . 15.8 m -72.22 -61.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.8 mmt -45.17 -24.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -104.43 -19.36 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 261' ' ' SER . 10.9 t30 -60.35 113.0 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.54 6.65 89.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.553 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.95 126.17 28.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.88 0.371 . . . . 0.0 110.93 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.56 100.16 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.0 tp -106.05 121.13 43.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.959 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 59.03 37.76 24.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 68.55 26.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -143.67 124.48 7.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 63.2 mtm -84.51 145.36 28.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -109.79 99.25 8.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 4.0 t -109.04 124.66 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 277' ' ' MET . 1.6 ttpm? -149.09 160.55 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 9.4 mmt -66.44 139.58 57.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.452 ' OD1' ' CB ' ' A' ' 280' ' ' ARG . 12.5 t70 -78.84 137.61 37.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.44 -40.13 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . 0.452 ' CB ' ' OD1' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -59.86 136.01 57.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -115.23 92.79 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.472 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 6.5 tp -60.77 140.39 93.18 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.649 0.738 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 54.3 Cg_endo -69.74 144.19 53.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.56 40.24 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.08 179.59 0.15 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -127.57 132.63 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -84.27 168.56 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -117.16 142.01 29.4 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.873 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 148.38 64.89 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.632 2.221 . . . . 0.0 112.385 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 177.72 5.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.684 2.256 . . . . 0.0 112.315 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -140.01 137.49 34.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -135.75 147.86 63.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.606 0.717 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -176.14 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.654 2.236 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -139.93 167.61 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -140.0 170.92 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.7 t -145.55 169.64 18.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 170.99 82.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 148.4 65.16 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.7 t -102.12 146.94 27.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 78.2 p -85.98 -1.53 57.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.488 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.4 t -171.65 139.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 76.4 p -120.49 138.04 54.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -179.44 134.9 2.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 41.4 t -120.16 158.38 27.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.859 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.1 t -166.35 143.31 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.41 131.98 34.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.421 ' CB ' HD22 ' A' ' 196' ' ' LEU . . . -60.65 -72.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.421 HD22 ' CB ' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -166.12 165.43 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -86.86 125.32 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.83 127.3 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.12 65.61 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.8 mtt85 -50.83 -42.5 58.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.82 142.61 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 165.3 72.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.469 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 35.0 p -45.76 -53.0 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.872 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 m -49.54 134.2 19.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.178 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.4 m -124.99 139.69 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -100.32 127.35 46.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 45.9 t -116.54 130.51 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.72 170.68 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.67 50.84 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 50.3 mt -100.03 159.95 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 214' ' ' VAL . 25.5 t0 -86.16 131.54 34.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -44.82 -23.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -75.73 -39.54 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 211' ' ' ASP . 70.1 t -59.74 112.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -109.83 172.84 16.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -51.19 -28.94 12.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' A' ' 221' ' ' GLU . 45.0 mttp -67.78 -52.94 31.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.442 ' HD2' ' CG2' ' A' ' 222' ' ' VAL . 19.5 tptm -65.38 -50.48 65.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 12.5 tp -49.91 -53.42 26.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -62.21 -61.79 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 217' ' ' LYS . 0.4 OUTLIER -43.15 -56.63 3.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.442 ' CG2' ' HD2' ' A' ' 218' ' ' LYS . 46.2 t -56.0 -46.94 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.3 m-85 -63.13 -14.84 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.4 t -59.18 -13.91 8.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 41.7 mtp -69.08 -60.71 2.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -44.93 -52.56 8.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.51 -127.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 68.0 t -114.78 119.88 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 248' ' ' VAL . 84.6 t -81.59 98.65 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.1 t -51.45 -43.74 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.35 117.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -108.3 153.38 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -167.73 167.1 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.403 ' CD1' HD21 ' A' ' 219' ' ' LEU . 16.3 mm -126.2 133.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.63 127.81 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -127.27 178.02 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.52 172.43 12.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -45.87 -45.25 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -72.78 -57.55 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.91 50.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -122.62 110.7 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.5 m -60.25 133.42 56.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.838 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 20.5 mtm105 -106.6 31.52 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 74.03 29.09 63.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.68 129.81 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.15 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.69 166.38 24.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 48.2 p -135.8 140.68 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.407 ' CG1' HG12 ' A' ' 229' ' ' VAL . 2.8 t -134.73 143.91 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.1 m -120.96 121.7 38.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -95.34 -176.32 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.83 -53.22 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -134.76 159.29 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 91.9 p -48.86 -36.98 18.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 30.8 mm -47.32 -63.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -58.75 -44.43 90.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.73 -54.55 22.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.72 -49.13 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.164 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -48.32 -47.31 36.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -69.23 -55.09 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 95.2 mt -45.74 -43.37 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -77.6 -59.93 2.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.4 mmt -51.06 -22.81 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.46 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 3.5 m-85 -103.07 -21.0 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -55.33 113.33 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.05 82.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -70.56 127.12 31.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.65 101.37 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.15 124.64 51.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 57.31 32.73 22.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 72.13 31.45 1.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -144.85 120.72 6.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.592 0.71 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 118.46 5.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.704 2.27 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 55.7 mtm -79.87 147.07 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -113.5 99.03 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.8 t -107.65 127.0 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.8 tttm -149.54 159.53 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 11.0 mtt -65.64 139.96 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.74 150.86 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -63.77 -69.18 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -117.04 104.97 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -114.29 38.31 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.461 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -155.13 140.76 12.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 0.0 110.937 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.461 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.76 -178.24 2.25 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 0.0 112.305 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.64 -57.52 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 175.24 88.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.488 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.59 101.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.836 0.35 . . . . 0.0 110.851 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 56.43 45.96 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -41.03 149.24 0.35 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 148.46 65.52 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.361 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.97 49.42 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -137.02 108.9 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -89.24 135.57 31.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.626 0.727 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 179.55 3.58 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.42 139.5 53.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -131.62 170.94 14.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 40.4 t -174.65 141.65 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.91 82.52 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 121.53 8.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.644 2.229 . . . . 0.0 112.375 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 8.7 t -66.34 157.23 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.3 t -167.46 116.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.457 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 81.1 p 39.48 42.31 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.4 p -106.94 124.38 49.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.47 -174.03 13.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.491 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -166.16 125.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.1 m -59.37 134.31 56.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.852 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.18 -65.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -52.82 -179.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.76 153.67 17.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -72.04 163.9 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -117.83 154.97 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -165.11 -141.51 3.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.49 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -81.1 74.02 8.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -106.91 146.87 30.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.21 -144.56 2.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 m -121.22 44.62 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.912 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.1 m -101.77 136.34 41.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.45 145.5 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.46 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 87.3 t80 -102.58 118.51 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -122.76 167.91 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.35 51.69 8.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.95 163.23 13.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 214' ' ' VAL . 1.7 t0 -80.75 118.14 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -41.27 -41.88 2.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -61.0 -37.45 82.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 211' ' ' ASP . 53.3 t -55.72 151.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -135.26 172.44 22.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.407 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 30.3 p-90 -57.09 -39.72 75.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.407 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 5.3 mtpm? -62.84 -48.49 78.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.407 ' NZ ' HG23 ' A' ' 222' ' ' VAL . 0.5 OUTLIER -63.81 -48.83 75.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.462 HD22 ' CG2' ' A' ' 248' ' ' VAL . 11.2 tp -55.88 -52.55 63.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -59.06 -60.26 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.24 -45.27 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.407 HG23 ' NZ ' ' A' ' 218' ' ' LYS . 85.9 t -69.21 -51.95 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.503 ' CD2' HG23 ' A' ' 248' ' ' VAL . 3.2 m-85 -56.76 -12.86 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.2 t -57.46 -12.23 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.3 mtm -65.31 -66.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.421 ' HB2' ' N ' ' A' ' 259' ' ' ALA . . . -48.83 -39.96 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.073 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 176.65 -171.78 44.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.4 122.16 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 232' ' ' ALA . 94.3 t -79.0 103.66 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.44 -39.31 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -148.62 120.3 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.422 ' CB ' HG13 ' A' ' 229' ' ' VAL . . . -124.98 135.48 52.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.69 167.54 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.64 133.51 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.4 mt -78.75 131.35 36.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.0 167.55 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 17.1 t0 -63.82 165.95 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' ASP . 35.5 pttt -36.76 -46.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.409 ' N ' ' HG3' ' A' ' 238' ' ' LYS . 3.0 m-20 -74.64 -58.66 3.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.19 42.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.54 115.52 29.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.5 m -66.11 122.94 18.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -106.69 21.5 17.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 75.21 28.24 62.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.46 HG21 ' CZ ' ' A' ' 206' ' ' PHE . 47.7 mt -127.71 124.31 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.78 176.33 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.494 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 57.6 p -142.8 136.73 29.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 223' ' ' PHE . 45.9 t -127.17 139.88 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.442 ' N ' HG11 ' A' ' 248' ' ' VAL . 91.6 m -123.21 111.06 16.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.183 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.565 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 91.0 m-85 -86.62 -175.25 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.49 -49.36 8.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -132.29 156.71 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 16.7 t -48.71 -52.81 21.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 27.9 mm -37.67 -62.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.137 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -53.77 -48.47 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.61 -60.69 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 95.7 t -42.87 -56.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -47.87 -52.29 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.421 ' N ' ' HB2' ' A' ' 226' ' ' ALA . . . -58.88 -42.86 90.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.503 ' O ' ' CB ' ' A' ' 264' ' ' ASN . 48.7 mt -62.62 -59.61 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.1 m -54.29 -42.81 70.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -69.85 -67.17 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.471 ' CE2' ' HA ' ' A' ' 223' ' ' PHE . 41.9 m-85 -57.47 -14.02 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.0 OUTLIER -65.34 110.56 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.57 81.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -69.89 146.03 51.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.97 102.43 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.76 123.52 50.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.434 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 12.1 m-85 56.2 40.61 29.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.5 t70 64.21 30.99 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -147.08 123.25 5.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.566 0.698 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 124.45 11.11 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.363 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 61.0 mtm -85.86 153.07 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -117.35 99.85 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.82 124.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 277' ' ' MET . 22.2 tttm -142.64 157.57 44.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.4 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 7.9 mtt -67.08 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.921 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.05 151.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.43 -46.72 5.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -126.13 111.26 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -101.2 86.77 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.466 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 9.1 tp -38.9 139.65 0.72 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.78 167.87 23.23 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -123.8 144.74 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 97.78 2.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.97 176.71 6.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -165.98 134.81 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -118.17 144.82 35.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 146.87 61.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.38 37.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.331 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -139.95 112.17 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.473 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 27.0 ttt85 -130.31 139.41 35.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.586 0.708 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.7 Cg_endo -69.75 136.9 34.2 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -139.43 151.75 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -122.87 152.72 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.7 t -124.82 170.34 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 145.53 67.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.522 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -176.58 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.66 2.24 . . . . 0.0 112.353 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 34.0 p -165.13 163.93 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 73.1 m -119.05 171.33 8.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.552 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 p -101.99 158.62 16.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.875 0.369 . . . . 0.0 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.4 p -103.04 -49.09 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 123.64 80.11 0.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.5 t -118.09 100.08 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 19.6 t -174.93 165.24 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -178.42 -109.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.535 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.83 158.13 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.96 -60.32 1.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -104.24 159.15 15.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.56 -51.84 1.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.133 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.31 60.62 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.16 154.57 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.327 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.59 84.35 1.95 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -148.84 107.47 0.36 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 7.2 t -79.1 -50.1 11.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.0 0.429 . . . . 0.0 110.846 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.1 m -42.71 142.92 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.403 HG12 ' CG1' ' A' ' 260' ' ' ILE . 15.7 m -126.08 148.39 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -104.06 111.67 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.2 t -101.75 138.11 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.158 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.6 170.09 16.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.12 54.43 3.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.04 148.95 30.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.83 141.49 44.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -51.41 -19.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -75.25 -42.48 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 41.5 t -60.74 109.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.5 13.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.448 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 42.1 p-90 -48.24 -34.88 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 99.1 mttt -60.15 -57.25 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -64.31 -57.73 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 22.8 tp -38.69 -49.57 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -67.25 -48.19 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.93 -32.11 60.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 263' ' ' PHE . 38.8 t -78.0 -43.59 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -66.42 -21.28 66.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -51.57 -19.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 7.9 mtm -65.67 -59.67 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.13 -45.35 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 178.81 -162.94 30.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.94 122.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 78.6 t -78.44 101.0 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 249' ' ' THR . 77.0 t -52.59 -42.08 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.419 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 29.2 ptt180 -163.81 117.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -107.98 151.61 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -166.59 172.95 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 23.5 mm -129.51 119.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.79 141.71 58.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -140.2 177.47 7.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.95 168.93 13.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -42.47 -59.06 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.43 -51.54 66.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.61 38.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -102.05 150.75 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.769 0.318 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 28.8 m -98.33 119.12 36.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -95.28 7.87 44.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 88.4 18.21 55.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 40.8 mt -112.04 128.85 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 111.159 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.8 168.28 21.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.4 p -139.01 135.77 34.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 35.0 t -130.47 139.31 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.8 m -120.8 115.81 23.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 80.8 m-85 -88.83 178.59 6.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -80.75 -55.23 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -117.81 145.03 44.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 83.8 p -47.06 -45.51 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -42.4 -62.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -55.63 -49.18 73.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.05 -49.79 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.3 -53.6 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -45.59 -42.95 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -66.57 -52.21 47.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.448 ' CD1' ' HG2' ' A' ' 277' ' ' MET . 75.8 mt -48.88 -48.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.5 m -71.96 -58.88 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 85.6 mmm -51.83 -24.49 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 222' ' ' VAL . 20.8 m-85 -102.05 -15.08 16.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.52 111.93 4.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.25 90.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -70.73 125.9 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.03 101.88 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.3 tp -108.6 123.7 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 58.72 39.25 24.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.7 26.65 9.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -145.54 124.61 6.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 0.0 110.836 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 119.49 6.43 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 59.7 mtm -80.5 154.91 27.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -119.95 108.81 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.411 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.7 t -116.79 122.31 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -131.72 147.95 52.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.448 ' HG2' ' CD1' ' A' ' 260' ' ' ILE . 3.4 mtp -58.05 132.08 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.79 165.37 22.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -119.84 88.73 2.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -104.53 112.88 26.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -119.04 87.87 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.064 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.456 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.7 tp -146.2 140.71 15.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.534 0.683 . . . . 0.0 110.946 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.74 149.19 66.68 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -74.24 -46.11 43.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.76 80.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -134.05 37.54 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.371 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -169.53 152.34 4.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -114.5 144.7 32.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 129.5 17.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 109.2 2.26 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -62.49 107.19 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -131.67 82.47 60.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 141.01 44.16 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.389 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -135.53 163.34 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -121.78 159.47 26.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 90.1 p -174.21 176.26 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.27 144.78 7.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 169.57 18.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.659 2.239 . . . . 0.0 112.346 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.5 m -138.82 144.28 39.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.1 t -124.71 129.95 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.4 p -170.35 139.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.8 m -157.96 148.48 20.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -156.26 72.2 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.8 t -124.62 153.7 41.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 110.855 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 51.9 m -88.92 -47.45 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 61.93 124.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -163.93 117.7 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.69 127.17 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -128.98 43.29 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.44 89.37 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.53 159.76 22.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -95.19 87.26 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 mt -105.14 41.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.63 132.67 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.499 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.3 m -95.07 44.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.83 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.3 m -74.87 137.13 41.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.77 137.26 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.521 ' CE1' HG22 ' A' ' 245' ' ' ILE . 67.6 t80 -99.73 123.52 44.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 66.4 t -112.8 128.42 69.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' A' ' 206' ' ' PHE . . . -132.07 167.55 19.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.4 t30 68.43 45.52 1.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 34.0 mt -104.31 133.84 48.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.47 ' OD2' ' CD2' ' A' ' 269' ' ' PHE . 0.5 OUTLIER -67.5 145.74 54.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -47.63 -33.75 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -58.02 -35.24 70.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.411 HG22 ' CG ' ' A' ' 211' ' ' ASP . 46.4 t -56.06 117.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -117.97 146.6 18.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.532 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 32.0 p-90 -35.44 -45.11 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.532 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 32.7 mtpt -55.92 -60.03 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 219' ' ' LEU . 15.9 tptm -54.19 -65.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 218' ' ' LYS . 14.3 tp -35.23 -58.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.42 -49.67 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.32 -20.9 12.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' A' ' 263' ' ' PHE . 89.1 t -91.34 -45.5 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.513 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.4 m-85 -64.58 -15.99 61.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 42.3 p -58.51 -15.28 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 29.4 mtm -66.42 -55.47 15.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.68 -41.0 80.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.24 -161.67 30.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.52 108.48 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 55.6 t -69.54 104.72 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 53.8 t -50.69 -46.46 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.437 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 0.2 OUTLIER -153.58 122.96 6.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.407 ' C ' ' OD1' ' A' ' 233' ' ' ASP . . . -117.73 133.42 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 232' ' ' ALA . 2.0 m-20 -161.17 167.17 26.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.7 138.56 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.83 123.98 27.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -129.84 172.32 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 238' ' ' LYS . 1.9 m-20 -80.02 170.16 16.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 237' ' ' ASP . 6.1 mtmp? -35.48 -64.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.33 -51.31 69.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.44 42.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -103.72 113.07 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 19.0 t -67.73 130.67 43.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -95.92 35.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.96 71.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.471 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.521 HG22 ' CE1' ' A' ' 206' ' ' PHE . 67.4 mt -137.03 128.62 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.136 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.69 170.36 18.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.5 p -138.43 138.23 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.9 151.34 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.437 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 15.6 m -133.48 118.89 18.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -88.82 175.98 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.11 -55.93 4.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.02 155.9 35.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 254' ' ' ILE . 69.0 p -51.67 -50.82 59.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 253' ' ' SER . 14.4 mm -36.39 -62.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -57.41 -45.96 84.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.3 49.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.07 -54.09 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -44.82 -43.01 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -72.45 -53.27 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.0 mt -42.68 -46.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.8 m -76.85 -63.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.0 mmm -45.89 -24.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 3.6 m-85 -100.3 -30.77 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -55.13 111.15 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.07 14.01 77.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -77.08 127.87 33.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.1 mt -85.83 99.94 11.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.67 125.34 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.47 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 25.8 m-85 58.86 33.95 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 70.35 28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -146.85 124.58 5.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.613 0.721 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 126.2 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.413 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 41.7 mtm -86.54 151.37 23.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -115.87 102.29 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.55 124.47 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 158.71 43.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 11.3 mtt -67.12 131.24 45.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -77.03 138.26 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.44 109.11 10.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -123.97 147.33 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -95.4 82.09 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 6.0 tp -102.53 135.52 19.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.601 0.715 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 96.31 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.675 2.25 . . . . 0.0 112.321 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.405 ' C ' ' HD2' ' A' ' 284' ' ' LYS . 0.1 OUTLIER -100.65 141.08 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.39 76.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -115.25 129.99 56.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -164.33 118.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.516 ' CG ' ' HD2' ' A' ' 289' ' ' PRO . 6.0 t80 -126.18 140.28 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 288' ' ' PHE . 53.7 Cg_endo -69.81 149.04 66.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 5.36 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.629 2.22 . . . . 0.0 112.339 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.64 155.98 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -130.36 145.14 56.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.576 0.703 . . . . 0.0 110.885 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.84 69.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.669 2.246 . . . . 0.0 112.3 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -122.85 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . 0.456 ' HG3' ' N ' ' A' ' 296' ' ' SER . 12.2 pt20 -116.52 -46.22 2.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 295' ' ' GLN . 93.3 p -149.8 135.33 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -97.4 -162.4 31.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 96.53 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.7 t -134.77 158.63 43.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 t -171.92 131.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.443 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 79.0 p -149.1 131.12 15.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.0 p -73.35 -23.05 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.24 114.21 0.67 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.7 t -83.07 102.44 11.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.853 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 52.5 p -165.05 166.04 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 90.16 92.31 1.23 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.449 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.31 153.49 41.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.25 107.07 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -122.73 94.18 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.65 67.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -176.35 138.4 4.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -93.81 104.16 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.3 OUTLIER -132.7 176.23 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 73.92 -179.64 41.26 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.514 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 204' ' ' THR . 9.9 m -120.21 -37.43 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 0.0 110.885 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' SER . 88.1 m -34.87 129.66 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.467 HG11 ' CG1' ' A' ' 260' ' ' ILE . 31.9 m -112.03 134.15 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -95.02 112.27 23.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.3 t -101.18 129.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -135.94 161.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.2 t30 67.54 47.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 46.1 mt -99.96 146.79 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -74.26 137.69 43.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -45.16 -36.43 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -59.97 -43.41 95.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.82 121.88 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -122.12 161.65 16.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.519 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.51 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 56.7 p-90 -35.53 -48.53 0.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.51 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 4.5 ptpt -50.85 -62.66 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 219' ' ' LEU . 18.5 tptp -50.93 -66.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.9 tp -35.43 -42.98 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -69.85 -64.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -42.98 -38.83 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 69.8 t -74.72 -39.83 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.123 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.1 m-85 -73.72 -10.33 59.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.6 t -62.31 -23.48 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.9 mtm -59.98 -61.53 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.58 -54.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.117 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.97 -144.65 4.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -99.54 114.85 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.444 HG12 ' CB ' ' A' ' 232' ' ' ALA . 42.2 t -78.82 103.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 249' ' ' THR . 40.3 t -50.87 -37.04 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.416 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 39.2 ptt85 -168.56 118.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.444 ' CB ' HG12 ' A' ' 229' ' ' VAL . . . -114.37 142.78 45.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -169.66 168.62 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.413 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.5 mm -116.52 141.8 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 36.1 mt -83.09 149.71 26.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -142.93 176.44 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 239' ' ' ASP . 6.0 t0 -84.8 171.36 12.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -39.7 -28.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 237' ' ' ASP . 13.8 t70 -87.19 -54.22 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 134.67 37.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -100.14 125.4 46.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.1 m -66.04 110.76 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -90.19 24.62 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 72.24 25.48 74.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.7 mt -132.43 125.44 53.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.164 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.38 168.15 21.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 52.5 p -132.54 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.112 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.432 ' HB ' ' CG2' ' A' ' 205' ' ' VAL . 63.0 t -134.54 138.65 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 230' ' ' VAL . 28.7 m -119.37 117.98 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.47 -178.83 5.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.23 -52.71 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.57 156.32 44.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 17.3 t -48.59 -49.83 35.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.4 mm -39.14 -64.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -53.59 -45.25 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.49 -56.39 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.2 t -50.28 -55.35 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -44.03 -51.58 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 263' ' ' PHE . . . -65.3 -50.8 64.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.467 ' CG1' HG11 ' A' ' 205' ' ' VAL . 84.7 mt -46.85 -52.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.4 m -72.48 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 53.4 mmm -46.61 -24.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 259' ' ' ALA . 26.2 m-85 -103.3 -23.36 13.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.13 110.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.68 89.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -69.98 130.56 42.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.09 100.99 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.6 tp -109.4 121.96 46.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 59.34 41.95 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 19.6 t70 63.39 24.97 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.28 125.34 7.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 138.19 37.05 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 32.9 mtm -97.39 152.91 18.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -115.74 99.17 7.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.5 t -112.93 118.45 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -139.11 146.14 40.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 24.4 mtt -56.0 135.02 52.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -61.49 114.45 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.25 -31.06 43.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -100.77 98.74 9.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -117.22 86.99 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.052 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.472 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 9.8 tp -66.27 139.49 96.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.646 0.736 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.7 160.51 49.44 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -53.17 2.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.17 125.01 0.2 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.66 168.11 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.563 ' CD2' ' HD3' ' A' ' 289' ' ' PRO . 3.5 p90 -148.08 148.14 30.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -128.98 83.29 66.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.648 0.737 . . . . 0.0 110.885 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 287' ' ' PHE . 53.9 Cg_endo -69.73 148.72 65.86 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.682 2.254 . . . . 0.0 112.365 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 173.34 11.16 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.274 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -120.8 110.74 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -107.51 80.76 0.97 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 96.27 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.694 2.263 . . . . 0.0 112.354 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -104.07 138.78 40.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -119.37 139.57 51.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.3 t -130.45 135.7 48.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -146.4 82.63 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.78 61.08 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.315 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 56.9 p -172.22 128.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 33.0 p -171.44 137.74 1.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.473 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 p -74.66 85.97 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 74.3 m -109.93 157.32 19.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 115.61 -105.56 1.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 m 38.73 42.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.7 m -148.02 141.73 25.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.24 90.06 0.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.82 165.42 18.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.92 123.9 21.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.4 pm0 -101.64 170.04 8.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.34 -45.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.11 54.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -107.23 173.37 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.403 ' C ' HD11 ' A' ' 201' ' ' LEU . 1.0 OUTLIER -97.31 143.8 27.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 166.78 82.28 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 204' ' ' THR . 16.7 m -67.56 -50.63 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 203' ' ' SER . 43.1 m -34.58 137.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.39 150.73 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -106.68 122.05 45.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.32 124.37 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -124.21 167.87 13.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 62.16 50.98 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.39 146.35 28.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.88 145.43 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.86 -26.63 36.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.03 -37.51 72.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.07 110.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.126 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -103.88 175.04 22.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.488 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 12.4 p-90 -57.13 -32.68 66.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.488 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 30.3 mmtt -66.43 -56.41 11.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -59.11 -56.42 22.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.2 tp -46.45 -51.26 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.65 -67.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -38.73 -49.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.405 HG13 ' CE1' ' A' ' 263' ' ' PHE . 23.8 t -59.66 -45.61 94.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.2 -14.39 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 t -55.64 -22.99 25.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.3 mtm -57.32 -63.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 259' ' ' ALA . . . -41.46 -50.03 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.13 -106.28 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 45.6 t -139.99 112.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 71.6 t -70.15 103.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 249' ' ' THR . 65.6 t -51.46 -37.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.407 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.2 ptm180 -168.16 121.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -107.73 151.03 26.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.36 161.36 30.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.34 126.37 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.11 123.97 22.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.941 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -129.67 171.18 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.07 174.99 8.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -45.5 -43.57 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -64.22 -56.67 13.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.26 30.84 0.26 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.492 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -103.02 145.04 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.8 t -81.88 123.97 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -91.24 34.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 62.8 26.36 68.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 72.1 mt -136.22 139.29 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 80.8 p -144.69 145.14 31.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.1 t -133.89 130.41 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.3 m -106.72 121.22 43.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 42.9 m-85 -96.06 177.89 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 3.6 mm-40 -76.8 -55.74 5.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -131.09 155.59 46.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.7 p -47.99 -32.18 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.66 -67.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.45 -43.33 75.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.54 -49.72 67.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 62.6 t -57.26 -53.15 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -48.24 -44.63 33.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 226' ' ' ALA . . . -66.77 -62.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 277' ' ' MET . 78.2 mt -40.8 -39.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.7 t -78.97 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 34.9 mtp -49.93 -21.39 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.405 ' CE1' HG13 ' A' ' 222' ' ' VAL . 41.9 m-85 -103.89 -21.97 13.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -55.58 111.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.72 18.21 71.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -78.39 125.16 28.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.46 101.66 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.6 tp -111.12 124.88 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 59.42 31.74 21.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 73.46 28.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -144.9 126.84 7.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 117.26 4.98 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 0.0 112.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 47.3 mtm -78.07 150.72 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -117.33 104.37 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.6 t -114.29 119.9 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 277' ' ' MET . 11.4 ttmt -136.55 157.22 47.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.436 ' HG2' ' CD1' ' A' ' 260' ' ' ILE . 3.9 mtt -64.68 132.34 49.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.46 165.76 15.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.68 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . 0.418 ' C ' ' HD3' ' A' ' 280' ' ' ARG . 0.0 OUTLIER -95.23 136.39 35.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -106.43 79.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.469 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 6.4 tp -58.67 140.43 85.4 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.469 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.6 Cg_endo -69.71 88.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 0.0 112.313 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -91.57 94.83 9.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.43 81.22 0.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -107.82 132.83 53.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.457 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 9.6 p90 -170.64 121.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -113.24 143.91 30.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.683 0.754 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 148.16 64.28 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 5.38 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.698 2.265 . . . . 0.0 112.356 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -97.07 158.13 15.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -124.88 80.94 62.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 126.29 13.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.309 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -127.52 112.68 15.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -124.73 146.97 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 t -165.41 129.13 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.63 83.43 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 171.26 14.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 92.0 p -149.59 176.49 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 66.3 m -134.92 148.85 50.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.806 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 p -169.99 163.06 9.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.883 0.373 . . . . 0.0 110.897 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.9 t -57.7 89.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -100.77 55.15 0.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.3 m -115.72 -60.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.7 m -65.39 100.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -153.1 152.53 24.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -171.47 175.16 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.16 171.98 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -96.35 -50.82 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.56 126.86 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -85.56 40.51 3.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -74.97 177.79 6.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.64 110.98 13.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -161.17 -162.34 12.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 33.9 m -86.02 37.97 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 90.0 m -79.77 131.44 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.0 138.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.185 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.435 ' CZ ' ' CG2' ' A' ' 245' ' ' ILE . 83.0 t80 -105.6 123.42 47.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.64 141.83 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 167.63 21.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 272' ' ' PRO . 62.7 t30 62.81 50.54 3.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.7 mt -104.16 158.51 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -77.16 133.65 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -50.61 -34.59 26.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.925 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -64.75 -35.86 82.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.59 139.68 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.16 21.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.421 ' CD2' ' C ' ' A' ' 216' ' ' TRP . 1.9 p-90 -44.54 -39.59 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.414 ' N ' ' CG ' ' A' ' 216' ' ' TRP . 57.6 mttt -60.42 -55.56 32.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -56.85 -57.69 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.4 tp -48.36 -52.58 21.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.5 -59.95 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -43.35 -44.96 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' A' ' 263' ' ' PHE . 16.9 t -64.57 -52.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.7 m-85 -56.08 -18.51 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -52.19 -20.3 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 15.7 mtp -61.61 -62.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.84 33.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 170.93 -144.99 8.64 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.64 130.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.2 t -84.84 97.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.79 -42.78 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -153.7 116.99 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -118.4 141.22 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -164.59 171.69 14.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 16.7 mm -127.23 135.68 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 88.3 mt -76.03 126.02 30.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.412 ' HB3' ' N ' ' A' ' 241' ' ' LYS . 20.9 mt-10 -134.63 168.36 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.407 ' CB ' ' HE3' ' A' ' 241' ' ' LYS . 21.8 t0 -73.86 175.57 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -38.66 -43.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.02 -60.7 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 138.48 40.86 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 236' ' ' GLU . 14.2 pttp -100.84 117.25 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.2 t -53.87 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -99.79 29.59 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 70.18 23.05 77.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.435 ' CG2' ' CZ ' ' A' ' 206' ' ' PHE . 32.7 mt -135.25 125.41 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.848 0.356 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.49 176.3 19.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.0 p -148.56 141.97 25.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.166 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.49 156.03 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 92.0 m -128.73 109.76 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.454 ' CZ ' ' CB ' ' A' ' 259' ' ' ALA . 64.8 m-85 -83.85 -178.37 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.87 -51.22 7.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.14 158.16 44.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 96.8 p -44.83 -50.99 9.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -38.79 -67.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.27 -43.71 53.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.72 1.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 44.4 t -43.31 -49.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.22 -41.12 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.454 ' CB ' ' CZ ' ' A' ' 250' ' ' PHE . . . -71.51 -55.38 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 264' ' ' ASN . 65.2 mt -50.13 -38.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 36.6 m -79.62 -53.81 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 15.1 mmt -58.78 -22.1 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.0 m-85 -103.69 -23.19 13.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t30 -58.81 110.5 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.59 88.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.13 131.31 42.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.08 100.03 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.414 ' CD2' ' SD ' ' A' ' 273' ' ' MET . 9.1 tp -106.77 121.84 45.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 57.78 43.67 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.45 ' O ' ' CG ' ' A' ' 270' ' ' ASP . 22.9 t70 62.53 26.39 15.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -146.98 126.98 6.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.642 0.734 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 209' ' ' ASN . 53.7 Cg_endo -69.66 131.8 22.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' MET . . . . . 0.414 ' SD ' ' CD2' ' A' ' 268' ' ' LEU . 19.2 mtm -95.43 143.19 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -107.36 100.25 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.9 t -109.06 124.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -146.93 127.5 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 1.7 ptp -61.89 138.27 58.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.35 162.85 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.52 82.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -106.11 86.69 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.9 85.08 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.08 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.473 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 3.0 tp -132.7 138.63 32.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.473 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.77 157.1 61.51 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.733 2.289 . . . . 0.0 112.286 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.97 146.49 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -123.34 125.28 5.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -124.05 133.91 53.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.347 . . . . 0.0 110.887 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -174.83 136.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -121.97 143.98 40.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.652 0.739 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 147.2 62.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.703 2.269 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 5.36 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 292' ' ' ARG . 0.2 OUTLIER -59.17 131.11 50.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.463 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 9.6 ttt85 -138.35 143.21 37.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.7 Cg_endo -69.8 115.48 4.12 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.637 2.225 . . . . 0.0 112.376 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -101.94 115.63 30.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -101.79 151.87 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 90.3 p -153.81 169.69 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -168.94 65.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -35.71 12.12 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.68 2.253 . . . . 0.0 112.337 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.6 m 40.91 42.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 93.5 p -67.01 160.32 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 39.7 p -124.5 -47.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.5 t -57.58 120.95 9.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -90.09 -131.09 4.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.478 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -135.06 171.27 14.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.2 m -85.82 -52.99 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 63.57 148.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 197' ' ' GLN . . . -132.76 79.02 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 195' ' ' ALA . 1.2 pp -37.56 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 195' ' ' ALA . 9.4 tp-100 -64.67 143.52 57.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.77 127.84 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 84.18 97.36 0.63 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -91.06 43.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.04 151.16 39.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -178.48 -153.91 12.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 21.7 p -124.38 -41.71 2.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 110.855 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 34.5 m -55.64 144.71 25.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.151 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.21 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -97.34 117.32 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.6 t -108.02 132.31 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.146 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.91 167.31 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 71.46 32.6 2.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.85 156.81 19.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.67 176.23 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -85.03 -30.23 24.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.74 33.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 81.4 t -107.27 128.83 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -126.26 152.91 18.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -40.3 -33.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -60.1 -53.37 58.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.429 ' HD2' ' CG2' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -63.71 -50.41 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.433 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 17.9 tp -51.25 -56.43 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . 0.447 ' CE ' ' HB1' ' A' ' 232' ' ' ALA . 22.8 ttmt -60.57 -55.8 29.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 224' ' ' SER . 26.9 mm-40 -46.95 -59.97 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.525 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 51.1 t -56.13 -51.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.508 ' CD2' HG21 ' A' ' 248' ' ' VAL . 4.2 m-85 -59.61 -13.98 11.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 5.4 t -58.53 -22.15 54.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.3 mtm -55.4 -62.07 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 250' ' ' PHE . . . -49.59 -55.96 11.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.62 -150.43 6.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.01 96.6 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.419 HG13 ' CB ' ' A' ' 232' ' ' ALA . 87.6 t -50.48 96.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 249' ' ' THR . 55.6 t -52.79 -50.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -139.62 119.82 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.447 ' HB1' ' CE ' ' A' ' 220' ' ' LYS . . . -126.64 133.19 51.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.437 ' CG ' ' C ' ' A' ' 232' ' ' ALA . 0.4 OUTLIER -163.14 165.3 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 4.6 mm -124.39 151.33 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 70.3 mt -100.58 142.38 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -117.51 178.64 4.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.1 179.04 6.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -50.54 -22.89 2.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -80.45 -30.15 37.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.48 -34.41 4.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -70.15 144.26 52.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.779 0.323 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.0 t -51.56 134.32 29.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -26.13 16.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.67 29.49 2.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 83.5 mt -137.52 132.91 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.79 171.65 24.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.544 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.4 p -134.37 139.97 45.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 223' ' ' PHE . 72.3 t -138.6 128.29 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.13 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 230' ' ' VAL . 94.0 m -111.79 123.11 49.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 226' ' ' ALA . 66.4 m-85 -96.7 175.51 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -69.96 -57.29 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.98 162.67 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.963 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.57 -38.42 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.6 mm -47.24 -66.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.79 -43.56 72.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.38 67.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 65.5 t -60.34 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.156 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -48.96 -43.88 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -68.36 -59.67 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.076 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.459 ' HA ' ' CG1' ' A' ' 275' ' ' VAL . 33.4 mt -43.99 -42.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.4 m -76.27 -60.66 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -50.14 -23.36 2.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.886 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.525 ' CZ ' HG11 ' A' ' 222' ' ' VAL . 3.6 m-85 -102.46 -22.8 13.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.63 111.38 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.95 17.87 71.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -77.21 122.5 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.5 mt -81.21 99.98 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.1 tp -108.55 122.01 46.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.21 43.6 20.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.438 ' O ' ' CG ' ' A' ' 270' ' ' ASP . 24.0 t0 63.24 25.45 14.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.74 125.22 8.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 126.55 13.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.54 155.93 20.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -121.14 101.12 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.459 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.7 t -111.56 117.8 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.7 tttm -136.81 157.6 46.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.405 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 14.0 mtt -65.61 136.83 56.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -84.7 177.7 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.76 79.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.87 107.56 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -89.48 78.42 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 5.8 tp -112.53 137.03 21.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.62 3.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -100.97 145.43 28.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.07 83.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -125.54 82.08 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.42 149.07 22.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -100.83 143.88 27.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.408 ' HA ' ' HD2' ' A' ' 290' ' ' PRO . 53.8 Cg_endo -69.77 110.32 2.53 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.734 2.289 . . . . 0.0 112.311 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 289' ' ' PRO . 53.7 Cg_endo -69.74 112.75 3.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.664 2.242 . . . . 0.0 112.359 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.3 130.96 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -128.26 143.83 49.54 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 159.15 54.48 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.49 146.68 40.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -113.12 136.51 52.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.0 t -140.97 144.97 35.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.81 84.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -177.11 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.754 2.303 . . . . 0.0 112.336 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 89.5 p -146.38 128.12 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.2 m -146.3 172.17 13.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 m -165.1 129.17 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.869 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 83.9 p -160.96 118.15 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -151.75 96.38 0.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.487 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 79.7 p -174.05 112.7 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.0 p -56.81 -29.54 62.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 47.08 49.82 17.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.53 91.25 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.58 124.92 26.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -96.04 113.65 25.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.39 162.38 17.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.053 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 100.99 64.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.06 -14.75 25.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.01 114.21 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 168.43 141.73 3.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 204' ' ' THR . 59.5 m -81.38 -43.88 18.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.955 0.407 . . . . 0.0 110.909 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 203' ' ' SER . 10.5 m -35.19 121.7 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.158 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 24.2 m -111.97 142.65 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -99.06 117.19 33.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.1 t -107.89 130.16 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -135.23 170.87 15.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 62.19 50.06 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 51.4 mt -101.41 158.78 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -67.88 174.42 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -92.46 -6.22 50.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.556 ' HD2' ' CE1' ' A' ' 269' ' ' PHE . 10.1 ptpt -111.51 31.58 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.9 t -108.5 132.25 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.62 158.53 15.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 35.1 p-90 -45.82 -31.39 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.435 ' CD ' HG22 ' A' ' 222' ' ' VAL . 2.5 tmtp? -63.13 -50.84 68.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.8 tp -59.39 -38.99 81.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -69.35 -64.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 222' ' ' VAL . 12.0 pt-20 -44.32 -40.91 5.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.442 ' N ' ' HG3' ' A' ' 221' ' ' GLU . 89.6 t -66.89 -52.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.538 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.2 m-85 -61.64 -14.01 27.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.5 t -52.03 -25.06 7.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.0 mtm -57.62 -64.25 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.76 -48.16 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -179.3 -154.65 13.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.81 127.05 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.38 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.42 HG13 ' CB ' ' A' ' 232' ' ' ALA . 73.5 t -84.54 99.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -148.54 118.97 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 229' ' ' VAL . . . -119.83 142.24 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -165.88 169.36 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 44.3 mm -129.53 132.91 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 71.3 mt -73.69 126.98 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -114.71 178.46 4.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -94.41 178.71 5.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -40.62 -54.48 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -66.32 -57.62 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 146.78 33.5 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.439 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -103.39 149.61 24.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 82.7 p -76.61 118.47 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -87.92 16.99 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.32 24.03 64.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 44.4 mt -135.78 126.27 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.133 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.19 168.65 20.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.52 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 73.5 p -138.32 145.49 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 t -139.1 155.25 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.1 m -129.76 115.48 17.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -89.01 -177.62 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.89 -55.68 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -129.29 158.58 38.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 14.8 p -51.08 -34.14 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -49.37 -68.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.37 -43.39 75.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.25 -46.6 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 76.2 t -63.26 -48.67 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -47.96 -49.49 30.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.32 -60.06 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 74.8 mt -39.9 -38.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.092 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 m -82.0 -64.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -48.46 -19.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.538 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.9 m-85 -104.81 -25.33 12.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.05 112.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.48 11.97 79.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.39 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.927 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.1 mt -79.91 99.87 7.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.422 ' CD2' ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -106.72 123.25 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . 0.556 ' CE1' ' HD2' ' A' ' 213' ' ' LYS . 9.2 m-85 60.03 37.43 21.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 68.79 24.97 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.94 127.13 8.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 120.29 7.09 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' MET . . . . . 0.422 ' SD ' ' CD2' ' A' ' 268' ' ' LEU . 35.3 mtm -80.88 151.91 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -115.89 105.73 13.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.71 125.73 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.159 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -144.7 157.33 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 7.9 mmt -63.05 137.88 58.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.01 147.24 43.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.14 79.64 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -93.79 170.56 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -135.02 103.21 5.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.474 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.2 tp -160.56 140.64 8.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.575 0.703 . . . . 0.0 110.953 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.78 139.02 39.15 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -71.57 -56.15 6.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.55 61.64 1.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.534 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -74.6 150.77 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -154.45 129.04 9.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.59 143.08 31.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 151.0 69.38 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.13 59.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -99.34 166.07 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.6 105.51 56.71 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.83 49.1 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.351 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -114.87 92.26 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -41.59 141.09 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.5 m -160.23 153.82 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 145.24 -84.71 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 1.85 4.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.704 2.269 . . . . 0.0 112.334 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 29.7 t -40.67 -49.4 3.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 93.6 p -63.73 132.84 52.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.505 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m -115.28 83.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.5 t -86.15 98.09 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.823 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.53 109.0 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 91.3 p -101.16 161.62 13.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.829 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.0 t -111.21 150.27 29.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.852 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -88.54 70.21 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.462 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.89 154.49 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 111.089 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -133.45 133.59 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -137.79 145.75 42.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.11 139.99 51.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -164.19 -167.01 24.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.456 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -93.79 -179.24 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.89 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.413 ' C ' HD23 ' A' ' 201' ' ' LEU . 6.7 tt -116.24 138.12 51.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -178.05 -123.82 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 26.0 m -109.01 53.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.853 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 30.4 m -87.0 159.04 19.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.49 143.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -100.37 113.26 25.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.33 135.04 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.88 165.46 27.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 t30 63.29 49.99 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 42.1 mt -100.85 162.91 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.11 132.57 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -44.06 -44.3 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -56.42 -40.17 74.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 74.2 t -51.91 123.58 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 218' ' ' LYS . . . -121.5 158.39 16.24 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.456 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 25.1 p-90 -38.89 -32.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.456 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 22.5 mtpp -72.35 -47.85 46.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.411 ' HD3' ' CG2' ' A' ' 222' ' ' VAL . 3.1 tmtt? -66.2 -49.64 66.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.3 tp -56.38 -50.84 70.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 26.5 tttm -66.55 -35.04 79.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.66 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.424 HG11 ' CE2' ' A' ' 263' ' ' PHE . 38.4 t -83.79 -49.13 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.134 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -59.1 -26.38 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.5 t -46.01 -24.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.1 mtm -57.91 -65.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.27 -42.34 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.92 -160.74 28.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.9 123.53 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.66 98.76 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 76.1 t -54.6 -48.07 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -136.55 123.28 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -126.28 128.98 47.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -163.56 163.87 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 19.3 mm -122.73 148.1 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 76.2 mt -88.65 125.08 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.428 ' N ' ' OE1' ' A' ' 236' ' ' GLU . 26.5 mp0 -132.57 167.96 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -61.04 173.56 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -50.86 -23.41 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -95.16 -55.48 3.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.6 37.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -88.75 144.41 26.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.3 m -83.43 120.6 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.31 -16.36 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 100.65 22.49 11.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 28.6 mt -132.01 123.08 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.123 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.46 169.5 15.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.1 p -135.33 135.47 40.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.81 143.48 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 24.5 m -126.54 117.6 23.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -88.08 -177.91 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.47 -48.39 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -132.92 155.7 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.3 p -49.14 -46.0 44.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 23.8 mm -41.02 -60.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.43 -42.02 90.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.0 -54.2 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.74 -49.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -47.92 -48.29 31.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.93 -58.28 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.425 ' HA ' ' CG1' ' A' ' 275' ' ' VAL . 80.3 mt -41.36 -46.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.2 m -77.09 -62.22 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 49.7 mmm -47.62 -21.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.424 ' CE2' HG11 ' A' ' 222' ' ' VAL . 4.6 m-85 -104.58 -30.64 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -50.52 115.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.98 16.56 76.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -81.58 121.28 26.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.8 100.63 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.6 tp -108.87 123.14 48.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 59.23 31.56 21.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 74.08 28.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -145.19 121.78 6.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 115.43 4.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 58.8 mtm -73.95 153.53 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -118.01 100.3 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.425 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.2 t -109.96 113.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 277' ' ' MET . 1.8 tppp? -124.1 157.6 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.457 ' N ' ' HG3' ' A' ' 276' ' ' LYS . 24.0 mtp -67.45 127.57 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -93.76 43.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 280' ' ' ARG . 15.7 tp10 -92.4 101.78 14.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 279' ' ' GLU . 17.4 tpt180 -35.42 138.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -74.03 81.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 5.5 tp -146.22 133.95 10.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.591 0.71 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 160.17 50.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.643 2.229 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -99.01 -48.85 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.45 43.77 1.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -68.57 134.36 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 287' ' ' PHE . 3.3 p90 -123.12 148.92 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -128.5 129.48 23.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 148.18 64.78 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 0.0 112.342 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -177.89 2.09 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.737 2.291 . . . . 0.0 112.342 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -139.57 161.55 37.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -117.82 143.83 33.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 0.0 110.819 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.8 23.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.322 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -105.28 118.24 36.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -105.45 134.26 48.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 30.5 t -68.99 150.79 47.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.95 83.59 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 161.28 46.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.333 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 1.1 t -83.7 159.63 21.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 80.4 p -150.65 177.47 10.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.531 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -157.89 118.72 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.5 m -152.83 153.63 33.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.85 -179.76 43.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.473 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.6 p -174.3 150.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.9 t -169.06 173.47 6.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.28 35.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.459 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.19 144.24 45.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 0.0 111.1 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.28 168.11 19.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.86 111.26 8.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.21 -45.91 65.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 100.64 96.66 2.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.51 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -82.41 -41.92 19.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 19.4 tp -86.99 151.44 23.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.64 150.27 13.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 20.2 m -133.4 41.48 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.986 0.422 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.8 m -89.09 130.6 35.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.06 130.38 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.114 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -95.32 118.58 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 80.8 t -106.31 140.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.82 163.51 32.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 65.66 43.37 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 mt -92.77 149.01 21.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 3.3 t70 -60.12 162.89 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.415 ' N ' ' CG ' ' A' ' 211' ' ' ASP . 19.1 m-85 -79.12 -34.32 43.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.479 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 20.8 mtpp -82.99 37.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -110.02 157.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.131 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.414 ' N ' HG11 ' A' ' 214' ' ' VAL . . . -150.53 155.98 26.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -46.99 -33.43 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.4 -44.83 77.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -56.49 12.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.4 tp -49.94 -61.25 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -50.25 -58.19 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -44.12 -39.89 4.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.549 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 20.0 t -73.73 -46.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.502 ' CE2' HG23 ' A' ' 248' ' ' VAL . 3.2 m-85 -59.65 -20.05 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.3 t -53.22 -22.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.846 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 11.0 mtm -62.93 -61.64 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -50.85 -52.98 36.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.082 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -176.2 -160.26 23.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 67.9 t -79.32 124.84 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 0.0 111.1 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.47 96.0 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.79 -45.57 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -139.84 121.26 15.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -125.92 124.12 40.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 35.5 mm -124.17 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.64 135.9 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -129.96 175.92 8.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 15.2 t0 -83.81 176.21 9.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' ASP . 3.4 mptt -37.06 -62.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 239' ' ' ASP . 1.9 t0 -55.79 -58.02 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 142.43 42.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -106.35 132.96 51.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.8 m -56.27 113.04 1.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -87.51 27.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 64.06 21.28 65.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 48.5 mt -132.81 132.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.099 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.69 176.99 18.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p -151.82 127.26 10.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.502 HG23 ' CE2' ' A' ' 223' ' ' PHE . 33.0 t -130.16 154.67 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.157 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 79.3 m -131.17 120.49 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 76.9 m-85 -87.55 -177.77 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.28 -55.03 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -111.35 143.55 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.8 p -48.31 -43.81 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.23 -60.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.03 -48.22 67.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.87 -53.34 19.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.153 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 85.8 t -54.33 -55.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -41.39 -56.99 2.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -57.08 -47.03 82.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 264' ' ' ASN . 73.1 mt -53.69 -56.83 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.8 t -64.68 -58.98 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -47.0 -57.96 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.549 ' CZ ' HG11 ' A' ' 222' ' ' VAL . 23.4 m-85 -65.66 -40.35 92.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 0.5 OUTLIER -45.04 114.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.43 19.93 67.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 263' ' ' PHE . 12.4 tt0 -87.9 124.73 33.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -79.4 99.99 7.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.7 tp -108.75 120.68 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 60.11 35.03 21.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 72.04 25.04 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -144.56 122.48 6.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 125.62 12.37 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 58.7 mtm -85.31 151.88 23.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -119.04 101.01 7.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 14.3 t -114.01 127.2 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 277' ' ' MET . 7.5 ttmm -143.32 159.98 41.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' MET . . . . . 0.435 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 8.9 mtp -66.5 117.04 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.8 110.37 2.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -74.15 -40.25 62.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -50.98 107.06 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -105.07 80.68 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.475 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.4 tp -69.7 135.68 88.04 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.603 0.716 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.3 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -126.77 113.97 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 152.43 136.66 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.02 175.85 9.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -146.44 148.42 32.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 289' ' ' PRO . 48.5 t80 -96.95 123.38 53.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.486 ' O ' ' CE2' ' A' ' 288' ' ' PHE . 54.3 Cg_endo -69.73 159.48 53.29 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.749 2.299 . . . . 0.0 112.346 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 121.52 8.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -138.36 134.95 34.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 292' ' ' ARG . 3.6 ptm85 -139.24 146.0 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 110.915 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 130.54 19.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.231 . . . . 0.0 112.345 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -129.78 138.92 51.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -106.94 146.53 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.4 t -156.84 160.72 39.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 172.36 82.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -176.41 1.49 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.707 2.272 . . . . 0.0 112.347 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 4.0 t -162.32 173.9 13.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 2.0 t -156.88 177.96 10.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 179.973 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.0 p -88.79 127.36 35.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 86.1 p -88.82 164.9 15.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 113.73 140.49 7.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.462 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 99.6 p -109.62 129.5 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.3 t -77.71 136.83 38.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 44.34 -122.52 4.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 55.96 54.62 7.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.106 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.41 112.45 8.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -111.36 100.87 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.2 111.98 23.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.056 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 61.36 73.85 0.45 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.516 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -53.38 109.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.63 147.96 22.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 141.59 103.61 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 204' ' ' THR . 15.1 m -75.56 -38.95 58.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 203' ' ' SER . 6.8 m -35.82 139.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.72 144.06 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -101.05 125.31 47.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.1 t -115.85 127.04 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -134.73 171.68 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.0 36.37 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 44.3 mt -89.16 144.94 25.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -63.44 142.28 58.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -57.49 -27.28 62.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -74.03 -34.57 64.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.55 133.32 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.14 158.17 22.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 46.3 p-90 -36.35 -33.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 24.9 mtpt -62.51 -53.15 58.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -67.06 -52.64 39.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.6 tp -46.92 -40.52 14.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -76.0 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -46.07 -33.88 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.19 -58.72 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.464 ' CD2' HG23 ' A' ' 248' ' ' VAL . 3.2 m-85 -52.06 -19.48 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.1 t -53.55 -15.74 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 30.6 mtm -65.53 -63.19 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.95 32.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -174.37 -136.28 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.437 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.99 117.67 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 232' ' ' ALA . 77.5 t -72.34 97.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 92.9 t -53.66 -52.85 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -142.66 117.86 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.448 ' CB ' HG12 ' A' ' 229' ' ' VAL . . . -118.65 143.13 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.89 158.0 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.831 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 26.7 mm -119.59 127.39 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.0 127.04 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.2 176.98 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 173.15 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -39.85 -58.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.89 -58.34 3.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.36 44.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.85 114.64 27.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.1 m -52.3 117.75 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -94.38 -20.0 20.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.46 24.55 21.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 91.9 mt -136.0 131.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.87 0.367 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -138.33 175.44 21.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.3 p -138.39 145.6 41.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.799 0.333 . . . . 0.0 111.156 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 223' ' ' PHE . 82.9 t -135.91 137.17 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 77.4 m -115.24 114.06 24.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 73.6 m-85 -88.2 169.78 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.416 ' HG2' ' CG2' ' A' ' 230' ' ' VAL . 14.6 mm-40 -75.74 -55.41 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -123.61 154.5 39.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 68.5 p -49.72 -47.69 50.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 35.1 mm -41.2 -63.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -54.33 -45.67 72.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.63 -49.82 64.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 42.1 t -56.19 -60.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -39.96 -50.54 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -61.63 -59.37 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.8 mt -42.49 -48.35 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 264' ' ' ASN . 7.0 m -73.36 -65.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.3 mmt -45.39 -22.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -103.82 -21.47 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 261' ' ' SER . 5.9 t30 -61.78 111.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.52 8.53 86.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -76.39 130.68 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -88.23 107.92 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.8 tp -114.37 123.58 49.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 60.3 32.28 20.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 74.18 25.94 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -147.07 127.8 7.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.865 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 130.57 19.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 48.3 mtm -91.46 132.82 35.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -96.76 105.31 17.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.69 127.33 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -149.54 150.87 32.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 28.8 mtt -57.88 139.06 55.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -52.95 137.82 31.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -83.32 -48.71 10.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -73.81 130.16 39.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -124.41 93.14 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.468 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 6.4 tp -85.51 140.46 36.06 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.468 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.5 Cg_endo -69.75 163.69 37.32 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.742 2.294 . . . . 0.0 112.325 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -98.82 -37.78 9.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.53 46.56 2.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.0 85.07 7.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -115.84 153.43 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.536 ' CD1' ' HD2' ' A' ' 289' ' ' PRO . 36.7 t80 -130.73 139.42 35.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' A' ' 288' ' ' PHE . 53.3 Cg_endo -69.74 110.54 2.58 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.629 2.22 . . . . 0.0 112.394 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 175.13 8.53 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.379 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.38 169.29 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.475 ' CD ' ' HD2' ' A' ' 293' ' ' PRO . 9.5 tpp180 -129.34 138.88 34.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.679 0.752 . . . . 0.0 110.854 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.475 ' HD2' ' CD ' ' A' ' 292' ' ' ARG . 54.3 Cg_endo -69.73 164.89 32.83 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.329 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -133.15 87.18 2.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -119.59 177.19 5.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.1 t -173.84 140.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 157.8 82.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.48 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 168.68 20.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.1 m -154.47 154.58 33.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 54.9 m -129.3 146.53 51.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 65.9 m -133.44 158.88 41.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.3 m -138.97 160.79 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.97 82.72 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.8 t -133.1 133.99 43.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.3 m -65.9 156.32 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.807 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 145.47 66.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.83 117.74 23.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -75.78 133.53 40.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.7 162.03 13.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -127.58 80.54 1.96 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 102.48 139.49 10.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -124.9 -42.59 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.69 105.06 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 174.24 162.56 26.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.4 p -132.76 -33.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.984 0.421 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 65.6 m -55.65 134.93 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 m -120.15 134.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -95.42 118.26 31.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 92.6 t -105.38 138.65 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.64 155.99 46.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 74.85 45.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 76.2 mt -99.56 134.82 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -57.57 162.51 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -72.05 -25.3 61.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -70.58 -42.88 70.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.43 139.48 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -141.3 159.9 26.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.505 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 16.6 p-90 -36.61 -33.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.359 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.505 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 9.9 mtpm? -68.23 -61.06 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -56.19 -54.24 47.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.454 HD22 ' CG2' ' A' ' 248' ' ' VAL . 13.9 tp -47.29 -58.07 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -49.96 -63.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -41.94 -42.86 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.549 HG12 ' CE1' ' A' ' 263' ' ' PHE . 69.8 t -67.61 -51.17 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -59.73 -28.19 67.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.3 t -45.46 -28.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.832 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 34.5 mtp -51.99 -68.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.67 -56.46 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.91 -170.95 31.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.46 104.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.45 99.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.411 HG23 ' C ' ' A' ' 250' ' ' PHE . 83.1 t -50.09 -50.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.1 ptm180 -153.45 117.44 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -108.53 146.32 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.136 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -165.04 172.09 13.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 49.2 mm -125.25 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 70.5 mt -77.48 136.45 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -130.9 178.16 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.09 177.28 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -38.72 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.08 -53.63 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.69 37.51 0.23 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -105.11 135.95 45.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 51.4 m -69.09 121.33 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -93.21 26.61 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 69.68 21.29 76.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.504 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 46.9 mt -124.99 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 111.147 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.98 166.79 24.55 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.6 p -136.24 143.84 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 223' ' ' PHE . 85.3 t -140.47 134.56 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 22.3 m -114.19 111.72 22.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -87.39 174.87 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -68.6 -60.01 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -127.2 162.67 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.7 p -51.77 -46.6 64.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.8 mm -40.34 -68.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -52.31 -44.83 65.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.476 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.21 -56.9 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 60.0 t -52.29 -45.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -52.74 -42.58 65.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -72.78 -50.27 25.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 72.0 mt -44.7 -52.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.3 m -72.22 -62.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 18.6 mmt -44.79 -23.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.549 ' CE1' HG12 ' A' ' 222' ' ' VAL . 22.9 m-85 -102.72 -28.02 12.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.44 ' OD1' ' C ' ' A' ' 264' ' ' ASN . 19.7 t-20 -56.42 111.05 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.57 11.49 84.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -74.53 128.31 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.42 102.38 10.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.2 tp -112.02 121.64 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 56.77 41.66 27.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.44 ' O ' ' CG ' ' A' ' 270' ' ' ASP . 28.8 t70 63.26 29.51 15.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -147.02 121.46 5.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.601 0.715 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 123.78 10.43 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.289 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 46.1 mtm -85.47 158.2 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -121.68 100.57 7.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.84 128.67 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -144.31 154.97 43.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 13.9 mmt -55.34 132.88 49.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 102.36 14.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.11 88.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -72.39 143.41 48.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -128.73 89.61 2.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.412 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.8 tp -123.26 139.8 32.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.615 0.721 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.412 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 52.9 Cg_endo -69.85 157.14 61.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.308 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -123.36 131.58 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.63 147.78 5.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.21 141.37 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.62 129.45 22.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -101.64 144.54 28.77 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.656 0.741 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 116.92 4.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 155.77 65.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.232 . . . . 0.0 112.338 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 292' ' ' ARG . 6.6 tp10 -126.48 136.57 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.464 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 26.3 ttm180 -38.21 139.73 0.63 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.5 Cg_endo -69.82 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -119.74 177.4 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -139.38 113.89 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 91.2 p -101.55 173.62 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.08 83.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.492 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.92 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.0 t -168.35 146.11 4.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 m -141.43 177.37 8.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.474 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.9 m -116.45 97.4 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.9 p -80.03 102.99 9.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -90.28 40.35 3.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 m -110.3 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 26.3 t -124.59 -36.73 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.01 9.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -84.79 110.37 18.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 196' ' ' LEU . 6.9 mp -125.58 -53.16 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.8 134.48 54.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.4 -51.67 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 46.02 61.25 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -63.7 80.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.6 mt -130.99 157.29 43.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.404 ' N ' ' NH2' ' A' ' 280' ' ' ARG . . . -112.63 -87.13 1.63 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.423 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 204' ' ' THR . 13.1 m -40.14 -45.63 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.835 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 203' ' ' SER . 42.1 m -36.56 128.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.433 HG12 ' CD1' ' A' ' 260' ' ' ILE . 20.1 m -109.4 139.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.513 ' CZ ' HG23 ' A' ' 245' ' ' ILE . 71.8 t80 -99.73 117.05 33.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.65 135.44 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.86 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.94 41.66 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.5 mt -89.25 166.61 13.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.55 139.14 31.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -51.65 -41.68 61.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.02 -33.88 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.04 132.5 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.68 164.75 23.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.492 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.6 p-90 -36.26 -31.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 215' ' ' GLY . 32.1 mttm -60.43 -69.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 219' ' ' LEU . 16.3 mmmt -54.11 -58.16 8.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.554 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 16.2 tp -36.94 -56.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . 0.452 ' HG3' ' CB ' ' A' ' 232' ' ' ALA . 6.8 ttpt -61.1 -67.22 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 224' ' ' SER . 6.3 mm-40 -41.16 -67.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 25.0 t -43.84 -49.08 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.8 m-85 -63.31 -26.14 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 8.2 t -46.45 -23.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 16.3 mtm -55.14 -66.53 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.436 ' HB3' ' N ' ' A' ' 259' ' ' ALA . . . -38.39 -50.84 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.31 -112.94 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.8 t -129.78 110.45 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.436 HG11 ' CG1' ' A' ' 248' ' ' VAL . 49.1 t -70.92 96.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 251' ' ' GLU . 98.3 t -50.05 -49.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.453 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 6.6 ptp85 -151.22 122.4 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.452 ' CB ' ' HG3' ' A' ' 220' ' ' LYS . . . -111.96 151.16 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -169.84 160.47 8.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.46 ' CD1' HD23 ' A' ' 219' ' ' LEU . 49.3 mm -120.01 128.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.0 114.98 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -128.13 174.21 9.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 0.8 OUTLIER -85.91 174.69 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' ASP . 36.8 mtmt -37.36 -48.98 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.44 -64.15 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.47 36.25 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.95 122.24 33.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.2 m -70.62 120.36 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 15.1 ttm105 -92.24 24.54 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.31 12.77 73.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.513 HG23 ' CZ ' ' A' ' 206' ' ' PHE . 47.4 mt -122.37 126.1 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.53 165.91 19.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.3 p -137.45 140.1 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.436 ' CG1' HG11 ' A' ' 229' ' ' VAL . 61.1 t -138.16 146.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.453 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 17.9 m -123.18 111.96 17.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 38.5 m-85 -86.17 165.88 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.451 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 0.7 OUTLIER -52.79 -52.63 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -143.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 254' ' ' ILE . 8.9 t -48.23 -54.21 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.5 mm -35.98 -68.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.159 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -48.71 -46.84 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.77 -60.86 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 94.5 t -42.88 -53.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -47.92 -56.82 6.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.436 ' N ' ' HB3' ' A' ' 226' ' ' ALA . . . -58.54 -55.4 35.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.445 ' HA ' ' CG1' ' A' ' 275' ' ' VAL . 91.7 mt -40.65 -58.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 264' ' ' ASN . 46.4 t -68.71 -61.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.8 mtt -44.42 -22.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -103.88 -26.71 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 264' ' ' ASN . 0.2 OUTLIER -52.34 116.73 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.51 82.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . 0.463 ' OE1' ' N ' ' A' ' 267' ' ' LEU . 6.3 tp-100 -78.24 130.15 35.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . 0.463 ' N ' ' OE1' ' A' ' 266' ' ' GLN . 13.0 mt -87.68 100.37 12.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.1 123.81 49.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 59.89 32.23 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.1 26.78 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -145.32 129.01 8.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 126.57 13.49 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' MET . . . . . 0.451 ' HE2' ' CG ' ' A' ' 266' ' ' GLN . 36.6 mtm -84.17 143.43 29.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -109.87 99.26 8.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.5 t -109.43 131.1 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -151.65 155.07 37.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 9.1 mmt -61.54 138.18 58.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CG ' ' N ' ' A' ' 279' ' ' GLU . 1.9 t70 -53.71 166.56 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 278' ' ' ASP . 2.9 tp10 -85.69 100.45 12.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . 0.404 ' NH2' ' N ' ' A' ' 202' ' ' GLY . 19.0 tpp180 -98.96 142.82 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.49 92.57 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.47 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 7.1 tp -75.04 140.07 73.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.76 -173.22 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.346 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -112.07 -32.83 6.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.85 176.74 50.95 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -136.64 178.93 6.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 110.853 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -137.39 119.32 15.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -110.14 143.99 29.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 124.76 11.4 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 106.63 1.7 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.49 107.37 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.26 151.35 42.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.843 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 125.47 12.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.5 139.98 52.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -109.21 134.14 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.4 t -151.42 108.49 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -130.51 81.44 0.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 173.03 11.56 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 65.1 p -107.66 151.18 26.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 57.9 p -85.02 166.16 16.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.516 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 p -150.54 150.88 31.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.817 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.7 t -143.47 165.73 26.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -137.2 59.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.4 t -174.02 108.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 96.0 p -150.44 144.51 25.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 127.3 51.36 0.15 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.472 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -105.36 92.78 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.49 57.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -76.65 51.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.82 87.55 2.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.09 41.01 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -76.98 115.65 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.43 148.28 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 148.75 168.39 14.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 204' ' ' THR . 34.1 p -106.44 -36.36 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.955 0.407 . . . . 0.0 110.851 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 203' ' ' SER . 62.3 m -34.25 126.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.15 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.81 134.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.35 120.82 35.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 210' ' ' LEU . 49.1 t -109.93 139.72 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.09 165.23 27.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 38.5 t30 62.78 46.43 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.405 ' CD2' HG11 ' A' ' 207' ' ' VAL . 30.8 mt -95.74 149.09 21.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.65 138.47 53.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -50.5 -39.96 49.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -61.26 -41.48 96.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.93 131.48 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -131.93 161.88 23.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -43.36 -34.63 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -62.3 -59.44 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -60.37 -57.18 13.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.4 tp -44.67 -55.86 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -56.04 -52.11 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.16 -58.08 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 71.2 t -52.89 -40.09 34.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.15 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.545 ' CE2' HG22 ' A' ' 248' ' ' VAL . 3.7 m-85 -69.04 -32.62 72.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.3 m -40.65 -25.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 223' ' ' PHE . 51.8 mtp -54.77 -66.31 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.4 -48.62 26.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.59 -165.14 28.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.04 107.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.14 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.83 104.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -42.74 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.072 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -144.42 120.31 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -122.65 133.4 54.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.104 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -164.68 167.69 18.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.82 142.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.3 125.39 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -137.11 176.08 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 238' ' ' LYS . 2.5 m-20 -109.22 178.51 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 237' ' ' ASP . 58.7 mttp -37.87 -59.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -48.12 -48.02 34.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 239' ' ' ASP . . . 105.84 24.8 6.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 239' ' ' ASP . 0.0 OUTLIER -94.07 139.0 31.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.9 m -70.36 120.84 16.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.438 ' NH1' ' HB3' ' A' ' 243' ' ' ARG . 5.4 mmm180 -96.85 27.44 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 64.7 28.11 72.88 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.532 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 75.7 mt -135.95 125.73 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.122 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.21 176.31 19.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.4 p -144.82 136.33 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.129 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.545 HG22 ' CE2' ' A' ' 223' ' ' PHE . 39.3 t -129.22 149.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.2 m -129.17 117.13 20.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.498 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 70.9 m-85 -91.22 -175.2 4.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.87 -54.78 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -129.37 163.63 25.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.5 p -53.91 -41.67 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.8 mm -46.13 -65.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.11 -45.09 68.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.28 -59.17 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -48.24 -56.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.169 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -44.06 -45.92 8.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -69.51 -48.36 60.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 95.3 mt -48.88 -52.82 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 m -69.75 -63.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -42.58 -38.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -88.21 -26.81 22.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -55.2 109.94 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.62 14.63 75.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -77.06 131.27 38.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.4 mt -88.7 103.02 15.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -110.3 122.21 47.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 59.25 34.07 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 71.53 27.49 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -144.48 117.74 5.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 119.86 6.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 47.5 mtm -79.15 163.17 25.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -126.66 100.65 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 129.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -146.23 145.83 30.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.5 mtt -56.79 126.99 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.44 158.16 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -114.29 86.8 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -135.01 114.51 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.53 68.39 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.467 ' CD1' ' HD2' ' A' ' 283' ' ' PRO . 5.3 tp -77.92 140.93 62.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.76 164.6 33.94 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.732 2.288 . . . . 0.0 112.323 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.6 -56.84 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 51.11 52.71 30.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.457 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -120.53 143.05 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -167.36 149.14 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -133.81 137.25 28.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.625 0.726 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 148.27 64.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 101.02 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -83.33 96.36 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -114.56 82.33 7.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 121.64 8.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.615 2.21 . . . . 0.0 112.341 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -128.34 131.34 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -129.13 132.95 47.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.6 t -157.73 145.14 18.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 140.05 145.25 4.64 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.425 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -177.89 2.1 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 1.8 t -132.69 170.2 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -168.22 151.1 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.807 0.337 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.9 138.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.559 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 72.1 t80 -97.0 116.39 29.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 245' ' ' ILE . 13.5 t -104.32 132.85 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.73 166.45 22.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 61.83 50.82 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 207' ' ' VAL . 42.7 mt -102.36 157.97 16.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.569 ' HB2' HG23 ' A' ' 214' ' ' VAL . 0.8 OUTLIER -79.52 136.55 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -48.2 -44.81 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.434 ' NZ ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -57.41 -36.58 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 211' ' ' ASP . 88.9 t -58.42 117.77 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -114.18 168.71 12.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -50.8 -25.33 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.71 -64.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.919 ' O ' HG23 ' A' ' 222' ' ' VAL . 34.6 tptt -57.62 -51.15 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.7 tp -49.24 -54.97 14.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -59.58 -52.9 63.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -50.67 -40.73 54.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 218' ' ' LYS . 29.0 t -66.87 -52.1 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.5 m-85 -60.83 -16.14 37.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.7 t -56.22 -19.3 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.2 mtp -61.69 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -48.57 -37.58 18.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 174.46 -159.8 28.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.2 t -88.03 126.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.886 HG11 ' HB2' ' A' ' 232' ' ' ALA . 93.1 t -84.87 101.99 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.532 ' CG2' ' CD ' ' A' ' 251' ' ' GLU . 45.3 t -59.57 -44.0 92.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.6 ttp85 -141.11 120.43 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.886 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -125.2 130.53 52.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -162.89 166.01 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.32 148.61 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.838 HD12 HG22 ' A' ' 245' ' ' ILE . 77.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.838 HG22 HD12 ' A' ' 235' ' ' LEU . 53.3 mt -132.61 129.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.142 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.87 176.99 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.4 p -139.35 132.78 30.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 223' ' ' PHE . 62.5 t -129.71 135.02 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 230' ' ' VAL . 58.0 m -124.24 115.6 21.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 71.4 m-85 -87.7 -175.45 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.532 ' CD ' ' CG2' ' A' ' 230' ' ' VAL . 24.0 mm-40 -90.23 -53.63 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -114.18 146.58 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 257' ' ' VAL . 93.4 p -50.33 -45.28 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.3 mm -46.53 -56.46 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.487 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 22.1 mt-10 -56.46 -48.4 77.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.408 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.06 -50.5 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 253' ' ' SER . 99.2 t -54.77 -54.78 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -44.94 -54.89 6.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.523 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -53.18 -58.65 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 275' ' ' VAL . 75.6 mt -41.73 -42.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 30.0 t -76.17 -65.74 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -20.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.1 m-85 -104.99 -19.98 13.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 110.16 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.5 84.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.69 130.56 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.9 mt -85.96 100.07 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.559 HD22 ' SD ' ' A' ' 273' ' ' MET . 9.1 tp -107.22 122.73 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 56.52 43.49 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.3 t0 62.38 28.97 17.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -147.09 125.68 6.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 135.17 29.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.559 ' SD ' HD22 ' A' ' 268' ' ' LEU . 33.3 mtm -99.33 153.19 19.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.423 ' NE2' ' HG3' ' A' ' 276' ' ' LYS . 20.2 t-160 -119.21 100.72 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 260' ' ' ILE . 3.4 t -105.25 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.423 ' HG3' ' NE2' ' A' ' 274' ' ' HIS . 30.4 mmtt -120.56 144.86 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 7.9 mtt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.852 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.818 0.342 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.456 HG12 HD11 ' A' ' 260' ' ' ILE . 31.7 m -115.11 132.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -97.0 124.27 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 275' ' ' VAL . 60.7 t -112.93 138.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -145.66 164.8 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 t30 67.82 42.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.8 161.78 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.61 ' HB3' HG23 ' A' ' 214' ' ' VAL . 44.2 t0 -82.24 133.45 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.482 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 16.8 m-85 -48.08 -29.48 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -72.02 -40.38 68.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 211' ' ' ASP . 76.8 t -58.22 141.15 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -141.8 166.17 26.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 217' ' ' LYS . 19.4 p-90 -39.68 -48.39 2.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.528 ' N ' ' CG ' ' A' ' 216' ' ' TRP . 35.5 mttm -47.58 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 222' ' ' VAL . 38.4 tptt -61.0 -49.34 77.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.546 HD22 HD11 ' A' ' 234' ' ' ILE . 9.6 tp -46.47 -48.01 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LYS . . . . . 0.408 ' HG3' HG11 ' A' ' 229' ' ' VAL . 13.4 tttm -68.05 -44.78 75.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.68 -44.39 77.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 218' ' ' LYS . 21.4 t -72.48 -52.99 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -56.9 -32.17 65.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.4 t -48.51 -21.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' MET . . . . . 0.425 ' O ' ' C ' ' A' ' 226' ' ' ALA . 29.1 mtm -57.66 -65.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 225' ' ' MET . . . -35.85 -50.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.15 -104.41 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.09 119.28 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.948 HG11 ' HB2' ' A' ' 232' ' ' ALA . 54.2 t -77.74 96.02 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 231' ' ' ARG . 60.8 t -54.17 -44.79 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.527 ' HG2' HG12 ' A' ' 230' ' ' VAL . 30.6 mmt180 -151.64 117.24 5.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.948 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -115.92 135.39 54.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 232' ' ' ALA . 36.3 m-20 -164.25 161.88 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.546 HD11 HD22 ' A' ' 219' ' ' LEU . 34.0 mm -113.23 150.08 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 245' ' ' ILE . 84.6 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 235' ' ' LEU . 41.5 mt -123.51 123.05 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 111.167 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.22 174.14 20.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.7 p -138.58 143.96 39.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.499 HG21 ' CD2' ' A' ' 223' ' ' PHE . 57.5 t -137.69 151.0 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 m -131.06 113.34 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 71.3 m-85 -88.73 172.42 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.2 -58.75 3.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -124.5 157.51 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 257' ' ' VAL . 4.0 t -49.36 -48.3 46.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.2 mm -38.9 -68.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -52.02 -48.28 64.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -48.6 -52.85 20.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 253' ' ' SER . 45.3 t -54.77 -51.25 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -46.35 -47.5 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 226' ' ' ALA . . . -65.92 -58.75 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.456 HD11 HG12 ' A' ' 205' ' ' VAL . 82.2 mt -41.23 -44.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.6 m -76.81 -65.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -46.71 -21.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.499 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 4.4 m-85 -103.73 -29.34 11.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t-20 -56.02 111.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.99 82.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -73.84 130.4 39.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.35 100.95 13.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 tp -108.71 122.28 46.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 58.22 37.39 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.5 28.64 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -145.68 117.77 5.13 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 123.58 10.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.728 2.286 . . . . 0.0 112.313 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 42.7 mtm -83.36 157.32 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.465 ' C ' ' CD2' ' A' ' 274' ' ' HIS . 3.8 t-160 -119.92 100.72 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.576 HG13 HG22 ' A' ' 207' ' ' VAL . 2.1 t -111.53 126.43 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -145.37 144.22 30.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.434 ' HG2' ' CD1' ' A' ' 260' ' ' ILE . 8.0 mtt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.833 0.349 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.582 HG12 HD11 ' A' ' 260' ' ' ILE . 22.1 m -103.73 133.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 86.9 t80 -98.32 106.64 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 245' ' ' ILE . 52.4 t -94.77 133.65 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.01 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.06 53.44 2.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.64 158.77 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -87.89 130.6 34.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.14 -23.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -69.09 -40.25 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.57 HG13 ' HE2' ' A' ' 218' ' ' LYS . 92.4 t -61.53 119.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.57 162.74 12.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 68.2 p-90 -43.65 -49.19 7.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.496 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 6.9 ptpt -53.75 -54.79 33.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.57 ' HE2' HG13 ' A' ' 214' ' ' VAL . 0.7 OUTLIER -53.49 -59.89 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.529 ' CD1' ' CE1' ' A' ' 223' ' ' PHE . 23.5 tp -46.55 -47.29 19.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -60.03 -55.5 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -53.0 -58.18 7.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.574 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 38.4 t -51.67 -41.15 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.766 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.6 m-85 -70.06 -28.88 65.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 t -42.38 -27.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 50.7 mtp -51.19 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.52 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.93 -57.06 4.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -164.79 -157.39 9.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.9 t -92.36 107.91 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 232' ' ' ALA . 54.0 t -60.75 100.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.512 HG12 ' HG2' ' A' ' 231' ' ' ARG . 89.1 t -55.81 -46.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.138 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.512 ' HG2' HG12 ' A' ' 230' ' ' VAL . 3.4 mmp_? -144.05 122.06 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -117.07 127.15 53.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -152.86 153.94 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 46.0 mm -119.03 128.47 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.572 HD12 ' CG2' ' A' ' 245' ' ' ILE . 58.6 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.655 HG21 ' CZ ' ' A' ' 206' ' ' PHE . 40.7 mt -132.97 136.27 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.148 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 174.54 18.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 68.4 p -142.24 131.07 22.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.766 HG11 ' HD2' ' A' ' 223' ' ' PHE . 70.7 t -127.85 129.36 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 230' ' ' VAL . 33.4 m -110.79 112.4 24.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 61.8 m-85 -88.46 173.3 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.15 -55.29 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.93 159.56 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 257' ' ' VAL . 51.1 p -52.63 -47.65 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.5 mm -42.61 -61.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.422 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 2.3 mp0 -54.6 -47.52 73.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.54 -56.31 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 253' ' ' SER . 23.0 t -51.8 -44.41 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -53.9 -46.89 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.52 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -70.8 -45.89 63.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.582 HD11 HG12 ' A' ' 205' ' ' VAL . 96.4 mt -49.71 -48.95 20.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 13.0 m -72.49 -54.19 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mtt -55.13 -22.49 17.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.574 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 22.1 m-85 -104.8 -16.2 14.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -63.81 110.5 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.03 86.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -71.16 132.63 45.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.7 mt -85.79 100.1 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.641 HD22 ' SD ' ' A' ' 273' ' ' MET . 15.6 tp -107.64 122.33 46.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 58.36 38.68 25.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 67.08 27.53 8.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -144.49 125.66 7.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 121.19 7.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.363 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.641 ' SD ' HD22 ' A' ' 268' ' ' LEU . 55.6 mtm -83.85 152.9 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -118.34 101.13 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.507 HG21 ' CB ' ' A' ' 263' ' ' PHE . 5.7 t -107.49 114.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -133.44 144.63 49.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.808 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.558 HG12 HD11 ' A' ' 260' ' ' ILE . 23.1 m -112.12 135.16 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -97.07 114.7 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.611 HG11 HD21 ' A' ' 210' ' ' LEU . 14.2 t -99.56 138.19 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -140.76 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 m120 62.51 41.88 9.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.611 HD21 HG11 ' A' ' 207' ' ' VAL . 53.5 mt -91.35 149.34 21.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 214' ' ' VAL . 6.7 t70 -78.76 136.17 37.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -43.24 -31.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.84 -39.76 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 211' ' ' ASP . 94.6 t -54.05 111.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.04 170.55 16.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.506 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 52.6 p-90 -57.97 -32.49 67.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.506 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 8.9 mmtp -68.47 -52.38 33.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.633 ' HD2' HG23 ' A' ' 222' ' ' VAL . 16.7 tptm -62.77 -41.52 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.47 -58.77 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -52.9 -58.6 6.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -49.66 -58.89 4.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.633 HG23 ' HD2' ' A' ' 218' ' ' LYS . 20.2 t -51.95 -40.17 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.3 m-85 -72.37 -17.07 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.1 t -58.32 -19.38 34.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 26.3 mtm -57.39 -67.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -40.26 -42.08 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -178.32 -103.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.12 117.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.656 HG11 ' HB2' ' A' ' 232' ' ' ALA . 39.7 t -75.62 102.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 249' ' ' THR . 79.0 t -50.69 -44.39 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.431 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 8.0 ptp180 -159.38 122.76 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.656 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.1 135.01 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -139.72 151.39 45.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.89 125.87 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.96 179.867 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 61.2 mt -132.83 126.31 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.369 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.35 167.31 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 56.3 p -139.94 128.68 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.619 HG21 ' CD2' ' A' ' 223' ' ' PHE . 36.0 t -124.63 140.5 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 230' ' ' VAL . 15.5 m -121.12 117.89 28.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.77 -176.74 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -83.19 -55.82 4.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -128.96 162.15 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 93.7 p -52.75 -48.24 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.1 mm -37.48 -62.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.39 -41.88 90.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.85 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.88 -49.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -48.49 -42.17 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -75.99 -49.56 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.558 HD11 HG12 ' A' ' 205' ' ' VAL . 42.8 mt -51.98 -41.4 31.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.2 t -76.68 -50.77 12.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 30.1 mtt -60.04 -21.66 61.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.495 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 25.0 m-85 -104.51 -22.15 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.6 110.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.9 84.11 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -72.66 123.46 23.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.893 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.78 105.88 14.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.06 121.93 45.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 58.76 35.11 24.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.62 27.74 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 33.5 mtp85 -142.9 119.51 6.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.722 . . . . 0.0 110.819 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.09 3.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.368 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 59.8 mtm -72.14 159.25 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 23.0 t-160 -125.63 103.56 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.463 HG21 ' CB ' ' A' ' 263' ' ' PHE . 2.6 t -111.8 110.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.084 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -124.59 142.18 51.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.424 ' HG3' HD13 ' A' ' 260' ' ' ILE . 15.0 mtt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.824 0.345 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 260' ' ' ILE . 30.5 m -104.99 137.23 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.97 118.46 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.26 134.34 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -137.49 171.91 13.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 m120 60.09 41.53 17.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.0 mt -90.05 155.41 19.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 214' ' ' VAL . 3.3 t70 -67.3 160.76 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -77.71 -33.82 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 65.8 mttt -85.53 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -108.91 164.2 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.609 ' N ' HG12 ' A' ' 214' ' ' VAL . . . -151.2 148.71 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -40.45 -35.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -66.56 -56.36 11.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.471 ' HD3' HG23 ' A' ' 222' ' ' VAL . 1.5 tmtm? -51.22 -44.16 61.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -69.4 -62.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -44.4 -42.28 6.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.605 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 27.1 t -70.29 -43.26 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.2 m-85 -69.19 -15.73 63.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -59.38 -13.21 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.0 mtp -67.5 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.585 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -46.26 -47.39 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.1 -141.44 3.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 50.1 t -105.51 114.68 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.767 HG11 ' HB2' ' A' ' 232' ' ' ALA . 53.5 t -72.11 101.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.177 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.02 -43.69 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.426 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 17.5 ptt180 -160.58 119.8 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.767 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.44 135.24 50.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 159.3 42.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.411 HD11 HD22 ' A' ' 219' ' ' LEU . 48.7 mm -119.31 144.04 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.517 HD12 ' CG2' ' A' ' 245' ' ' ILE . 36.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.517 ' CG2' HD12 ' A' ' 235' ' ' LEU . 51.8 mt -131.33 126.18 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.26 175.27 20.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 p -143.48 138.47 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 229' ' ' VAL . 44.1 t -135.19 143.51 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 89.2 m -124.4 123.74 40.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 256' ' ' ALA . 74.2 m-85 -97.62 175.5 6.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -60.15 2.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -109.49 142.58 40.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 257' ' ' VAL . 85.7 p -47.82 -43.24 27.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 mm -46.88 -57.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.44 -49.79 75.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 250' ' ' PHE . . . -51.32 -48.03 62.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 253' ' ' SER . 65.7 t -57.6 -53.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -46.07 -46.92 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.585 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -64.4 -50.55 67.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.519 HD13 ' HG2' ' A' ' 277' ' ' MET . 96.6 mt -47.53 -50.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 264' ' ' ASN . 15.8 m -72.22 -61.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.8 mmt -45.17 -24.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.605 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 23.6 m-85 -104.43 -19.36 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 261' ' ' SER . 10.9 t30 -60.35 113.0 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.54 6.65 89.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.553 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.95 126.17 28.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.88 0.371 . . . . 0.0 110.93 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.56 100.16 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.563 HD22 ' SD ' ' A' ' 273' ' ' MET . 16.0 tp -106.05 121.13 43.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.959 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 59.03 37.76 24.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 68.55 26.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -143.67 124.48 7.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.563 ' SD ' HD22 ' A' ' 268' ' ' LEU . 63.2 mtm -84.51 145.36 28.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 21.6 t-160 -109.79 99.25 8.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.438 HG21 ' CB ' ' A' ' 263' ' ' PHE . 4.0 t -109.04 124.66 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 277' ' ' MET . 1.6 ttpm? -149.09 160.55 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.519 ' HG2' HD13 ' A' ' 260' ' ' ILE . 9.4 mmt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 260' ' ' ILE . 11.4 m -124.99 139.69 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -100.32 127.35 46.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 210' ' ' LEU . 45.9 t -116.54 130.51 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.72 170.68 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.67 50.84 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.485 HD11 ' CG1' ' A' ' 207' ' ' VAL . 50.3 mt -100.03 159.95 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 214' ' ' VAL . 25.5 t0 -86.16 131.54 34.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -44.82 -23.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -75.73 -39.54 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 268' ' ' LEU . 70.1 t -59.74 112.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -109.83 172.84 16.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -51.19 -28.94 12.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' A' ' 221' ' ' GLU . 45.0 mttp -67.78 -52.94 31.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.736 ' O ' HG23 ' A' ' 222' ' ' VAL . 19.5 tptm -65.38 -50.48 65.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.665 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.5 tp -49.91 -53.42 26.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -62.21 -61.79 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 217' ' ' LYS . 0.4 OUTLIER -43.15 -56.63 3.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 218' ' ' LYS . 46.2 t -56.0 -46.94 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 248' ' ' VAL . 3.3 m-85 -63.13 -14.84 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.4 t -59.18 -13.91 8.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 41.7 mtp -69.08 -60.71 2.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.567 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -44.93 -52.56 8.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.51 -127.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 68.0 t -114.78 119.88 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 232' ' ' ALA . 84.6 t -81.59 98.65 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.1 t -51.45 -43.74 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.35 117.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.3 153.38 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -167.73 167.1 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.665 ' CD1' HD22 ' A' ' 219' ' ' LEU . 16.3 mm -126.2 133.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.477 HD12 HG22 ' A' ' 245' ' ' ILE . 44.0 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.477 HG22 HD12 ' A' ' 235' ' ' LEU . 71.1 mt -134.68 129.81 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.15 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.69 166.38 24.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 48.2 p -135.8 140.68 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 223' ' ' PHE . 2.8 t -134.73 143.91 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.1 m -120.96 121.7 38.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -95.34 -176.32 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.83 -53.22 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -134.76 159.29 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 257' ' ' VAL . 91.9 p -48.86 -36.98 18.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 30.8 mm -47.32 -63.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -58.75 -44.43 90.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.73 -54.55 22.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 253' ' ' SER . 89.1 t -55.72 -49.13 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -48.32 -47.31 36.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.567 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -69.23 -55.09 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.619 HD11 HG12 ' A' ' 205' ' ' VAL . 95.2 mt -45.74 -43.37 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -77.6 -59.93 2.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.4 mmt -51.06 -22.81 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.498 ' CB ' HG21 ' A' ' 275' ' ' VAL . 3.5 m-85 -103.07 -21.0 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -55.33 113.33 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.05 82.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -70.56 127.12 31.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.65 101.37 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.453 HD23 HG21 ' A' ' 214' ' ' VAL . 9.9 tp -110.15 124.64 51.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 57.31 32.73 22.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 72.13 31.45 1.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -144.85 120.72 6.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.592 0.71 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 118.46 5.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.704 2.27 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 55.7 mtm -79.87 147.07 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -113.5 99.03 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 263' ' ' PHE . 1.8 t -107.65 127.0 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.8 tttm -149.54 159.53 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 11.0 mtt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.841 0.353 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.697 HG12 HD11 ' A' ' 260' ' ' ILE . 20.4 m -124.45 145.5 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -102.58 118.51 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -122.76 167.91 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.35 51.69 8.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.95 163.23 13.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.62 ' HB3' HG23 ' A' ' 214' ' ' VAL . 1.7 t0 -80.75 118.14 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -41.27 -41.88 2.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -61.0 -37.45 82.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 211' ' ' ASP . 53.3 t -55.72 151.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -135.26 172.44 22.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 30.3 p-90 -57.09 -39.72 75.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 5.3 mtpm? -62.84 -48.49 78.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.761 ' HZ1' HD11 ' A' ' 268' ' ' LEU . 0.5 OUTLIER -63.81 -48.83 75.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 11.2 tp -55.88 -52.55 63.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -59.06 -60.26 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.24 -45.27 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 218' ' ' LYS . 85.9 t -69.21 -51.95 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.773 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.2 m-85 -56.76 -12.86 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.2 t -57.46 -12.23 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.3 mtm -65.31 -66.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.818 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -48.83 -39.96 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.073 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 176.65 -171.78 44.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.4 122.16 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 232' ' ' ALA . 94.3 t -79.0 103.66 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.44 -39.31 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -148.62 120.3 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -124.98 135.48 52.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.69 167.54 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.64 133.51 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 245' ' ' ILE . 86.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 235' ' ' LEU . 47.7 mt -127.71 124.31 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.78 176.33 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.494 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 57.6 p -142.8 136.73 29.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.773 HG21 ' CD2' ' A' ' 223' ' ' PHE . 45.9 t -127.17 139.88 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.6 m -123.21 111.06 16.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.563 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 91.0 m-85 -86.62 -175.25 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.49 -49.36 8.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -132.29 156.71 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 16.7 t -48.71 -52.81 21.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 27.9 mm -37.67 -62.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.137 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.788 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 33.7 mt-10 -53.77 -48.47 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.563 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.61 -60.69 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.451 HG22 ' CE ' ' A' ' 277' ' ' MET . 95.7 t -42.87 -56.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -47.87 -52.29 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.818 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -58.88 -42.86 90.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.697 HD11 HG12 ' A' ' 205' ' ' VAL . 48.7 mt -62.62 -59.61 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.1 m -54.29 -42.81 70.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -69.85 -67.17 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 223' ' ' PHE . 41.9 m-85 -57.47 -14.02 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.0 OUTLIER -65.34 110.56 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.57 81.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 10.5 mm100 -69.89 146.03 51.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 267' ' ' LEU . 11.1 mt -97.97 102.43 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.761 HD11 ' HZ1' ' A' ' 218' ' ' LYS . 16.9 tp -112.76 123.52 50.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.434 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 12.1 m-85 56.2 40.61 29.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.5 t70 64.21 30.99 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -147.08 123.25 5.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.566 0.698 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 266' ' ' GLN . 54.1 Cg_endo -69.73 124.45 11.11 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.363 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.407 ' SD ' HD22 ' A' ' 268' ' ' LEU . 61.0 mtm -85.86 153.07 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 15.2 t-160 -117.35 99.85 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.82 124.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 277' ' ' MET . 22.2 tttm -142.64 157.57 44.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.575 ' HG2' HD13 ' A' ' 260' ' ' ILE . 7.9 mtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.921 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.84 0.352 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.653 HG12 HD11 ' A' ' 260' ' ' ILE . 15.7 m -126.08 148.39 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -104.06 111.67 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 245' ' ' ILE . 15.2 t -101.75 138.11 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.158 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.6 170.09 16.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.12 54.43 3.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.04 148.95 30.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.83 141.49 44.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -51.41 -19.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -75.25 -42.48 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.456 HG21 HD23 ' A' ' 268' ' ' LEU . 41.5 t -60.74 109.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.5 13.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.473 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 42.1 p-90 -48.24 -34.88 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 99.1 mttt -60.15 -57.25 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -64.31 -57.73 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 22.8 tp -38.69 -49.57 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -67.25 -48.19 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.93 -32.11 60.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.778 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 38.8 t -78.0 -43.59 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.632 ' CD2' HG11 ' A' ' 248' ' ' VAL . 3.5 m-85 -66.42 -21.28 66.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -51.57 -19.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 7.9 mtm -65.67 -59.67 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -53.13 -45.35 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 178.81 -162.94 30.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.94 122.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 232' ' ' ALA . 78.6 t -78.44 101.0 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.496 HG23 ' C ' ' A' ' 250' ' ' PHE . 77.0 t -52.59 -42.08 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.423 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 29.2 ptt180 -163.81 117.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.799 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -107.98 151.61 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -166.59 172.95 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 23.5 mm -129.51 119.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 245' ' ' ILE . 96.7 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.683 HG22 HD12 ' A' ' 235' ' ' LEU . 40.8 mt -112.04 128.85 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 111.159 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.8 168.28 21.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.4 p -139.01 135.77 34.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.632 HG11 ' CD2' ' A' ' 223' ' ' PHE . 35.0 t -130.47 139.31 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.8 m -120.8 115.81 23.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 80.8 m-85 -88.83 178.59 6.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -80.75 -55.23 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -117.81 145.03 44.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 257' ' ' VAL . 83.8 p -47.06 -45.51 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -42.4 -62.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -55.63 -49.18 73.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.05 -49.79 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 253' ' ' SER . 65.2 t -57.3 -53.6 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -45.59 -42.95 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -66.57 -52.21 47.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.653 HD11 HG12 ' A' ' 205' ' ' VAL . 75.8 mt -48.88 -48.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.5 m -71.96 -58.88 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 85.6 mmm -51.83 -24.49 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.778 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 20.8 m-85 -102.05 -15.08 16.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.52 111.93 4.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.25 90.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -70.73 125.9 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.03 101.88 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.669 HD22 ' SD ' ' A' ' 273' ' ' MET . 12.3 tp -108.6 123.7 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 58.72 39.25 24.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.7 26.65 9.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -145.54 124.61 6.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 0.0 110.836 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 119.49 6.43 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.669 ' SD ' HD22 ' A' ' 268' ' ' LEU . 59.7 mtm -80.5 154.91 27.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -119.95 108.81 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.549 HG21 ' CB ' ' A' ' 263' ' ' PHE . 2.7 t -116.79 122.31 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -131.72 147.95 52.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.52 ' HG2' HD13 ' A' ' 260' ' ' ILE . 3.4 mtp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.821 0.344 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.77 137.26 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 208' ' ' ALA . 67.6 t80 -99.73 123.52 44.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.663 ' CG1' HD11 ' A' ' 210' ' ' LEU . 66.4 t -112.8 128.42 69.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.412 ' HB2' ' CE2' ' A' ' 206' ' ' PHE . . . -132.07 167.55 19.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.4 t30 68.43 45.52 1.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.663 HD11 ' CG1' ' A' ' 207' ' ' VAL . 34.0 mt -104.31 133.84 48.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.47 ' OD2' ' CD2' ' A' ' 269' ' ' PHE . 0.5 OUTLIER -67.5 145.74 54.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -47.63 -33.75 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -58.02 -35.24 70.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.42 HG23 ' CG ' ' A' ' 211' ' ' ASP . 46.4 t -56.06 117.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -117.97 146.6 18.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.555 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 32.0 p-90 -35.44 -45.11 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.555 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 32.7 mtpt -55.92 -60.03 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 219' ' ' LEU . 15.9 tptm -54.19 -65.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.822 HD22 HD11 ' A' ' 234' ' ' ILE . 14.3 tp -35.23 -58.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LYS . . . . . 0.432 ' HD2' ' HB3' ' A' ' 232' ' ' ALA . 69.3 tttt -59.42 -49.67 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.918 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.32 -20.9 12.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 89.1 t -91.34 -45.5 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.513 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.4 m-85 -64.58 -15.99 61.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 42.3 p -58.51 -15.28 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 29.4 mtm -66.42 -55.47 15.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.622 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -57.68 -41.0 80.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.24 -161.67 30.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.52 108.48 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.79 HG11 ' HB2' ' A' ' 232' ' ' ALA . 55.6 t -69.54 104.72 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 53.8 t -50.69 -46.46 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.438 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 0.2 OUTLIER -153.58 122.96 6.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.79 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -117.73 133.42 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 232' ' ' ALA . 2.0 m-20 -161.17 167.17 26.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.822 HD11 HD22 ' A' ' 219' ' ' LEU . 7.0 mm -124.7 138.56 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.4 mt -137.03 128.62 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.69 170.36 18.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.5 p -138.43 138.23 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 229' ' ' VAL . 3.0 t -137.9 151.34 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 15.6 m -133.48 118.89 18.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -88.82 175.98 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.11 -55.93 4.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.02 155.9 35.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 254' ' ' ILE . 69.0 p -51.67 -50.82 59.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 253' ' ' SER . 14.4 mm -36.39 -62.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.557 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 13.3 mt-10 -57.41 -45.96 84.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.3 49.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.07 -54.09 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -44.82 -43.01 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -72.45 -53.27 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.0 mt -42.68 -46.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.8 m -76.85 -63.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.0 mmm -45.89 -24.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.547 ' HB3' HG21 ' A' ' 275' ' ' VAL . 3.6 m-85 -100.3 -30.77 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -55.13 111.15 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.07 14.01 77.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -77.08 127.87 33.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.1 mt -85.83 99.94 11.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.67 125.34 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.47 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 25.8 m-85 58.86 33.95 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 70.35 28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -146.85 124.58 5.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.613 0.721 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 126.2 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.413 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 41.7 mtm -86.54 151.37 23.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -115.87 102.29 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 263' ' ' PHE . 1.7 t -115.55 124.47 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 158.71 43.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 11.3 mtt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.448 HG12 HD11 ' A' ' 260' ' ' ILE . 31.9 m -112.03 134.15 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -95.02 112.27 23.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.494 ' CG1' HD11 ' A' ' 210' ' ' LEU . 12.3 t -101.18 129.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.475 ' HB3' ' ND1' ' A' ' 274' ' ' HIS . . . -135.94 161.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.2 t30 67.54 47.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' A' ' 207' ' ' VAL . 46.1 mt -99.96 146.79 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -74.26 137.69 43.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -45.16 -36.43 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -59.97 -43.41 95.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.82 121.88 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -122.12 161.65 16.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.519 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.51 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 56.7 p-90 -35.53 -48.53 0.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.51 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 4.5 ptpt -50.85 -62.66 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 219' ' ' LEU . 18.5 tptp -50.93 -66.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.9 tp -35.43 -42.98 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -69.85 -64.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -42.98 -38.83 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 69.8 t -74.72 -39.83 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.123 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.64 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.1 m-85 -73.72 -10.33 59.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.6 t -62.31 -23.48 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.9 mtm -59.98 -61.53 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.58 -54.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.117 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.97 -144.65 4.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -99.54 114.85 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.91 HG11 ' HB2' ' A' ' 232' ' ' ALA . 42.2 t -78.82 103.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 249' ' ' THR . 40.3 t -50.87 -37.04 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.416 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 39.2 ptt85 -168.56 118.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.91 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -114.37 142.78 45.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -169.66 168.62 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.402 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.5 mm -116.52 141.8 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 36.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.7 mt -132.43 125.44 53.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.164 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.38 168.15 21.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 52.5 p -132.54 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.112 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.64 HG11 ' HD2' ' A' ' 223' ' ' PHE . 63.0 t -134.54 138.65 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 230' ' ' VAL . 28.7 m -119.37 117.98 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.47 -178.83 5.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.23 -52.71 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.57 156.32 44.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 17.3 t -48.59 -49.83 35.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.4 mm -39.14 -64.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -53.59 -45.25 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.49 -56.39 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.2 t -50.28 -55.35 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -44.03 -51.58 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 263' ' ' PHE . . . -65.3 -50.8 64.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 205' ' ' VAL . 84.7 mt -46.85 -52.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.4 m -72.48 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 53.4 mmm -46.61 -24.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.553 ' CE2' ' HB1' ' A' ' 259' ' ' ALA . 26.2 m-85 -103.3 -23.36 13.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.13 110.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.68 89.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -69.98 130.56 42.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.09 100.99 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.6 tp -109.4 121.96 46.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 59.34 41.95 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 19.6 t70 63.39 24.97 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.28 125.34 7.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 138.19 37.05 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 32.9 mtm -97.39 152.91 18.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.475 ' ND1' ' HB3' ' A' ' 208' ' ' ALA . 5.7 t-160 -115.74 99.17 7.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 263' ' ' PHE . 1.5 t -112.93 118.45 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -139.11 146.14 40.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 24.4 mtt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.649 HG12 HD11 ' A' ' 260' ' ' ILE . 3.6 m -124.39 150.73 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 208' ' ' ALA . 71.0 t80 -106.68 122.05 45.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.32 124.37 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.567 ' HB2' ' CE2' ' A' ' 206' ' ' PHE . . . -124.21 167.87 13.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 62.16 50.98 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.39 146.35 28.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.88 145.43 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.86 -26.63 36.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.03 -37.51 72.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.07 110.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.126 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -103.88 175.04 22.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.498 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 12.4 p-90 -57.13 -32.68 66.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 30.3 mmtt -66.43 -56.41 11.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -59.11 -56.42 22.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.603 HD22 HD11 ' A' ' 234' ' ' ILE . 14.2 tp -46.45 -51.26 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.65 -67.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -38.73 -49.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.543 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 23.8 t -59.66 -45.61 94.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.62 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.1 m-85 -66.2 -14.39 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 t -55.64 -22.99 25.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.3 mtm -57.32 -63.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.51 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -41.46 -50.03 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.13 -106.28 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 45.6 t -139.99 112.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.651 HG11 ' HB2' ' A' ' 232' ' ' ALA . 71.6 t -70.15 103.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 249' ' ' THR . 65.6 t -51.46 -37.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.405 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.2 ptm180 -168.16 121.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.651 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -107.73 151.03 26.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.36 161.36 30.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.603 HD11 HD22 ' A' ' 219' ' ' LEU . 32.8 mm -128.34 126.37 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 245' ' ' ILE . 82.6 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.941 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 235' ' ' LEU . 72.1 mt -136.22 139.29 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 80.8 p -144.69 145.14 31.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.62 HG11 ' HD2' ' A' ' 223' ' ' PHE . 21.1 t -133.89 130.41 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.3 m -106.72 121.22 43.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 42.9 m-85 -96.06 177.89 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 3.6 mm-40 -76.8 -55.74 5.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -131.09 155.59 46.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.824 ' O ' HG23 ' A' ' 257' ' ' VAL . 38.7 p -47.99 -32.18 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.66 -67.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.45 -43.33 75.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.54 -49.72 67.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 253' ' ' SER . 62.6 t -57.26 -53.15 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -48.24 -44.63 33.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -66.77 -62.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.649 HD11 HG12 ' A' ' 205' ' ' VAL . 78.2 mt -40.8 -39.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.7 t -78.97 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 34.9 mtp -49.93 -21.39 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.543 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 41.9 m-85 -103.89 -21.97 13.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -55.58 111.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.72 18.21 71.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -78.39 125.16 28.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.46 101.66 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.455 HD22 ' SD ' ' A' ' 273' ' ' MET . 11.6 tp -111.12 124.88 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 59.42 31.74 21.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 73.46 28.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -144.9 126.84 7.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 117.26 4.98 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 0.0 112.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.455 ' SD ' HD22 ' A' ' 268' ' ' LEU . 47.3 mtm -78.07 150.72 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 14.6 t-160 -117.33 104.37 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.53 HG21 ' HB3' ' A' ' 263' ' ' PHE . 1.6 t -114.29 119.9 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 277' ' ' MET . 11.4 ttmt -136.55 157.22 47.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.457 ' HG2' HD13 ' A' ' 260' ' ' ILE . 3.9 mtt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.819 0.342 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.527 HG12 HD11 ' A' ' 260' ' ' ILE . 35.4 m -108.0 138.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.185 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.435 ' CZ ' ' CG2' ' A' ' 245' ' ' ILE . 83.0 t80 -105.6 123.42 47.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.674 HG22 HG13 ' A' ' 275' ' ' VAL . 58.5 t -110.64 141.83 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 167.63 21.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 272' ' ' PRO . 62.7 t30 62.81 50.54 3.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 207' ' ' VAL . 83.7 mt -104.16 158.51 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -77.16 133.65 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -50.61 -34.59 26.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.925 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -64.75 -35.86 82.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.59 139.68 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.16 21.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 1.9 p-90 -44.54 -39.59 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 57.6 mttt -60.42 -55.56 32.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.826 ' NZ ' HD11 ' A' ' 268' ' ' LEU . 1.8 tmtt? -56.85 -57.69 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.4 tp -48.36 -52.58 21.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LYS . . . . . 0.532 ' HG2' HG11 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -57.5 -59.95 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -43.35 -44.96 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 218' ' ' LYS . 16.9 t -64.57 -52.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.7 m-85 -56.08 -18.51 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -52.19 -20.3 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 15.7 mtp -61.61 -62.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 255' ' ' GLU . . . -50.78 -35.84 33.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 170.93 -144.99 8.64 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.64 130.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.993 HG11 ' HB2' ' A' ' 232' ' ' ALA . 33.2 t -84.84 97.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.79 -42.78 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -153.7 116.99 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.993 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -118.4 141.22 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -164.59 171.69 14.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 16.7 mm -127.23 135.68 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.922 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.526 -0.229 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.435 ' CG2' ' CZ ' ' A' ' 206' ' ' PHE . 32.7 mt -135.25 125.41 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.848 0.356 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.49 176.3 19.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.0 p -148.56 141.97 25.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.166 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 249' ' ' THR . 45.4 t -132.49 156.03 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 248' ' ' VAL . 92.0 m -128.73 109.76 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.454 ' CZ ' ' CB ' ' A' ' 259' ' ' ALA . 64.8 m-85 -83.85 -178.37 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.87 -51.22 7.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.14 158.16 44.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 96.8 p -44.83 -50.99 9.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -38.79 -67.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.639 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 5.7 mm-40 -50.27 -43.71 53.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.72 1.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 44.4 t -43.31 -49.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.22 -41.12 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.62 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -71.51 -55.38 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 205' ' ' VAL . 65.2 mt -50.13 -38.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 36.6 m -79.62 -53.81 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 15.1 mmt -58.78 -22.1 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.0 m-85 -103.69 -23.19 13.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t30 -58.81 110.5 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.59 88.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.13 131.31 42.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.08 100.03 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.826 HD11 ' NZ ' ' A' ' 218' ' ' LYS . 9.1 tp -106.77 121.84 45.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 57.78 43.67 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 22.9 t70 62.53 26.39 15.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -146.98 126.98 6.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.642 0.734 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 209' ' ' ASN . 53.7 Cg_endo -69.66 131.8 22.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.801 ' SD ' HD22 ' A' ' 268' ' ' LEU . 19.2 mtm -95.43 143.19 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -107.36 100.25 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 207' ' ' VAL . 1.9 t -109.06 124.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -146.93 127.5 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.788 0.328 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.575 HG12 HD11 ' A' ' 260' ' ' ILE . 10.7 m -127.21 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -97.34 117.32 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.6 t -108.02 132.31 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.146 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.91 167.31 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.46 ' O ' ' ND2' ' A' ' 209' ' ' ASN . 0.1 OUTLIER 71.46 32.6 2.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.85 156.81 19.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' A' ' 214' ' ' VAL . 6.9 t70 -71.67 176.23 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -85.03 -30.23 24.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.74 33.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 211' ' ' ASP . 81.4 t -107.27 128.83 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -126.26 152.91 18.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -40.3 -33.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -60.1 -53.37 58.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.575 ' O ' HG23 ' A' ' 222' ' ' VAL . 0.0 OUTLIER -63.71 -50.41 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.648 HD22 ' CD1' ' A' ' 234' ' ' ILE . 17.9 tp -51.25 -56.43 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 232' ' ' ALA . 22.8 ttmt -60.57 -55.8 29.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 224' ' ' SER . 26.9 mm-40 -46.95 -59.97 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 218' ' ' LYS . 51.1 t -56.13 -51.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.571 ' CD2' HG21 ' A' ' 248' ' ' VAL . 4.2 m-85 -59.61 -13.98 11.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 5.4 t -58.53 -22.15 54.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.3 mtm -55.4 -62.07 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -49.59 -55.96 11.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.62 -150.43 6.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.01 96.6 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.993 HG11 ' HB2' ' A' ' 232' ' ' ALA . 87.6 t -50.48 96.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 249' ' ' THR . 55.6 t -52.79 -50.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -139.62 119.82 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.993 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -126.64 133.19 51.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.437 ' CG ' ' C ' ' A' ' 232' ' ' ALA . 0.4 OUTLIER -163.14 165.3 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.648 ' CD1' HD22 ' A' ' 219' ' ' LEU . 4.6 mm -124.39 151.33 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.916 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 83.5 mt -137.52 132.91 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.79 171.65 24.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.544 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.4 p -134.37 139.97 45.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.781 HG13 HG13 ' A' ' 229' ' ' VAL . 72.3 t -138.6 128.29 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.13 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 230' ' ' VAL . 94.0 m -111.79 123.11 49.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 226' ' ' ALA . 66.4 m-85 -96.7 175.51 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -69.96 -57.29 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.98 162.67 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.963 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.591 ' O ' HG23 ' A' ' 257' ' ' VAL . 0.9 OUTLIER -52.57 -38.42 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.6 mm -47.24 -66.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.49 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 4.9 mm-40 -54.79 -43.56 72.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.38 67.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 253' ' ' SER . 65.5 t -60.34 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -48.96 -43.88 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.626 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -68.36 -59.67 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.076 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 275' ' ' VAL . 33.4 mt -43.99 -42.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.4 m -76.27 -60.66 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -50.14 -23.36 2.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.886 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 3.6 m-85 -102.46 -22.8 13.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.63 111.38 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.95 17.87 71.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -77.21 122.5 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 267' ' ' LEU . 11.5 mt -81.21 99.98 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.545 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -108.55 122.01 46.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.21 43.6 20.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 24.0 t0 63.24 25.45 14.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.74 125.22 8.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 126.55 13.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.545 ' SD ' HD22 ' A' ' 268' ' ' LEU . 46.0 mtm -85.54 155.93 20.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -121.14 101.12 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 260' ' ' ILE . 2.7 t -111.56 117.8 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.7 tttm -136.81 157.6 46.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.447 ' CE ' HG22 ' A' ' 257' ' ' VAL . 14.0 mtt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.802 0.334 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 260' ' ' ILE . 24.2 m -111.97 142.65 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -99.06 117.19 33.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 245' ' ' ILE . 33.1 t -107.89 130.16 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -135.23 170.87 15.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 62.19 50.06 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 51.4 mt -101.41 158.78 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' A' ' 214' ' ' VAL . 18.1 t0 -67.88 174.42 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -92.46 -6.22 50.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.58 ' HD2' ' CE1' ' A' ' 269' ' ' PHE . 10.1 ptpt -111.51 31.58 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 211' ' ' ASP . 14.9 t -108.5 132.25 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.62 158.53 15.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.418 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 35.1 p-90 -45.82 -31.39 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 32.3 mtpt -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.804 ' O ' HG23 ' A' ' 222' ' ' VAL . 2.5 tmtp? -63.13 -50.84 68.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.8 tp -59.39 -38.99 81.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -69.35 -64.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 222' ' ' VAL . 12.0 pt-20 -44.32 -40.91 5.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 218' ' ' LYS . 89.6 t -66.89 -52.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.538 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.2 m-85 -61.64 -14.01 27.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.5 t -52.03 -25.06 7.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.0 mtm -57.62 -64.25 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -47.76 -48.16 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -179.3 -154.65 13.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.81 127.05 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.38 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.958 HG11 ' HB2' ' A' ' 232' ' ' ALA . 73.5 t -84.54 99.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -148.54 118.97 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.958 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -119.83 142.24 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -165.88 169.36 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 219' ' ' LEU . 44.3 mm -129.53 132.91 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 207' ' ' VAL . 44.4 mt -135.78 126.27 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.133 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.19 168.65 20.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.52 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 73.5 p -138.32 145.49 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 t -139.1 155.25 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.1 m -129.76 115.48 17.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -89.01 -177.62 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.89 -55.68 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -129.29 158.58 38.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 257' ' ' VAL . 14.8 p -51.08 -34.14 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -49.37 -68.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.37 -43.39 75.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.25 -46.6 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 253' ' ' SER . 76.2 t -63.26 -48.67 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -47.96 -49.49 30.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.4 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -64.32 -60.06 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.677 HD11 HG12 ' A' ' 205' ' ' VAL . 74.8 mt -39.9 -38.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 m -82.0 -64.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -48.46 -19.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.538 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.9 m-85 -104.81 -25.33 12.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.05 112.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.48 11.97 79.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLN . . . . . 0.462 ' NE2' ' N ' ' A' ' 267' ' ' LEU . 0.0 OUTLIER -77.09 124.39 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.927 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.462 ' N ' ' NE2' ' A' ' 266' ' ' GLN . 13.1 mt -79.91 99.87 7.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.758 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -106.72 123.25 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' PHE . . . . . 0.58 ' CE1' ' HD2' ' A' ' 213' ' ' LYS . 9.2 m-85 60.03 37.43 21.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 68.79 24.97 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.94 127.13 8.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 120.29 7.09 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.758 ' SD ' HD22 ' A' ' 268' ' ' LEU . 35.3 mtm -80.88 151.91 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -115.89 105.73 13.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.71 125.73 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.159 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -144.7 157.33 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.415 ' HG2' HD13 ' A' ' 260' ' ' ILE . 7.9 mmt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 205' ' ' VAL . 30.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.69 HG12 HD11 ' A' ' 260' ' ' ILE . 22.3 m -132.49 143.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -100.37 113.26 25.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 245' ' ' ILE . 3.7 t -101.33 135.04 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -139.88 165.46 27.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 t30 63.29 49.99 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 42.1 mt -100.85 162.91 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 214' ' ' VAL . 0.6 OUTLIER -83.11 132.57 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -44.06 -44.3 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -56.42 -40.17 74.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 211' ' ' ASP . 74.2 t -51.91 123.58 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 218' ' ' LYS . . . -121.5 158.39 16.24 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.48 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 25.1 p-90 -38.89 -32.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.48 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 22.5 mtpp -72.35 -47.85 46.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 222' ' ' VAL . 3.1 tmtt? -66.2 -49.64 66.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.427 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.3 tp -56.38 -50.84 70.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' A' ' 232' ' ' ALA . 26.5 tttm -66.55 -35.04 79.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.66 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 218' ' ' LYS . 38.4 t -83.79 -49.13 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.134 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -59.1 -26.38 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.5 t -46.01 -24.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.1 mtm -57.91 -65.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.27 -42.34 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.92 -160.74 28.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.9 123.53 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 232' ' ' ALA . 47.0 t -83.66 98.76 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 76.1 t -54.6 -48.07 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -136.55 123.28 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -126.28 128.98 47.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -163.56 163.87 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.427 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.3 mm -122.73 148.1 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 207' ' ' VAL . 28.6 mt -132.01 123.08 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.123 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.46 169.5 15.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.1 p -135.33 135.47 40.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.81 143.48 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 24.5 m -126.54 117.6 23.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 226' ' ' ALA . 67.7 m-85 -88.08 -177.91 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.47 -48.39 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -132.92 155.7 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.3 p -49.14 -46.0 44.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 23.8 mm -41.02 -60.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.43 -42.02 90.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.0 -54.2 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.74 -49.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -47.92 -48.29 31.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -67.93 -58.28 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.69 HD11 HG12 ' A' ' 205' ' ' VAL . 80.3 mt -41.36 -46.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.2 m -77.09 -62.22 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 49.7 mmm -47.62 -21.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.416 ' CB ' HG21 ' A' ' 275' ' ' VAL . 4.6 m-85 -104.58 -30.64 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -50.52 115.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.98 16.56 76.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -81.58 121.28 26.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.8 100.63 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.571 HD21 ' HZ1' ' A' ' 218' ' ' LYS . 13.6 tp -108.87 123.14 48.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 59.23 31.56 21.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 74.08 28.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -145.19 121.78 6.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 115.43 4.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 58.8 mtm -73.95 153.53 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 1.4 t60 -118.01 100.3 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.2 t -109.96 113.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 277' ' ' MET . 1.8 tppp? -124.1 157.6 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.643 ' HG2' HD13 ' A' ' 260' ' ' ILE . 24.0 mtp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.531 HG12 HD11 ' A' ' 260' ' ' ILE . 34.4 m -111.06 130.38 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -95.32 118.58 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 275' ' ' VAL . 80.8 t -106.31 140.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.82 163.51 32.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 65.66 43.37 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.548 HD11 ' CG1' ' A' ' 207' ' ' VAL . 45.2 mt -92.77 149.01 21.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 3.3 t70 -60.12 162.89 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.415 ' N ' ' CG ' ' A' ' 211' ' ' ASP . 19.1 m-85 -79.12 -34.32 43.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.479 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 20.8 mtpp -82.99 37.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -110.02 157.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.131 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 214' ' ' VAL . . . -150.53 155.98 26.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -46.99 -33.43 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.4 -44.83 77.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -56.49 12.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.4 tp -49.94 -61.25 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LYS . . . . . 0.544 ' HG3' HG11 ' A' ' 229' ' ' VAL . 35.9 tttm -50.25 -58.19 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -44.12 -39.89 4.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.647 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 20.0 t -73.73 -46.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.65 -20.05 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.3 t -53.22 -22.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.846 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 11.0 mtm -62.93 -61.64 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -50.85 -52.98 36.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -176.2 -160.26 23.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 67.9 t -79.32 124.84 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 0.0 111.1 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 232' ' ' ALA . 79.6 t -87.47 96.0 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.79 -45.57 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -139.84 121.26 15.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.952 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -125.92 124.12 40.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.551 ' CD1' HD22 ' A' ' 219' ' ' LEU . 35.5 mm -124.17 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 245' ' ' ILE . 86.6 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 207' ' ' VAL . 48.5 mt -132.81 132.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.69 176.99 18.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p -151.82 127.26 10.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.649 ' CG1' HG13 ' A' ' 229' ' ' VAL . 33.0 t -130.16 154.67 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.157 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 248' ' ' VAL . 79.3 m -131.17 120.49 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 76.9 m-85 -87.55 -177.77 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.28 -55.03 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -111.35 143.55 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.8 p -48.31 -43.81 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.23 -60.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.03 -48.22 67.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.87 -53.34 19.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.153 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.508 ' HA ' HD12 ' A' ' 260' ' ' ILE . 85.8 t -54.33 -55.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -41.39 -56.99 2.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.509 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -57.08 -47.03 82.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.593 HD13 ' HG2' ' A' ' 277' ' ' MET . 73.1 mt -53.69 -56.83 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.8 t -64.68 -58.98 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -47.0 -57.96 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.647 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 23.4 m-85 -65.66 -40.35 92.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 0.7 OUTLIER -45.04 114.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.43 19.93 67.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -87.9 124.73 33.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -79.4 99.99 7.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.466 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.7 tp -108.75 120.68 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 60.11 35.03 21.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 72.04 25.04 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -144.56 122.48 6.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 125.62 12.37 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.466 ' SD ' HD22 ' A' ' 268' ' ' LEU . 58.7 mtm -85.31 151.88 23.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -119.04 101.01 7.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 207' ' ' VAL . 14.3 t -114.01 127.2 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 277' ' ' MET . 7.5 ttmm -143.32 159.98 41.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 260' ' ' ILE . 8.9 mtp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 260' ' ' ILE . 11.8 m -125.72 144.06 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -101.05 125.31 47.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.437 ' CG1' HD11 ' A' ' 210' ' ' LEU . 9.1 t -115.85 127.04 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -134.73 171.68 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.0 36.37 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.437 HD11 ' CG1' ' A' ' 207' ' ' VAL . 44.3 mt -89.16 144.94 25.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 214' ' ' VAL . 30.2 t0 -63.44 142.28 58.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -57.49 -27.28 62.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -74.03 -34.57 64.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 211' ' ' ASP . 54.4 t -59.55 133.32 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.14 158.17 22.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.504 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 46.3 p-90 -36.35 -33.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.504 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 24.9 mtpt -62.51 -53.15 58.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -67.06 -52.64 39.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 234' ' ' ILE . 12.6 tp -46.92 -40.52 14.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LYS . . . . . 0.572 ' HE3' ' HB3' ' A' ' 232' ' ' ALA . 32.4 ttmt -76.0 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -46.07 -33.88 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.19 -58.72 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.543 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.2 m-85 -52.06 -19.48 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.1 t -53.55 -15.74 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 30.6 mtm -65.53 -63.19 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.95 32.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -174.37 -136.28 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.437 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.99 117.67 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.932 HG11 ' HB2' ' A' ' 232' ' ' ALA . 77.5 t -72.34 97.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 92.9 t -53.66 -52.85 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -142.66 117.86 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.932 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -118.65 143.13 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.89 158.0 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.831 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 219' ' ' LEU . 26.7 mm -119.59 127.39 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 91.9 mt -136.0 131.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.87 0.367 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.607 ' HA3' HD13 ' A' ' 234' ' ' ILE . . . -138.33 175.44 21.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.3 p -138.39 145.6 41.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.799 0.333 . . . . 0.0 111.156 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.638 HG13 HG13 ' A' ' 229' ' ' VAL . 82.9 t -135.91 137.17 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 77.4 m -115.24 114.06 24.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 73.6 m-85 -88.2 169.78 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.409 ' HG2' ' CG2' ' A' ' 230' ' ' VAL . 14.6 mm-40 -75.74 -55.41 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -123.61 154.5 39.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 257' ' ' VAL . 68.5 p -49.72 -47.69 50.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 35.1 mm -41.2 -63.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -54.33 -45.67 72.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.63 -49.82 64.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 253' ' ' SER . 42.1 t -56.19 -60.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -39.96 -50.54 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -61.63 -59.37 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.481 HD11 HG12 ' A' ' 205' ' ' VAL . 35.8 mt -42.49 -48.35 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 264' ' ' ASN . 7.0 m -73.36 -65.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.3 mmt -45.39 -22.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.425 ' HB3' HG21 ' A' ' 275' ' ' VAL . 25.7 m-85 -103.82 -21.47 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 261' ' ' SER . 5.9 t30 -61.78 111.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.52 8.53 86.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -76.39 130.68 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -88.23 107.92 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.517 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.8 tp -114.37 123.58 49.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 60.3 32.28 20.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 74.18 25.94 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -147.07 127.8 7.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.865 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 130.57 19.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.517 ' SD ' HD22 ' A' ' 268' ' ' LEU . 48.3 mtm -91.46 132.82 35.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -96.76 105.31 17.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 263' ' ' PHE . 2.6 t -120.69 127.33 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -149.54 150.87 32.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.465 ' HG3' HD13 ' A' ' 260' ' ' ILE . 28.8 mtt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.791 0.329 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 m -120.15 134.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 245' ' ' ILE . 74.7 t80 -95.42 118.26 31.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 275' ' ' VAL . 92.6 t -105.38 138.65 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.64 155.99 46.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 74.85 45.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.466 HD11 ' CG1' ' A' ' 207' ' ' VAL . 76.2 mt -99.56 134.82 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -57.57 162.51 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -72.05 -25.3 61.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -70.58 -42.88 70.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.43 139.48 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -141.3 159.9 26.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.529 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 16.6 p-90 -36.61 -33.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.359 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.529 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 9.9 mtpm? -68.23 -61.06 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.466 ' HD3' HG23 ' A' ' 222' ' ' VAL . 4.3 tmtm? -56.19 -54.24 47.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.9 tp -47.29 -58.07 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -49.96 -63.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -41.94 -42.86 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.62 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 69.8 t -67.61 -51.17 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -59.73 -28.19 67.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.3 t -45.46 -28.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.832 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 34.5 mtp -51.99 -68.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -42.67 -56.46 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.91 -170.95 31.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.46 104.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 232' ' ' ALA . 78.4 t -62.45 99.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.675 HG22 ' OE2' ' A' ' 251' ' ' GLU . 83.1 t -50.09 -50.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.445 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.1 ptm180 -153.45 117.44 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.808 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.53 146.32 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -165.04 172.09 13.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 49.2 mm -125.25 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.667 HD12 HG22 ' A' ' 245' ' ' ILE . 70.5 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.667 HG22 HD12 ' A' ' 235' ' ' LEU . 46.9 mt -124.99 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.98 166.79 24.55 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.6 p -136.24 143.84 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 223' ' ' PHE . 85.3 t -140.47 134.56 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.445 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 22.3 m -114.19 111.72 22.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -87.39 174.87 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.675 ' OE2' HG22 ' A' ' 230' ' ' VAL . 42.1 mm-40 -68.6 -60.01 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -127.2 162.67 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.7 p -51.77 -46.6 64.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.8 mm -40.34 -68.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.494 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 5.4 mm-40 -52.31 -44.83 65.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.21 -56.9 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.608 HG22 ' CE ' ' A' ' 277' ' ' MET . 60.0 t -52.29 -45.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -52.74 -42.58 65.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -72.78 -50.27 25.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 257' ' ' VAL . 72.0 mt -44.7 -52.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.3 m -72.22 -62.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 18.6 mmt -44.79 -23.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.62 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 22.9 m-85 -102.72 -28.02 12.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.44 ' OD1' ' C ' ' A' ' 264' ' ' ASN . 19.7 t-20 -56.42 111.05 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.57 11.49 84.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -74.53 128.31 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.8 mt -81.42 102.38 10.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.577 HD22 ' SD ' ' A' ' 273' ' ' MET . 14.2 tp -112.02 121.64 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 56.77 41.66 27.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 28.8 t70 63.26 29.51 15.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -147.02 121.46 5.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.601 0.715 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 123.78 10.43 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.289 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.577 ' SD ' HD22 ' A' ' 268' ' ' LEU . 46.1 mtm -85.47 158.2 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -121.68 100.57 7.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 207' ' ' VAL . 1.7 t -112.84 128.67 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -144.31 154.97 43.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.608 ' CE ' HG22 ' A' ' 257' ' ' VAL . 13.9 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.689 HG12 HD11 ' A' ' 260' ' ' ILE . 20.1 m -109.4 139.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -99.73 117.05 33.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.65 135.44 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -139.86 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.94 41.66 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.5 mt -89.25 166.61 13.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.691 ' HB2' HG23 ' A' ' 214' ' ' VAL . 1.1 m-20 -93.55 139.14 31.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -51.65 -41.68 61.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.02 -33.88 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.691 HG23 ' HB2' ' A' ' 211' ' ' ASP . 47.6 t -67.04 132.5 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.68 164.75 23.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.492 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.6 p-90 -36.26 -31.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 215' ' ' GLY . 32.1 mttm -60.43 -69.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 219' ' ' LEU . 16.3 mmmt -54.11 -58.16 8.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 1.016 HD22 HD11 ' A' ' 234' ' ' ILE . 16.2 tp -36.94 -56.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 6.8 ttpt -61.1 -67.22 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 224' ' ' SER . 6.3 mm-40 -41.16 -67.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 25.0 t -43.84 -49.08 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.8 m-85 -63.31 -26.14 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 8.2 t -46.45 -23.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 16.3 mtm -55.14 -66.53 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.83 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -38.39 -50.84 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.31 -112.94 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.8 t -129.78 110.45 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.733 HG11 ' HB2' ' A' ' 232' ' ' ALA . 49.1 t -70.92 96.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 251' ' ' GLU . 98.3 t -50.05 -49.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.47 HH11 HG21 ' A' ' 249' ' ' THR . 6.6 ptp85 -151.22 122.4 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.733 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -111.96 151.16 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -169.84 160.47 8.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 1.016 HD11 HD22 ' A' ' 219' ' ' LEU . 49.3 mm -120.01 128.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.875 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.4 mt -122.37 126.1 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.53 165.91 19.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.3 p -137.45 140.1 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.581 HG13 HG13 ' A' ' 229' ' ' VAL . 61.1 t -138.16 146.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.47 HG21 HH11 ' A' ' 231' ' ' ARG . 17.9 m -123.18 111.96 17.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 38.5 m-85 -86.17 165.88 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 0.7 OUTLIER -52.79 -52.63 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -143.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 254' ' ' ILE . 8.9 t -48.23 -54.21 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.5 mm -35.98 -68.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.159 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.444 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 24.1 mp0 -48.71 -46.84 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.562 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.77 -60.86 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.401 HG22 ' CE ' ' A' ' 277' ' ' MET . 94.5 t -42.88 -53.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -47.92 -56.82 6.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.83 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -58.54 -55.4 35.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.689 HD11 HG12 ' A' ' 205' ' ' VAL . 91.7 mt -40.65 -58.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 264' ' ' ASN . 46.4 t -68.71 -61.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.8 mtt -44.42 -22.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -103.88 -26.71 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 264' ' ' ASN . 0.2 OUTLIER -52.34 116.73 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.51 82.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' GLN . . . . . 0.463 ' OE1' ' N ' ' A' ' 267' ' ' LEU . 6.3 tp-100 -78.24 130.15 35.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' LEU . . . . . 0.463 ' N ' ' OE1' ' A' ' 266' ' ' GLN . 13.0 mt -87.68 100.37 12.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.406 HD22 ' SD ' ' A' ' 273' ' ' MET . 22.0 tp -108.1 123.81 49.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 59.89 32.23 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.1 26.78 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -145.32 129.01 8.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 126.57 13.49 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' MET . . . . . 0.406 ' SD ' HD22 ' A' ' 268' ' ' LEU . 36.6 mtm -84.17 143.43 29.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' HIS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 14.5 t-160 -109.87 99.26 8.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 260' ' ' ILE . 2.5 t -109.43 131.1 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -151.65 155.07 37.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' MET . . . . . 0.401 ' CE ' HG22 ' A' ' 257' ' ' VAL . 9.1 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 62.3 m . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.81 134.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.35 120.82 35.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.787 HG11 HD21 ' A' ' 210' ' ' LEU . 49.1 t -109.93 139.72 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.09 165.23 27.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 38.5 t30 62.78 46.43 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.787 HD21 HG11 ' A' ' 207' ' ' VAL . 30.8 mt -95.74 149.09 21.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.609 ' HB2' HG23 ' A' ' 214' ' ' VAL . 1.2 m-20 -69.65 138.47 53.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -50.5 -39.96 49.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -61.26 -41.48 96.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 211' ' ' ASP . 59.9 t -50.93 131.48 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -131.93 161.88 23.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -43.36 -34.63 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -62.3 -59.44 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -60.37 -57.18 13.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.4 tp -44.67 -55.86 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -56.04 -52.11 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.16 -58.08 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.565 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 71.2 t -52.89 -40.09 34.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.15 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 225' ' ' MET . 3.7 m-85 -69.04 -32.62 72.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.3 m -40.65 -25.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 223' ' ' PHE . 51.8 mtp -54.77 -66.31 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 255' ' ' GLU . . . -47.4 -48.62 26.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.59 -165.14 28.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.04 107.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.14 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.87 HG11 ' HB2' ' A' ' 232' ' ' ALA . 77.4 t -63.83 104.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -42.74 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.072 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -144.42 120.31 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.87 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -122.65 133.4 54.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -164.68 167.69 18.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.82 142.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 75.7 mt -135.95 125.73 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.122 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.21 176.31 19.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.4 p -144.82 136.33 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.129 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 223' ' ' PHE . 39.3 t -129.22 149.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.2 m -129.17 117.13 20.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.496 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 70.9 m-85 -91.22 -175.2 4.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.87 -54.78 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -129.37 163.63 25.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.5 p -53.91 -41.67 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.8 mm -46.13 -65.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.638 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 42.0 mt-10 -53.11 -45.09 68.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.496 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.28 -59.17 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -48.24 -56.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.169 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -44.06 -45.92 8.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -69.51 -48.36 60.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 95.3 mt -48.88 -52.82 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 m -69.75 -63.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -42.58 -38.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 19.4 m-85 -88.21 -26.81 22.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -55.2 109.94 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.62 14.63 75.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -77.06 131.27 38.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.4 mt -88.7 103.02 15.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -110.3 122.21 47.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 59.25 34.07 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 71.53 27.49 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -144.48 117.74 5.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 119.86 6.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 47.5 mtm -79.15 163.17 25.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -126.66 100.65 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 129.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -146.23 145.83 30.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.5 mtt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.85 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.7 t -51.17 148.54 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.4 t -46.94 -62.34 1.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.2 79.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -60.02 126.15 26.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.2 p -128.99 163.89 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -167.76 136.59 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -169.8 169.4 8.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 pp -170.19 175.24 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -119.49 92.75 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.41 85.04 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 129.21 69.47 0.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -75.57 79.94 2.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.9 mt -119.91 177.93 4.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 105.5 178.7 23.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 86.1 p -119.44 -38.65 2.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 97.5 m -40.79 139.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.9 138.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.559 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 72.1 t80 -97.0 116.39 29.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 245' ' ' ILE . 13.5 t -104.32 132.85 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.73 166.45 22.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 61.83 50.82 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 207' ' ' VAL . 42.7 mt -102.36 157.97 16.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.569 ' HB2' HG23 ' A' ' 214' ' ' VAL . 0.8 OUTLIER -79.52 136.55 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -48.2 -44.81 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.434 ' NZ ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -57.41 -36.58 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 211' ' ' ASP . 88.9 t -58.42 117.77 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -114.18 168.71 12.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -50.8 -25.33 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.71 -64.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.919 ' O ' HG23 ' A' ' 222' ' ' VAL . 34.6 tptt -57.62 -51.15 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.7 tp -49.24 -54.97 14.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -59.58 -52.9 63.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -50.67 -40.73 54.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 218' ' ' LYS . 29.0 t -66.87 -52.1 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.5 m-85 -60.83 -16.14 37.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.7 t -56.22 -19.3 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.2 mtp -61.69 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -48.57 -37.58 18.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 174.46 -159.8 28.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.2 t -88.03 126.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.886 HG11 ' HB2' ' A' ' 232' ' ' ALA . 93.1 t -84.87 101.99 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.532 ' CG2' ' CD ' ' A' ' 251' ' ' GLU . 45.3 t -59.57 -44.0 92.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.6 ttp85 -141.11 120.43 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.886 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -125.2 130.53 52.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -162.89 166.01 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.32 148.61 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.838 HD12 HG22 ' A' ' 245' ' ' ILE . 77.6 mt -91.55 132.46 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 36.6 mp0 -120.41 164.59 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -115.85 178.76 4.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -40.06 -55.57 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.79 -40.43 55.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 114.27 -34.35 4.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -70.14 129.65 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.792 0.33 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 m -50.66 134.64 24.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -92.89 28.58 2.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 72.16 29.77 66.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.457 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.838 HG22 HD12 ' A' ' 235' ' ' LEU . 53.3 mt -132.61 129.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.142 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.87 176.99 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.4 p -139.35 132.78 30.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 223' ' ' PHE . 62.5 t -129.71 135.02 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 230' ' ' VAL . 58.0 m -124.24 115.6 21.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 71.4 m-85 -87.7 -175.45 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.532 ' CD ' ' CG2' ' A' ' 230' ' ' VAL . 24.0 mm-40 -90.23 -53.63 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -114.18 146.58 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 257' ' ' VAL . 93.4 p -50.33 -45.28 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.3 mm -46.53 -56.46 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.487 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 22.1 mt-10 -56.46 -48.4 77.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.408 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.06 -50.5 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 253' ' ' SER . 99.2 t -54.77 -54.78 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -44.94 -54.89 6.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.523 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -53.18 -58.65 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 275' ' ' VAL . 75.6 mt -41.73 -42.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 30.0 t -76.17 -65.74 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -20.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.1 m-85 -104.99 -19.98 13.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 110.16 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.5 84.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.69 130.56 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.9 mt -85.96 100.07 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.559 HD22 ' SD ' ' A' ' 273' ' ' MET . 9.1 tp -107.22 122.73 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 56.52 43.49 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.3 t0 62.38 28.97 17.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -147.09 125.68 6.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 135.17 29.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.559 ' SD ' HD22 ' A' ' 268' ' ' LEU . 33.3 mtm -99.33 153.19 19.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.423 ' NE2' ' HG3' ' A' ' 276' ' ' LYS . 20.2 t-160 -119.21 100.72 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 260' ' ' ILE . 3.4 t -105.25 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.423 ' HG3' ' NE2' ' A' ' 274' ' ' HIS . 30.4 mmtt -120.56 144.86 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 7.9 mtt -55.82 134.07 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.8 162.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.68 -55.38 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -65.15 99.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -94.35 81.92 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -69.2 140.74 90.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.558 0.694 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.594 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.5 Cg_endo -69.77 179.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.341 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -128.84 36.02 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 41.66 42.25 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -133.02 98.7 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -174.18 131.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.64 143.07 36.49 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.653 0.74 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 148.59 65.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 96.07 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -125.0 109.86 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -126.62 138.17 31.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.656 0.741 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 93.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.362 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLN . . . . . 0.451 ' CD ' ' O ' ' A' ' 294' ' ' GLN . 0.0 OUTLIER -139.81 112.83 8.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -139.9 124.69 18.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.6 t -168.27 134.49 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 163.83 66.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 85.96 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 96.9 p -147.04 115.36 6.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.5 p -161.53 112.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 m -151.47 125.78 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.7 p -112.04 170.39 8.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.3 -125.99 1.47 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.9 m 49.3 30.12 3.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 110.862 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 53.4 p -104.52 119.46 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.48 111.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.71 169.3 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 pp -166.85 157.14 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -126.87 115.49 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.15 108.5 14.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.129 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.2 105.74 3.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.0 mtp85 -77.15 147.31 36.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 110.894 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 17.9 tp -47.53 96.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 152.3 109.51 0.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.3 m -101.22 46.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.6 m -93.31 136.71 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.456 HG12 HD11 ' A' ' 260' ' ' ILE . 31.7 m -115.11 132.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -97.0 124.27 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 275' ' ' VAL . 60.7 t -112.93 138.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -145.66 164.8 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 t30 67.82 42.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.8 161.78 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.61 ' HB3' HG23 ' A' ' 214' ' ' VAL . 44.2 t0 -82.24 133.45 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.482 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 16.8 m-85 -48.08 -29.48 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -72.02 -40.38 68.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 211' ' ' ASP . 76.8 t -58.22 141.15 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -141.8 166.17 26.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 217' ' ' LYS . 19.4 p-90 -39.68 -48.39 2.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.528 ' N ' ' CG ' ' A' ' 216' ' ' TRP . 35.5 mttm -47.58 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 222' ' ' VAL . 38.4 tptt -61.0 -49.34 77.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.546 HD22 HD11 ' A' ' 234' ' ' ILE . 9.6 tp -46.47 -48.01 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.408 ' HG3' HG11 ' A' ' 229' ' ' VAL . 13.4 tttm -68.05 -44.78 75.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.68 -44.39 77.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 218' ' ' LYS . 21.4 t -72.48 -52.99 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -56.9 -32.17 65.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.4 t -48.51 -21.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' MET . . . . . 0.425 ' O ' ' C ' ' A' ' 226' ' ' ALA . 29.1 mtm -57.66 -65.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 225' ' ' MET . . . -35.85 -50.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.15 -104.41 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.09 119.28 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.948 HG11 ' HB2' ' A' ' 232' ' ' ALA . 54.2 t -77.74 96.02 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 231' ' ' ARG . 60.8 t -54.17 -44.79 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.527 ' HG2' HG12 ' A' ' 230' ' ' VAL . 30.6 mmt180 -151.64 117.24 5.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.948 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -115.92 135.39 54.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 232' ' ' ALA . 36.3 m-20 -164.25 161.88 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.546 HD11 HD22 ' A' ' 219' ' ' LEU . 34.0 mm -113.23 150.08 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 245' ' ' ILE . 84.6 mt -90.56 124.54 35.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -135.67 156.31 49.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 179.8 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -44.98 -51.58 9.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -60.59 -56.98 14.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.89 39.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -100.04 131.51 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.323 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.7 m -90.29 120.58 31.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.11 71.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 235' ' ' LEU . 41.5 mt -123.51 123.05 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 111.167 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.22 174.14 20.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.7 p -138.58 143.96 39.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.499 HG21 ' CD2' ' A' ' 223' ' ' PHE . 57.5 t -137.69 151.0 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 m -131.06 113.34 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 71.3 m-85 -88.73 172.42 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.2 -58.75 3.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -124.5 157.51 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 257' ' ' VAL . 4.0 t -49.36 -48.3 46.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.2 mm -38.9 -68.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -52.02 -48.28 64.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -48.6 -52.85 20.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 253' ' ' SER . 45.3 t -54.77 -51.25 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -46.35 -47.5 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 226' ' ' ALA . . . -65.92 -58.75 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.456 HD11 HG12 ' A' ' 205' ' ' VAL . 82.2 mt -41.23 -44.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.6 m -76.81 -65.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -46.71 -21.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.499 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 4.4 m-85 -103.73 -29.34 11.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t-20 -56.02 111.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.99 82.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -73.84 130.4 39.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.35 100.95 13.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 tp -108.71 122.28 46.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 58.22 37.39 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.5 28.64 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -145.68 117.77 5.13 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 123.58 10.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.728 2.286 . . . . 0.0 112.313 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 42.7 mtm -83.36 157.32 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.465 ' C ' ' CD2' ' A' ' 274' ' ' HIS . 3.8 t-160 -119.92 100.72 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.576 HG13 HG22 ' A' ' 207' ' ' VAL . 2.1 t -111.53 126.43 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -145.37 144.22 30.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.434 ' HG2' ' CD1' ' A' ' 260' ' ' ILE . 8.0 mtt -54.96 126.21 23.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -88.89 162.33 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -113.6 96.23 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -104.15 98.75 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -92.62 86.26 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.588 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -139.64 140.82 26.13 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.588 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.7 Cg_endo -69.8 115.65 4.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -117.66 119.33 34.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 85.59 1.55 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.454 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -94.34 157.37 16.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.5 p90 -145.82 123.41 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -124.69 80.46 61.92 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.612 0.72 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 147.51 63.39 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.375 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 110.92 2.67 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.12 164.3 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -127.38 80.42 71.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.03 67.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.632 2.221 . . . . 0.0 112.387 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -135.96 123.73 22.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.76 111.25 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -163.06 151.17 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 168.1 83.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 146.51 60.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.8 p -112.64 145.73 39.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.6 t -174.82 152.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t -140.39 173.65 11.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.341 . . . . 0.0 110.863 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.1 t -127.0 169.35 13.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 192' ' ' SER . . . -170.18 -98.6 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.5 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 191' ' ' GLY . 36.9 p 34.73 43.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.87 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 p -82.32 150.06 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -155.06 139.98 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.77 172.96 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.3 168.07 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -130.2 112.95 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -134.36 176.68 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.5 59.86 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 200' ' ' ARG . 1.2 mpp_? -97.9 178.98 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 110.818 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 201' ' ' LEU . 7.3 mp -116.26 142.12 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -158.94 -148.84 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.7 p -125.4 0.99 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.8 m -98.41 120.93 39.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.164 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.582 HG12 HD11 ' A' ' 260' ' ' ILE . 22.1 m -103.73 133.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 86.9 t80 -98.32 106.64 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 245' ' ' ILE . 52.4 t -94.77 133.65 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.01 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.06 53.44 2.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.64 158.77 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -87.89 130.6 34.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.14 -23.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -69.09 -40.25 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.57 HG13 ' HE2' ' A' ' 218' ' ' LYS . 92.4 t -61.53 119.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.57 162.74 12.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 68.2 p-90 -43.65 -49.19 7.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.496 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 6.9 ptpt -53.75 -54.79 33.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.57 ' HE2' HG13 ' A' ' 214' ' ' VAL . 0.7 OUTLIER -53.49 -59.89 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.529 ' CD1' ' CE1' ' A' ' 223' ' ' PHE . 23.5 tp -46.55 -47.29 19.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -60.03 -55.5 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -53.0 -58.18 7.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.574 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 38.4 t -51.67 -41.15 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.766 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.6 m-85 -70.06 -28.88 65.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 t -42.38 -27.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 50.7 mtp -51.19 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.52 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.93 -57.06 4.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -164.79 -157.39 9.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.9 t -92.36 107.91 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 232' ' ' ALA . 54.0 t -60.75 100.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.512 HG12 ' HG2' ' A' ' 231' ' ' ARG . 89.1 t -55.81 -46.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.138 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.512 ' HG2' HG12 ' A' ' 230' ' ' VAL . 3.4 mmp_? -144.05 122.06 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -117.07 127.15 53.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -152.86 153.94 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 46.0 mm -119.03 128.47 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.572 HD12 ' CG2' ' A' ' 245' ' ' ILE . 58.6 mt -61.58 122.21 14.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.4 171.64 14.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -93.5 163.36 13.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -41.11 -47.9 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.95 -44.49 92.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.17 23.73 1.93 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.54 151.51 23.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.4 p -79.24 130.42 35.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.412 ' HD2' HD12 ' A' ' 245' ' ' ILE . 0.0 OUTLIER -97.12 -31.29 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.862 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.95 9.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.655 HG21 ' CZ ' ' A' ' 206' ' ' PHE . 40.7 mt -132.97 136.27 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.148 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 174.54 18.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 68.4 p -142.24 131.07 22.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.766 HG11 ' HD2' ' A' ' 223' ' ' PHE . 70.7 t -127.85 129.36 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 230' ' ' VAL . 33.4 m -110.79 112.4 24.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 61.8 m-85 -88.46 173.3 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.15 -55.29 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.93 159.56 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 257' ' ' VAL . 51.1 p -52.63 -47.65 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.5 mm -42.61 -61.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.422 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 2.3 mp0 -54.6 -47.52 73.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.54 -56.31 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 253' ' ' SER . 23.0 t -51.8 -44.41 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -53.9 -46.89 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.52 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -70.8 -45.89 63.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.582 HD11 HG12 ' A' ' 205' ' ' VAL . 96.4 mt -49.71 -48.95 20.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 13.0 m -72.49 -54.19 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mtt -55.13 -22.49 17.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.574 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 22.1 m-85 -104.8 -16.2 14.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -63.81 110.5 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.03 86.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -71.16 132.63 45.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.7 mt -85.79 100.1 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.641 HD22 ' SD ' ' A' ' 273' ' ' MET . 15.6 tp -107.64 122.33 46.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 58.36 38.68 25.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 67.08 27.53 8.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -144.49 125.66 7.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 121.19 7.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.363 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.641 ' SD ' HD22 ' A' ' 268' ' ' LEU . 55.6 mtm -83.85 152.9 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -118.34 101.13 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.507 HG21 ' CB ' ' A' ' 263' ' ' PHE . 5.7 t -107.49 114.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -133.44 144.63 49.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 12.0 mtt -58.89 139.2 56.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.36 170.87 10.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.816 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.17 -48.85 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -111.64 88.69 2.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -124.31 36.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.051 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.589 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.7 tp -163.96 140.76 5.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.645 0.736 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.589 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.6 Cg_endo -69.69 150.09 68.19 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.67 2.246 . . . . 0.0 112.363 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -82.4 85.64 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.69 111.7 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.534 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -133.63 124.05 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -155.12 126.07 7.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.521 ' CG ' ' HD2' ' A' ' 289' ' ' PRO . 3.9 t80 -130.56 140.54 38.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.691 0.758 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 288' ' ' PHE . 53.5 Cg_endo -69.78 149.22 66.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.336 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 174.69 9.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.0 105.23 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -75.67 143.54 75.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.598 0.713 . . . . 0.0 110.848 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.44 19.35 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.732 2.288 . . . . 0.0 112.328 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -107.15 134.0 50.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -120.78 111.95 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.2 t -146.3 131.3 18.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.8 -158.4 13.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 2.6 3.41 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.664 2.242 . . . . 0.0 112.318 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.6 t -40.6 -34.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 t -150.69 109.14 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.449 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 t -164.36 171.69 14.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.3 t -74.49 -45.37 46.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.65 145.01 11.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -89.08 139.26 30.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.8 m -45.62 -45.21 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 71.6 53.62 9.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.81 167.07 16.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.075 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 196' ' ' LEU . 1.1 pp -171.07 169.07 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.44 -49.45 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.09 178.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.32 -74.15 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -102.46 -40.31 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.42 88.36 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -179.81 86.5 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 36.0 m -116.64 52.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.866 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.4 m -100.99 134.78 43.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.558 HG12 HD11 ' A' ' 260' ' ' ILE . 23.1 m -112.12 135.16 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -97.07 114.7 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.611 HG11 HD21 ' A' ' 210' ' ' LEU . 14.2 t -99.56 138.19 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -140.76 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 m120 62.51 41.88 9.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.611 HD21 HG11 ' A' ' 207' ' ' VAL . 53.5 mt -91.35 149.34 21.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 214' ' ' VAL . 6.7 t70 -78.76 136.17 37.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -43.24 -31.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.84 -39.76 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 211' ' ' ASP . 94.6 t -54.05 111.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.04 170.55 16.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.506 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 52.6 p-90 -57.97 -32.49 67.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.506 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 8.9 mmtp -68.47 -52.38 33.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.633 ' HD2' HG23 ' A' ' 222' ' ' VAL . 16.7 tptm -62.77 -41.52 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.47 -58.77 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -52.9 -58.6 6.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -49.66 -58.89 4.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.633 HG23 ' HD2' ' A' ' 218' ' ' LYS . 20.2 t -51.95 -40.17 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.3 m-85 -72.37 -17.07 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.1 t -58.32 -19.38 34.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 26.3 mtm -57.39 -67.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -40.26 -42.08 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -178.32 -103.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.12 117.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.656 HG11 ' HB2' ' A' ' 232' ' ' ALA . 39.7 t -75.62 102.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 249' ' ' THR . 79.0 t -50.69 -44.39 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 8.0 ptp180 -159.38 122.76 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.656 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.1 135.01 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -139.72 151.39 45.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.89 125.87 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.96 124.23 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.96 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -121.31 167.4 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 240' ' ' GLY . 3.3 t70 -88.52 162.09 16.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 237' ' ' ASP . 5.0 mtpm? -34.41 -58.64 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.96 -43.28 60.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 237' ' ' ASP . . . 119.08 15.64 5.56 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.42 ' HA ' ' NZ ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -89.28 167.99 12.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.898 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.4 m -71.66 146.21 48.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 -23.32 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 101.85 18.47 17.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 61.2 mt -132.83 126.31 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.369 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.35 167.31 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 56.3 p -139.94 128.68 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.619 HG21 ' CD2' ' A' ' 223' ' ' PHE . 36.0 t -124.63 140.5 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 230' ' ' VAL . 15.5 m -121.12 117.89 28.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.77 -176.74 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -83.19 -55.82 4.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -128.96 162.15 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 93.7 p -52.75 -48.24 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.1 mm -37.48 -62.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.39 -41.88 90.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.85 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.88 -49.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -48.49 -42.17 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -75.99 -49.56 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.558 HD11 HG12 ' A' ' 205' ' ' VAL . 42.8 mt -51.98 -41.4 31.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.2 t -76.68 -50.77 12.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 30.1 mtt -60.04 -21.66 61.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.495 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 25.0 m-85 -104.51 -22.15 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.6 110.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.9 84.11 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -72.66 123.46 23.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.893 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.78 105.88 14.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.06 121.93 45.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 58.76 35.11 24.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.62 27.74 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 33.5 mtp85 -142.9 119.51 6.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.722 . . . . 0.0 110.819 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.09 3.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.368 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 59.8 mtm -72.14 159.25 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 23.0 t-160 -125.63 103.56 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.463 HG21 ' CB ' ' A' ' 263' ' ' PHE . 2.6 t -111.8 110.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.084 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -124.59 142.18 51.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.424 ' HG3' HD13 ' A' ' 260' ' ' ILE . 15.0 mtt -56.88 137.95 54.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.08 147.04 52.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -89.85 -54.96 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.43 ' HB2' ' NH1' ' A' ' 280' ' ' ARG . 2.1 ptm85 -131.95 128.13 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -129.57 44.93 2.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.718 HD12 ' HD2' ' A' ' 283' ' ' PRO . 4.0 tp -126.45 133.47 25.02 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.718 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.5 Cg_endo -69.79 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -39.59 -40.35 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.74 150.44 0.31 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.81 35.27 2.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.366 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.66 39.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -115.33 81.32 8.29 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 157.59 59.99 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.369 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 100.04 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.08 150.33 41.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -101.59 149.38 36.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -24.66 29.45 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.707 2.271 . . . . 0.0 112.354 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -76.35 146.55 38.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -78.88 151.41 31.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 29.5 t -59.32 -42.02 90.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.02 154.95 16.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -13.27 34.39 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.655 2.237 . . . . 0.0 112.333 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 3.7 t -49.55 -62.29 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.0 m -76.63 97.67 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 89.8 p -157.03 161.91 39.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.823 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.0 t -133.97 152.84 52.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.07 122.24 1.43 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.3 m -118.5 168.61 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.2 t -123.38 -55.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 104.16 95.25 2.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.65 141.93 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.64 150.18 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -109.06 158.0 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.02 163.75 27.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -126.69 156.14 19.91 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -119.31 -41.39 2.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 110.865 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 201' ' ' LEU . 7.4 tt -65.82 125.85 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.438 ' N ' HD23 ' A' ' 201' ' ' LEU . . . 146.49 165.08 11.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 204' ' ' THR . 89.2 p -107.04 -47.51 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 110.836 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 203' ' ' SER . 0.5 OUTLIER -34.61 114.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 260' ' ' ILE . 30.5 m -104.99 137.23 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.97 118.46 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.26 134.34 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -137.49 171.91 13.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 m120 60.09 41.53 17.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.0 mt -90.05 155.41 19.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 214' ' ' VAL . 3.3 t70 -67.3 160.76 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -77.71 -33.82 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 65.8 mttt -85.53 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -108.91 164.2 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.609 ' N ' HG12 ' A' ' 214' ' ' VAL . . . -151.2 148.71 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -40.45 -35.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -66.56 -56.36 11.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.471 ' HD3' HG23 ' A' ' 222' ' ' VAL . 1.5 tmtm? -51.22 -44.16 61.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -69.4 -62.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -44.4 -42.28 6.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.605 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 27.1 t -70.29 -43.26 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.2 m-85 -69.19 -15.73 63.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -59.38 -13.21 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.0 mtp -67.5 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.585 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -46.26 -47.39 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.1 -141.44 3.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 50.1 t -105.51 114.68 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.767 HG11 ' HB2' ' A' ' 232' ' ' ALA . 53.5 t -72.11 101.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.177 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.02 -43.69 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.426 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 17.5 ptt180 -160.58 119.8 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.767 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.44 135.24 50.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 159.3 42.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.411 HD11 HD22 ' A' ' 219' ' ' LEU . 48.7 mm -119.31 144.04 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.517 HD12 ' CG2' ' A' ' 245' ' ' ILE . 36.8 mt -80.55 107.53 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -142.42 144.72 33.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 239' ' ' ASP . 3.0 p30 -61.92 160.77 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -35.78 -30.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 237' ' ' ASP . 27.8 m-20 -67.16 -57.29 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 127.02 31.22 0.76 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -96.41 128.09 43.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.1 m -91.37 118.28 30.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -93.17 35.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 68.47 25.05 75.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.458 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.517 ' CG2' HD12 ' A' ' 235' ' ' LEU . 51.8 mt -131.33 126.18 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.26 175.27 20.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 p -143.48 138.47 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 229' ' ' VAL . 44.1 t -135.19 143.51 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 89.2 m -124.4 123.74 40.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 256' ' ' ALA . 74.2 m-85 -97.62 175.5 6.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -60.15 2.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -109.49 142.58 40.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 257' ' ' VAL . 85.7 p -47.82 -43.24 27.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 mm -46.88 -57.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.44 -49.79 75.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 250' ' ' PHE . . . -51.32 -48.03 62.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 253' ' ' SER . 65.7 t -57.6 -53.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -46.07 -46.92 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.585 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -64.4 -50.55 67.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.519 HD13 ' HG2' ' A' ' 277' ' ' MET . 96.6 mt -47.53 -50.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 264' ' ' ASN . 15.8 m -72.22 -61.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.8 mmt -45.17 -24.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.605 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 23.6 m-85 -104.43 -19.36 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 261' ' ' SER . 10.9 t30 -60.35 113.0 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.54 6.65 89.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.553 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.95 126.17 28.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.88 0.371 . . . . 0.0 110.93 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.56 100.16 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.563 HD22 ' SD ' ' A' ' 273' ' ' MET . 16.0 tp -106.05 121.13 43.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.959 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 59.03 37.76 24.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 68.55 26.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -143.67 124.48 7.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.563 ' SD ' HD22 ' A' ' 268' ' ' LEU . 63.2 mtm -84.51 145.36 28.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 21.6 t-160 -109.79 99.25 8.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.438 HG21 ' CB ' ' A' ' 263' ' ' PHE . 4.0 t -109.04 124.66 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 277' ' ' MET . 1.6 ttpm? -149.09 160.55 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.519 ' HG2' HD13 ' A' ' 260' ' ' ILE . 9.4 mmt -66.44 139.58 57.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.452 ' OD1' ' CB ' ' A' ' 280' ' ' ARG . 12.5 t70 -78.84 137.61 37.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.44 -40.13 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.452 ' CB ' ' OD1' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -59.86 136.01 57.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -115.23 92.79 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.585 HD12 ' HD2' ' A' ' 283' ' ' PRO . 6.5 tp -60.77 140.39 93.18 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.649 0.738 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.585 ' HD2' HD12 ' A' ' 282' ' ' LEU . 54.3 Cg_endo -69.74 144.19 53.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.56 40.24 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.08 179.59 0.15 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -127.57 132.63 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -84.27 168.56 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -117.16 142.01 29.4 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.873 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 148.38 64.89 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.632 2.221 . . . . 0.0 112.385 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 177.72 5.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.684 2.256 . . . . 0.0 112.315 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -140.01 137.49 34.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -135.75 147.86 63.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.606 0.717 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -176.14 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.654 2.236 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -139.93 167.61 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -140.0 170.92 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.7 t -145.55 169.64 18.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 170.99 82.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 148.4 65.16 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.7 t -102.12 146.94 27.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 78.2 p -85.98 -1.53 57.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.488 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.4 t -171.65 139.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 76.4 p -120.49 138.04 54.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -179.44 134.9 2.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 41.4 t -120.16 158.38 27.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.859 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.1 t -166.35 143.31 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.41 131.98 34.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.615 ' HB1' HD23 ' A' ' 196' ' ' LEU . . . -60.65 -72.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.615 HD23 ' HB1' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -166.12 165.43 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -86.86 125.32 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.83 127.3 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.12 65.61 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.8 mtt85 -50.83 -42.5 58.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.82 142.61 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 165.3 72.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.469 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 35.0 p -45.76 -53.0 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.872 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 m -49.54 134.2 19.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.178 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 260' ' ' ILE . 11.4 m -124.99 139.69 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -100.32 127.35 46.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 210' ' ' LEU . 45.9 t -116.54 130.51 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.72 170.68 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.67 50.84 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.485 HD11 ' CG1' ' A' ' 207' ' ' VAL . 50.3 mt -100.03 159.95 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 214' ' ' VAL . 25.5 t0 -86.16 131.54 34.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -44.82 -23.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -75.73 -39.54 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 268' ' ' LEU . 70.1 t -59.74 112.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -109.83 172.84 16.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -51.19 -28.94 12.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' A' ' 221' ' ' GLU . 45.0 mttp -67.78 -52.94 31.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.736 ' O ' HG23 ' A' ' 222' ' ' VAL . 19.5 tptm -65.38 -50.48 65.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.665 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.5 tp -49.91 -53.42 26.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -62.21 -61.79 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 217' ' ' LYS . 0.4 OUTLIER -43.15 -56.63 3.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 218' ' ' LYS . 46.2 t -56.0 -46.94 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 248' ' ' VAL . 3.3 m-85 -63.13 -14.84 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.4 t -59.18 -13.91 8.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 41.7 mtp -69.08 -60.71 2.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.567 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -44.93 -52.56 8.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.51 -127.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 68.0 t -114.78 119.88 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 232' ' ' ALA . 84.6 t -81.59 98.65 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.1 t -51.45 -43.74 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.35 117.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.3 153.38 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -167.73 167.1 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.665 ' CD1' HD22 ' A' ' 219' ' ' LEU . 16.3 mm -126.2 133.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.477 HD12 HG22 ' A' ' 245' ' ' ILE . 44.0 mt -79.63 127.81 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -127.27 178.02 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.52 172.43 12.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -45.87 -45.25 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -72.78 -57.55 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.91 50.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -122.62 110.7 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.5 m -60.25 133.42 56.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.838 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.46 ' NH2' HD12 ' A' ' 245' ' ' ILE . 20.5 mtm105 -106.6 31.52 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 74.03 29.09 63.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.477 HG22 HD12 ' A' ' 235' ' ' LEU . 71.1 mt -134.68 129.81 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.15 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.69 166.38 24.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 48.2 p -135.8 140.68 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 223' ' ' PHE . 2.8 t -134.73 143.91 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.1 m -120.96 121.7 38.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -95.34 -176.32 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.83 -53.22 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -134.76 159.29 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 257' ' ' VAL . 91.9 p -48.86 -36.98 18.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 30.8 mm -47.32 -63.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -58.75 -44.43 90.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.73 -54.55 22.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 253' ' ' SER . 89.1 t -55.72 -49.13 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -48.32 -47.31 36.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.567 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -69.23 -55.09 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.619 HD11 HG12 ' A' ' 205' ' ' VAL . 95.2 mt -45.74 -43.37 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -77.6 -59.93 2.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.4 mmt -51.06 -22.81 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.498 ' CB ' HG21 ' A' ' 275' ' ' VAL . 3.5 m-85 -103.07 -21.0 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -55.33 113.33 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.05 82.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -70.56 127.12 31.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.65 101.37 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.453 HD23 HG21 ' A' ' 214' ' ' VAL . 9.9 tp -110.15 124.64 51.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 57.31 32.73 22.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 72.13 31.45 1.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -144.85 120.72 6.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.592 0.71 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 118.46 5.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.704 2.27 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 55.7 mtm -79.87 147.07 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -113.5 99.03 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 263' ' ' PHE . 1.8 t -107.65 127.0 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.8 tttm -149.54 159.53 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 11.0 mtt -65.64 139.96 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.74 150.86 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -63.77 -69.18 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -117.04 104.97 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -114.29 38.31 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.592 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -155.13 140.76 12.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 0.0 110.937 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.592 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.76 -178.24 2.25 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 0.0 112.305 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.64 -57.52 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 175.24 88.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.488 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.59 101.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.836 0.35 . . . . 0.0 110.851 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 56.43 45.96 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -41.03 149.24 0.35 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 148.46 65.52 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.361 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.97 49.42 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -137.02 108.9 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -89.24 135.57 31.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.626 0.727 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 179.55 3.58 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.42 139.5 53.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -131.62 170.94 14.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 40.4 t -174.65 141.65 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.91 82.52 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 121.53 8.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.644 2.229 . . . . 0.0 112.375 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 8.7 t -66.34 157.23 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.3 t -167.46 116.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.457 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 81.1 p 39.48 42.31 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.4 p -106.94 124.38 49.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.47 -174.03 13.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.491 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -166.16 125.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.1 m -59.37 134.31 56.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.852 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.18 -65.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -52.82 -179.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.76 153.67 17.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -72.04 163.9 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -117.83 154.97 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -165.11 -141.51 3.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.49 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -81.1 74.02 8.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 201' ' ' LEU . 1.9 mm? -106.91 146.87 30.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.21 -144.56 2.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 m -121.22 44.62 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.912 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.1 m -101.77 136.34 41.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.697 HG12 HD11 ' A' ' 260' ' ' ILE . 20.4 m -124.45 145.5 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -102.58 118.51 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -122.76 167.91 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.35 51.69 8.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.95 163.23 13.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.62 ' HB3' HG23 ' A' ' 214' ' ' VAL . 1.7 t0 -80.75 118.14 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -41.27 -41.88 2.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -61.0 -37.45 82.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 211' ' ' ASP . 53.3 t -55.72 151.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -135.26 172.44 22.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 30.3 p-90 -57.09 -39.72 75.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 5.3 mtpm? -62.84 -48.49 78.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.761 ' HZ1' HD11 ' A' ' 268' ' ' LEU . 0.5 OUTLIER -63.81 -48.83 75.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 11.2 tp -55.88 -52.55 63.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -59.06 -60.26 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.24 -45.27 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 218' ' ' LYS . 85.9 t -69.21 -51.95 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.773 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.2 m-85 -56.76 -12.86 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.2 t -57.46 -12.23 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.3 mtm -65.31 -66.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.818 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -48.83 -39.96 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.073 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 176.65 -171.78 44.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.4 122.16 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 232' ' ' ALA . 94.3 t -79.0 103.66 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.44 -39.31 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -148.62 120.3 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -124.98 135.48 52.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.69 167.54 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.64 133.51 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 245' ' ' ILE . 86.4 mt -78.75 131.35 36.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.0 167.55 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 17.1 t0 -63.82 165.95 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 239' ' ' ASP . 35.5 pttt -36.76 -46.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 238' ' ' LYS . 3.0 m-20 -74.64 -58.66 3.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.19 42.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.54 115.52 29.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.5 m -66.11 122.94 18.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -106.69 21.5 17.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 75.21 28.24 62.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 235' ' ' LEU . 47.7 mt -127.71 124.31 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.78 176.33 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.494 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 57.6 p -142.8 136.73 29.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.773 HG21 ' CD2' ' A' ' 223' ' ' PHE . 45.9 t -127.17 139.88 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.6 m -123.21 111.06 16.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.563 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 91.0 m-85 -86.62 -175.25 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.49 -49.36 8.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -132.29 156.71 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 16.7 t -48.71 -52.81 21.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 27.9 mm -37.67 -62.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.137 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.788 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 33.7 mt-10 -53.77 -48.47 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.563 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.61 -60.69 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.451 HG22 ' CE ' ' A' ' 277' ' ' MET . 95.7 t -42.87 -56.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -47.87 -52.29 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.818 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -58.88 -42.86 90.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.697 HD11 HG12 ' A' ' 205' ' ' VAL . 48.7 mt -62.62 -59.61 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.1 m -54.29 -42.81 70.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -69.85 -67.17 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 223' ' ' PHE . 41.9 m-85 -57.47 -14.02 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.0 OUTLIER -65.34 110.56 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.57 81.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 10.5 mm100 -69.89 146.03 51.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 267' ' ' LEU . 11.1 mt -97.97 102.43 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.761 HD11 ' HZ1' ' A' ' 218' ' ' LYS . 16.9 tp -112.76 123.52 50.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.434 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 12.1 m-85 56.2 40.61 29.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.5 t70 64.21 30.99 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -147.08 123.25 5.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.566 0.698 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 266' ' ' GLN . 54.1 Cg_endo -69.73 124.45 11.11 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.363 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.407 ' SD ' HD22 ' A' ' 268' ' ' LEU . 61.0 mtm -85.86 153.07 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 15.2 t-160 -117.35 99.85 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.82 124.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 277' ' ' MET . 22.2 tttm -142.64 157.57 44.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.575 ' HG2' HD13 ' A' ' 260' ' ' ILE . 7.9 mtt -67.08 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.921 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.05 151.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.43 -46.72 5.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -126.13 111.26 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -101.2 86.77 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.578 HD12 ' HD2' ' A' ' 283' ' ' PRO . 9.1 tp -38.9 139.65 0.72 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.578 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.78 167.87 23.23 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -123.8 144.74 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 97.78 2.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.97 176.71 6.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -165.98 134.81 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -118.17 144.82 35.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 146.87 61.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.38 37.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.331 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -139.95 112.17 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.476 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 27.0 ttt85 -130.31 139.41 35.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.586 0.708 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.7 Cg_endo -69.75 136.9 34.2 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -139.43 151.75 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -122.87 152.72 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.7 t -124.82 170.34 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 145.53 67.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.522 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -176.58 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.66 2.24 . . . . 0.0 112.353 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 34.0 p -165.13 163.93 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 73.1 m -119.05 171.33 8.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.552 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 p -101.99 158.62 16.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.875 0.369 . . . . 0.0 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.4 p -103.04 -49.09 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 123.64 80.11 0.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.5 t -118.09 100.08 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 19.6 t -174.93 165.24 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -178.42 -109.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.535 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.83 158.13 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.96 -60.32 1.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -104.24 159.15 15.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.56 -51.84 1.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.133 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.31 60.62 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.16 154.57 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.327 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.59 84.35 1.95 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -148.84 107.47 0.36 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 7.2 t -79.1 -50.1 11.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.0 0.429 . . . . 0.0 110.846 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.1 m -42.71 142.92 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.653 HG12 HD11 ' A' ' 260' ' ' ILE . 15.7 m -126.08 148.39 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -104.06 111.67 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 245' ' ' ILE . 15.2 t -101.75 138.11 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.158 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.6 170.09 16.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.12 54.43 3.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.04 148.95 30.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.83 141.49 44.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -51.41 -19.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -75.25 -42.48 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.456 HG21 HD23 ' A' ' 268' ' ' LEU . 41.5 t -60.74 109.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.5 13.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.473 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 42.1 p-90 -48.24 -34.88 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 99.1 mttt -60.15 -57.25 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -64.31 -57.73 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 22.8 tp -38.69 -49.57 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -67.25 -48.19 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.93 -32.11 60.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.778 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 38.8 t -78.0 -43.59 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.632 ' CD2' HG11 ' A' ' 248' ' ' VAL . 3.5 m-85 -66.42 -21.28 66.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -51.57 -19.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 7.9 mtm -65.67 -59.67 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -53.13 -45.35 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 178.81 -162.94 30.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.94 122.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 232' ' ' ALA . 78.6 t -78.44 101.0 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.496 HG23 ' C ' ' A' ' 250' ' ' PHE . 77.0 t -52.59 -42.08 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.423 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 29.2 ptt180 -163.81 117.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.799 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -107.98 151.61 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -166.59 172.95 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 23.5 mm -129.51 119.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 245' ' ' ILE . 96.7 mt -64.79 141.71 58.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -140.2 177.47 7.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.95 168.93 13.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -42.47 -59.06 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.43 -51.54 66.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.61 38.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -102.05 150.75 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.769 0.318 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 28.8 m -98.33 119.12 36.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -95.28 7.87 44.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 88.4 18.21 55.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.683 HG22 HD12 ' A' ' 235' ' ' LEU . 40.8 mt -112.04 128.85 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 111.159 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.8 168.28 21.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.4 p -139.01 135.77 34.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.632 HG11 ' CD2' ' A' ' 223' ' ' PHE . 35.0 t -130.47 139.31 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.8 m -120.8 115.81 23.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 80.8 m-85 -88.83 178.59 6.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -80.75 -55.23 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -117.81 145.03 44.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 257' ' ' VAL . 83.8 p -47.06 -45.51 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -42.4 -62.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -55.63 -49.18 73.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.05 -49.79 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 253' ' ' SER . 65.2 t -57.3 -53.6 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -45.59 -42.95 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -66.57 -52.21 47.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.653 HD11 HG12 ' A' ' 205' ' ' VAL . 75.8 mt -48.88 -48.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.5 m -71.96 -58.88 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 85.6 mmm -51.83 -24.49 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.778 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 20.8 m-85 -102.05 -15.08 16.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.52 111.93 4.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.25 90.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -70.73 125.9 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.03 101.88 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.669 HD22 ' SD ' ' A' ' 273' ' ' MET . 12.3 tp -108.6 123.7 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 58.72 39.25 24.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.7 26.65 9.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -145.54 124.61 6.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 0.0 110.836 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 119.49 6.43 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.669 ' SD ' HD22 ' A' ' 268' ' ' LEU . 59.7 mtm -80.5 154.91 27.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -119.95 108.81 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.549 HG21 ' CB ' ' A' ' 263' ' ' PHE . 2.7 t -116.79 122.31 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -131.72 147.95 52.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.52 ' HG2' HD13 ' A' ' 260' ' ' ILE . 3.4 mtp -58.05 132.08 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.79 165.37 22.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -119.84 88.73 2.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -104.53 112.88 26.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -119.04 87.87 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.064 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.7 tp -146.2 140.71 15.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.534 0.683 . . . . 0.0 110.946 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.74 149.19 66.68 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -74.24 -46.11 43.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.76 80.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -134.05 37.54 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.371 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -169.53 152.34 4.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -114.5 144.7 32.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 129.5 17.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 109.2 2.26 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -62.49 107.19 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -131.67 82.47 60.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 141.01 44.16 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.389 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -135.53 163.34 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.78 159.47 26.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 90.1 p -174.21 176.26 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.27 144.78 7.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 169.57 18.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.659 2.239 . . . . 0.0 112.346 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.5 m -138.82 144.28 39.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.1 t -124.71 129.95 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.4 p -170.35 139.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.8 m -157.96 148.48 20.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -156.26 72.2 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.8 t -124.62 153.7 41.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 110.855 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 51.9 m -88.92 -47.45 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 61.93 124.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -163.93 117.7 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.69 127.17 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -128.98 43.29 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.44 89.37 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.53 159.76 22.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -95.19 87.26 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 mt -105.14 41.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.63 132.67 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.499 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.3 m -95.07 44.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.83 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.3 m -74.87 137.13 41.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.77 137.26 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 208' ' ' ALA . 67.6 t80 -99.73 123.52 44.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.663 ' CG1' HD11 ' A' ' 210' ' ' LEU . 66.4 t -112.8 128.42 69.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.412 ' HB2' ' CE2' ' A' ' 206' ' ' PHE . . . -132.07 167.55 19.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.4 t30 68.43 45.52 1.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.663 HD11 ' CG1' ' A' ' 207' ' ' VAL . 34.0 mt -104.31 133.84 48.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.47 ' OD2' ' CD2' ' A' ' 269' ' ' PHE . 0.5 OUTLIER -67.5 145.74 54.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -47.63 -33.75 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -58.02 -35.24 70.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.42 HG23 ' CG ' ' A' ' 211' ' ' ASP . 46.4 t -56.06 117.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -117.97 146.6 18.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.555 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 32.0 p-90 -35.44 -45.11 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.555 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 32.7 mtpt -55.92 -60.03 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 219' ' ' LEU . 15.9 tptm -54.19 -65.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.822 HD22 HD11 ' A' ' 234' ' ' ILE . 14.3 tp -35.23 -58.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.432 ' HD2' ' HB3' ' A' ' 232' ' ' ALA . 69.3 tttt -59.42 -49.67 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.918 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.32 -20.9 12.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 89.1 t -91.34 -45.5 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.513 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.4 m-85 -64.58 -15.99 61.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 42.3 p -58.51 -15.28 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 29.4 mtm -66.42 -55.47 15.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.622 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -57.68 -41.0 80.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.24 -161.67 30.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.52 108.48 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.79 HG11 ' HB2' ' A' ' 232' ' ' ALA . 55.6 t -69.54 104.72 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 53.8 t -50.69 -46.46 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 0.2 OUTLIER -153.58 122.96 6.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.79 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -117.73 133.42 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 232' ' ' ALA . 2.0 m-20 -161.17 167.17 26.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.822 HD11 HD22 ' A' ' 219' ' ' LEU . 7.0 mm -124.7 138.56 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.83 123.98 27.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -129.84 172.32 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 238' ' ' LYS . 1.9 m-20 -80.02 170.16 16.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 237' ' ' ASP . 6.1 mtmp? -35.48 -64.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.33 -51.31 69.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.44 42.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -103.72 113.07 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 19.0 t -67.73 130.67 43.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -95.92 35.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.96 71.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.471 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.4 mt -137.03 128.62 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.69 170.36 18.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.5 p -138.43 138.23 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 229' ' ' VAL . 3.0 t -137.9 151.34 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 15.6 m -133.48 118.89 18.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -88.82 175.98 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.11 -55.93 4.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.02 155.9 35.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 254' ' ' ILE . 69.0 p -51.67 -50.82 59.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 253' ' ' SER . 14.4 mm -36.39 -62.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.557 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 13.3 mt-10 -57.41 -45.96 84.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.3 49.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.07 -54.09 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -44.82 -43.01 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -72.45 -53.27 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.0 mt -42.68 -46.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.8 m -76.85 -63.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.0 mmm -45.89 -24.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.547 ' HB3' HG21 ' A' ' 275' ' ' VAL . 3.6 m-85 -100.3 -30.77 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -55.13 111.15 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.07 14.01 77.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -77.08 127.87 33.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.1 mt -85.83 99.94 11.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.67 125.34 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.47 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 25.8 m-85 58.86 33.95 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 70.35 28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -146.85 124.58 5.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.613 0.721 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 126.2 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.413 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 41.7 mtm -86.54 151.37 23.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -115.87 102.29 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 263' ' ' PHE . 1.7 t -115.55 124.47 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 158.71 43.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 11.3 mtt -67.12 131.24 45.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -77.03 138.26 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.44 109.11 10.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -123.97 147.33 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -95.4 82.09 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 6.0 tp -102.53 135.52 19.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.601 0.715 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 96.31 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.675 2.25 . . . . 0.0 112.321 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 284' ' ' LYS . 0.1 OUTLIER -100.65 141.08 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.39 76.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -115.25 129.99 56.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -164.33 118.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.52 ' CG ' ' HD2' ' A' ' 289' ' ' PRO . 6.0 t80 -126.18 140.28 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 288' ' ' PHE . 53.7 Cg_endo -69.81 149.04 66.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 5.36 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.629 2.22 . . . . 0.0 112.339 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.64 155.98 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -130.36 145.14 56.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.576 0.703 . . . . 0.0 110.885 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.84 69.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.669 2.246 . . . . 0.0 112.3 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -122.85 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 296' ' ' SER . 12.2 pt20 -116.52 -46.22 2.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.468 ' N ' ' HG3' ' A' ' 295' ' ' GLN . 93.3 p -149.8 135.33 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -97.4 -162.4 31.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 96.53 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.7 t -134.77 158.63 43.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 t -171.92 131.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.443 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 79.0 p -149.1 131.12 15.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.0 p -73.35 -23.05 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.24 114.21 0.67 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.7 t -83.07 102.44 11.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.853 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 52.5 p -165.05 166.04 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 90.16 92.31 1.23 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.449 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.31 153.49 41.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.25 107.07 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -122.73 94.18 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.65 67.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.473 ' O ' HD23 ' A' ' 201' ' ' LEU . . . -176.35 138.4 4.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -93.81 104.16 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.3 OUTLIER -132.7 176.23 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 73.92 -179.64 41.26 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.514 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 204' ' ' THR . 9.9 m -120.21 -37.43 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 0.0 110.885 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' SER . 88.1 m -34.87 129.66 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.448 HG12 HD11 ' A' ' 260' ' ' ILE . 31.9 m -112.03 134.15 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -95.02 112.27 23.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.494 ' CG1' HD11 ' A' ' 210' ' ' LEU . 12.3 t -101.18 129.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.475 ' HB3' ' ND1' ' A' ' 274' ' ' HIS . . . -135.94 161.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.2 t30 67.54 47.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' A' ' 207' ' ' VAL . 46.1 mt -99.96 146.79 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -74.26 137.69 43.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -45.16 -36.43 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -59.97 -43.41 95.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.82 121.88 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -122.12 161.65 16.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.519 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.51 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 56.7 p-90 -35.53 -48.53 0.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.51 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 4.5 ptpt -50.85 -62.66 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 219' ' ' LEU . 18.5 tptp -50.93 -66.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.9 tp -35.43 -42.98 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -69.85 -64.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -42.98 -38.83 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 69.8 t -74.72 -39.83 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.123 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.64 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.1 m-85 -73.72 -10.33 59.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.6 t -62.31 -23.48 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.9 mtm -59.98 -61.53 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.58 -54.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.117 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.97 -144.65 4.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -99.54 114.85 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.91 HG11 ' HB2' ' A' ' 232' ' ' ALA . 42.2 t -78.82 103.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 249' ' ' THR . 40.3 t -50.87 -37.04 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.416 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 39.2 ptt85 -168.56 118.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.91 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -114.37 142.78 45.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -169.66 168.62 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.402 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.5 mm -116.52 141.8 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 36.1 mt -83.09 149.71 26.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -142.93 176.44 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 239' ' ' ASP . 6.0 t0 -84.8 171.36 12.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HD2' ' C ' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -39.7 -28.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 237' ' ' ASP . 13.8 t70 -87.19 -54.22 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 134.67 37.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -100.14 125.4 46.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.1 m -66.04 110.76 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -90.19 24.62 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 72.24 25.48 74.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.7 mt -132.43 125.44 53.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.164 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.38 168.15 21.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 52.5 p -132.54 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.112 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.64 HG11 ' HD2' ' A' ' 223' ' ' PHE . 63.0 t -134.54 138.65 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 230' ' ' VAL . 28.7 m -119.37 117.98 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.47 -178.83 5.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.23 -52.71 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.57 156.32 44.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 17.3 t -48.59 -49.83 35.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.4 mm -39.14 -64.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -53.59 -45.25 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.49 -56.39 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.2 t -50.28 -55.35 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -44.03 -51.58 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 263' ' ' PHE . . . -65.3 -50.8 64.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 205' ' ' VAL . 84.7 mt -46.85 -52.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.4 m -72.48 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 53.4 mmm -46.61 -24.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.553 ' CE2' ' HB1' ' A' ' 259' ' ' ALA . 26.2 m-85 -103.3 -23.36 13.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.13 110.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.68 89.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -69.98 130.56 42.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.09 100.99 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.6 tp -109.4 121.96 46.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 59.34 41.95 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 19.6 t70 63.39 24.97 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.28 125.34 7.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 138.19 37.05 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 32.9 mtm -97.39 152.91 18.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.475 ' ND1' ' HB3' ' A' ' 208' ' ' ALA . 5.7 t-160 -115.74 99.17 7.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 263' ' ' PHE . 1.5 t -112.93 118.45 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -139.11 146.14 40.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 24.4 mtt -56.0 135.02 52.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -61.49 114.45 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.25 -31.06 43.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -100.77 98.74 9.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -117.22 86.99 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.052 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.589 HD12 ' HD2' ' A' ' 283' ' ' PRO . 9.8 tp -66.27 139.49 96.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.646 0.736 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.589 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.7 160.51 49.44 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -53.17 2.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.17 125.01 0.2 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.66 168.11 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.566 ' CD2' ' HD3' ' A' ' 289' ' ' PRO . 3.5 p90 -148.08 148.14 30.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -128.98 83.29 66.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.648 0.737 . . . . 0.0 110.885 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 287' ' ' PHE . 53.9 Cg_endo -69.73 148.72 65.86 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.682 2.254 . . . . 0.0 112.365 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 173.34 11.16 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.274 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -120.8 110.74 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -107.51 80.76 0.97 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 96.27 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.694 2.263 . . . . 0.0 112.354 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -104.07 138.78 40.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -119.37 139.57 51.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.3 t -130.45 135.7 48.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -146.4 82.63 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.78 61.08 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.315 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 56.9 p -172.22 128.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 33.0 p -171.44 137.74 1.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.473 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 p -74.66 85.97 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 74.3 m -109.93 157.32 19.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 115.61 -105.56 1.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 m 38.73 42.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.7 m -148.02 141.73 25.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.24 90.06 0.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.82 165.42 18.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.92 123.9 21.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.4 pm0 -101.64 170.04 8.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.34 -45.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.11 54.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -107.23 173.37 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.583 HD12 ' C ' ' A' ' 201' ' ' LEU . 1.0 OUTLIER -97.31 143.8 27.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 166.78 82.28 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 204' ' ' THR . 16.7 m -67.56 -50.63 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 203' ' ' SER . 43.1 m -34.58 137.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.649 HG12 HD11 ' A' ' 260' ' ' ILE . 3.6 m -124.39 150.73 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 208' ' ' ALA . 71.0 t80 -106.68 122.05 45.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.32 124.37 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.567 ' HB2' ' CE2' ' A' ' 206' ' ' PHE . . . -124.21 167.87 13.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 62.16 50.98 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.39 146.35 28.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.88 145.43 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.86 -26.63 36.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.03 -37.51 72.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.07 110.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.126 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -103.88 175.04 22.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.498 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 12.4 p-90 -57.13 -32.68 66.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 30.3 mmtt -66.43 -56.41 11.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -59.11 -56.42 22.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.603 HD22 HD11 ' A' ' 234' ' ' ILE . 14.2 tp -46.45 -51.26 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.65 -67.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -38.73 -49.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.543 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 23.8 t -59.66 -45.61 94.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.62 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.1 m-85 -66.2 -14.39 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 t -55.64 -22.99 25.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.3 mtm -57.32 -63.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.51 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -41.46 -50.03 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.13 -106.28 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 45.6 t -139.99 112.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.651 HG11 ' HB2' ' A' ' 232' ' ' ALA . 71.6 t -70.15 103.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 249' ' ' THR . 65.6 t -51.46 -37.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.405 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.2 ptm180 -168.16 121.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.651 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -107.73 151.03 26.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.36 161.36 30.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.603 HD11 HD22 ' A' ' 219' ' ' LEU . 32.8 mm -128.34 126.37 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 245' ' ' ILE . 82.6 mt -68.11 123.97 22.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.941 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -129.67 171.18 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.07 174.99 8.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -45.5 -43.57 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -64.22 -56.67 13.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.26 30.84 0.26 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.492 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -103.02 145.04 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.8 t -81.88 123.97 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -91.24 34.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 62.8 26.36 68.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 235' ' ' LEU . 72.1 mt -136.22 139.29 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 80.8 p -144.69 145.14 31.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.62 HG11 ' HD2' ' A' ' 223' ' ' PHE . 21.1 t -133.89 130.41 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.3 m -106.72 121.22 43.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 42.9 m-85 -96.06 177.89 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 3.6 mm-40 -76.8 -55.74 5.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -131.09 155.59 46.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.824 ' O ' HG23 ' A' ' 257' ' ' VAL . 38.7 p -47.99 -32.18 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.66 -67.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.45 -43.33 75.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.54 -49.72 67.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 253' ' ' SER . 62.6 t -57.26 -53.15 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -48.24 -44.63 33.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -66.77 -62.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.649 HD11 HG12 ' A' ' 205' ' ' VAL . 78.2 mt -40.8 -39.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.7 t -78.97 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 34.9 mtp -49.93 -21.39 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.543 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 41.9 m-85 -103.89 -21.97 13.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -55.58 111.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.72 18.21 71.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -78.39 125.16 28.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.46 101.66 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.455 HD22 ' SD ' ' A' ' 273' ' ' MET . 11.6 tp -111.12 124.88 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 59.42 31.74 21.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 73.46 28.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -144.9 126.84 7.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 117.26 4.98 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 0.0 112.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.455 ' SD ' HD22 ' A' ' 268' ' ' LEU . 47.3 mtm -78.07 150.72 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 14.6 t-160 -117.33 104.37 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.53 HG21 ' HB3' ' A' ' 263' ' ' PHE . 1.6 t -114.29 119.9 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 277' ' ' MET . 11.4 ttmt -136.55 157.22 47.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.457 ' HG2' HD13 ' A' ' 260' ' ' ILE . 3.9 mtt -64.68 132.34 49.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.46 165.76 15.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.68 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.418 ' C ' ' HD3' ' A' ' 280' ' ' ARG . 0.0 OUTLIER -95.23 136.39 35.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -106.43 79.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.584 HD12 ' HD2' ' A' ' 283' ' ' PRO . 6.4 tp -58.67 140.43 85.4 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.584 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.6 Cg_endo -69.71 88.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 0.0 112.313 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -91.57 94.83 9.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.43 81.22 0.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -107.82 132.83 53.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.457 ' CG ' ' O ' ' A' ' 287' ' ' PHE . 9.6 p90 -170.64 121.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -113.24 143.91 30.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.683 0.754 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 148.16 64.28 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 5.38 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.698 2.265 . . . . 0.0 112.356 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -97.07 158.13 15.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -124.88 80.94 62.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 126.29 13.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.309 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -127.52 112.68 15.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -124.73 146.97 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 t -165.41 129.13 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.63 83.43 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 171.26 14.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 92.0 p -149.59 176.49 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 66.3 m -134.92 148.85 50.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.806 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 p -169.99 163.06 9.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.883 0.373 . . . . 0.0 110.897 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.9 t -57.7 89.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -100.77 55.15 0.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.3 m -115.72 -60.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.7 m -65.39 100.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -153.1 152.53 24.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -171.47 175.16 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.16 171.98 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -96.35 -50.82 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.56 126.86 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -85.56 40.51 3.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -74.97 177.79 6.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.505 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.2 OUTLIER -127.64 110.98 13.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -161.17 -162.34 12.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 33.9 m -86.02 37.97 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 90.0 m -79.77 131.44 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.527 HG12 HD11 ' A' ' 260' ' ' ILE . 35.4 m -108.0 138.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.185 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.435 ' CZ ' ' CG2' ' A' ' 245' ' ' ILE . 83.0 t80 -105.6 123.42 47.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.674 HG22 HG13 ' A' ' 275' ' ' VAL . 58.5 t -110.64 141.83 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 167.63 21.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 272' ' ' PRO . 62.7 t30 62.81 50.54 3.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 207' ' ' VAL . 83.7 mt -104.16 158.51 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -77.16 133.65 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -50.61 -34.59 26.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.925 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -64.75 -35.86 82.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.59 139.68 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.16 21.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 1.9 p-90 -44.54 -39.59 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 57.6 mttt -60.42 -55.56 32.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.826 ' NZ ' HD11 ' A' ' 268' ' ' LEU . 1.8 tmtt? -56.85 -57.69 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.4 tp -48.36 -52.58 21.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.532 ' HG2' HG11 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -57.5 -59.95 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -43.35 -44.96 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 218' ' ' LYS . 16.9 t -64.57 -52.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.7 m-85 -56.08 -18.51 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -52.19 -20.3 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 15.7 mtp -61.61 -62.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 255' ' ' GLU . . . -50.78 -35.84 33.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 170.93 -144.99 8.64 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.64 130.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.993 HG11 ' HB2' ' A' ' 232' ' ' ALA . 33.2 t -84.84 97.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.79 -42.78 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -153.7 116.99 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.993 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -118.4 141.22 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -164.59 171.69 14.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 16.7 mm -127.23 135.68 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 88.3 mt -76.03 126.02 30.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.415 ' HB3' ' N ' ' A' ' 241' ' ' LYS . 20.9 mt-10 -134.63 168.36 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.418 ' CB ' ' HE3' ' A' ' 241' ' ' LYS . 21.8 t0 -73.86 175.57 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -38.66 -43.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.02 -60.7 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 138.48 40.86 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.418 ' HE3' ' CB ' ' A' ' 237' ' ' ASP . 14.2 pttp -100.84 117.25 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.2 t -53.87 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -99.79 29.59 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 70.18 23.05 77.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.435 ' CG2' ' CZ ' ' A' ' 206' ' ' PHE . 32.7 mt -135.25 125.41 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.848 0.356 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.49 176.3 19.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.0 p -148.56 141.97 25.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.166 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 249' ' ' THR . 45.4 t -132.49 156.03 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 248' ' ' VAL . 92.0 m -128.73 109.76 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.454 ' CZ ' ' CB ' ' A' ' 259' ' ' ALA . 64.8 m-85 -83.85 -178.37 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.87 -51.22 7.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.14 158.16 44.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 96.8 p -44.83 -50.99 9.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -38.79 -67.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.639 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 5.7 mm-40 -50.27 -43.71 53.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.72 1.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 44.4 t -43.31 -49.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.22 -41.12 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.62 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -71.51 -55.38 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 205' ' ' VAL . 65.2 mt -50.13 -38.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 36.6 m -79.62 -53.81 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 15.1 mmt -58.78 -22.1 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.0 m-85 -103.69 -23.19 13.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t30 -58.81 110.5 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.59 88.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.13 131.31 42.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.08 100.03 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.826 HD11 ' NZ ' ' A' ' 218' ' ' LYS . 9.1 tp -106.77 121.84 45.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 57.78 43.67 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 22.9 t70 62.53 26.39 15.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -146.98 126.98 6.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.642 0.734 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 209' ' ' ASN . 53.7 Cg_endo -69.66 131.8 22.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.801 ' SD ' HD22 ' A' ' 268' ' ' LEU . 19.2 mtm -95.43 143.19 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -107.36 100.25 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 207' ' ' VAL . 1.9 t -109.06 124.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -146.93 127.5 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 1.7 ptp -61.89 138.27 58.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.35 162.85 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.52 82.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -106.11 86.69 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.9 85.08 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.08 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.768 HD12 ' HD2' ' A' ' 283' ' ' PRO . 3.0 tp -132.7 138.63 32.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.768 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.77 157.1 61.51 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.733 2.289 . . . . 0.0 112.286 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.97 146.49 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -123.34 125.28 5.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -124.05 133.91 53.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.347 . . . . 0.0 110.887 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -174.83 136.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -121.97 143.98 40.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.652 0.739 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 147.2 62.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.703 2.269 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 5.36 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 292' ' ' ARG . 0.2 OUTLIER -59.17 131.11 50.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.456 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 9.6 ttt85 -138.35 143.21 37.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.7 Cg_endo -69.8 115.48 4.12 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.637 2.225 . . . . 0.0 112.376 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -101.94 115.63 30.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -101.79 151.87 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 90.3 p -153.81 169.69 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -168.94 65.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -35.71 12.12 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.68 2.253 . . . . 0.0 112.337 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.6 m 40.91 42.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 93.5 p -67.01 160.32 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 39.7 p -124.5 -47.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.5 t -57.58 120.95 9.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -90.09 -131.09 4.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.478 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -135.06 171.27 14.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.2 m -85.82 -52.99 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 63.57 148.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 197' ' ' GLN . . . -132.76 79.02 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 197' ' ' GLN . 1.2 pp -37.56 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.637 ' N ' HD12 ' A' ' 196' ' ' LEU . 9.4 tp-100 -64.67 143.52 57.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.77 127.84 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 84.18 97.36 0.63 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -91.06 43.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.04 151.16 39.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -178.48 -153.91 12.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 21.7 p -124.38 -41.71 2.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 110.855 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 34.5 m -55.64 144.71 25.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.151 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.575 HG12 HD11 ' A' ' 260' ' ' ILE . 10.7 m -127.21 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -97.34 117.32 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.6 t -108.02 132.31 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.146 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.91 167.31 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.46 ' O ' ' ND2' ' A' ' 209' ' ' ASN . 0.1 OUTLIER 71.46 32.6 2.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.85 156.81 19.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' A' ' 214' ' ' VAL . 6.9 t70 -71.67 176.23 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -85.03 -30.23 24.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.74 33.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 211' ' ' ASP . 81.4 t -107.27 128.83 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -126.26 152.91 18.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -40.3 -33.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -60.1 -53.37 58.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.575 ' O ' HG23 ' A' ' 222' ' ' VAL . 0.0 OUTLIER -63.71 -50.41 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.648 HD22 ' CD1' ' A' ' 234' ' ' ILE . 17.9 tp -51.25 -56.43 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 232' ' ' ALA . 22.8 ttmt -60.57 -55.8 29.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 224' ' ' SER . 26.9 mm-40 -46.95 -59.97 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 218' ' ' LYS . 51.1 t -56.13 -51.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.571 ' CD2' HG21 ' A' ' 248' ' ' VAL . 4.2 m-85 -59.61 -13.98 11.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 5.4 t -58.53 -22.15 54.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.3 mtm -55.4 -62.07 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -49.59 -55.96 11.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.62 -150.43 6.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.01 96.6 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.993 HG11 ' HB2' ' A' ' 232' ' ' ALA . 87.6 t -50.48 96.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 249' ' ' THR . 55.6 t -52.79 -50.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -139.62 119.82 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.993 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -126.64 133.19 51.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.437 ' CG ' ' C ' ' A' ' 232' ' ' ALA . 0.4 OUTLIER -163.14 165.3 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.648 ' CD1' HD22 ' A' ' 219' ' ' LEU . 4.6 mm -124.39 151.33 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 70.3 mt -100.58 142.38 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -117.51 178.64 4.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.1 179.04 6.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -50.54 -22.89 2.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -80.45 -30.15 37.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.48 -34.41 4.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -70.15 144.26 52.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.779 0.323 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.0 t -51.56 134.32 29.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -26.13 16.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.67 29.49 2.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 83.5 mt -137.52 132.91 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.79 171.65 24.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.544 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.4 p -134.37 139.97 45.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.781 HG13 HG13 ' A' ' 229' ' ' VAL . 72.3 t -138.6 128.29 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.13 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 230' ' ' VAL . 94.0 m -111.79 123.11 49.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 226' ' ' ALA . 66.4 m-85 -96.7 175.51 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -69.96 -57.29 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.98 162.67 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.963 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.591 ' O ' HG23 ' A' ' 257' ' ' VAL . 0.9 OUTLIER -52.57 -38.42 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.6 mm -47.24 -66.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.49 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 4.9 mm-40 -54.79 -43.56 72.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.38 67.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 253' ' ' SER . 65.5 t -60.34 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -48.96 -43.88 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.626 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -68.36 -59.67 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.076 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 275' ' ' VAL . 33.4 mt -43.99 -42.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.4 m -76.27 -60.66 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -50.14 -23.36 2.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.886 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 3.6 m-85 -102.46 -22.8 13.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.63 111.38 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.95 17.87 71.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -77.21 122.5 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 267' ' ' LEU . 11.5 mt -81.21 99.98 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.545 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -108.55 122.01 46.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.21 43.6 20.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 24.0 t0 63.24 25.45 14.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.74 125.22 8.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 126.55 13.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.545 ' SD ' HD22 ' A' ' 268' ' ' LEU . 46.0 mtm -85.54 155.93 20.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -121.14 101.12 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 260' ' ' ILE . 2.7 t -111.56 117.8 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.7 tttm -136.81 157.6 46.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.447 ' CE ' HG22 ' A' ' 257' ' ' VAL . 14.0 mtt -65.61 136.83 56.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -84.7 177.7 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.76 79.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.87 107.56 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -89.48 78.42 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 5.8 tp -112.53 137.03 21.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.62 3.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -100.97 145.43 28.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.07 83.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -125.54 82.08 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.42 149.07 22.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -100.83 143.88 27.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.477 ' HA ' ' HD2' ' A' ' 290' ' ' PRO . 53.8 Cg_endo -69.77 110.32 2.53 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.734 2.289 . . . . 0.0 112.311 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 289' ' ' PRO . 53.7 Cg_endo -69.74 112.75 3.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.664 2.242 . . . . 0.0 112.359 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.3 130.96 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -128.26 143.83 49.54 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 159.15 54.48 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.49 146.68 40.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -113.12 136.51 52.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.0 t -140.97 144.97 35.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.81 84.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -177.11 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.754 2.303 . . . . 0.0 112.336 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 89.5 p -146.38 128.12 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.2 m -146.3 172.17 13.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 m -165.1 129.17 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.869 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 83.9 p -160.96 118.15 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -151.75 96.38 0.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.487 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 79.7 p -174.05 112.7 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.0 p -56.81 -29.54 62.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 47.08 49.82 17.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.53 91.25 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.58 124.92 26.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -96.04 113.65 25.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.39 162.38 17.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.053 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 100.99 64.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.06 -14.75 25.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.01 114.21 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 168.43 141.73 3.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 204' ' ' THR . 59.5 m -81.38 -43.88 18.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.955 0.407 . . . . 0.0 110.909 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 203' ' ' SER . 10.5 m -35.19 121.7 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.158 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 260' ' ' ILE . 24.2 m -111.97 142.65 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -99.06 117.19 33.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 245' ' ' ILE . 33.1 t -107.89 130.16 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -135.23 170.87 15.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 62.19 50.06 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 51.4 mt -101.41 158.78 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' A' ' 214' ' ' VAL . 18.1 t0 -67.88 174.42 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -92.46 -6.22 50.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.58 ' HD2' ' CE1' ' A' ' 269' ' ' PHE . 10.1 ptpt -111.51 31.58 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 211' ' ' ASP . 14.9 t -108.5 132.25 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.62 158.53 15.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.418 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 35.1 p-90 -45.82 -31.39 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 32.3 mtpt -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.804 ' O ' HG23 ' A' ' 222' ' ' VAL . 2.5 tmtp? -63.13 -50.84 68.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.8 tp -59.39 -38.99 81.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -69.35 -64.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 222' ' ' VAL . 12.0 pt-20 -44.32 -40.91 5.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 218' ' ' LYS . 89.6 t -66.89 -52.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.538 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.2 m-85 -61.64 -14.01 27.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.5 t -52.03 -25.06 7.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.0 mtm -57.62 -64.25 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -47.76 -48.16 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -179.3 -154.65 13.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.81 127.05 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.38 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.958 HG11 ' HB2' ' A' ' 232' ' ' ALA . 73.5 t -84.54 99.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -148.54 118.97 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.958 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -119.83 142.24 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -165.88 169.36 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 219' ' ' LEU . 44.3 mm -129.53 132.91 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 71.3 mt -73.69 126.98 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -114.71 178.46 4.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -94.41 178.71 5.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -40.62 -54.48 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -66.32 -57.62 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 146.78 33.5 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.439 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -103.39 149.61 24.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 82.7 p -76.61 118.47 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -87.92 16.99 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.32 24.03 64.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 207' ' ' VAL . 44.4 mt -135.78 126.27 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.133 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.19 168.65 20.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.52 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 73.5 p -138.32 145.49 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 t -139.1 155.25 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.1 m -129.76 115.48 17.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -89.01 -177.62 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.89 -55.68 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -129.29 158.58 38.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 257' ' ' VAL . 14.8 p -51.08 -34.14 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -49.37 -68.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.37 -43.39 75.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.25 -46.6 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 253' ' ' SER . 76.2 t -63.26 -48.67 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -47.96 -49.49 30.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.4 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -64.32 -60.06 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.677 HD11 HG12 ' A' ' 205' ' ' VAL . 74.8 mt -39.9 -38.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 m -82.0 -64.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -48.46 -19.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.538 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.9 m-85 -104.81 -25.33 12.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.05 112.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.48 11.97 79.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLN . . . . . 0.462 ' NE2' ' N ' ' A' ' 267' ' ' LEU . 0.0 OUTLIER -77.09 124.39 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.927 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.462 ' N ' ' NE2' ' A' ' 266' ' ' GLN . 13.1 mt -79.91 99.87 7.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.758 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -106.72 123.25 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PHE . . . . . 0.58 ' CE1' ' HD2' ' A' ' 213' ' ' LYS . 9.2 m-85 60.03 37.43 21.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 68.79 24.97 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.94 127.13 8.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 120.29 7.09 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.758 ' SD ' HD22 ' A' ' 268' ' ' LEU . 35.3 mtm -80.88 151.91 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -115.89 105.73 13.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.71 125.73 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.159 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -144.7 157.33 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.415 ' HG2' HD13 ' A' ' 260' ' ' ILE . 7.9 mmt -63.05 137.88 58.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.01 147.24 43.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.14 79.64 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -93.79 170.56 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -135.02 103.21 5.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.612 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.2 tp -160.56 140.64 8.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.575 0.703 . . . . 0.0 110.953 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.612 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.78 139.02 39.15 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -71.57 -56.15 6.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.55 61.64 1.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.534 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -74.6 150.77 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -154.45 129.04 9.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.59 143.08 31.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 151.0 69.38 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.13 59.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -99.34 166.07 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 293' ' ' PRO . 0.0 OUTLIER -111.6 105.51 56.71 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 292' ' ' ARG . 53.7 Cg_endo -69.74 142.83 49.1 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.351 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -114.87 92.26 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -41.59 141.09 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.5 m -160.23 153.82 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 145.24 -84.71 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 1.85 4.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.704 2.269 . . . . 0.0 112.334 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 29.7 t -40.67 -49.4 3.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 93.6 p -63.73 132.84 52.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.505 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m -115.28 83.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.5 t -86.15 98.09 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.823 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.53 109.0 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 91.3 p -101.16 161.62 13.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.829 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.0 t -111.21 150.27 29.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.852 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -88.54 70.21 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.462 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.89 154.49 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 111.089 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -133.45 133.59 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -137.79 145.75 42.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.11 139.99 51.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -164.19 -167.01 24.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.456 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -93.79 -179.24 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.89 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 201' ' ' LEU . 6.7 tt -116.24 138.12 51.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -178.05 -123.82 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 26.0 m -109.01 53.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.853 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 205' ' ' VAL . 30.4 m -87.0 159.04 19.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.69 HG12 HD11 ' A' ' 260' ' ' ILE . 22.3 m -132.49 143.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -100.37 113.26 25.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 245' ' ' ILE . 3.7 t -101.33 135.04 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -139.88 165.46 27.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 t30 63.29 49.99 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 42.1 mt -100.85 162.91 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 214' ' ' VAL . 0.6 OUTLIER -83.11 132.57 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -44.06 -44.3 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -56.42 -40.17 74.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 211' ' ' ASP . 74.2 t -51.91 123.58 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 218' ' ' LYS . . . -121.5 158.39 16.24 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.48 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 25.1 p-90 -38.89 -32.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.48 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 22.5 mtpp -72.35 -47.85 46.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 222' ' ' VAL . 3.1 tmtt? -66.2 -49.64 66.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.427 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.3 tp -56.38 -50.84 70.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' A' ' 232' ' ' ALA . 26.5 tttm -66.55 -35.04 79.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.66 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 218' ' ' LYS . 38.4 t -83.79 -49.13 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.134 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -59.1 -26.38 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.5 t -46.01 -24.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.1 mtm -57.91 -65.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.27 -42.34 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.92 -160.74 28.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.9 123.53 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 232' ' ' ALA . 47.0 t -83.66 98.76 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 76.1 t -54.6 -48.07 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -136.55 123.28 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -126.28 128.98 47.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -163.56 163.87 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.427 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.3 mm -122.73 148.1 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 76.2 mt -88.65 125.08 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' A' ' 236' ' ' GLU . 26.5 mp0 -132.57 167.96 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -61.04 173.56 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -50.86 -23.41 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -95.16 -55.48 3.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.6 37.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -88.75 144.41 26.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.3 m -83.43 120.6 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.31 -16.36 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 100.65 22.49 11.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 207' ' ' VAL . 28.6 mt -132.01 123.08 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.123 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.46 169.5 15.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.1 p -135.33 135.47 40.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.81 143.48 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 24.5 m -126.54 117.6 23.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 226' ' ' ALA . 67.7 m-85 -88.08 -177.91 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.47 -48.39 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -132.92 155.7 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.3 p -49.14 -46.0 44.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 23.8 mm -41.02 -60.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.43 -42.02 90.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.0 -54.2 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.74 -49.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -47.92 -48.29 31.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -67.93 -58.28 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.69 HD11 HG12 ' A' ' 205' ' ' VAL . 80.3 mt -41.36 -46.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.2 m -77.09 -62.22 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 49.7 mmm -47.62 -21.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.416 ' CB ' HG21 ' A' ' 275' ' ' VAL . 4.6 m-85 -104.58 -30.64 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -50.52 115.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.98 16.56 76.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -81.58 121.28 26.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.8 100.63 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.571 HD21 ' HZ1' ' A' ' 218' ' ' LYS . 13.6 tp -108.87 123.14 48.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 59.23 31.56 21.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 74.08 28.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -145.19 121.78 6.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 115.43 4.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 58.8 mtm -73.95 153.53 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 1.4 t60 -118.01 100.3 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.2 t -109.96 113.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 277' ' ' MET . 1.8 tppp? -124.1 157.6 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.643 ' HG2' HD13 ' A' ' 260' ' ' ILE . 24.0 mtp -67.45 127.57 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -93.76 43.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 280' ' ' ARG . 15.7 tp10 -92.4 101.78 14.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 279' ' ' GLU . 17.4 tpt180 -35.42 138.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -74.03 81.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 5.5 tp -146.22 133.95 10.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.591 0.71 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 160.17 50.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.643 2.229 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -99.01 -48.85 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.45 43.77 1.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -68.57 134.36 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.511 ' CD1' ' C ' ' A' ' 287' ' ' PHE . 3.3 p90 -123.12 148.92 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -128.5 129.48 23.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 148.18 64.78 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 0.0 112.342 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -177.89 2.09 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.737 2.291 . . . . 0.0 112.342 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -139.57 161.55 37.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -117.82 143.83 33.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 0.0 110.819 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.8 23.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.322 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -105.28 118.24 36.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -105.45 134.26 48.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 30.5 t -68.99 150.79 47.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.95 83.59 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 161.28 46.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.333 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 1.1 t -83.7 159.63 21.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 80.4 p -150.65 177.47 10.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.531 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -157.89 118.72 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.5 m -152.83 153.63 33.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.85 -179.76 43.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.473 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.6 p -174.3 150.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.9 t -169.06 173.47 6.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.28 35.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.459 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.19 144.24 45.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 0.0 111.1 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.28 168.11 19.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.86 111.26 8.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.21 -45.91 65.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 100.64 96.66 2.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.51 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -82.41 -41.92 19.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 19.4 tp -86.99 151.44 23.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.64 150.27 13.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 20.2 m -133.4 41.48 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.986 0.422 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.8 m -89.09 130.6 35.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.531 HG12 HD11 ' A' ' 260' ' ' ILE . 34.4 m -111.06 130.38 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -95.32 118.58 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 275' ' ' VAL . 80.8 t -106.31 140.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.82 163.51 32.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 65.66 43.37 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.548 HD11 ' CG1' ' A' ' 207' ' ' VAL . 45.2 mt -92.77 149.01 21.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 3.3 t70 -60.12 162.89 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.415 ' N ' ' CG ' ' A' ' 211' ' ' ASP . 19.1 m-85 -79.12 -34.32 43.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.479 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 20.8 mtpp -82.99 37.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -110.02 157.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.131 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 214' ' ' VAL . . . -150.53 155.98 26.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -46.99 -33.43 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.4 -44.83 77.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -56.49 12.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.4 tp -49.94 -61.25 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.544 ' HG3' HG11 ' A' ' 229' ' ' VAL . 35.9 tttm -50.25 -58.19 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -44.12 -39.89 4.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.647 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 20.0 t -73.73 -46.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.65 -20.05 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.3 t -53.22 -22.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.846 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 11.0 mtm -62.93 -61.64 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -50.85 -52.98 36.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -176.2 -160.26 23.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 67.9 t -79.32 124.84 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 0.0 111.1 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 232' ' ' ALA . 79.6 t -87.47 96.0 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.79 -45.57 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -139.84 121.26 15.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.952 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -125.92 124.12 40.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.551 ' CD1' HD22 ' A' ' 219' ' ' LEU . 35.5 mm -124.17 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 245' ' ' ILE . 86.6 mt -76.64 135.9 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -129.96 175.92 8.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 15.2 t0 -83.81 176.21 9.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' ASP . 3.4 mptt -37.06 -62.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 239' ' ' ASP . 1.9 t0 -55.79 -58.02 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 142.43 42.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -106.35 132.96 51.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.8 m -56.27 113.04 1.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -87.51 27.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 64.06 21.28 65.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 207' ' ' VAL . 48.5 mt -132.81 132.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.69 176.99 18.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p -151.82 127.26 10.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.649 ' CG1' HG13 ' A' ' 229' ' ' VAL . 33.0 t -130.16 154.67 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.157 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 248' ' ' VAL . 79.3 m -131.17 120.49 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 76.9 m-85 -87.55 -177.77 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.28 -55.03 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -111.35 143.55 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.8 p -48.31 -43.81 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.23 -60.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.03 -48.22 67.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.87 -53.34 19.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.153 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.508 ' HA ' HD12 ' A' ' 260' ' ' ILE . 85.8 t -54.33 -55.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -41.39 -56.99 2.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.509 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -57.08 -47.03 82.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.593 HD13 ' HG2' ' A' ' 277' ' ' MET . 73.1 mt -53.69 -56.83 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.8 t -64.68 -58.98 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -47.0 -57.96 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.647 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 23.4 m-85 -65.66 -40.35 92.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 0.7 OUTLIER -45.04 114.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.43 19.93 67.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -87.9 124.73 33.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -79.4 99.99 7.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.466 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.7 tp -108.75 120.68 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 60.11 35.03 21.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 72.04 25.04 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -144.56 122.48 6.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 125.62 12.37 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.466 ' SD ' HD22 ' A' ' 268' ' ' LEU . 58.7 mtm -85.31 151.88 23.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -119.04 101.01 7.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 207' ' ' VAL . 14.3 t -114.01 127.2 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 277' ' ' MET . 7.5 ttmm -143.32 159.98 41.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 260' ' ' ILE . 8.9 mtp -66.5 117.04 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.8 110.37 2.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -74.15 -40.25 62.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -50.98 107.06 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -105.07 80.68 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.873 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.4 tp -69.7 135.68 88.04 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.603 0.716 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.873 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.3 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -126.77 113.97 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 152.43 136.66 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.02 175.85 9.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -146.44 148.42 32.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 289' ' ' PRO . 48.5 t80 -96.95 123.38 53.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.486 ' O ' ' CE2' ' A' ' 288' ' ' PHE . 54.3 Cg_endo -69.73 159.48 53.29 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.749 2.299 . . . . 0.0 112.346 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 121.52 8.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -138.36 134.95 34.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 292' ' ' ARG . 3.6 ptm85 -139.24 146.0 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 110.915 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 130.54 19.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.231 . . . . 0.0 112.345 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -129.78 138.92 51.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -106.94 146.53 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.4 t -156.84 160.72 39.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 172.36 82.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -176.41 1.49 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.707 2.272 . . . . 0.0 112.347 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 4.0 t -162.32 173.9 13.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 2.0 t -156.88 177.96 10.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 179.973 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.0 p -88.79 127.36 35.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 86.1 p -88.82 164.9 15.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 113.73 140.49 7.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.462 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 99.6 p -109.62 129.5 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.3 t -77.71 136.83 38.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 44.34 -122.52 4.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 55.96 54.62 7.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.106 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 196' ' ' LEU . 5.7 mp -72.41 112.45 8.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -111.36 100.87 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.2 111.98 23.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.056 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 61.36 73.85 0.45 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.516 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -53.38 109.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 201' ' ' LEU . 0.9 OUTLIER -93.63 147.96 22.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 141.59 103.61 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 204' ' ' THR . 15.1 m -75.56 -38.95 58.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 203' ' ' SER . 6.8 m -35.82 139.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 260' ' ' ILE . 11.8 m -125.72 144.06 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -101.05 125.31 47.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.437 ' CG1' HD11 ' A' ' 210' ' ' LEU . 9.1 t -115.85 127.04 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -134.73 171.68 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.0 36.37 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.437 HD11 ' CG1' ' A' ' 207' ' ' VAL . 44.3 mt -89.16 144.94 25.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 214' ' ' VAL . 30.2 t0 -63.44 142.28 58.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -57.49 -27.28 62.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -74.03 -34.57 64.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 211' ' ' ASP . 54.4 t -59.55 133.32 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.14 158.17 22.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.504 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 46.3 p-90 -36.35 -33.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.504 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 24.9 mtpt -62.51 -53.15 58.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -67.06 -52.64 39.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 234' ' ' ILE . 12.6 tp -46.92 -40.52 14.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.572 ' HE3' ' HB3' ' A' ' 232' ' ' ALA . 32.4 ttmt -76.0 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -46.07 -33.88 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.19 -58.72 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.543 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.2 m-85 -52.06 -19.48 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.1 t -53.55 -15.74 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 30.6 mtm -65.53 -63.19 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.95 32.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -174.37 -136.28 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.437 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.99 117.67 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.932 HG11 ' HB2' ' A' ' 232' ' ' ALA . 77.5 t -72.34 97.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 92.9 t -53.66 -52.85 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -142.66 117.86 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.932 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -118.65 143.13 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.89 158.0 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.831 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 219' ' ' LEU . 26.7 mm -119.59 127.39 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.0 127.04 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.2 176.98 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 173.15 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -39.85 -58.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.89 -58.34 3.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.36 44.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.85 114.64 27.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.1 m -52.3 117.75 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -94.38 -20.0 20.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.46 24.55 21.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 91.9 mt -136.0 131.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.87 0.367 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.607 ' HA3' HD13 ' A' ' 234' ' ' ILE . . . -138.33 175.44 21.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.3 p -138.39 145.6 41.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.799 0.333 . . . . 0.0 111.156 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.638 HG13 HG13 ' A' ' 229' ' ' VAL . 82.9 t -135.91 137.17 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 77.4 m -115.24 114.06 24.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 73.6 m-85 -88.2 169.78 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.409 ' HG2' ' CG2' ' A' ' 230' ' ' VAL . 14.6 mm-40 -75.74 -55.41 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -123.61 154.5 39.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 257' ' ' VAL . 68.5 p -49.72 -47.69 50.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 35.1 mm -41.2 -63.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -54.33 -45.67 72.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.63 -49.82 64.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 253' ' ' SER . 42.1 t -56.19 -60.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -39.96 -50.54 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -61.63 -59.37 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.481 HD11 HG12 ' A' ' 205' ' ' VAL . 35.8 mt -42.49 -48.35 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 264' ' ' ASN . 7.0 m -73.36 -65.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.3 mmt -45.39 -22.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.425 ' HB3' HG21 ' A' ' 275' ' ' VAL . 25.7 m-85 -103.82 -21.47 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 261' ' ' SER . 5.9 t30 -61.78 111.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.52 8.53 86.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -76.39 130.68 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -88.23 107.92 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.517 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.8 tp -114.37 123.58 49.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 60.3 32.28 20.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 74.18 25.94 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -147.07 127.8 7.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.865 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 130.57 19.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.517 ' SD ' HD22 ' A' ' 268' ' ' LEU . 48.3 mtm -91.46 132.82 35.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -96.76 105.31 17.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 263' ' ' PHE . 2.6 t -120.69 127.33 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -149.54 150.87 32.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.465 ' HG3' HD13 ' A' ' 260' ' ' ILE . 28.8 mtt -57.88 139.06 55.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -52.95 137.82 31.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -83.32 -48.71 10.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -73.81 130.16 39.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -124.41 93.14 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.584 HD12 ' HD2' ' A' ' 283' ' ' PRO . 6.4 tp -85.51 140.46 36.06 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.584 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.5 Cg_endo -69.75 163.69 37.32 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.742 2.294 . . . . 0.0 112.325 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -98.82 -37.78 9.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.53 46.56 2.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.0 85.07 7.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -115.84 153.43 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.551 ' CD1' ' HD2' ' A' ' 289' ' ' PRO . 36.7 t80 -130.73 139.42 35.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.551 ' HD2' ' CD1' ' A' ' 288' ' ' PHE . 53.3 Cg_endo -69.74 110.54 2.58 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.629 2.22 . . . . 0.0 112.394 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 289' ' ' PRO . 53.9 Cg_endo -69.78 175.13 8.53 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.379 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.38 169.29 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.482 ' CD ' ' HD2' ' A' ' 293' ' ' PRO . 9.5 tpp180 -129.34 138.88 34.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.679 0.752 . . . . 0.0 110.854 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.482 ' HD2' ' CD ' ' A' ' 292' ' ' ARG . 54.3 Cg_endo -69.73 164.89 32.83 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.329 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -133.15 87.18 2.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -119.59 177.19 5.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.1 t -173.84 140.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 157.8 82.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.48 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 168.68 20.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.1 m -154.47 154.58 33.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 54.9 m -129.3 146.53 51.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 65.9 m -133.44 158.88 41.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.3 m -138.97 160.79 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.97 82.72 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.8 t -133.1 133.99 43.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.3 m -65.9 156.32 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.807 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 145.47 66.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.83 117.74 23.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 196' ' ' LEU . 2.5 pt? -75.78 133.53 40.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -63.7 162.03 13.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -127.58 80.54 1.96 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 102.48 139.49 10.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -124.9 -42.59 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.69 105.06 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 174.24 162.56 26.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.4 p -132.76 -33.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.984 0.421 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 65.6 m -55.65 134.93 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 m -120.15 134.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 245' ' ' ILE . 74.7 t80 -95.42 118.26 31.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 275' ' ' VAL . 92.6 t -105.38 138.65 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.64 155.99 46.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 74.85 45.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.466 HD11 ' CG1' ' A' ' 207' ' ' VAL . 76.2 mt -99.56 134.82 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -57.57 162.51 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -72.05 -25.3 61.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -70.58 -42.88 70.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.43 139.48 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -141.3 159.9 26.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.529 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 16.6 p-90 -36.61 -33.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.359 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.529 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 9.9 mtpm? -68.23 -61.06 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.466 ' HD3' HG23 ' A' ' 222' ' ' VAL . 4.3 tmtm? -56.19 -54.24 47.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.9 tp -47.29 -58.07 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -49.96 -63.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -41.94 -42.86 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.62 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 69.8 t -67.61 -51.17 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -59.73 -28.19 67.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.3 t -45.46 -28.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.832 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 34.5 mtp -51.99 -68.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -42.67 -56.46 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.91 -170.95 31.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.46 104.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 232' ' ' ALA . 78.4 t -62.45 99.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.675 HG22 ' OE2' ' A' ' 251' ' ' GLU . 83.1 t -50.09 -50.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.445 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.1 ptm180 -153.45 117.44 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.808 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.53 146.32 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -165.04 172.09 13.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 49.2 mm -125.25 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.667 HD12 HG22 ' A' ' 245' ' ' ILE . 70.5 mt -77.48 136.45 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -130.9 178.16 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.09 177.28 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.409 ' C ' ' HD3' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -38.72 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.08 -53.63 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.69 37.51 0.23 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -105.11 135.95 45.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 51.4 m -69.09 121.33 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -93.21 26.61 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 69.68 21.29 76.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.504 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.667 HG22 HD12 ' A' ' 235' ' ' LEU . 46.9 mt -124.99 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.98 166.79 24.55 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.6 p -136.24 143.84 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 223' ' ' PHE . 85.3 t -140.47 134.56 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.445 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 22.3 m -114.19 111.72 22.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -87.39 174.87 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.675 ' OE2' HG22 ' A' ' 230' ' ' VAL . 42.1 mm-40 -68.6 -60.01 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -127.2 162.67 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.7 p -51.77 -46.6 64.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.8 mm -40.34 -68.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.494 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 5.4 mm-40 -52.31 -44.83 65.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.21 -56.9 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.608 HG22 ' CE ' ' A' ' 277' ' ' MET . 60.0 t -52.29 -45.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -52.74 -42.58 65.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -72.78 -50.27 25.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 257' ' ' VAL . 72.0 mt -44.7 -52.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.3 m -72.22 -62.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 18.6 mmt -44.79 -23.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.62 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 22.9 m-85 -102.72 -28.02 12.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.44 ' OD1' ' C ' ' A' ' 264' ' ' ASN . 19.7 t-20 -56.42 111.05 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.57 11.49 84.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -74.53 128.31 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.8 mt -81.42 102.38 10.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.577 HD22 ' SD ' ' A' ' 273' ' ' MET . 14.2 tp -112.02 121.64 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 56.77 41.66 27.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 28.8 t70 63.26 29.51 15.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -147.02 121.46 5.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.601 0.715 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 123.78 10.43 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.289 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.577 ' SD ' HD22 ' A' ' 268' ' ' LEU . 46.1 mtm -85.47 158.2 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -121.68 100.57 7.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 207' ' ' VAL . 1.7 t -112.84 128.67 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -144.31 154.97 43.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.608 ' CE ' HG22 ' A' ' 257' ' ' VAL . 13.9 mmt -55.34 132.88 49.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 102.36 14.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.11 88.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -72.39 143.41 48.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -128.73 89.61 2.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.8 tp -123.26 139.8 32.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.615 0.721 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.525 ' HD2' HD12 ' A' ' 282' ' ' LEU . 52.9 Cg_endo -69.85 157.14 61.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.308 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -123.36 131.58 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.63 147.78 5.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.21 141.37 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.62 129.45 22.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -101.64 144.54 28.77 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.656 0.741 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 116.92 4.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 155.77 65.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.232 . . . . 0.0 112.338 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 292' ' ' ARG . 6.6 tp10 -126.48 136.57 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.46 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 26.3 ttm180 -38.21 139.73 0.63 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.5 Cg_endo -69.82 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -119.74 177.4 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -139.38 113.89 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 91.2 p -101.55 173.62 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.08 83.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.492 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.92 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.0 t -168.35 146.11 4.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 m -141.43 177.37 8.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.474 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.9 m -116.45 97.4 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.9 p -80.03 102.99 9.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -90.28 40.35 3.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 m -110.3 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 26.3 t -124.59 -36.73 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.01 9.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -84.79 110.37 18.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.9 mp -125.58 -53.16 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.8 134.48 54.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.4 -51.67 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 46.02 61.25 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -63.7 80.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.6 mt -130.99 157.29 43.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.404 ' N ' ' NH2' ' A' ' 280' ' ' ARG . . . -112.63 -87.13 1.63 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.423 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 204' ' ' THR . 13.1 m -40.14 -45.63 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.835 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 203' ' ' SER . 42.1 m -36.56 128.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.689 HG12 HD11 ' A' ' 260' ' ' ILE . 20.1 m -109.4 139.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -99.73 117.05 33.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.65 135.44 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -139.86 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.94 41.66 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.5 mt -89.25 166.61 13.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.691 ' HB2' HG23 ' A' ' 214' ' ' VAL . 1.1 m-20 -93.55 139.14 31.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -51.65 -41.68 61.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.02 -33.88 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.691 HG23 ' HB2' ' A' ' 211' ' ' ASP . 47.6 t -67.04 132.5 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.68 164.75 23.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.492 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.6 p-90 -36.26 -31.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 215' ' ' GLY . 32.1 mttm -60.43 -69.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 219' ' ' LEU . 16.3 mmmt -54.11 -58.16 8.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 1.016 HD22 HD11 ' A' ' 234' ' ' ILE . 16.2 tp -36.94 -56.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 6.8 ttpt -61.1 -67.22 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 224' ' ' SER . 6.3 mm-40 -41.16 -67.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 25.0 t -43.84 -49.08 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.8 m-85 -63.31 -26.14 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 8.2 t -46.45 -23.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 16.3 mtm -55.14 -66.53 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.83 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -38.39 -50.84 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.31 -112.94 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.8 t -129.78 110.45 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.733 HG11 ' HB2' ' A' ' 232' ' ' ALA . 49.1 t -70.92 96.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 251' ' ' GLU . 98.3 t -50.05 -49.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.47 HH11 HG21 ' A' ' 249' ' ' THR . 6.6 ptp85 -151.22 122.4 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.733 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -111.96 151.16 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -169.84 160.47 8.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 1.016 HD11 HD22 ' A' ' 219' ' ' LEU . 49.3 mm -120.01 128.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.0 114.98 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -128.13 174.21 9.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 0.8 OUTLIER -85.91 174.69 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' ASP . 36.8 mtmt -37.36 -48.98 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.44 -64.15 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.47 36.25 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.95 122.24 33.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.2 m -70.62 120.36 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 15.1 ttm105 -92.24 24.54 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.31 12.77 73.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.4 mt -122.37 126.1 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.53 165.91 19.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.3 p -137.45 140.1 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.581 HG13 HG13 ' A' ' 229' ' ' VAL . 61.1 t -138.16 146.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.47 HG21 HH11 ' A' ' 231' ' ' ARG . 17.9 m -123.18 111.96 17.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 38.5 m-85 -86.17 165.88 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 0.7 OUTLIER -52.79 -52.63 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -143.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 254' ' ' ILE . 8.9 t -48.23 -54.21 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.5 mm -35.98 -68.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.159 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.444 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 24.1 mp0 -48.71 -46.84 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.562 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.77 -60.86 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.401 HG22 ' CE ' ' A' ' 277' ' ' MET . 94.5 t -42.88 -53.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -47.92 -56.82 6.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.83 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -58.54 -55.4 35.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.689 HD11 HG12 ' A' ' 205' ' ' VAL . 91.7 mt -40.65 -58.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 264' ' ' ASN . 46.4 t -68.71 -61.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.8 mtt -44.42 -22.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -103.88 -26.71 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 264' ' ' ASN . 0.2 OUTLIER -52.34 116.73 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.51 82.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLN . . . . . 0.463 ' OE1' ' N ' ' A' ' 267' ' ' LEU . 6.3 tp-100 -78.24 130.15 35.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' LEU . . . . . 0.463 ' N ' ' OE1' ' A' ' 266' ' ' GLN . 13.0 mt -87.68 100.37 12.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.406 HD22 ' SD ' ' A' ' 273' ' ' MET . 22.0 tp -108.1 123.81 49.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 59.89 32.23 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.1 26.78 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -145.32 129.01 8.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 126.57 13.49 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.406 ' SD ' HD22 ' A' ' 268' ' ' LEU . 36.6 mtm -84.17 143.43 29.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' HIS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 14.5 t-160 -109.87 99.26 8.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 260' ' ' ILE . 2.5 t -109.43 131.1 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -151.65 155.07 37.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' MET . . . . . 0.401 ' CE ' HG22 ' A' ' 257' ' ' VAL . 9.1 mmt -61.54 138.18 58.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CG ' ' N ' ' A' ' 279' ' ' GLU . 1.9 t70 -53.71 166.56 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 278' ' ' ASP . 2.9 tp10 -85.69 100.45 12.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ARG . . . . . 0.404 ' NH2' ' N ' ' A' ' 202' ' ' GLY . 19.0 tpp180 -98.96 142.82 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.49 92.57 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.587 HD12 ' HD2' ' A' ' 283' ' ' PRO . 7.1 tp -75.04 140.07 73.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.587 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.76 -173.22 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.346 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -112.07 -32.83 6.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.85 176.74 50.95 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -136.64 178.93 6.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 110.853 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -137.39 119.32 15.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -110.14 143.99 29.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 124.76 11.4 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 106.63 1.7 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.49 107.37 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.26 151.35 42.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.843 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 125.47 12.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.5 139.98 52.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -109.21 134.14 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.4 t -151.42 108.49 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -130.51 81.44 0.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 173.03 11.56 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 65.1 p -107.66 151.18 26.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 57.9 p -85.02 166.16 16.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.516 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 p -150.54 150.88 31.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.817 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.7 t -143.47 165.73 26.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -137.2 59.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.4 t -174.02 108.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 96.0 p -150.44 144.51 25.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 127.3 51.36 0.15 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.472 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -105.36 92.78 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.49 57.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -76.65 51.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.82 87.55 2.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.09 41.01 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -76.98 115.65 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.43 148.28 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 148.75 168.39 14.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 204' ' ' THR . 34.1 p -106.44 -36.36 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.955 0.407 . . . . 0.0 110.851 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 203' ' ' SER . 62.3 m -34.25 126.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.15 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.81 134.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.35 120.82 35.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.787 HG11 HD21 ' A' ' 210' ' ' LEU . 49.1 t -109.93 139.72 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.09 165.23 27.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 38.5 t30 62.78 46.43 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.787 HD21 HG11 ' A' ' 207' ' ' VAL . 30.8 mt -95.74 149.09 21.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.609 ' HB2' HG23 ' A' ' 214' ' ' VAL . 1.2 m-20 -69.65 138.47 53.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -50.5 -39.96 49.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -61.26 -41.48 96.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 211' ' ' ASP . 59.9 t -50.93 131.48 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -131.93 161.88 23.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -43.36 -34.63 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -62.3 -59.44 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -60.37 -57.18 13.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.4 tp -44.67 -55.86 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -56.04 -52.11 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.16 -58.08 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.565 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 71.2 t -52.89 -40.09 34.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.15 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 225' ' ' MET . 3.7 m-85 -69.04 -32.62 72.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.3 m -40.65 -25.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 223' ' ' PHE . 51.8 mtp -54.77 -66.31 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 255' ' ' GLU . . . -47.4 -48.62 26.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.59 -165.14 28.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.04 107.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.14 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.87 HG11 ' HB2' ' A' ' 232' ' ' ALA . 77.4 t -63.83 104.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -42.74 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.072 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -144.42 120.31 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.87 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -122.65 133.4 54.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -164.68 167.69 18.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.82 142.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.3 125.39 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -137.11 176.08 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 238' ' ' LYS . 2.5 m-20 -109.22 178.51 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 237' ' ' ASP . 58.7 mttp -37.87 -59.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -48.12 -48.02 34.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 239' ' ' ASP . . . 105.84 24.8 6.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 239' ' ' ASP . 0.0 OUTLIER -94.07 139.0 31.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.9 m -70.36 120.84 16.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 243' ' ' ARG . 5.4 mmm180 -96.85 27.44 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 64.7 28.11 72.88 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.532 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 75.7 mt -135.95 125.73 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.122 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.21 176.31 19.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.4 p -144.82 136.33 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.129 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 223' ' ' PHE . 39.3 t -129.22 149.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.2 m -129.17 117.13 20.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.496 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 70.9 m-85 -91.22 -175.2 4.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.87 -54.78 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -129.37 163.63 25.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.5 p -53.91 -41.67 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.8 mm -46.13 -65.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.638 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 42.0 mt-10 -53.11 -45.09 68.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.496 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.28 -59.17 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -48.24 -56.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.169 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -44.06 -45.92 8.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -69.51 -48.36 60.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 95.3 mt -48.88 -52.82 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 m -69.75 -63.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -42.58 -38.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 19.4 m-85 -88.21 -26.81 22.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -55.2 109.94 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.62 14.63 75.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -77.06 131.27 38.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.4 mt -88.7 103.02 15.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -110.3 122.21 47.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 59.25 34.07 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 71.53 27.49 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -144.48 117.74 5.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 119.86 6.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 47.5 mtm -79.15 163.17 25.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -126.66 100.65 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 129.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -146.23 145.83 30.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.5 mtt -56.79 126.99 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.44 158.16 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -114.29 86.8 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -135.01 114.51 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.53 68.39 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.3 tp -77.92 140.93 62.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.76 164.6 33.94 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.732 2.288 . . . . 0.0 112.323 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.6 -56.84 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 51.11 52.71 30.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.457 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -120.53 143.05 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -167.36 149.14 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -133.81 137.25 28.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.625 0.726 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 148.27 64.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 101.02 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -83.33 96.36 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -114.56 82.33 7.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 121.64 8.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.615 2.21 . . . . 0.0 112.341 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -128.34 131.34 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -129.13 132.95 47.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.6 t -157.73 145.14 18.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 140.05 145.25 4.64 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.425 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -177.89 2.1 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 1.8 t -132.69 170.2 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -168.22 151.1 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.807 0.337 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.9 138.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.559 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 72.1 t80 -97.0 116.39 29.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 245' ' ' ILE . 13.5 t -104.32 132.85 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.73 166.45 22.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 61.83 50.82 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 207' ' ' VAL . 42.7 mt -102.36 157.97 16.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.569 ' HB2' HG23 ' A' ' 214' ' ' VAL . 0.8 OUTLIER -79.52 136.55 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -48.2 -44.81 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.434 ' NZ ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -57.41 -36.58 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 211' ' ' ASP . 88.9 t -58.42 117.77 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -114.18 168.71 12.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -50.8 -25.33 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.71 -64.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.919 ' O ' HG23 ' A' ' 222' ' ' VAL . 34.6 tptt -57.62 -51.15 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.7 tp -49.24 -54.97 14.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -59.58 -52.9 63.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -50.67 -40.73 54.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 218' ' ' LYS . 29.0 t -66.87 -52.1 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.5 m-85 -60.83 -16.14 37.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.7 t -56.22 -19.3 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.2 mtp -61.69 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -48.57 -37.58 18.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 174.46 -159.8 28.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.2 t -88.03 126.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.886 HG11 ' HB2' ' A' ' 232' ' ' ALA . 93.1 t -84.87 101.99 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.532 ' CG2' ' CD ' ' A' ' 251' ' ' GLU . 45.3 t -59.57 -44.0 92.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.6 ttp85 -141.11 120.43 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.886 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -125.2 130.53 52.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -162.89 166.01 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.32 148.61 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.838 HD12 HG22 ' A' ' 245' ' ' ILE . 77.6 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.838 HG22 HD12 ' A' ' 235' ' ' LEU . 53.3 mt -132.61 129.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.142 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.87 176.99 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.4 p -139.35 132.78 30.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 223' ' ' PHE . 62.5 t -129.71 135.02 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 230' ' ' VAL . 58.0 m -124.24 115.6 21.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 71.4 m-85 -87.7 -175.45 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.532 ' CD ' ' CG2' ' A' ' 230' ' ' VAL . 24.0 mm-40 -90.23 -53.63 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -114.18 146.58 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 257' ' ' VAL . 93.4 p -50.33 -45.28 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.3 mm -46.53 -56.46 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.487 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 22.1 mt-10 -56.46 -48.4 77.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.408 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.06 -50.5 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 253' ' ' SER . 99.2 t -54.77 -54.78 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -44.94 -54.89 6.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.523 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -53.18 -58.65 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 275' ' ' VAL . 75.6 mt -41.73 -42.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 30.0 t -76.17 -65.74 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -20.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.1 m-85 -104.99 -19.98 13.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 110.16 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.5 84.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.69 130.56 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.9 mt -85.96 100.07 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.559 HD22 ' SD ' ' A' ' 273' ' ' MET . 9.1 tp -107.22 122.73 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 56.52 43.49 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.3 t0 62.38 28.97 17.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -147.09 125.68 6.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 135.17 29.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.559 ' SD ' HD22 ' A' ' 268' ' ' LEU . 33.3 mtm -99.33 153.19 19.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.423 ' NE2' ' HG3' ' A' ' 276' ' ' LYS . 20.2 t-160 -119.21 100.72 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 260' ' ' ILE . 3.4 t -105.25 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.423 ' HG3' ' NE2' ' A' ' 274' ' ' HIS . 30.4 mmtt -120.56 144.86 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 7.9 mtt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.818 0.342 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.456 HG12 HD11 ' A' ' 260' ' ' ILE . 31.7 m -115.11 132.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -97.0 124.27 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 275' ' ' VAL . 60.7 t -112.93 138.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -145.66 164.8 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 t30 67.82 42.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.8 161.78 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.61 ' HB3' HG23 ' A' ' 214' ' ' VAL . 44.2 t0 -82.24 133.45 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.482 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 16.8 m-85 -48.08 -29.48 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -72.02 -40.38 68.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 211' ' ' ASP . 76.8 t -58.22 141.15 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -141.8 166.17 26.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 217' ' ' LYS . 19.4 p-90 -39.68 -48.39 2.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.528 ' N ' ' CG ' ' A' ' 216' ' ' TRP . 35.5 mttm -47.58 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 222' ' ' VAL . 38.4 tptt -61.0 -49.34 77.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.546 HD22 HD11 ' A' ' 234' ' ' ILE . 9.6 tp -46.47 -48.01 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . 0.408 ' HG3' HG11 ' A' ' 229' ' ' VAL . 13.4 tttm -68.05 -44.78 75.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.68 -44.39 77.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 218' ' ' LYS . 21.4 t -72.48 -52.99 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -56.9 -32.17 65.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.4 t -48.51 -21.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . 0.425 ' O ' ' C ' ' A' ' 226' ' ' ALA . 29.1 mtm -57.66 -65.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 225' ' ' MET . . . -35.85 -50.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.15 -104.41 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.09 119.28 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.948 HG11 ' HB2' ' A' ' 232' ' ' ALA . 54.2 t -77.74 96.02 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 231' ' ' ARG . 60.8 t -54.17 -44.79 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.527 ' HG2' HG12 ' A' ' 230' ' ' VAL . 30.6 mmt180 -151.64 117.24 5.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.948 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -115.92 135.39 54.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 232' ' ' ALA . 36.3 m-20 -164.25 161.88 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.546 HD11 HD22 ' A' ' 219' ' ' LEU . 34.0 mm -113.23 150.08 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 245' ' ' ILE . 84.6 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 235' ' ' LEU . 41.5 mt -123.51 123.05 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 111.167 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.22 174.14 20.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.7 p -138.58 143.96 39.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.499 HG21 ' CD2' ' A' ' 223' ' ' PHE . 57.5 t -137.69 151.0 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 m -131.06 113.34 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 71.3 m-85 -88.73 172.42 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.2 -58.75 3.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -124.5 157.51 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 257' ' ' VAL . 4.0 t -49.36 -48.3 46.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.2 mm -38.9 -68.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -52.02 -48.28 64.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -48.6 -52.85 20.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 253' ' ' SER . 45.3 t -54.77 -51.25 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -46.35 -47.5 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 226' ' ' ALA . . . -65.92 -58.75 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.456 HD11 HG12 ' A' ' 205' ' ' VAL . 82.2 mt -41.23 -44.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.6 m -76.81 -65.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -46.71 -21.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.499 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 4.4 m-85 -103.73 -29.34 11.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t-20 -56.02 111.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.99 82.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -73.84 130.4 39.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.35 100.95 13.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 tp -108.71 122.28 46.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 58.22 37.39 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.5 28.64 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -145.68 117.77 5.13 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 123.58 10.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.728 2.286 . . . . 0.0 112.313 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 42.7 mtm -83.36 157.32 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.465 ' C ' ' CD2' ' A' ' 274' ' ' HIS . 3.8 t-160 -119.92 100.72 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.576 HG13 HG22 ' A' ' 207' ' ' VAL . 2.1 t -111.53 126.43 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -145.37 144.22 30.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.434 ' HG2' ' CD1' ' A' ' 260' ' ' ILE . 8.0 mtt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.833 0.349 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.582 HG12 HD11 ' A' ' 260' ' ' ILE . 22.1 m -103.73 133.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 86.9 t80 -98.32 106.64 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 245' ' ' ILE . 52.4 t -94.77 133.65 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.01 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.06 53.44 2.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.64 158.77 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -87.89 130.6 34.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.14 -23.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -69.09 -40.25 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.57 HG13 ' HE2' ' A' ' 218' ' ' LYS . 92.4 t -61.53 119.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.57 162.74 12.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 68.2 p-90 -43.65 -49.19 7.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.496 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 6.9 ptpt -53.75 -54.79 33.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.57 ' HE2' HG13 ' A' ' 214' ' ' VAL . 0.7 OUTLIER -53.49 -59.89 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.529 ' CD1' ' CE1' ' A' ' 223' ' ' PHE . 23.5 tp -46.55 -47.29 19.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -60.03 -55.5 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -53.0 -58.18 7.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.574 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 38.4 t -51.67 -41.15 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.766 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.6 m-85 -70.06 -28.88 65.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 t -42.38 -27.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 50.7 mtp -51.19 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.52 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.93 -57.06 4.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -164.79 -157.39 9.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.9 t -92.36 107.91 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 232' ' ' ALA . 54.0 t -60.75 100.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.512 HG12 ' HG2' ' A' ' 231' ' ' ARG . 89.1 t -55.81 -46.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.138 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.512 ' HG2' HG12 ' A' ' 230' ' ' VAL . 3.4 mmp_? -144.05 122.06 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -117.07 127.15 53.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -152.86 153.94 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 46.0 mm -119.03 128.47 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.572 HD12 ' CG2' ' A' ' 245' ' ' ILE . 58.6 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.655 HG21 ' CZ ' ' A' ' 206' ' ' PHE . 40.7 mt -132.97 136.27 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.148 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 174.54 18.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 68.4 p -142.24 131.07 22.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.766 HG11 ' HD2' ' A' ' 223' ' ' PHE . 70.7 t -127.85 129.36 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 230' ' ' VAL . 33.4 m -110.79 112.4 24.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 61.8 m-85 -88.46 173.3 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.15 -55.29 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.93 159.56 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 257' ' ' VAL . 51.1 p -52.63 -47.65 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.5 mm -42.61 -61.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.422 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 2.3 mp0 -54.6 -47.52 73.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.54 -56.31 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 253' ' ' SER . 23.0 t -51.8 -44.41 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -53.9 -46.89 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.52 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -70.8 -45.89 63.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.582 HD11 HG12 ' A' ' 205' ' ' VAL . 96.4 mt -49.71 -48.95 20.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 13.0 m -72.49 -54.19 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mtt -55.13 -22.49 17.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.574 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 22.1 m-85 -104.8 -16.2 14.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -63.81 110.5 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.03 86.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -71.16 132.63 45.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.7 mt -85.79 100.1 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.641 HD22 ' SD ' ' A' ' 273' ' ' MET . 15.6 tp -107.64 122.33 46.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 58.36 38.68 25.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 67.08 27.53 8.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -144.49 125.66 7.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 121.19 7.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.363 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.641 ' SD ' HD22 ' A' ' 268' ' ' LEU . 55.6 mtm -83.85 152.9 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -118.34 101.13 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.507 HG21 ' CB ' ' A' ' 263' ' ' PHE . 5.7 t -107.49 114.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -133.44 144.63 49.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.808 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.888 0.375 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.558 HG12 HD11 ' A' ' 260' ' ' ILE . 23.1 m -112.12 135.16 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -97.07 114.7 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.611 HG11 HD21 ' A' ' 210' ' ' LEU . 14.2 t -99.56 138.19 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -140.76 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 m120 62.51 41.88 9.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.611 HD21 HG11 ' A' ' 207' ' ' VAL . 53.5 mt -91.35 149.34 21.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 214' ' ' VAL . 6.7 t70 -78.76 136.17 37.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -43.24 -31.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.84 -39.76 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 211' ' ' ASP . 94.6 t -54.05 111.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.04 170.55 16.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.506 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 52.6 p-90 -57.97 -32.49 67.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.506 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 8.9 mmtp -68.47 -52.38 33.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.633 ' HD2' HG23 ' A' ' 222' ' ' VAL . 16.7 tptm -62.77 -41.52 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.47 -58.77 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -52.9 -58.6 6.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -49.66 -58.89 4.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.633 HG23 ' HD2' ' A' ' 218' ' ' LYS . 20.2 t -51.95 -40.17 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.3 m-85 -72.37 -17.07 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.1 t -58.32 -19.38 34.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 26.3 mtm -57.39 -67.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -40.26 -42.08 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -178.32 -103.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.12 117.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.656 HG11 ' HB2' ' A' ' 232' ' ' ALA . 39.7 t -75.62 102.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 249' ' ' THR . 79.0 t -50.69 -44.39 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.431 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 8.0 ptp180 -159.38 122.76 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.656 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.1 135.01 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -139.72 151.39 45.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.89 125.87 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.96 179.867 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 61.2 mt -132.83 126.31 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.369 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.35 167.31 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 56.3 p -139.94 128.68 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.619 HG21 ' CD2' ' A' ' 223' ' ' PHE . 36.0 t -124.63 140.5 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 230' ' ' VAL . 15.5 m -121.12 117.89 28.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.77 -176.74 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -83.19 -55.82 4.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -128.96 162.15 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 93.7 p -52.75 -48.24 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.1 mm -37.48 -62.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.39 -41.88 90.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.85 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.88 -49.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -48.49 -42.17 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -75.99 -49.56 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.558 HD11 HG12 ' A' ' 205' ' ' VAL . 42.8 mt -51.98 -41.4 31.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.2 t -76.68 -50.77 12.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 30.1 mtt -60.04 -21.66 61.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.495 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 25.0 m-85 -104.51 -22.15 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.6 110.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.9 84.11 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -72.66 123.46 23.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.893 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.78 105.88 14.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.06 121.93 45.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 58.76 35.11 24.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.62 27.74 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 33.5 mtp85 -142.9 119.51 6.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.722 . . . . 0.0 110.819 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.09 3.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.368 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 59.8 mtm -72.14 159.25 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 23.0 t-160 -125.63 103.56 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.463 HG21 ' CB ' ' A' ' 263' ' ' PHE . 2.6 t -111.8 110.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.084 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -124.59 142.18 51.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.424 ' HG3' HD13 ' A' ' 260' ' ' ILE . 15.0 mtt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.824 0.345 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 260' ' ' ILE . 30.5 m -104.99 137.23 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.97 118.46 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.26 134.34 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -137.49 171.91 13.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 m120 60.09 41.53 17.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.0 mt -90.05 155.41 19.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 214' ' ' VAL . 3.3 t70 -67.3 160.76 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -77.71 -33.82 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 65.8 mttt -85.53 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -108.91 164.2 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.609 ' N ' HG12 ' A' ' 214' ' ' VAL . . . -151.2 148.71 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -40.45 -35.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -66.56 -56.36 11.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.471 ' HD3' HG23 ' A' ' 222' ' ' VAL . 1.5 tmtm? -51.22 -44.16 61.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -69.4 -62.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -44.4 -42.28 6.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.605 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 27.1 t -70.29 -43.26 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.2 m-85 -69.19 -15.73 63.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -59.38 -13.21 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.0 mtp -67.5 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.585 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -46.26 -47.39 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.1 -141.44 3.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 50.1 t -105.51 114.68 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.767 HG11 ' HB2' ' A' ' 232' ' ' ALA . 53.5 t -72.11 101.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.177 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.02 -43.69 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.426 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 17.5 ptt180 -160.58 119.8 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.767 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.44 135.24 50.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 159.3 42.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.411 HD11 HD22 ' A' ' 219' ' ' LEU . 48.7 mm -119.31 144.04 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.517 HD12 ' CG2' ' A' ' 245' ' ' ILE . 36.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.517 ' CG2' HD12 ' A' ' 235' ' ' LEU . 51.8 mt -131.33 126.18 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.26 175.27 20.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 p -143.48 138.47 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 229' ' ' VAL . 44.1 t -135.19 143.51 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 89.2 m -124.4 123.74 40.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 256' ' ' ALA . 74.2 m-85 -97.62 175.5 6.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -60.15 2.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -109.49 142.58 40.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 257' ' ' VAL . 85.7 p -47.82 -43.24 27.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 mm -46.88 -57.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.44 -49.79 75.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 250' ' ' PHE . . . -51.32 -48.03 62.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 253' ' ' SER . 65.7 t -57.6 -53.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -46.07 -46.92 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.585 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -64.4 -50.55 67.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.519 HD13 ' HG2' ' A' ' 277' ' ' MET . 96.6 mt -47.53 -50.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 264' ' ' ASN . 15.8 m -72.22 -61.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.8 mmt -45.17 -24.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.605 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 23.6 m-85 -104.43 -19.36 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 261' ' ' SER . 10.9 t30 -60.35 113.0 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.54 6.65 89.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.553 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.95 126.17 28.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.88 0.371 . . . . 0.0 110.93 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.56 100.16 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.563 HD22 ' SD ' ' A' ' 273' ' ' MET . 16.0 tp -106.05 121.13 43.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.959 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 59.03 37.76 24.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 68.55 26.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -143.67 124.48 7.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.563 ' SD ' HD22 ' A' ' 268' ' ' LEU . 63.2 mtm -84.51 145.36 28.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 21.6 t-160 -109.79 99.25 8.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.438 HG21 ' CB ' ' A' ' 263' ' ' PHE . 4.0 t -109.04 124.66 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 277' ' ' MET . 1.6 ttpm? -149.09 160.55 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.519 ' HG2' HD13 ' A' ' 260' ' ' ILE . 9.4 mmt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 260' ' ' ILE . 11.4 m -124.99 139.69 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -100.32 127.35 46.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 210' ' ' LEU . 45.9 t -116.54 130.51 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.72 170.68 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.67 50.84 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.485 HD11 ' CG1' ' A' ' 207' ' ' VAL . 50.3 mt -100.03 159.95 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 214' ' ' VAL . 25.5 t0 -86.16 131.54 34.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -44.82 -23.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -75.73 -39.54 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 268' ' ' LEU . 70.1 t -59.74 112.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -109.83 172.84 16.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -51.19 -28.94 12.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' A' ' 221' ' ' GLU . 45.0 mttp -67.78 -52.94 31.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.736 ' O ' HG23 ' A' ' 222' ' ' VAL . 19.5 tptm -65.38 -50.48 65.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.665 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.5 tp -49.91 -53.42 26.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -62.21 -61.79 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 217' ' ' LYS . 0.4 OUTLIER -43.15 -56.63 3.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 218' ' ' LYS . 46.2 t -56.0 -46.94 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 248' ' ' VAL . 3.3 m-85 -63.13 -14.84 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.4 t -59.18 -13.91 8.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 41.7 mtp -69.08 -60.71 2.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.567 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -44.93 -52.56 8.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.51 -127.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 68.0 t -114.78 119.88 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 232' ' ' ALA . 84.6 t -81.59 98.65 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.1 t -51.45 -43.74 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.35 117.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.3 153.38 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -167.73 167.1 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.665 ' CD1' HD22 ' A' ' 219' ' ' LEU . 16.3 mm -126.2 133.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.477 HD12 HG22 ' A' ' 245' ' ' ILE . 44.0 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.477 HG22 HD12 ' A' ' 235' ' ' LEU . 71.1 mt -134.68 129.81 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.15 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.69 166.38 24.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 48.2 p -135.8 140.68 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 223' ' ' PHE . 2.8 t -134.73 143.91 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.1 m -120.96 121.7 38.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -95.34 -176.32 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.83 -53.22 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -134.76 159.29 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 257' ' ' VAL . 91.9 p -48.86 -36.98 18.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 30.8 mm -47.32 -63.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -58.75 -44.43 90.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.73 -54.55 22.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 253' ' ' SER . 89.1 t -55.72 -49.13 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -48.32 -47.31 36.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.567 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -69.23 -55.09 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.619 HD11 HG12 ' A' ' 205' ' ' VAL . 95.2 mt -45.74 -43.37 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -77.6 -59.93 2.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.4 mmt -51.06 -22.81 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.498 ' CB ' HG21 ' A' ' 275' ' ' VAL . 3.5 m-85 -103.07 -21.0 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -55.33 113.33 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.05 82.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -70.56 127.12 31.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.65 101.37 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.453 HD23 HG21 ' A' ' 214' ' ' VAL . 9.9 tp -110.15 124.64 51.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 57.31 32.73 22.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 72.13 31.45 1.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -144.85 120.72 6.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.592 0.71 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 118.46 5.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.704 2.27 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 55.7 mtm -79.87 147.07 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -113.5 99.03 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 263' ' ' PHE . 1.8 t -107.65 127.0 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.8 tttm -149.54 159.53 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 11.0 mtt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.841 0.353 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.697 HG12 HD11 ' A' ' 260' ' ' ILE . 20.4 m -124.45 145.5 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -102.58 118.51 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -122.76 167.91 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.35 51.69 8.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.95 163.23 13.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.62 ' HB3' HG23 ' A' ' 214' ' ' VAL . 1.7 t0 -80.75 118.14 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -41.27 -41.88 2.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -61.0 -37.45 82.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 211' ' ' ASP . 53.3 t -55.72 151.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -135.26 172.44 22.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 30.3 p-90 -57.09 -39.72 75.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 5.3 mtpm? -62.84 -48.49 78.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.761 ' HZ1' HD11 ' A' ' 268' ' ' LEU . 0.5 OUTLIER -63.81 -48.83 75.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 11.2 tp -55.88 -52.55 63.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -59.06 -60.26 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.24 -45.27 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 218' ' ' LYS . 85.9 t -69.21 -51.95 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.773 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.2 m-85 -56.76 -12.86 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.2 t -57.46 -12.23 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.3 mtm -65.31 -66.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.818 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -48.83 -39.96 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.073 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 176.65 -171.78 44.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.4 122.16 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 232' ' ' ALA . 94.3 t -79.0 103.66 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.44 -39.31 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -148.62 120.3 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -124.98 135.48 52.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.69 167.54 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.64 133.51 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 245' ' ' ILE . 86.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 235' ' ' LEU . 47.7 mt -127.71 124.31 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.78 176.33 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.494 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 57.6 p -142.8 136.73 29.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.773 HG21 ' CD2' ' A' ' 223' ' ' PHE . 45.9 t -127.17 139.88 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.6 m -123.21 111.06 16.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.563 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 91.0 m-85 -86.62 -175.25 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.49 -49.36 8.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -132.29 156.71 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 16.7 t -48.71 -52.81 21.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 27.9 mm -37.67 -62.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.137 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.788 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 33.7 mt-10 -53.77 -48.47 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.563 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.61 -60.69 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.451 HG22 ' CE ' ' A' ' 277' ' ' MET . 95.7 t -42.87 -56.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -47.87 -52.29 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.818 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -58.88 -42.86 90.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.697 HD11 HG12 ' A' ' 205' ' ' VAL . 48.7 mt -62.62 -59.61 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.1 m -54.29 -42.81 70.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -69.85 -67.17 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 223' ' ' PHE . 41.9 m-85 -57.47 -14.02 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.0 OUTLIER -65.34 110.56 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.57 81.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 10.5 mm100 -69.89 146.03 51.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.1 mt -97.97 102.43 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.761 HD11 ' HZ1' ' A' ' 218' ' ' LYS . 16.9 tp -112.76 123.52 50.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.434 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 12.1 m-85 56.2 40.61 29.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.5 t70 64.21 30.99 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -147.08 123.25 5.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.566 0.698 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 266' ' ' GLN . 54.1 Cg_endo -69.73 124.45 11.11 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.363 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.407 ' SD ' HD22 ' A' ' 268' ' ' LEU . 61.0 mtm -85.86 153.07 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 15.2 t-160 -117.35 99.85 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.82 124.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 277' ' ' MET . 22.2 tttm -142.64 157.57 44.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.575 ' HG2' HD13 ' A' ' 260' ' ' ILE . 7.9 mtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.921 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.84 0.352 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.653 HG12 HD11 ' A' ' 260' ' ' ILE . 15.7 m -126.08 148.39 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -104.06 111.67 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 245' ' ' ILE . 15.2 t -101.75 138.11 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.158 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.6 170.09 16.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.12 54.43 3.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.04 148.95 30.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.83 141.49 44.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -51.41 -19.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -75.25 -42.48 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.456 HG21 HD23 ' A' ' 268' ' ' LEU . 41.5 t -60.74 109.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.5 13.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.473 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 42.1 p-90 -48.24 -34.88 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 99.1 mttt -60.15 -57.25 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -64.31 -57.73 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 22.8 tp -38.69 -49.57 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -67.25 -48.19 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.93 -32.11 60.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.778 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 38.8 t -78.0 -43.59 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.632 ' CD2' HG11 ' A' ' 248' ' ' VAL . 3.5 m-85 -66.42 -21.28 66.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -51.57 -19.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 7.9 mtm -65.67 -59.67 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -53.13 -45.35 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 178.81 -162.94 30.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.94 122.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 232' ' ' ALA . 78.6 t -78.44 101.0 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.496 HG23 ' C ' ' A' ' 250' ' ' PHE . 77.0 t -52.59 -42.08 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.423 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 29.2 ptt180 -163.81 117.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.799 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -107.98 151.61 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -166.59 172.95 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 23.5 mm -129.51 119.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 245' ' ' ILE . 96.7 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.683 HG22 HD12 ' A' ' 235' ' ' LEU . 40.8 mt -112.04 128.85 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 111.159 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.8 168.28 21.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.4 p -139.01 135.77 34.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.632 HG11 ' CD2' ' A' ' 223' ' ' PHE . 35.0 t -130.47 139.31 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.8 m -120.8 115.81 23.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 80.8 m-85 -88.83 178.59 6.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -80.75 -55.23 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -117.81 145.03 44.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 257' ' ' VAL . 83.8 p -47.06 -45.51 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -42.4 -62.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -55.63 -49.18 73.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.05 -49.79 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 253' ' ' SER . 65.2 t -57.3 -53.6 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -45.59 -42.95 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -66.57 -52.21 47.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.653 HD11 HG12 ' A' ' 205' ' ' VAL . 75.8 mt -48.88 -48.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.5 m -71.96 -58.88 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 85.6 mmm -51.83 -24.49 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.778 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 20.8 m-85 -102.05 -15.08 16.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.52 111.93 4.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.25 90.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -70.73 125.9 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.03 101.88 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.669 HD22 ' SD ' ' A' ' 273' ' ' MET . 12.3 tp -108.6 123.7 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 58.72 39.25 24.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.7 26.65 9.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -145.54 124.61 6.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 0.0 110.836 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 119.49 6.43 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.669 ' SD ' HD22 ' A' ' 268' ' ' LEU . 59.7 mtm -80.5 154.91 27.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -119.95 108.81 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.549 HG21 ' CB ' ' A' ' 263' ' ' PHE . 2.7 t -116.79 122.31 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -131.72 147.95 52.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.52 ' HG2' HD13 ' A' ' 260' ' ' ILE . 3.4 mtp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.821 0.344 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.77 137.26 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 208' ' ' ALA . 67.6 t80 -99.73 123.52 44.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.663 ' CG1' HD11 ' A' ' 210' ' ' LEU . 66.4 t -112.8 128.42 69.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.412 ' HB2' ' CE2' ' A' ' 206' ' ' PHE . . . -132.07 167.55 19.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.4 t30 68.43 45.52 1.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.663 HD11 ' CG1' ' A' ' 207' ' ' VAL . 34.0 mt -104.31 133.84 48.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.47 ' OD2' ' CD2' ' A' ' 269' ' ' PHE . 0.5 OUTLIER -67.5 145.74 54.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -47.63 -33.75 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -58.02 -35.24 70.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.42 HG23 ' CG ' ' A' ' 211' ' ' ASP . 46.4 t -56.06 117.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -117.97 146.6 18.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.555 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 32.0 p-90 -35.44 -45.11 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.555 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 32.7 mtpt -55.92 -60.03 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 219' ' ' LEU . 15.9 tptm -54.19 -65.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.822 HD22 HD11 ' A' ' 234' ' ' ILE . 14.3 tp -35.23 -58.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . 0.432 ' HD2' ' HB3' ' A' ' 232' ' ' ALA . 69.3 tttt -59.42 -49.67 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.918 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.32 -20.9 12.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 89.1 t -91.34 -45.5 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.513 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.4 m-85 -64.58 -15.99 61.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 42.3 p -58.51 -15.28 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 29.4 mtm -66.42 -55.47 15.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.622 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -57.68 -41.0 80.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.24 -161.67 30.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.52 108.48 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.79 HG11 ' HB2' ' A' ' 232' ' ' ALA . 55.6 t -69.54 104.72 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 53.8 t -50.69 -46.46 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.438 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 0.2 OUTLIER -153.58 122.96 6.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.79 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -117.73 133.42 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 232' ' ' ALA . 2.0 m-20 -161.17 167.17 26.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.822 HD11 HD22 ' A' ' 219' ' ' LEU . 7.0 mm -124.7 138.56 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.4 mt -137.03 128.62 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.69 170.36 18.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.5 p -138.43 138.23 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 229' ' ' VAL . 3.0 t -137.9 151.34 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 15.6 m -133.48 118.89 18.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -88.82 175.98 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.11 -55.93 4.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.02 155.9 35.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 254' ' ' ILE . 69.0 p -51.67 -50.82 59.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 253' ' ' SER . 14.4 mm -36.39 -62.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.557 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 13.3 mt-10 -57.41 -45.96 84.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.3 49.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.07 -54.09 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -44.82 -43.01 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -72.45 -53.27 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.0 mt -42.68 -46.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.8 m -76.85 -63.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.0 mmm -45.89 -24.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.547 ' HB3' HG21 ' A' ' 275' ' ' VAL . 3.6 m-85 -100.3 -30.77 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -55.13 111.15 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.07 14.01 77.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -77.08 127.87 33.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.1 mt -85.83 99.94 11.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.67 125.34 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.47 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 25.8 m-85 58.86 33.95 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 70.35 28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -146.85 124.58 5.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.613 0.721 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 126.2 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.413 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 41.7 mtm -86.54 151.37 23.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -115.87 102.29 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 263' ' ' PHE . 1.7 t -115.55 124.47 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 158.71 43.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 11.3 mtt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.448 HG12 HD11 ' A' ' 260' ' ' ILE . 31.9 m -112.03 134.15 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -95.02 112.27 23.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.494 ' CG1' HD11 ' A' ' 210' ' ' LEU . 12.3 t -101.18 129.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.475 ' HB3' ' ND1' ' A' ' 274' ' ' HIS . . . -135.94 161.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.2 t30 67.54 47.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' A' ' 207' ' ' VAL . 46.1 mt -99.96 146.79 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -74.26 137.69 43.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -45.16 -36.43 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -59.97 -43.41 95.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.82 121.88 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -122.12 161.65 16.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.519 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.51 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 56.7 p-90 -35.53 -48.53 0.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.51 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 4.5 ptpt -50.85 -62.66 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 219' ' ' LEU . 18.5 tptp -50.93 -66.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.9 tp -35.43 -42.98 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -69.85 -64.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -42.98 -38.83 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 69.8 t -74.72 -39.83 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.123 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.64 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.1 m-85 -73.72 -10.33 59.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.6 t -62.31 -23.48 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.9 mtm -59.98 -61.53 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.58 -54.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.117 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.97 -144.65 4.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -99.54 114.85 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.91 HG11 ' HB2' ' A' ' 232' ' ' ALA . 42.2 t -78.82 103.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 249' ' ' THR . 40.3 t -50.87 -37.04 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.416 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 39.2 ptt85 -168.56 118.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.91 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -114.37 142.78 45.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -169.66 168.62 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.402 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.5 mm -116.52 141.8 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 36.1 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.862 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.7 mt -132.43 125.44 53.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.164 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.38 168.15 21.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 52.5 p -132.54 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.112 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.64 HG11 ' HD2' ' A' ' 223' ' ' PHE . 63.0 t -134.54 138.65 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 230' ' ' VAL . 28.7 m -119.37 117.98 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.47 -178.83 5.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.23 -52.71 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.57 156.32 44.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 17.3 t -48.59 -49.83 35.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.4 mm -39.14 -64.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -53.59 -45.25 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.49 -56.39 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.2 t -50.28 -55.35 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -44.03 -51.58 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 263' ' ' PHE . . . -65.3 -50.8 64.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 205' ' ' VAL . 84.7 mt -46.85 -52.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.4 m -72.48 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 53.4 mmm -46.61 -24.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.553 ' CE2' ' HB1' ' A' ' 259' ' ' ALA . 26.2 m-85 -103.3 -23.36 13.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.13 110.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.68 89.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -69.98 130.56 42.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.09 100.99 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.6 tp -109.4 121.96 46.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 59.34 41.95 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 19.6 t70 63.39 24.97 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.28 125.34 7.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 138.19 37.05 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 32.9 mtm -97.39 152.91 18.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.475 ' ND1' ' HB3' ' A' ' 208' ' ' ALA . 5.7 t-160 -115.74 99.17 7.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 263' ' ' PHE . 1.5 t -112.93 118.45 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -139.11 146.14 40.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 24.4 mtt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.649 HG12 HD11 ' A' ' 260' ' ' ILE . 3.6 m -124.39 150.73 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 208' ' ' ALA . 71.0 t80 -106.68 122.05 45.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.32 124.37 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.567 ' HB2' ' CE2' ' A' ' 206' ' ' PHE . . . -124.21 167.87 13.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 62.16 50.98 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.39 146.35 28.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.88 145.43 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.86 -26.63 36.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.03 -37.51 72.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.07 110.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.126 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -103.88 175.04 22.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.498 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 12.4 p-90 -57.13 -32.68 66.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 30.3 mmtt -66.43 -56.41 11.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -59.11 -56.42 22.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.603 HD22 HD11 ' A' ' 234' ' ' ILE . 14.2 tp -46.45 -51.26 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.65 -67.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -38.73 -49.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.543 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 23.8 t -59.66 -45.61 94.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.62 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.1 m-85 -66.2 -14.39 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 t -55.64 -22.99 25.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.3 mtm -57.32 -63.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.51 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -41.46 -50.03 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.13 -106.28 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 45.6 t -139.99 112.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.651 HG11 ' HB2' ' A' ' 232' ' ' ALA . 71.6 t -70.15 103.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 249' ' ' THR . 65.6 t -51.46 -37.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.405 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.2 ptm180 -168.16 121.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.651 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -107.73 151.03 26.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.36 161.36 30.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.603 HD11 HD22 ' A' ' 219' ' ' LEU . 32.8 mm -128.34 126.37 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 245' ' ' ILE . 82.6 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.941 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 235' ' ' LEU . 72.1 mt -136.22 139.29 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 80.8 p -144.69 145.14 31.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.62 HG11 ' HD2' ' A' ' 223' ' ' PHE . 21.1 t -133.89 130.41 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.3 m -106.72 121.22 43.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 42.9 m-85 -96.06 177.89 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 3.6 mm-40 -76.8 -55.74 5.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -131.09 155.59 46.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.824 ' O ' HG23 ' A' ' 257' ' ' VAL . 38.7 p -47.99 -32.18 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.66 -67.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.45 -43.33 75.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.54 -49.72 67.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 253' ' ' SER . 62.6 t -57.26 -53.15 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -48.24 -44.63 33.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -66.77 -62.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.649 HD11 HG12 ' A' ' 205' ' ' VAL . 78.2 mt -40.8 -39.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.7 t -78.97 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 34.9 mtp -49.93 -21.39 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.543 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 41.9 m-85 -103.89 -21.97 13.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -55.58 111.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.72 18.21 71.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -78.39 125.16 28.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.46 101.66 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.455 HD22 ' SD ' ' A' ' 273' ' ' MET . 11.6 tp -111.12 124.88 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 59.42 31.74 21.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 73.46 28.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -144.9 126.84 7.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 117.26 4.98 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 0.0 112.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.455 ' SD ' HD22 ' A' ' 268' ' ' LEU . 47.3 mtm -78.07 150.72 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 14.6 t-160 -117.33 104.37 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.53 HG21 ' HB3' ' A' ' 263' ' ' PHE . 1.6 t -114.29 119.9 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 277' ' ' MET . 11.4 ttmt -136.55 157.22 47.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.457 ' HG2' HD13 ' A' ' 260' ' ' ILE . 3.9 mtt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 90.0 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.819 0.342 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.527 HG12 HD11 ' A' ' 260' ' ' ILE . 35.4 m -108.0 138.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.185 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.435 ' CZ ' ' CG2' ' A' ' 245' ' ' ILE . 83.0 t80 -105.6 123.42 47.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.674 HG22 HG13 ' A' ' 275' ' ' VAL . 58.5 t -110.64 141.83 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 167.63 21.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 272' ' ' PRO . 62.7 t30 62.81 50.54 3.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 207' ' ' VAL . 83.7 mt -104.16 158.51 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -77.16 133.65 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -50.61 -34.59 26.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.925 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -64.75 -35.86 82.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.59 139.68 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.16 21.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 1.9 p-90 -44.54 -39.59 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 57.6 mttt -60.42 -55.56 32.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.826 ' NZ ' HD11 ' A' ' 268' ' ' LEU . 1.8 tmtt? -56.85 -57.69 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.4 tp -48.36 -52.58 21.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . 0.532 ' HG2' HG11 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -57.5 -59.95 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -43.35 -44.96 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 218' ' ' LYS . 16.9 t -64.57 -52.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.7 m-85 -56.08 -18.51 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -52.19 -20.3 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 15.7 mtp -61.61 -62.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 255' ' ' GLU . . . -50.78 -35.84 33.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 170.93 -144.99 8.64 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.64 130.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.993 HG11 ' HB2' ' A' ' 232' ' ' ALA . 33.2 t -84.84 97.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.79 -42.78 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -153.7 116.99 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.993 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -118.4 141.22 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -164.59 171.69 14.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 16.7 mm -127.23 135.68 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.922 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.526 -0.229 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.435 ' CG2' ' CZ ' ' A' ' 206' ' ' PHE . 32.7 mt -135.25 125.41 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.848 0.356 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.49 176.3 19.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.0 p -148.56 141.97 25.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.166 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 249' ' ' THR . 45.4 t -132.49 156.03 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 248' ' ' VAL . 92.0 m -128.73 109.76 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.454 ' CZ ' ' CB ' ' A' ' 259' ' ' ALA . 64.8 m-85 -83.85 -178.37 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.87 -51.22 7.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.14 158.16 44.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 96.8 p -44.83 -50.99 9.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -38.79 -67.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.639 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 5.7 mm-40 -50.27 -43.71 53.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.72 1.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 44.4 t -43.31 -49.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.22 -41.12 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.62 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -71.51 -55.38 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 205' ' ' VAL . 65.2 mt -50.13 -38.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 36.6 m -79.62 -53.81 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 15.1 mmt -58.78 -22.1 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.0 m-85 -103.69 -23.19 13.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t30 -58.81 110.5 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.59 88.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.13 131.31 42.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.08 100.03 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.826 HD11 ' NZ ' ' A' ' 218' ' ' LYS . 9.1 tp -106.77 121.84 45.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 57.78 43.67 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 22.9 t70 62.53 26.39 15.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -146.98 126.98 6.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.642 0.734 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 209' ' ' ASN . 53.7 Cg_endo -69.66 131.8 22.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.801 ' SD ' HD22 ' A' ' 268' ' ' LEU . 19.2 mtm -95.43 143.19 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -107.36 100.25 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 207' ' ' VAL . 1.9 t -109.06 124.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -146.93 127.5 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.788 0.328 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.575 HG12 HD11 ' A' ' 260' ' ' ILE . 10.7 m -127.21 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -97.34 117.32 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.6 t -108.02 132.31 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.146 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.91 167.31 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 71.46 32.6 2.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.85 156.81 19.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' A' ' 214' ' ' VAL . 6.9 t70 -71.67 176.23 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -85.03 -30.23 24.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.74 33.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 211' ' ' ASP . 81.4 t -107.27 128.83 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -126.26 152.91 18.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -40.3 -33.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -60.1 -53.37 58.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.575 ' O ' HG23 ' A' ' 222' ' ' VAL . 0.0 OUTLIER -63.71 -50.41 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.648 HD22 ' CD1' ' A' ' 234' ' ' ILE . 17.9 tp -51.25 -56.43 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 232' ' ' ALA . 22.8 ttmt -60.57 -55.8 29.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 224' ' ' SER . 26.9 mm-40 -46.95 -59.97 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 218' ' ' LYS . 51.1 t -56.13 -51.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.571 ' CD2' HG21 ' A' ' 248' ' ' VAL . 4.2 m-85 -59.61 -13.98 11.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 5.4 t -58.53 -22.15 54.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.3 mtm -55.4 -62.07 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -49.59 -55.96 11.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.62 -150.43 6.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.01 96.6 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.993 HG11 ' HB2' ' A' ' 232' ' ' ALA . 87.6 t -50.48 96.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 249' ' ' THR . 55.6 t -52.79 -50.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -139.62 119.82 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.993 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -126.64 133.19 51.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.437 ' CG ' ' C ' ' A' ' 232' ' ' ALA . 0.4 OUTLIER -163.14 165.3 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.648 ' CD1' HD22 ' A' ' 219' ' ' LEU . 4.6 mm -124.39 151.33 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.916 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 83.5 mt -137.52 132.91 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.79 171.65 24.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.544 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.4 p -134.37 139.97 45.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.781 HG13 HG13 ' A' ' 229' ' ' VAL . 72.3 t -138.6 128.29 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.13 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 230' ' ' VAL . 94.0 m -111.79 123.11 49.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 226' ' ' ALA . 66.4 m-85 -96.7 175.51 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -69.96 -57.29 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.98 162.67 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.963 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.591 ' O ' HG23 ' A' ' 257' ' ' VAL . 0.9 OUTLIER -52.57 -38.42 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.6 mm -47.24 -66.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.49 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 4.9 mm-40 -54.79 -43.56 72.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.38 67.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 253' ' ' SER . 65.5 t -60.34 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -48.96 -43.88 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.626 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -68.36 -59.67 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.076 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 275' ' ' VAL . 33.4 mt -43.99 -42.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.4 m -76.27 -60.66 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -50.14 -23.36 2.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.886 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 3.6 m-85 -102.46 -22.8 13.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.63 111.38 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.95 17.87 71.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -77.21 122.5 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.5 mt -81.21 99.98 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.545 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -108.55 122.01 46.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.21 43.6 20.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 24.0 t0 63.24 25.45 14.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.74 125.22 8.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 126.55 13.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.545 ' SD ' HD22 ' A' ' 268' ' ' LEU . 46.0 mtm -85.54 155.93 20.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -121.14 101.12 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 260' ' ' ILE . 2.7 t -111.56 117.8 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.7 tttm -136.81 157.6 46.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.447 ' CE ' HG22 ' A' ' 257' ' ' VAL . 14.0 mtt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.802 0.334 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 260' ' ' ILE . 24.2 m -111.97 142.65 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -99.06 117.19 33.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 245' ' ' ILE . 33.1 t -107.89 130.16 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -135.23 170.87 15.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 62.19 50.06 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 51.4 mt -101.41 158.78 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' A' ' 214' ' ' VAL . 18.1 t0 -67.88 174.42 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -92.46 -6.22 50.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.58 ' HD2' ' CE1' ' A' ' 269' ' ' PHE . 10.1 ptpt -111.51 31.58 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 211' ' ' ASP . 14.9 t -108.5 132.25 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.62 158.53 15.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.418 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 35.1 p-90 -45.82 -31.39 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 32.3 mtpt -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.804 ' O ' HG23 ' A' ' 222' ' ' VAL . 2.5 tmtp? -63.13 -50.84 68.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.8 tp -59.39 -38.99 81.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -69.35 -64.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 222' ' ' VAL . 12.0 pt-20 -44.32 -40.91 5.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 218' ' ' LYS . 89.6 t -66.89 -52.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.538 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.2 m-85 -61.64 -14.01 27.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.5 t -52.03 -25.06 7.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.0 mtm -57.62 -64.25 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -47.76 -48.16 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -179.3 -154.65 13.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.81 127.05 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.38 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.958 HG11 ' HB2' ' A' ' 232' ' ' ALA . 73.5 t -84.54 99.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -148.54 118.97 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.958 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -119.83 142.24 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -165.88 169.36 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 219' ' ' LEU . 44.3 mm -129.53 132.91 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 207' ' ' VAL . 44.4 mt -135.78 126.27 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.133 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.19 168.65 20.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.52 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 73.5 p -138.32 145.49 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 t -139.1 155.25 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.1 m -129.76 115.48 17.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -89.01 -177.62 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.89 -55.68 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -129.29 158.58 38.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 257' ' ' VAL . 14.8 p -51.08 -34.14 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -49.37 -68.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.37 -43.39 75.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.25 -46.6 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 253' ' ' SER . 76.2 t -63.26 -48.67 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -47.96 -49.49 30.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.4 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -64.32 -60.06 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.677 HD11 HG12 ' A' ' 205' ' ' VAL . 74.8 mt -39.9 -38.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 m -82.0 -64.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -48.46 -19.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.538 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.9 m-85 -104.81 -25.33 12.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.05 112.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.48 11.97 79.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.39 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.927 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.1 mt -79.91 99.87 7.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.758 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -106.72 123.25 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . 0.58 ' CE1' ' HD2' ' A' ' 213' ' ' LYS . 9.2 m-85 60.03 37.43 21.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 68.79 24.97 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.94 127.13 8.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 120.29 7.09 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.758 ' SD ' HD22 ' A' ' 268' ' ' LEU . 35.3 mtm -80.88 151.91 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -115.89 105.73 13.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.71 125.73 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.159 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -144.7 157.33 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.415 ' HG2' HD13 ' A' ' 260' ' ' ILE . 7.9 mmt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 205' ' ' VAL . 30.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.69 HG12 HD11 ' A' ' 260' ' ' ILE . 22.3 m -132.49 143.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -100.37 113.26 25.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 245' ' ' ILE . 3.7 t -101.33 135.04 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -139.88 165.46 27.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 t30 63.29 49.99 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 42.1 mt -100.85 162.91 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 214' ' ' VAL . 0.6 OUTLIER -83.11 132.57 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -44.06 -44.3 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -56.42 -40.17 74.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 211' ' ' ASP . 74.2 t -51.91 123.58 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 218' ' ' LYS . . . -121.5 158.39 16.24 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.48 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 25.1 p-90 -38.89 -32.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.48 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 22.5 mtpp -72.35 -47.85 46.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 222' ' ' VAL . 3.1 tmtt? -66.2 -49.64 66.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.427 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.3 tp -56.38 -50.84 70.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' A' ' 232' ' ' ALA . 26.5 tttm -66.55 -35.04 79.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.66 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 218' ' ' LYS . 38.4 t -83.79 -49.13 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.134 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -59.1 -26.38 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.5 t -46.01 -24.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.1 mtm -57.91 -65.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.27 -42.34 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.92 -160.74 28.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.9 123.53 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 232' ' ' ALA . 47.0 t -83.66 98.76 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 76.1 t -54.6 -48.07 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -136.55 123.28 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -126.28 128.98 47.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -163.56 163.87 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.427 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.3 mm -122.73 148.1 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 207' ' ' VAL . 28.6 mt -132.01 123.08 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.123 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.46 169.5 15.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.1 p -135.33 135.47 40.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.81 143.48 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 24.5 m -126.54 117.6 23.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 226' ' ' ALA . 67.7 m-85 -88.08 -177.91 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.47 -48.39 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -132.92 155.7 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.3 p -49.14 -46.0 44.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 23.8 mm -41.02 -60.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.43 -42.02 90.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.0 -54.2 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.74 -49.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -47.92 -48.29 31.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -67.93 -58.28 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.69 HD11 HG12 ' A' ' 205' ' ' VAL . 80.3 mt -41.36 -46.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.2 m -77.09 -62.22 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 49.7 mmm -47.62 -21.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.416 ' CB ' HG21 ' A' ' 275' ' ' VAL . 4.6 m-85 -104.58 -30.64 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -50.52 115.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.98 16.56 76.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -81.58 121.28 26.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.8 100.63 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.571 HD21 ' HZ1' ' A' ' 218' ' ' LYS . 13.6 tp -108.87 123.14 48.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 59.23 31.56 21.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 74.08 28.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -145.19 121.78 6.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 115.43 4.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 58.8 mtm -73.95 153.53 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 18.2 t-160 -118.01 100.3 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.2 t -109.96 113.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 277' ' ' MET . 1.8 tppp? -124.1 157.6 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.643 ' HG2' HD13 ' A' ' 260' ' ' ILE . 24.0 mtp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.531 HG12 HD11 ' A' ' 260' ' ' ILE . 34.4 m -111.06 130.38 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -95.32 118.58 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 275' ' ' VAL . 80.8 t -106.31 140.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.82 163.51 32.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 65.66 43.37 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.548 HD11 ' CG1' ' A' ' 207' ' ' VAL . 45.2 mt -92.77 149.01 21.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 3.3 t70 -60.12 162.89 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.415 ' N ' ' CG ' ' A' ' 211' ' ' ASP . 19.1 m-85 -79.12 -34.32 43.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.479 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 20.8 mtpp -82.99 37.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -110.02 157.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.131 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 214' ' ' VAL . . . -150.53 155.98 26.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -46.99 -33.43 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.4 -44.83 77.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -56.49 12.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.4 tp -49.94 -61.25 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . 0.544 ' HG3' HG11 ' A' ' 229' ' ' VAL . 35.9 tttm -50.25 -58.19 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -44.12 -39.89 4.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.647 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 20.0 t -73.73 -46.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.65 -20.05 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.3 t -53.22 -22.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.846 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 11.0 mtm -62.93 -61.64 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -50.85 -52.98 36.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -176.2 -160.26 23.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 67.9 t -79.32 124.84 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 0.0 111.1 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 232' ' ' ALA . 79.6 t -87.47 96.0 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.79 -45.57 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -139.84 121.26 15.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.952 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -125.92 124.12 40.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.551 ' CD1' HD22 ' A' ' 219' ' ' LEU . 35.5 mm -124.17 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 245' ' ' ILE . 86.6 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 207' ' ' VAL . 48.5 mt -132.81 132.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.69 176.99 18.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p -151.82 127.26 10.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.649 ' CG1' HG13 ' A' ' 229' ' ' VAL . 33.0 t -130.16 154.67 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.157 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 248' ' ' VAL . 79.3 m -131.17 120.49 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 76.9 m-85 -87.55 -177.77 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.28 -55.03 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -111.35 143.55 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.8 p -48.31 -43.81 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.23 -60.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.03 -48.22 67.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.87 -53.34 19.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.153 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.508 ' HA ' HD12 ' A' ' 260' ' ' ILE . 85.8 t -54.33 -55.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -41.39 -56.99 2.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.509 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -57.08 -47.03 82.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.593 HD13 ' HG2' ' A' ' 277' ' ' MET . 73.1 mt -53.69 -56.83 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.8 t -64.68 -58.98 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -47.0 -57.96 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.647 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 23.4 m-85 -65.66 -40.35 92.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 0.5 OUTLIER -45.04 114.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.43 19.93 67.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -87.9 124.73 33.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -79.4 99.99 7.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.466 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.7 tp -108.75 120.68 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 60.11 35.03 21.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 72.04 25.04 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -144.56 122.48 6.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 125.62 12.37 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.466 ' SD ' HD22 ' A' ' 268' ' ' LEU . 58.7 mtm -85.31 151.88 23.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -119.04 101.01 7.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 207' ' ' VAL . 14.3 t -114.01 127.2 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 277' ' ' MET . 7.5 ttmm -143.32 159.98 41.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 260' ' ' ILE . 8.9 mtp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 260' ' ' ILE . 11.8 m -125.72 144.06 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -101.05 125.31 47.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.437 ' CG1' HD11 ' A' ' 210' ' ' LEU . 9.1 t -115.85 127.04 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -134.73 171.68 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.0 36.37 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.437 HD11 ' CG1' ' A' ' 207' ' ' VAL . 44.3 mt -89.16 144.94 25.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 214' ' ' VAL . 30.2 t0 -63.44 142.28 58.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -57.49 -27.28 62.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -74.03 -34.57 64.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 211' ' ' ASP . 54.4 t -59.55 133.32 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.14 158.17 22.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.504 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 46.3 p-90 -36.35 -33.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.504 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 24.9 mtpt -62.51 -53.15 58.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -67.06 -52.64 39.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 234' ' ' ILE . 12.6 tp -46.92 -40.52 14.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . 0.572 ' HE3' ' HB3' ' A' ' 232' ' ' ALA . 32.4 ttmt -76.0 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -46.07 -33.88 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.19 -58.72 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.543 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.2 m-85 -52.06 -19.48 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.1 t -53.55 -15.74 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 30.6 mtm -65.53 -63.19 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.95 32.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -174.37 -136.28 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.437 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.99 117.67 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.932 HG11 ' HB2' ' A' ' 232' ' ' ALA . 77.5 t -72.34 97.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 92.9 t -53.66 -52.85 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -142.66 117.86 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.932 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -118.65 143.13 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.89 158.0 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.831 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 219' ' ' LEU . 26.7 mm -119.59 127.39 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 91.9 mt -136.0 131.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.87 0.367 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.607 ' HA3' HD13 ' A' ' 234' ' ' ILE . . . -138.33 175.44 21.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.3 p -138.39 145.6 41.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.799 0.333 . . . . 0.0 111.156 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.638 HG13 HG13 ' A' ' 229' ' ' VAL . 82.9 t -135.91 137.17 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 77.4 m -115.24 114.06 24.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 73.6 m-85 -88.2 169.78 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.409 ' HG2' ' CG2' ' A' ' 230' ' ' VAL . 14.6 mm-40 -75.74 -55.41 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -123.61 154.5 39.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 257' ' ' VAL . 68.5 p -49.72 -47.69 50.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 35.1 mm -41.2 -63.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -54.33 -45.67 72.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.63 -49.82 64.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 253' ' ' SER . 42.1 t -56.19 -60.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -39.96 -50.54 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -61.63 -59.37 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.481 HD11 HG12 ' A' ' 205' ' ' VAL . 35.8 mt -42.49 -48.35 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 264' ' ' ASN . 7.0 m -73.36 -65.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.3 mmt -45.39 -22.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.425 ' HB3' HG21 ' A' ' 275' ' ' VAL . 25.7 m-85 -103.82 -21.47 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 261' ' ' SER . 5.9 t30 -61.78 111.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.52 8.53 86.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -76.39 130.68 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -88.23 107.92 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.517 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.8 tp -114.37 123.58 49.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 60.3 32.28 20.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 74.18 25.94 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -147.07 127.8 7.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.865 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 130.57 19.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.517 ' SD ' HD22 ' A' ' 268' ' ' LEU . 48.3 mtm -91.46 132.82 35.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -96.76 105.31 17.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 263' ' ' PHE . 2.6 t -120.69 127.33 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -149.54 150.87 32.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.465 ' HG3' HD13 ' A' ' 260' ' ' ILE . 28.8 mtt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.791 0.329 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 m -120.15 134.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 245' ' ' ILE . 74.7 t80 -95.42 118.26 31.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 275' ' ' VAL . 92.6 t -105.38 138.65 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.64 155.99 46.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 74.85 45.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.466 HD11 ' CG1' ' A' ' 207' ' ' VAL . 76.2 mt -99.56 134.82 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -57.57 162.51 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -72.05 -25.3 61.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -70.58 -42.88 70.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.43 139.48 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -141.3 159.9 26.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.529 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 16.6 p-90 -36.61 -33.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.359 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.529 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 9.9 mtpm? -68.23 -61.06 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.466 ' HD3' HG23 ' A' ' 222' ' ' VAL . 4.3 tmtm? -56.19 -54.24 47.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.9 tp -47.29 -58.07 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -49.96 -63.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -41.94 -42.86 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.62 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 69.8 t -67.61 -51.17 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -59.73 -28.19 67.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.3 t -45.46 -28.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.832 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 34.5 mtp -51.99 -68.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -42.67 -56.46 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.91 -170.95 31.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.46 104.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 232' ' ' ALA . 78.4 t -62.45 99.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.675 HG22 ' OE2' ' A' ' 251' ' ' GLU . 83.1 t -50.09 -50.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.445 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.1 ptm180 -153.45 117.44 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.808 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.53 146.32 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -165.04 172.09 13.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 49.2 mm -125.25 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.667 HD12 HG22 ' A' ' 245' ' ' ILE . 70.5 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.667 HG22 HD12 ' A' ' 235' ' ' LEU . 46.9 mt -124.99 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.98 166.79 24.55 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.6 p -136.24 143.84 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 223' ' ' PHE . 85.3 t -140.47 134.56 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.445 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 22.3 m -114.19 111.72 22.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -87.39 174.87 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.675 ' OE2' HG22 ' A' ' 230' ' ' VAL . 42.1 mm-40 -68.6 -60.01 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -127.2 162.67 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.7 p -51.77 -46.6 64.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.8 mm -40.34 -68.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.494 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 5.4 mm-40 -52.31 -44.83 65.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.21 -56.9 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.608 HG22 ' CE ' ' A' ' 277' ' ' MET . 60.0 t -52.29 -45.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -52.74 -42.58 65.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -72.78 -50.27 25.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 257' ' ' VAL . 72.0 mt -44.7 -52.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.3 m -72.22 -62.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 18.6 mmt -44.79 -23.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.62 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 22.9 m-85 -102.72 -28.02 12.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.44 ' C ' ' OD1' ' A' ' 264' ' ' ASN . 19.7 t-20 -56.42 111.05 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.57 11.49 84.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -74.53 128.31 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.8 mt -81.42 102.38 10.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.577 HD22 ' SD ' ' A' ' 273' ' ' MET . 14.2 tp -112.02 121.64 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 56.77 41.66 27.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 28.8 t70 63.26 29.51 15.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -147.02 121.46 5.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.601 0.715 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 123.78 10.43 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.289 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.577 ' SD ' HD22 ' A' ' 268' ' ' LEU . 46.1 mtm -85.47 158.2 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -121.68 100.57 7.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 207' ' ' VAL . 1.7 t -112.84 128.67 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -144.31 154.97 43.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.608 ' CE ' HG22 ' A' ' 257' ' ' VAL . 13.9 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.689 HG12 HD11 ' A' ' 260' ' ' ILE . 20.1 m -109.4 139.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -99.73 117.05 33.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.65 135.44 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -139.86 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.94 41.66 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.5 mt -89.25 166.61 13.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.691 ' HB2' HG23 ' A' ' 214' ' ' VAL . 1.1 m-20 -93.55 139.14 31.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -51.65 -41.68 61.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.02 -33.88 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.691 HG23 ' HB2' ' A' ' 211' ' ' ASP . 47.6 t -67.04 132.5 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.68 164.75 23.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.492 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.6 p-90 -36.26 -31.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 215' ' ' GLY . 32.1 mttm -60.43 -69.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 219' ' ' LEU . 16.3 mmmt -54.11 -58.16 8.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 1.016 HD22 HD11 ' A' ' 234' ' ' ILE . 16.2 tp -36.94 -56.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 6.8 ttpt -61.1 -67.22 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 224' ' ' SER . 6.3 mm-40 -41.16 -67.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 25.0 t -43.84 -49.08 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.8 m-85 -63.31 -26.14 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 8.2 t -46.45 -23.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 16.3 mtm -55.14 -66.53 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.83 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -38.39 -50.84 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.31 -112.94 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.8 t -129.78 110.45 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.733 HG11 ' HB2' ' A' ' 232' ' ' ALA . 49.1 t -70.92 96.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 251' ' ' GLU . 98.3 t -50.05 -49.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.47 HH11 HG21 ' A' ' 249' ' ' THR . 6.6 ptp85 -151.22 122.4 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.733 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -111.96 151.16 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -169.84 160.47 8.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 1.016 HD11 HD22 ' A' ' 219' ' ' LEU . 49.3 mm -120.01 128.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.875 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.4 mt -122.37 126.1 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.53 165.91 19.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.3 p -137.45 140.1 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.581 HG13 HG13 ' A' ' 229' ' ' VAL . 61.1 t -138.16 146.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.47 HG21 HH11 ' A' ' 231' ' ' ARG . 17.9 m -123.18 111.96 17.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 38.5 m-85 -86.17 165.88 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 0.7 OUTLIER -52.79 -52.63 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -143.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 254' ' ' ILE . 8.9 t -48.23 -54.21 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.5 mm -35.98 -68.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.159 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.444 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 24.1 mp0 -48.71 -46.84 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.562 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.77 -60.86 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.401 HG22 ' CE ' ' A' ' 277' ' ' MET . 94.5 t -42.88 -53.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -47.92 -56.82 6.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.83 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -58.54 -55.4 35.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.689 HD11 HG12 ' A' ' 205' ' ' VAL . 91.7 mt -40.65 -58.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 264' ' ' ASN . 46.4 t -68.71 -61.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.8 mtt -44.42 -22.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -103.88 -26.71 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 264' ' ' ASN . 0.2 OUTLIER -52.34 116.73 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.51 82.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . 0.463 ' OE1' ' N ' ' A' ' 267' ' ' LEU . 6.3 tp-100 -78.24 130.15 35.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . 0.463 ' N ' ' OE1' ' A' ' 266' ' ' GLN . 13.0 mt -87.68 100.37 12.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.406 HD22 ' SD ' ' A' ' 273' ' ' MET . 22.0 tp -108.1 123.81 49.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 59.89 32.23 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.1 26.78 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -145.32 129.01 8.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 126.57 13.49 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . 0.406 ' SD ' HD22 ' A' ' 268' ' ' LEU . 36.6 mtm -84.17 143.43 29.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 14.5 t-160 -109.87 99.26 8.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 260' ' ' ILE . 2.5 t -109.43 131.1 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -151.65 155.07 37.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . 0.401 ' CE ' HG22 ' A' ' 257' ' ' VAL . 9.1 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 62.3 m . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.81 134.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.35 120.82 35.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.787 HG11 HD21 ' A' ' 210' ' ' LEU . 49.1 t -109.93 139.72 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.09 165.23 27.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 38.5 t30 62.78 46.43 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.787 HD21 HG11 ' A' ' 207' ' ' VAL . 30.8 mt -95.74 149.09 21.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.609 ' HB2' HG23 ' A' ' 214' ' ' VAL . 1.2 m-20 -69.65 138.47 53.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -50.5 -39.96 49.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -61.26 -41.48 96.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 211' ' ' ASP . 59.9 t -50.93 131.48 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -131.93 161.88 23.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -43.36 -34.63 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -62.3 -59.44 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -60.37 -57.18 13.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.4 tp -44.67 -55.86 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -56.04 -52.11 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.16 -58.08 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.565 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 71.2 t -52.89 -40.09 34.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.15 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 225' ' ' MET . 3.7 m-85 -69.04 -32.62 72.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.3 m -40.65 -25.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 223' ' ' PHE . 51.8 mtp -54.77 -66.31 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 255' ' ' GLU . . . -47.4 -48.62 26.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.59 -165.14 28.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.04 107.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.14 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.87 HG11 ' HB2' ' A' ' 232' ' ' ALA . 77.4 t -63.83 104.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -42.74 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.072 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -144.42 120.31 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.87 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -122.65 133.4 54.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -164.68 167.69 18.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.82 142.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 75.7 mt -135.95 125.73 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.122 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.21 176.31 19.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.4 p -144.82 136.33 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.129 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 223' ' ' PHE . 39.3 t -129.22 149.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.2 m -129.17 117.13 20.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.496 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 70.9 m-85 -91.22 -175.2 4.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.87 -54.78 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -129.37 163.63 25.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.5 p -53.91 -41.67 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.8 mm -46.13 -65.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.638 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 42.0 mt-10 -53.11 -45.09 68.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.496 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.28 -59.17 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -48.24 -56.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.169 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -44.06 -45.92 8.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -69.51 -48.36 60.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 95.3 mt -48.88 -52.82 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 m -69.75 -63.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -42.58 -38.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 19.4 m-85 -88.21 -26.81 22.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -55.2 109.94 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.62 14.63 75.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -77.06 131.27 38.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.4 mt -88.7 103.02 15.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -110.3 122.21 47.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 59.25 34.07 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 71.53 27.49 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -144.48 117.74 5.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 119.86 6.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 47.5 mtm -79.15 163.17 25.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -126.66 100.65 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 129.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -146.23 145.83 30.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.5 mtt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.85 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.7 t -51.17 148.54 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.4 t -46.94 -62.34 1.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.2 79.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -60.02 126.15 26.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.2 p -128.99 163.89 24.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -167.76 136.59 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -169.8 169.4 8.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.837 0.351 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 pp -170.19 175.24 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -119.49 92.75 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -124.41 85.04 2.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 129.21 69.47 0.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -75.57 79.94 2.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.9 mt -119.91 177.93 4.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 105.5 178.7 23.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 86.1 p -119.44 -38.65 2.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 97.5 m -40.79 139.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.9 138.28 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.559 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 72.1 t80 -97.0 116.39 29.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 245' ' ' ILE . 13.5 t -104.32 132.85 49.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.73 166.45 22.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 61.83 50.82 4.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 207' ' ' VAL . 42.7 mt -102.36 157.97 16.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.569 ' HB2' HG23 ' A' ' 214' ' ' VAL . 0.8 OUTLIER -79.52 136.55 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -48.2 -44.81 33.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.434 ' NZ ' ' HA ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -57.41 -36.58 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 211' ' ' ASP . 88.9 t -58.42 117.77 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -114.18 168.71 12.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -50.8 -25.33 4.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.71 -64.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.919 ' O ' HG23 ' A' ' 222' ' ' VAL . 34.6 tptt -57.62 -51.15 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 14.7 tp -49.24 -54.97 14.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -59.58 -52.9 63.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -50.67 -40.73 54.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 218' ' ' LYS . 29.0 t -66.87 -52.1 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.5 m-85 -60.83 -16.14 37.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.7 t -56.22 -19.3 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.2 mtp -61.69 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -48.57 -37.58 18.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 174.46 -159.8 28.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.2 t -88.03 126.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.135 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.886 HG11 ' HB2' ' A' ' 232' ' ' ALA . 93.1 t -84.87 101.99 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.532 ' CG2' ' CD ' ' A' ' 251' ' ' GLU . 45.3 t -59.57 -44.0 92.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.6 ttp85 -141.11 120.43 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.886 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -125.2 130.53 52.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -162.89 166.01 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 48.2 mm -113.32 148.61 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.838 HD12 HG22 ' A' ' 245' ' ' ILE . 77.6 mt -91.55 132.46 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 36.6 mp0 -120.41 164.59 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -115.85 178.76 4.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -40.06 -55.57 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.79 -40.43 55.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 114.27 -34.35 4.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -70.14 129.65 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.792 0.33 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 50.5 m -50.66 134.64 24.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -92.89 28.58 2.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 72.16 29.77 66.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.457 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.838 HG22 HD12 ' A' ' 235' ' ' LEU . 53.3 mt -132.61 129.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.854 0.359 . . . . 0.0 111.142 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.87 176.99 18.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.473 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 77.4 p -139.35 132.78 30.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 111.099 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 223' ' ' PHE . 62.5 t -129.71 135.02 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 230' ' ' VAL . 58.0 m -124.24 115.6 21.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 71.4 m-85 -87.7 -175.45 5.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.532 ' CD ' ' CG2' ' A' ' 230' ' ' VAL . 24.0 mm-40 -90.23 -53.63 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -114.18 146.58 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 257' ' ' VAL . 93.4 p -50.33 -45.28 54.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.3 mm -46.53 -56.46 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.487 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 22.1 mt-10 -56.46 -48.4 77.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.408 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.06 -50.5 61.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 253' ' ' SER . 99.2 t -54.77 -54.78 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -44.94 -54.89 6.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.523 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -53.18 -58.65 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.126 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 275' ' ' VAL . 75.6 mt -41.73 -42.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 30.0 t -76.17 -65.74 0.88 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -20.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.1 m-85 -104.99 -19.98 13.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -60.78 110.16 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.5 84.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.494 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.69 130.56 42.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.9 mt -85.96 100.07 11.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.559 HD22 ' SD ' ' A' ' 273' ' ' MET . 9.1 tp -107.22 122.73 47.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 56.52 43.49 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.864 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.3 t0 62.38 28.97 17.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -147.09 125.68 6.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.612 0.72 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 135.17 29.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.347 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.559 ' SD ' HD22 ' A' ' 268' ' ' LEU . 33.3 mtm -99.33 153.19 19.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.423 ' NE2' ' HG3' ' A' ' 276' ' ' LYS . 20.2 t-160 -119.21 100.72 7.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.855 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.594 ' O ' HG23 ' A' ' 260' ' ' ILE . 3.4 t -105.25 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.178 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.423 ' HG3' ' NE2' ' A' ' 274' ' ' HIS . 30.4 mmtt -120.56 144.86 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 7.9 mtt -55.82 134.07 51.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -54.8 162.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -91.68 -55.38 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.941 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -65.15 99.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -94.35 81.92 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -69.2 140.74 90.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.558 0.694 . . . . 0.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.594 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.5 Cg_endo -69.77 179.94 3.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.714 2.276 . . . . 0.0 112.341 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -128.84 36.02 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 41.66 42.25 3.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -133.02 98.7 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -174.18 131.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -138.64 143.07 36.49 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.653 0.74 . . . . 0.0 110.885 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 148.59 65.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 96.07 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.725 2.283 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -125.0 109.86 13.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.6 ttt180 -126.62 138.17 31.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.656 0.741 . . . . 0.0 110.848 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 93.08 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.279 . . . . 0.0 112.362 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . 0.451 ' CD ' ' O ' ' A' ' 294' ' ' GLN . 0.0 OUTLIER -139.81 112.83 8.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -139.9 124.69 18.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.6 t -168.27 134.49 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.81 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 163.83 66.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 85.96 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.685 2.256 . . . . 0.0 112.344 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 96.9 p -147.04 115.36 6.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.5 p -161.53 112.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 m -151.47 125.78 9.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.874 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.7 p -112.04 170.39 8.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.3 -125.99 1.47 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.9 m 49.3 30.12 3.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.869 0.366 . . . . 0.0 110.862 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 53.4 p -104.52 119.46 39.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.818 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -131.48 111.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.71 169.3 8.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 pp -166.85 157.14 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -126.87 115.49 19.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -119.15 108.5 14.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.129 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.2 105.74 3.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 27.0 mtp85 -77.15 147.31 36.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 0.0 110.894 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 17.9 tp -47.53 96.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 152.3 109.51 0.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.3 m -101.22 46.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 58.6 m -93.31 136.71 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.161 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.456 HG12 HD11 ' A' ' 260' ' ' ILE . 31.7 m -115.11 132.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -97.0 124.27 40.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 275' ' ' VAL . 60.7 t -112.93 138.91 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -145.66 164.8 30.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.1 t30 67.82 42.31 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.7 mt -91.8 161.78 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.61 ' HB3' HG23 ' A' ' 214' ' ' VAL . 44.2 t0 -82.24 133.45 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.482 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 16.8 m-85 -48.08 -29.48 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -72.02 -40.38 68.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.61 HG23 ' HB3' ' A' ' 211' ' ' ASP . 76.8 t -58.22 141.15 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.1 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -141.8 166.17 26.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.528 ' CG ' ' N ' ' A' ' 217' ' ' LYS . 19.4 p-90 -39.68 -48.39 2.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.809 0.338 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.528 ' N ' ' CG ' ' A' ' 216' ' ' TRP . 35.5 mttm -47.58 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 222' ' ' VAL . 38.4 tptt -61.0 -49.34 77.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.546 HD22 HD11 ' A' ' 234' ' ' ILE . 9.6 tp -46.47 -48.01 19.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.408 ' HG3' HG11 ' A' ' 229' ' ' VAL . 13.4 tttm -68.05 -44.78 75.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.904 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.68 -44.39 77.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 218' ' ' LYS . 21.4 t -72.48 -52.99 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -56.9 -32.17 65.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.4 t -48.51 -21.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . 0.425 ' O ' ' C ' ' A' ' 226' ' ' ALA . 29.1 mtm -57.66 -65.62 0.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 225' ' ' MET . . . -35.85 -50.56 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.15 -104.41 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.455 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.09 119.28 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.948 HG11 ' HB2' ' A' ' 232' ' ' ALA . 54.2 t -77.74 96.02 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 231' ' ' ARG . 60.8 t -54.17 -44.79 65.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.527 ' HG2' HG12 ' A' ' 230' ' ' VAL . 30.6 mmt180 -151.64 117.24 5.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.948 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -115.92 135.39 54.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 232' ' ' ALA . 36.3 m-20 -164.25 161.88 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.546 HD11 HD22 ' A' ' 219' ' ' LEU . 34.0 mm -113.23 150.08 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 245' ' ' ILE . 84.6 mt -90.56 124.54 35.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -135.67 156.31 49.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 179.8 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -44.98 -51.58 9.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -60.59 -56.98 14.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.89 39.32 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -100.04 131.51 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.323 . . . . 0.0 110.898 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.7 m -90.29 120.58 31.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 65.84 24.11 71.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 235' ' ' LEU . 41.5 mt -123.51 123.05 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.361 . . . . 0.0 111.167 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.22 174.14 20.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 46.7 p -138.58 143.96 39.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.113 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.499 HG21 ' CD2' ' A' ' 223' ' ' PHE . 57.5 t -137.69 151.0 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.096 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 m -131.06 113.34 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 71.3 m-85 -88.73 172.42 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.2 -58.75 3.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -124.5 157.51 35.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 257' ' ' VAL . 4.0 t -49.36 -48.3 46.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.2 mm -38.9 -68.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -52.02 -48.28 64.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -48.6 -52.85 20.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 253' ' ' SER . 45.3 t -54.77 -51.25 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -46.35 -47.5 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 226' ' ' ALA . . . -65.92 -58.75 4.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.456 HD11 HG12 ' A' ' 205' ' ' VAL . 82.2 mt -41.23 -44.56 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 2.6 m -76.81 -65.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -46.71 -21.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.499 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 4.4 m-85 -103.73 -29.34 11.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t-20 -56.02 111.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.857 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.99 82.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -73.84 130.4 39.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.35 100.95 13.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 tp -108.71 122.28 46.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 58.22 37.39 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 67.5 28.64 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -145.68 117.77 5.13 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 123.58 10.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.728 2.286 . . . . 0.0 112.313 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 42.7 mtm -83.36 157.32 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.465 ' C ' ' CD2' ' A' ' 274' ' ' HIS . 3.8 t-160 -119.92 100.72 7.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.576 HG13 HG22 ' A' ' 207' ' ' VAL . 2.1 t -111.53 126.43 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -145.37 144.22 30.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.434 ' HG2' ' CD1' ' A' ' 260' ' ' ILE . 8.0 mtt -54.96 126.21 23.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.891 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -88.89 162.33 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -113.6 96.23 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 25.3 ttt85 -104.15 98.75 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -92.62 86.26 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.588 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -139.64 140.82 26.13 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.588 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.7 Cg_endo -69.8 115.65 4.2 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -117.66 119.33 34.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 85.59 1.55 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.454 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -94.34 157.37 16.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.417 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 2.5 p90 -145.82 123.41 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -124.69 80.46 61.92 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.612 0.72 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 147.51 63.39 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.669 2.246 . . . . 0.0 112.375 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 110.92 2.67 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.665 2.243 . . . . 0.0 112.356 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -138.12 164.3 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 32.5 ttp85 -127.38 80.42 71.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.03 67.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.632 2.221 . . . . 0.0 112.387 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -135.96 123.73 22.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.76 111.25 14.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -163.06 151.17 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 168.1 83.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 146.51 60.09 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.66 2.24 . . . . 0.0 112.355 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 23.8 p -112.64 145.73 39.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.6 t -174.82 152.4 1.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.855 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t -140.39 173.65 11.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.817 0.341 . . . . 0.0 110.863 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.1 t -127.0 169.35 13.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 192' ' ' SER . . . -170.18 -98.6 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.5 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 191' ' ' GLY . 36.9 p 34.73 43.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 110.87 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 p -82.32 150.06 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.852 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -155.06 139.98 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.77 172.96 6.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.3 168.07 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -130.2 112.95 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -134.36 176.68 8.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.5 59.86 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 200' ' ' ARG . 1.2 mpp_? -97.9 178.98 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 110.818 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 201' ' ' LEU . 7.3 mp -116.26 142.12 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -158.94 -148.84 5.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.7 p -125.4 0.99 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.002 0.43 . . . . 0.0 110.873 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.8 m -98.41 120.93 39.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.164 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.582 HG12 HD11 ' A' ' 260' ' ' ILE . 22.1 m -103.73 133.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 245' ' ' ILE . 86.9 t80 -98.32 106.64 18.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 245' ' ' ILE . 52.4 t -94.77 133.65 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.63 166.01 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.06 53.44 2.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.64 158.77 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -87.89 130.6 34.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.14 -23.83 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -69.09 -40.25 78.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.57 HG13 ' HE2' ' A' ' 218' ' ' LYS . 92.4 t -61.53 119.25 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.57 162.74 12.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.496 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 68.2 p-90 -43.65 -49.19 7.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.496 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 6.9 ptpt -53.75 -54.79 33.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.57 ' HE2' HG13 ' A' ' 214' ' ' VAL . 0.7 OUTLIER -53.49 -59.89 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.529 ' CD1' ' CE1' ' A' ' 223' ' ' PHE . 23.5 tp -46.55 -47.29 19.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -60.03 -55.5 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -53.0 -58.18 7.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.574 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 38.4 t -51.67 -41.15 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.766 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.6 m-85 -70.06 -28.88 65.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 t -42.38 -27.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 50.7 mtp -51.19 -69.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.52 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.93 -57.06 4.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -164.79 -157.39 9.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.9 t -92.36 107.91 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 232' ' ' ALA . 54.0 t -60.75 100.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.512 HG12 ' HG2' ' A' ' 231' ' ' ARG . 89.1 t -55.81 -46.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.138 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.512 ' HG2' HG12 ' A' ' 230' ' ' VAL . 3.4 mmp_? -144.05 122.06 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -117.07 127.15 53.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.077 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -152.86 153.94 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 46.0 mm -119.03 128.47 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.572 HD12 ' CG2' ' A' ' 245' ' ' ILE . 58.6 mt -61.58 122.21 14.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -134.4 171.64 14.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -93.5 163.36 13.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -41.11 -47.9 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -63.95 -44.49 92.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.17 23.73 1.93 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.54 151.51 23.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 110.913 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 65.4 p -79.24 130.42 35.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.412 ' HD2' HD12 ' A' ' 245' ' ' ILE . 0.0 OUTLIER -97.12 -31.29 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.862 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 111.41 15.95 9.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.655 HG21 ' CZ ' ' A' ' 206' ' ' PHE . 40.7 mt -132.97 136.27 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.148 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 174.54 18.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 68.4 p -142.24 131.07 22.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.766 HG11 ' HD2' ' A' ' 223' ' ' PHE . 70.7 t -127.85 129.36 69.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 230' ' ' VAL . 33.4 m -110.79 112.4 24.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 61.8 m-85 -88.46 173.3 8.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.15 -55.29 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.93 159.56 33.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 257' ' ' VAL . 51.1 p -52.63 -47.65 66.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.5 mm -42.61 -61.07 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.422 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 2.3 mp0 -54.6 -47.52 73.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.54 -56.31 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 253' ' ' SER . 23.0 t -51.8 -44.41 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -53.9 -46.89 71.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.52 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -70.8 -45.89 63.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.582 HD11 HG12 ' A' ' 205' ' ' VAL . 96.4 mt -49.71 -48.95 20.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 13.0 m -72.49 -54.19 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.5 mtt -55.13 -22.49 17.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.574 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 22.1 m-85 -104.8 -16.2 14.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -63.81 110.5 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.03 86.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -71.16 132.63 45.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.7 mt -85.79 100.1 11.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.641 HD22 ' SD ' ' A' ' 273' ' ' MET . 15.6 tp -107.64 122.33 46.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 58.36 38.68 25.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 67.08 27.53 8.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -144.49 125.66 7.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.633 0.73 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 121.19 7.89 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 0.0 112.363 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.641 ' SD ' HD22 ' A' ' 268' ' ' LEU . 55.6 mtm -83.85 152.9 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -118.34 101.13 7.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.507 HG21 ' CB ' ' A' ' 263' ' ' PHE . 5.7 t -107.49 114.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -133.44 144.63 49.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 12.0 mtt -58.89 139.2 56.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.36 170.87 10.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.816 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -96.17 -48.85 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.857 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -111.64 88.69 2.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -124.31 36.46 4.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.051 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.589 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.7 tp -163.96 140.76 5.4 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.645 0.736 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.589 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.6 Cg_endo -69.69 150.09 68.19 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.67 2.246 . . . . 0.0 112.363 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -82.4 85.64 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.69 111.7 0.56 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.534 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -133.63 124.05 26.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -155.12 126.07 7.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.521 ' CG ' ' HD2' ' A' ' 289' ' ' PRO . 3.9 t80 -130.56 140.54 38.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.691 0.758 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 288' ' ' PHE . 53.5 Cg_endo -69.78 149.22 66.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.336 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 174.69 9.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.333 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -140.0 105.23 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -75.67 143.54 75.45 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.598 0.713 . . . . 0.0 110.848 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 130.44 19.35 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.732 2.288 . . . . 0.0 112.328 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -107.15 134.0 50.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -120.78 111.95 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.2 t -146.3 131.3 18.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -169.8 -158.4 13.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 2.6 3.41 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.664 2.242 . . . . 0.0 112.318 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 35.6 t -40.6 -34.19 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 21.0 t -150.69 109.14 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.449 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.1 t -164.36 171.69 14.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.886 0.374 . . . . 0.0 110.857 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.3 t -74.49 -45.37 46.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 108.65 145.01 11.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.451 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -89.08 139.26 30.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.8 m -45.62 -45.21 13.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 71.6 53.62 9.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.81 167.07 16.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.075 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 196' ' ' LEU . 1.1 pp -171.07 169.07 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.955 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.44 -49.45 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -55.09 178.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.32 -74.15 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -102.46 -40.31 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.1 mp -75.42 88.36 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -179.81 86.5 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 36.0 m -116.64 52.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.91 0.386 . . . . 0.0 110.866 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 67.4 m -100.99 134.78 43.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.558 HG12 HD11 ' A' ' 260' ' ' ILE . 23.1 m -112.12 135.16 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -97.07 114.7 26.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.611 HG11 HD21 ' A' ' 210' ' ' LEU . 14.2 t -99.56 138.19 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -140.76 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 m120 62.51 41.88 9.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.611 HD21 HG11 ' A' ' 207' ' ' VAL . 53.5 mt -91.35 149.34 21.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 214' ' ' VAL . 6.7 t70 -78.76 136.17 37.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -43.24 -31.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.84 -39.76 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 211' ' ' ASP . 94.6 t -54.05 111.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.103 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -106.04 170.55 16.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.506 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 52.6 p-90 -57.97 -32.49 67.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.506 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 8.9 mmtp -68.47 -52.38 33.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.633 ' HD2' HG23 ' A' ' 222' ' ' VAL . 16.7 tptm -62.77 -41.52 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.47 -58.77 7.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -52.9 -58.6 6.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -49.66 -58.89 4.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.633 HG23 ' HD2' ' A' ' 218' ' ' LYS . 20.2 t -51.95 -40.17 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.3 m-85 -72.37 -17.07 61.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 11.1 t -58.32 -19.38 34.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 26.3 mtm -57.39 -67.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.911 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -40.26 -42.08 1.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -178.32 -103.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.12 117.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 111.119 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.656 HG11 ' HB2' ' A' ' 232' ' ' ALA . 39.7 t -75.62 102.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 249' ' ' THR . 79.0 t -50.69 -44.39 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 8.0 ptp180 -159.38 122.76 3.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.656 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.1 135.01 50.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -139.72 151.39 45.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.89 125.87 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.96 124.23 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.96 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -121.31 167.4 12.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 240' ' ' GLY . 3.3 t70 -88.52 162.09 16.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 237' ' ' ASP . 5.0 mtpm? -34.41 -58.64 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.96 -43.28 60.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 237' ' ' ASP . . . 119.08 15.64 5.56 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.42 ' NZ ' ' HA ' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -89.28 167.99 12.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.898 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.4 m -71.66 146.21 48.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.24 -23.32 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 101.85 18.47 17.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 61.2 mt -132.83 126.31 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.369 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.35 167.31 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 56.3 p -139.94 128.68 23.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.619 HG21 ' CD2' ' A' ' 223' ' ' PHE . 36.0 t -124.63 140.5 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.107 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 230' ' ' VAL . 15.5 m -121.12 117.89 28.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.77 -176.74 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -83.19 -55.82 4.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -128.96 162.15 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 93.7 p -52.75 -48.24 66.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.839 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.1 mm -37.48 -62.92 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -59.39 -41.88 90.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.85 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.88 -49.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -48.49 -42.17 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -75.99 -49.56 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.558 HD11 HG12 ' A' ' 205' ' ' VAL . 42.8 mt -51.98 -41.4 31.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.2 t -76.68 -50.77 12.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 30.1 mtt -60.04 -21.66 61.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.495 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 25.0 m-85 -104.51 -22.15 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.6 110.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.9 84.11 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -72.66 123.46 23.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 110.893 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.78 105.88 14.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.06 121.93 45.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 58.76 35.11 24.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 70.62 27.74 3.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 33.5 mtp85 -142.9 119.51 6.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.615 0.722 . . . . 0.0 110.819 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.09 3.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.368 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 59.8 mtm -72.14 159.25 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 23.0 t-160 -125.63 103.56 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.463 HG21 ' CB ' ' A' ' 263' ' ' PHE . 2.6 t -111.8 110.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.084 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -124.59 142.18 51.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.424 ' HG3' HD13 ' A' ' 260' ' ' ILE . 15.0 mtt -56.88 137.95 54.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.08 147.04 52.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -89.85 -54.96 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.43 ' NH1' ' HB2' ' A' ' 280' ' ' ARG . 2.1 ptm85 -131.95 128.13 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -129.57 44.93 2.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.718 HD12 ' HD2' ' A' ' 283' ' ' PRO . 4.0 tp -126.45 133.47 25.02 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.718 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.5 Cg_endo -69.79 124.92 11.55 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.668 2.245 . . . . 0.0 112.343 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -39.59 -40.35 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.74 150.44 0.31 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.81 35.27 2.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.87 0.366 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.66 39.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -115.33 81.32 8.29 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.685 0.755 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 157.59 59.99 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.369 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 100.04 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.665 2.243 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.08 150.33 41.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -101.59 149.38 36.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -24.66 29.45 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.707 2.271 . . . . 0.0 112.354 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -76.35 146.55 38.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -78.88 151.41 31.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 29.5 t -59.32 -42.02 90.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.862 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.02 154.95 16.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -13.27 34.39 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.655 2.237 . . . . 0.0 112.333 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 3.7 t -49.55 -62.29 1.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.0 m -76.63 97.67 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 89.8 p -157.03 161.91 39.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.823 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.0 t -133.97 152.84 52.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -149.07 122.24 1.43 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.3 m -118.5 168.61 10.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.2 t -123.38 -55.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 104.16 95.25 2.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.65 141.93 22.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 111.1 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -142.64 150.18 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -109.06 158.0 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.02 163.75 27.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -126.69 156.14 19.91 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -119.31 -41.39 2.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 0.0 110.865 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.51 ' C ' HD23 ' A' ' 201' ' ' LEU . 7.4 tt -65.82 125.85 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.438 ' N ' HD23 ' A' ' 201' ' ' LEU . . . 146.49 165.08 11.36 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 204' ' ' THR . 89.2 p -107.04 -47.51 3.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 110.836 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 203' ' ' SER . 0.5 OUTLIER -34.61 114.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.152 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 260' ' ' ILE . 30.5 m -104.99 137.23 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -98.97 118.46 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.26 134.34 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -137.49 171.91 13.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 m120 60.09 41.53 17.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 41.0 mt -90.05 155.41 19.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 214' ' ' VAL . 3.3 t70 -67.3 160.76 26.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -77.71 -33.82 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.409 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 65.8 mttt -85.53 40.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -108.91 164.2 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.609 ' N ' HG12 ' A' ' 214' ' ' VAL . . . -151.2 148.71 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -40.45 -35.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -66.56 -56.36 11.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.471 ' HD3' HG23 ' A' ' 222' ' ' VAL . 1.5 tmtm? -51.22 -44.16 61.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -69.4 -62.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -44.4 -42.28 6.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.605 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 27.1 t -70.29 -43.26 78.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.082 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.2 m-85 -69.19 -15.73 63.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.5 t -59.38 -13.21 7.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 28.0 mtp -67.5 -64.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.585 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -46.26 -47.39 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.1 -141.44 3.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 50.1 t -105.51 114.68 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 0.0 111.126 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.767 HG11 ' HB2' ' A' ' 232' ' ' ALA . 53.5 t -72.11 101.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.177 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.6 t -51.02 -43.69 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.426 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 17.5 ptt180 -160.58 119.8 2.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.767 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.44 135.24 50.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 159.3 42.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.411 HD11 HD22 ' A' ' 219' ' ' LEU . 48.7 mm -119.31 144.04 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.517 HD12 ' CG2' ' A' ' 245' ' ' ILE . 36.8 mt -80.55 107.53 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -142.42 144.72 33.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 239' ' ' ASP . 3.0 p30 -61.92 160.77 11.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -35.78 -30.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 237' ' ' ASP . 27.8 m-20 -67.16 -57.29 7.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 127.02 31.22 0.76 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp -96.41 128.09 43.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.1 m -91.37 118.28 30.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -93.17 35.88 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 68.47 25.05 75.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.458 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.517 ' CG2' HD12 ' A' ' 235' ' ' LEU . 51.8 mt -131.33 126.18 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.132 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.26 175.27 20.78 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 p -143.48 138.47 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 111.12 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.503 HG13 HG13 ' A' ' 229' ' ' VAL . 44.1 t -135.19 143.51 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 89.2 m -124.4 123.74 40.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.201 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 256' ' ' ALA . 74.2 m-85 -97.62 175.5 6.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -60.15 2.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -109.49 142.58 40.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 257' ' ' VAL . 85.7 p -47.82 -43.24 27.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 mm -46.88 -57.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.44 -49.79 75.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 250' ' ' PHE . . . -51.32 -48.03 62.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 253' ' ' SER . 65.7 t -57.6 -53.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -46.07 -46.92 17.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.585 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -64.4 -50.55 67.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.519 HD13 ' HG2' ' A' ' 277' ' ' MET . 96.6 mt -47.53 -50.79 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 264' ' ' ASN . 15.8 m -72.22 -61.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.8 mmt -45.17 -24.94 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.605 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 23.6 m-85 -104.43 -19.36 14.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 261' ' ' SER . 10.9 t30 -60.35 113.0 2.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.54 6.65 89.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.553 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.95 126.17 28.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.88 0.371 . . . . 0.0 110.93 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.56 100.16 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.563 HD22 ' SD ' ' A' ' 273' ' ' MET . 16.0 tp -106.05 121.13 43.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.959 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 59.03 37.76 24.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 68.55 26.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -143.67 124.48 7.95 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 122.59 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.563 ' SD ' HD22 ' A' ' 268' ' ' LEU . 63.2 mtm -84.51 145.36 28.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 21.6 t-160 -109.79 99.25 8.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.438 HG21 ' CB ' ' A' ' 263' ' ' PHE . 4.0 t -109.04 124.66 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.444 ' CG ' ' N ' ' A' ' 277' ' ' MET . 1.6 ttpm? -149.09 160.55 43.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.519 ' HG2' HD13 ' A' ' 260' ' ' ILE . 9.4 mmt -66.44 139.58 57.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.452 ' OD1' ' CB ' ' A' ' 280' ' ' ARG . 12.5 t70 -78.84 137.61 37.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.44 -40.13 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.452 ' CB ' ' OD1' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -59.86 136.01 57.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -115.23 92.79 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.585 HD12 ' HD2' ' A' ' 283' ' ' PRO . 6.5 tp -60.77 140.39 93.18 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.649 0.738 . . . . 0.0 110.898 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.585 ' HD2' HD12 ' A' ' 282' ' ' LEU . 54.3 Cg_endo -69.74 144.19 53.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.37 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -127.56 40.24 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.08 179.59 0.15 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -127.57 132.63 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -84.27 168.56 15.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -117.16 142.01 29.4 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.63 0.729 . . . . 0.0 110.873 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 148.38 64.89 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.632 2.221 . . . . 0.0 112.385 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 177.72 5.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.684 2.256 . . . . 0.0 112.315 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -140.01 137.49 34.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -135.75 147.86 63.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.606 0.717 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -176.14 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.654 2.236 . . . . 0.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -139.93 167.61 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -140.0 170.92 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.7 t -145.55 169.64 18.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 170.99 82.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 148.4 65.16 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.651 2.234 . . . . 0.0 112.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 2.7 t -102.12 146.94 27.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 78.2 p -85.98 -1.53 57.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.488 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.4 t -171.65 139.46 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 76.4 p -120.49 138.04 54.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -179.44 134.9 2.38 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 41.4 t -120.16 158.38 27.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.859 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.1 t -166.35 143.31 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.41 131.98 34.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.615 ' HB1' HD23 ' A' ' 196' ' ' LEU . . . -60.65 -72.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.615 HD23 ' HB1' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -166.12 165.43 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -86.86 125.32 33.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.83 127.3 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.12 65.61 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.8 mtt85 -50.83 -42.5 58.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.82 142.61 27.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 165.3 72.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.469 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 35.0 p -45.76 -53.0 10.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.872 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.3 m -49.54 134.2 19.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.178 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 260' ' ' ILE . 11.4 m -124.99 139.69 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -100.32 127.35 46.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 210' ' ' LEU . 45.9 t -116.54 130.51 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.72 170.68 14.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.103 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.67 50.84 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.485 HD11 ' CG1' ' A' ' 207' ' ' VAL . 50.3 mt -100.03 159.95 14.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.917 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 214' ' ' VAL . 25.5 t0 -86.16 131.54 34.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -44.82 -23.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -75.73 -39.54 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 268' ' ' LEU . 70.1 t -59.74 112.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -109.83 172.84 16.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 28.5 p-90 -51.19 -28.94 12.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' A' ' 221' ' ' GLU . 45.0 mttp -67.78 -52.94 31.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.736 ' O ' HG23 ' A' ' 222' ' ' VAL . 19.5 tptm -65.38 -50.48 65.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.854 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.665 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.5 tp -49.91 -53.42 26.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -62.21 -61.79 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 217' ' ' LYS . 0.4 OUTLIER -43.15 -56.63 3.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 218' ' ' LYS . 46.2 t -56.0 -46.94 80.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 248' ' ' VAL . 3.3 m-85 -63.13 -14.84 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.4 t -59.18 -13.91 8.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 41.7 mtp -69.08 -60.71 2.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.567 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -44.93 -52.56 8.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.51 -127.43 0.97 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 68.0 t -114.78 119.88 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 0.0 111.14 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.82 HG11 ' HB2' ' A' ' 232' ' ' ALA . 84.6 t -81.59 98.65 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.172 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 66.1 t -51.45 -43.74 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -161.35 117.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.82 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.3 153.38 23.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -167.73 167.1 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.665 ' CD1' HD22 ' A' ' 219' ' ' LEU . 16.3 mm -126.2 133.78 68.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.152 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.477 HD12 HG22 ' A' ' 245' ' ' ILE . 44.0 mt -79.63 127.81 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -127.27 178.02 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.52 172.43 12.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.866 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -45.87 -45.25 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -72.78 -57.55 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.91 50.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.482 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -122.62 110.7 15.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.5 m -60.25 133.42 56.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.838 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.46 ' NH2' HD12 ' A' ' 245' ' ' ILE . 20.5 mtm105 -106.6 31.52 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 74.03 29.09 63.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.477 HG22 HD12 ' A' ' 235' ' ' LEU . 71.1 mt -134.68 129.81 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.878 0.371 . . . . 0.0 111.15 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -136.69 166.38 24.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 48.2 p -135.8 140.68 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 223' ' ' PHE . 2.8 t -134.73 143.91 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.1 m -120.96 121.7 38.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -95.34 -176.32 3.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.83 -53.22 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -134.76 159.29 41.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 257' ' ' VAL . 91.9 p -48.86 -36.98 18.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 30.8 mm -47.32 -63.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 -58.75 -44.43 90.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.73 -54.55 22.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 253' ' ' SER . 89.1 t -55.72 -49.13 76.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -48.32 -47.31 36.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.567 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -69.23 -55.09 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.619 HD11 HG12 ' A' ' 205' ' ' VAL . 95.2 mt -45.74 -43.37 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.3 t -77.6 -59.93 2.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 17.4 mmt -51.06 -22.81 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.498 ' CB ' HG21 ' A' ' 275' ' ' VAL . 3.5 m-85 -103.07 -21.0 13.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -55.33 113.33 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.05 82.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -70.56 127.12 31.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.65 101.37 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.453 HD23 HG21 ' A' ' 214' ' ' VAL . 9.9 tp -110.15 124.64 51.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.926 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 57.31 32.73 22.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 72.13 31.45 1.94 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.844 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -144.85 120.72 6.01 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.592 0.71 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 118.46 5.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.704 2.27 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 55.7 mtm -79.87 147.07 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -113.5 99.03 7.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 263' ' ' PHE . 1.8 t -107.65 127.0 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.157 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.8 tttm -149.54 159.53 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.421 ' N ' ' CG ' ' A' ' 276' ' ' LYS . 11.0 mtt -65.64 139.96 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.74 150.86 47.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -63.77 -69.18 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -117.04 104.97 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -114.29 38.31 3.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.592 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.6 tp -155.13 140.76 12.6 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 0.0 110.937 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.592 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.76 -178.24 2.25 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.684 2.256 . . . . 0.0 112.305 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.64 -57.52 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 175.24 88.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.488 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.59 101.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.836 0.35 . . . . 0.0 110.851 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 56.43 45.96 21.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -41.03 149.24 0.35 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.694 0.759 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 148.46 65.52 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.361 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.97 49.42 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.71 2.273 . . . . 0.0 112.309 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -137.02 108.9 7.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -89.24 135.57 31.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.626 0.727 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 179.55 3.58 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.699 2.266 . . . . 0.0 112.339 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.42 139.5 53.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -131.62 170.94 14.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 40.4 t -174.65 141.65 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 165.91 82.52 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 121.53 8.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.644 2.229 . . . . 0.0 112.375 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 8.7 t -66.34 157.23 32.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.3 t -167.46 116.27 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.457 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 81.1 p 39.48 42.31 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.4 p -106.94 124.38 49.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.794 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -126.47 -174.03 13.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.491 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -166.16 125.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.1 m -59.37 134.31 56.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.852 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.18 -65.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -52.82 -179.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.76 153.67 17.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -72.04 163.9 27.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -117.83 154.97 30.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -165.11 -141.51 3.15 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.49 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -81.1 74.02 8.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 201' ' ' LEU . 1.9 mm? -106.91 146.87 30.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -78.21 -144.56 2.42 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 m -121.22 44.62 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.401 . . . . 0.0 110.912 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.1 m -101.77 136.34 41.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.091 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.697 HG12 HD11 ' A' ' 260' ' ' ILE . 20.4 m -124.45 145.5 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -102.58 118.51 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -122.76 167.91 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.3 t30 58.35 51.69 8.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.95 163.23 13.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.62 ' HB3' HG23 ' A' ' 214' ' ' VAL . 1.7 t0 -80.75 118.14 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -41.27 -41.88 2.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -61.0 -37.45 82.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 211' ' ' ASP . 53.3 t -55.72 151.85 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -135.26 172.44 22.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.472 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 30.3 p-90 -57.09 -39.72 75.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 5.3 mtpm? -62.84 -48.49 78.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.761 ' HZ1' HD11 ' A' ' 268' ' ' LEU . 0.5 OUTLIER -63.81 -48.83 75.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 11.2 tp -55.88 -52.55 63.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -59.06 -60.26 4.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -41.24 -45.27 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 218' ' ' LYS . 85.9 t -69.21 -51.95 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.773 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.2 m-85 -56.76 -12.86 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 37.2 t -57.46 -12.23 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.3 mtm -65.31 -66.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.818 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -48.83 -39.96 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.073 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 176.65 -171.78 44.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 78.3 t -79.4 122.16 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.146 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 232' ' ' ALA . 94.3 t -79.0 103.66 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.44 -39.31 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -148.62 120.3 8.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -124.98 135.48 52.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -161.69 167.54 24.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 47.1 mm -119.64 133.51 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 245' ' ' ILE . 86.4 mt -78.75 131.35 36.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -134.0 167.55 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 17.1 t0 -63.82 165.95 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 239' ' ' ASP . 35.5 pttt -36.76 -46.7 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 238' ' ' LYS . 3.0 m-20 -74.64 -58.66 3.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.19 42.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.54 115.52 29.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.5 m -66.11 122.94 18.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -106.69 21.5 17.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 75.21 28.24 62.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 235' ' ' LEU . 47.7 mt -127.71 124.31 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 111.182 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.78 176.33 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.494 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 57.6 p -142.8 136.73 29.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.773 HG21 ' CD2' ' A' ' 223' ' ' PHE . 45.9 t -127.17 139.88 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.6 m -123.21 111.06 16.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.563 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 91.0 m-85 -86.62 -175.25 5.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.49 -49.36 8.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -132.29 156.71 46.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 254' ' ' ILE . 16.7 t -48.71 -52.81 21.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 253' ' ' SER . 27.9 mm -37.67 -62.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.137 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.788 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 33.7 mt-10 -53.77 -48.47 69.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.563 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.61 -60.69 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.451 HG22 ' CE ' ' A' ' 277' ' ' MET . 95.7 t -42.87 -56.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -47.87 -52.29 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.818 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -58.88 -42.86 90.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.697 HD11 HG12 ' A' ' 205' ' ' VAL . 48.7 mt -62.62 -59.61 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.1 m -54.29 -42.81 70.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -69.85 -67.17 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.844 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 223' ' ' PHE . 41.9 m-85 -57.47 -14.02 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.0 OUTLIER -65.34 110.56 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.57 81.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.487 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 10.5 mm100 -69.89 146.03 51.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.1 mt -97.97 102.43 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.761 HD11 ' HZ1' ' A' ' 218' ' ' LYS . 16.9 tp -112.76 123.52 50.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.434 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 12.1 m-85 56.2 40.61 29.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 34.5 t70 64.21 30.99 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -147.08 123.25 5.52 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.566 0.698 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 266' ' ' GLN . 54.1 Cg_endo -69.73 124.45 11.11 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 0.0 112.363 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.407 ' SD ' HD22 ' A' ' 268' ' ' LEU . 61.0 mtm -85.86 153.07 22.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 15.2 t-160 -117.35 99.85 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.82 124.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 277' ' ' MET . 22.2 tttm -142.64 157.57 44.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.575 ' HG2' HD13 ' A' ' 260' ' ' ILE . 7.9 mtt -67.08 130.56 43.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.921 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.05 151.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.856 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.43 -46.72 5.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -126.13 111.26 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.859 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -101.2 86.77 3.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.578 HD12 ' HD2' ' A' ' 283' ' ' PRO . 9.1 tp -38.9 139.65 0.72 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.578 0.704 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.578 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.78 167.87 23.23 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.671 2.247 . . . . 0.0 112.358 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -123.8 144.74 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 97.78 2.19 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.97 176.71 6.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -165.98 134.81 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -118.17 144.82 35.64 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 146.87 61.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.664 2.243 . . . . 0.0 112.364 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.38 37.8 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.679 2.253 . . . . 0.0 112.331 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -139.95 112.17 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.476 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 27.0 ttt85 -130.31 139.41 35.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.586 0.708 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.7 Cg_endo -69.75 136.9 34.2 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -139.43 151.75 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -122.87 152.72 40.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.7 t -124.82 170.34 11.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 145.53 67.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.522 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -176.58 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.66 2.24 . . . . 0.0 112.353 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 34.0 p -165.13 163.93 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 73.1 m -119.05 171.33 8.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.874 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.552 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 28.9 p -101.99 158.62 16.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.875 0.369 . . . . 0.0 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 81.4 p -103.04 -49.09 3.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 123.64 80.11 0.47 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.5 t -118.09 100.08 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 19.6 t -174.93 165.24 3.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -178.42 -109.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.535 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.83 158.13 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 111.106 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.96 -60.32 1.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -104.24 159.15 15.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.56 -51.84 1.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.133 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.31 60.62 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -81.16 154.57 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.327 . . . . 0.0 110.886 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.59 84.35 1.95 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -148.84 107.47 0.36 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 7.2 t -79.1 -50.1 11.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.0 0.429 . . . . 0.0 110.846 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.1 m -42.71 142.92 0.77 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.653 HG12 HD11 ' A' ' 260' ' ' ILE . 15.7 m -126.08 148.39 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -104.06 111.67 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 245' ' ' ILE . 15.2 t -101.75 138.11 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.158 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.6 170.09 16.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 t30 61.12 54.43 3.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.04 148.95 30.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.83 141.49 44.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -51.41 -19.12 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -75.25 -42.48 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.456 HG21 HD23 ' A' ' 268' ' ' LEU . 41.5 t -60.74 109.11 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -108.1 168.5 13.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.473 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 42.1 p-90 -48.24 -34.88 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 99.1 mttt -60.15 -57.25 13.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -64.31 -57.73 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 22.8 tp -38.69 -49.57 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -67.25 -48.19 68.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.93 -32.11 60.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.778 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 38.8 t -78.0 -43.59 28.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.632 ' CD2' HG11 ' A' ' 248' ' ' VAL . 3.5 m-85 -66.42 -21.28 66.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 35.8 t -51.57 -19.75 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 7.9 mtm -65.67 -59.67 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -53.13 -45.35 68.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 178.81 -162.94 30.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.94 122.57 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 232' ' ' ALA . 78.6 t -78.44 101.0 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.496 HG23 ' C ' ' A' ' 250' ' ' PHE . 77.0 t -52.59 -42.08 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.423 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 29.2 ptt180 -163.81 117.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.799 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -107.98 151.61 25.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.091 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -166.59 172.95 10.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 23.5 mm -129.51 119.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.683 HD12 HG22 ' A' ' 245' ' ' ILE . 96.7 mt -64.79 141.71 58.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -140.2 177.47 7.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -85.95 168.93 13.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -42.47 -59.06 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.43 -51.54 66.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.61 38.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -102.05 150.75 22.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.769 0.318 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 28.8 m -98.33 119.12 36.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -95.28 7.87 44.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.871 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 88.4 18.21 55.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.683 HG22 HD12 ' A' ' 235' ' ' LEU . 40.8 mt -112.04 128.85 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 111.159 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.8 168.28 21.91 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.4 p -139.01 135.77 34.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 111.172 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.632 HG11 ' CD2' ' A' ' 223' ' ' PHE . 35.0 t -130.47 139.31 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.8 m -120.8 115.81 23.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 80.8 m-85 -88.83 178.59 6.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -80.75 -55.23 4.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -117.81 145.03 44.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 257' ' ' VAL . 83.8 p -47.06 -45.51 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -42.4 -62.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -55.63 -49.18 73.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.05 -49.79 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.13 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 253' ' ' SER . 65.2 t -57.3 -53.6 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -45.59 -42.95 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -66.57 -52.21 47.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.653 HD11 HG12 ' A' ' 205' ' ' VAL . 75.8 mt -48.88 -48.06 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.5 m -71.96 -58.88 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 85.6 mmm -51.83 -24.49 6.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.778 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 20.8 m-85 -102.05 -15.08 16.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.52 111.93 4.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.25 90.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -70.73 125.9 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.03 101.88 10.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.669 HD22 ' SD ' ' A' ' 273' ' ' MET . 12.3 tp -108.6 123.7 49.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 58.72 39.25 24.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 66.7 26.65 9.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -145.54 124.61 6.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.583 0.706 . . . . 0.0 110.836 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 119.49 6.43 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.33 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.669 ' SD ' HD22 ' A' ' 268' ' ' LEU . 59.7 mtm -80.5 154.91 27.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -119.95 108.81 14.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.549 HG21 ' CB ' ' A' ' 263' ' ' PHE . 2.7 t -116.79 122.31 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -131.72 147.95 52.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.52 ' HG2' HD13 ' A' ' 260' ' ' ILE . 3.4 mtp -58.05 132.08 52.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -79.79 165.37 22.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -119.84 88.73 2.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 34.3 ttt-85 -104.53 112.88 26.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -119.04 87.87 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.064 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.7 tp -146.2 140.71 15.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.534 0.683 . . . . 0.0 110.946 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.74 149.19 66.68 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.349 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -74.24 -46.11 43.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.84 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.76 80.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -134.05 37.54 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.371 . . . . 0.0 110.876 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -169.53 152.34 4.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -114.5 144.7 32.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 129.5 17.7 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.669 2.246 . . . . 0.0 112.337 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 109.2 2.26 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -62.49 107.19 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -131.67 82.47 60.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 141.01 44.16 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.702 2.268 . . . . 0.0 112.389 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -135.53 163.34 30.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -121.78 159.47 26.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 90.1 p -174.21 176.26 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -175.27 144.78 7.46 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 169.57 18.68 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.659 2.239 . . . . 0.0 112.346 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.5 m -138.82 144.28 39.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.1 t -124.71 129.95 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.4 p -170.35 139.63 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.8 m -157.96 148.48 20.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.81 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -156.26 72.2 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 32.8 t -124.62 153.7 41.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 110.855 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 51.9 m -88.92 -47.45 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 61.93 124.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -163.93 117.7 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.114 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.69 127.17 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -128.98 43.29 3.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -103.44 89.37 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.53 159.76 22.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -95.19 87.26 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 110.85 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 mt -105.14 41.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.63 132.67 0.48 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.499 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.3 m -95.07 44.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.908 0.385 . . . . 0.0 110.83 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.3 m -74.87 137.13 41.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.77 137.26 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 208' ' ' ALA . 67.6 t80 -99.73 123.52 44.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.934 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.663 ' CG1' HD11 ' A' ' 210' ' ' LEU . 66.4 t -112.8 128.42 69.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.412 ' HB2' ' CE2' ' A' ' 206' ' ' PHE . . . -132.07 167.55 19.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.4 t30 68.43 45.52 1.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.663 HD11 ' CG1' ' A' ' 207' ' ' VAL . 34.0 mt -104.31 133.84 48.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.47 ' OD2' ' CD2' ' A' ' 269' ' ' PHE . 0.5 OUTLIER -67.5 145.74 54.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.861 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -47.63 -33.75 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -58.02 -35.24 70.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.42 HG23 ' CG ' ' A' ' 211' ' ' ASP . 46.4 t -56.06 117.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -117.97 146.6 18.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.555 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 32.0 p-90 -35.44 -45.11 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.555 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 32.7 mtpt -55.92 -60.03 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 219' ' ' LEU . 15.9 tptm -54.19 -65.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.822 HD22 HD11 ' A' ' 234' ' ' ILE . 14.3 tp -35.23 -58.14 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.432 ' HD2' ' HB3' ' A' ' 232' ' ' ALA . 69.3 tttt -59.42 -49.67 76.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.918 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.32 -20.9 12.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 89.1 t -91.34 -45.5 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.084 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.513 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 4.4 m-85 -64.58 -15.99 61.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 42.3 p -58.51 -15.28 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 29.4 mtm -66.42 -55.47 15.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.622 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -57.68 -41.0 80.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.24 -161.67 30.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -83.52 108.48 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.134 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.79 HG11 ' HB2' ' A' ' 232' ' ' ALA . 55.6 t -69.54 104.72 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 53.8 t -50.69 -46.46 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 0.2 OUTLIER -153.58 122.96 6.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.79 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -117.73 133.42 55.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 232' ' ' ALA . 2.0 m-20 -161.17 167.17 26.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.822 HD11 HD22 ' A' ' 219' ' ' LEU . 7.0 mm -124.7 138.56 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.83 123.98 27.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -129.84 172.32 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 238' ' ' LYS . 1.9 m-20 -80.02 170.16 16.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 237' ' ' ASP . 6.1 mtmp? -35.48 -64.29 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.33 -51.31 69.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.44 42.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -103.72 113.07 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 19.0 t -67.73 130.67 43.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -95.92 35.38 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.904 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 62.92 27.96 71.13 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.471 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 67.4 mt -137.03 128.62 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.846 0.355 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.69 170.36 18.49 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.5 p -138.43 138.23 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.126 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 229' ' ' VAL . 3.0 t -137.9 151.34 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.438 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 15.6 m -133.48 118.89 18.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -88.82 175.98 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.11 -55.93 4.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -123.02 155.9 35.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 254' ' ' ILE . 69.0 p -51.67 -50.82 59.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 253' ' ' SER . 14.4 mm -36.39 -62.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.122 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.557 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 13.3 mt-10 -57.41 -45.96 84.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.3 49.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.116 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.07 -54.09 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -44.82 -43.01 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -72.45 -53.27 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.0 mt -42.68 -46.54 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 9.8 m -76.85 -63.2 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.0 mmm -45.89 -24.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.547 ' HB3' HG21 ' A' ' 275' ' ' VAL . 3.6 m-85 -100.3 -30.77 11.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -55.13 111.15 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.07 14.01 77.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.532 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -77.08 127.87 33.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.933 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.1 mt -85.83 99.94 11.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.67 125.34 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.47 ' CD2' ' OD2' ' A' ' 211' ' ' ASP . 25.8 m-85 58.86 33.95 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 70.35 28.96 3.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -146.85 124.58 5.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.613 0.721 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 126.2 13.04 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.651 2.234 . . . . 0.0 112.413 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 41.7 mtm -86.54 151.37 23.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.828 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -115.87 102.29 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.547 HG21 ' HB3' ' A' ' 263' ' ' PHE . 1.7 t -115.55 124.47 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 158.71 43.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 11.3 mtt -67.12 131.24 45.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -77.03 138.26 39.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.44 109.11 10.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -123.97 147.33 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -95.4 82.09 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 6.0 tp -102.53 135.52 19.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.601 0.715 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 96.31 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.675 2.25 . . . . 0.0 112.321 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER -100.65 141.08 34.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.39 76.51 0.42 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.499 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -115.25 129.99 56.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -164.33 118.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.52 ' CG ' ' HD2' ' A' ' 289' ' ' PRO . 6.0 t80 -126.18 140.28 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.875 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 288' ' ' PHE . 53.7 Cg_endo -69.81 149.04 66.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 5.36 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.629 2.22 . . . . 0.0 112.339 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.64 155.98 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -130.36 145.14 56.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.576 0.703 . . . . 0.0 110.885 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.84 69.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.669 2.246 . . . . 0.0 112.3 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -122.85 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 296' ' ' SER . 12.2 pt20 -116.52 -46.22 2.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.468 ' N ' ' HG3' ' A' ' 295' ' ' GLN . 93.3 p -149.8 135.33 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -97.4 -162.4 31.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 96.53 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.7 t -134.77 158.63 43.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.4 t -171.92 131.48 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.443 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 79.0 p -149.1 131.12 15.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.0 p -73.35 -23.05 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.24 114.21 0.67 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.7 t -83.07 102.44 11.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.853 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 52.5 p -165.05 166.04 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 90.16 92.31 1.23 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.449 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.31 153.49 41.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.819 0.342 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.0 mp -118.25 107.07 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -122.73 94.18 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.65 67.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.473 ' O ' HD23 ' A' ' 201' ' ' LEU . . . -176.35 138.4 4.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -93.81 104.16 16.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 201' ' ' LEU . 0.3 OUTLIER -132.7 176.23 8.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 73.92 -179.64 41.26 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.514 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 204' ' ' THR . 9.9 m -120.21 -37.43 3.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 0.0 110.885 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.437 ' C ' ' O ' ' A' ' 203' ' ' SER . 88.1 m -34.87 129.66 0.44 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.448 HG12 HD11 ' A' ' 260' ' ' ILE . 31.9 m -112.03 134.15 55.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -95.02 112.27 23.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.494 ' CG1' HD11 ' A' ' 210' ' ' LEU . 12.3 t -101.18 129.8 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.475 ' HB3' ' ND1' ' A' ' 274' ' ' HIS . . . -135.94 161.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.2 t30 67.54 47.87 1.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' A' ' 207' ' ' VAL . 46.1 mt -99.96 146.79 26.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -74.26 137.69 43.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -45.16 -36.43 3.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -59.97 -43.41 95.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 85.3 t -58.82 121.88 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.095 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 216' ' ' TRP . . . -122.12 161.65 16.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.519 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.51 ' CD2' ' N ' ' A' ' 217' ' ' LYS . 56.7 p-90 -35.53 -48.53 0.51 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.928 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.51 ' N ' ' CD2' ' A' ' 216' ' ' TRP . 4.5 ptpt -50.85 -62.66 1.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 219' ' ' LEU . 18.5 tptp -50.93 -66.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 223' ' ' PHE . 14.9 tp -35.43 -42.98 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.902 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -69.85 -64.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.848 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -42.98 -38.83 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 69.8 t -74.72 -39.83 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.123 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.64 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.1 m-85 -73.72 -10.33 59.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.6 t -62.31 -23.48 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 25.9 mtm -59.98 -61.53 2.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.58 -54.34 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.117 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.97 -144.65 4.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.5 t -99.54 114.85 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.91 HG11 ' HB2' ' A' ' 232' ' ' ALA . 42.2 t -78.82 103.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 249' ' ' THR . 40.3 t -50.87 -37.04 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.416 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 39.2 ptt85 -168.56 118.58 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.91 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -114.37 142.78 45.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -169.66 168.62 9.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.402 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.5 mm -116.52 141.8 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 36.1 mt -83.09 149.71 26.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -142.93 176.44 9.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 239' ' ' ASP . 6.0 t0 -84.8 171.36 12.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.426 ' HD2' ' C ' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -39.7 -28.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 237' ' ' ASP . 13.8 t70 -87.19 -54.22 4.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 134.67 37.0 0.22 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.465 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -100.14 125.4 46.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.1 m -66.04 110.76 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -90.19 24.62 2.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 72.24 25.48 74.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 24.7 mt -132.43 125.44 53.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.164 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.38 168.15 21.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 52.5 p -132.54 141.37 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.841 0.353 . . . . 0.0 111.112 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.64 HG11 ' HD2' ' A' ' 223' ' ' PHE . 63.0 t -134.54 138.65 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 230' ' ' VAL . 28.7 m -119.37 117.98 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.47 -178.83 5.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.23 -52.71 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -129.57 156.32 44.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 17.3 t -48.59 -49.83 35.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.4 mm -39.14 -64.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -53.59 -45.25 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.49 -56.39 15.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.2 t -50.28 -55.35 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -44.03 -51.58 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 263' ' ' PHE . . . -65.3 -50.8 64.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.058 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 205' ' ' VAL . 84.7 mt -46.85 -52.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.4 m -72.48 -59.97 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 53.4 mmm -46.61 -24.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.553 ' CE2' ' HB1' ' A' ' 259' ' ' ALA . 26.2 m-85 -103.3 -23.36 13.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -58.13 110.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.3 6.68 89.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -69.98 130.56 42.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.09 100.99 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.6 tp -109.4 121.96 46.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 59.34 41.95 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 19.6 t70 63.39 24.97 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.28 125.34 7.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.592 0.711 . . . . 0.0 110.858 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 138.19 37.05 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 32.9 mtm -97.39 152.91 18.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.475 ' ND1' ' HB3' ' A' ' 208' ' ' ALA . 5.7 t-160 -115.74 99.17 7.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 263' ' ' PHE . 1.5 t -112.93 118.45 57.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -139.11 146.14 40.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.837 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 24.4 mtt -56.0 135.02 52.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -61.49 114.45 3.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -79.25 -31.06 43.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -100.77 98.74 9.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -117.22 86.99 2.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.052 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.589 HD12 ' HD2' ' A' ' 283' ' ' PRO . 9.8 tp -66.27 139.49 96.38 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.646 0.736 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.589 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.7 160.51 49.44 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.739 2.293 . . . . 0.0 112.325 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -53.17 2.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.17 125.01 0.2 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.504 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.66 168.11 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.566 ' CD2' ' HD3' ' A' ' 289' ' ' PRO . 3.5 p90 -148.08 148.14 30.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -128.98 83.29 66.67 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.648 0.737 . . . . 0.0 110.885 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 287' ' ' PHE . 53.9 Cg_endo -69.73 148.72 65.86 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.682 2.254 . . . . 0.0 112.365 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 173.34 11.16 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.274 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -120.8 110.74 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -107.51 80.76 0.97 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 96.27 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.694 2.263 . . . . 0.0 112.354 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -104.07 138.78 40.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -119.37 139.57 51.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 41.3 t -130.45 135.7 48.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -146.4 82.63 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 146.78 61.08 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.315 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 56.9 p -172.22 128.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 33.0 p -171.44 137.74 1.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.473 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 61.8 p -74.66 85.97 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.859 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 74.3 m -109.93 157.32 19.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 115.61 -105.56 1.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.4 m 38.73 42.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.7 m -148.02 141.73 25.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.874 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -123.24 90.06 0.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.82 165.42 18.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.92 123.9 21.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 14.4 pm0 -101.64 170.04 8.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.34 -45.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.11 54.23 0.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -107.23 173.37 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.583 ' C ' HD12 ' A' ' 201' ' ' LEU . 1.0 OUTLIER -97.31 143.8 27.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 166.78 82.28 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 204' ' ' THR . 16.7 m -67.56 -50.63 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.411 . . . . 0.0 110.856 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 203' ' ' SER . 43.1 m -34.58 137.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.649 HG12 HD11 ' A' ' 260' ' ' ILE . 3.6 m -124.39 150.73 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 208' ' ' ALA . 71.0 t80 -106.68 122.05 45.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.927 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -108.32 124.37 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.567 ' HB2' ' CE2' ' A' ' 206' ' ' PHE . . . -124.21 167.87 13.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.2 m120 62.16 50.98 3.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.2 mt -104.39 146.35 28.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.88 145.43 42.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.86 -26.63 36.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -71.03 -37.51 72.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.07 110.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.126 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -103.88 175.04 22.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.498 ' CE2' ' HG2' ' A' ' 217' ' ' LYS . 12.4 p-90 -57.13 -32.68 66.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.908 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' A' ' 216' ' ' TRP . 30.3 mmtt -66.43 -56.41 11.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -59.11 -56.42 22.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.603 HD22 HD11 ' A' ' 234' ' ' ILE . 14.2 tp -46.45 -51.26 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.65 -67.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -38.73 -49.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.543 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 23.8 t -59.66 -45.61 94.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.105 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.62 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.1 m-85 -66.2 -14.39 61.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 t -55.64 -22.99 25.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 19.3 mtm -57.32 -63.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.51 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -41.46 -50.03 3.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.13 -106.28 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 45.6 t -139.99 112.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.651 HG11 ' HB2' ' A' ' 232' ' ' ALA . 71.6 t -70.15 103.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.103 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 249' ' ' THR . 65.6 t -51.46 -37.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.405 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.2 ptm180 -168.16 121.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.866 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.651 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -107.73 151.03 26.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.36 161.36 30.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.603 HD11 HD22 ' A' ' 219' ' ' LEU . 32.8 mm -128.34 126.37 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 245' ' ' ILE . 82.6 mt -68.11 123.97 22.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.941 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -129.67 171.18 12.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.933 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.07 174.99 8.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -45.5 -43.57 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -64.22 -56.67 13.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 137.26 30.84 0.26 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.492 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -103.02 145.04 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 18.8 t -81.88 123.97 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -91.24 34.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 62.8 26.36 68.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 235' ' ' LEU . 72.1 mt -136.22 139.29 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 111.089 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.467 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 80.8 p -144.69 145.14 31.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.34 . . . . 0.0 111.147 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.62 HG11 ' HD2' ' A' ' 223' ' ' PHE . 21.1 t -133.89 130.41 55.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 230' ' ' VAL . 7.3 m -106.72 121.22 43.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 42.9 m-85 -96.06 177.89 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 3.6 mm-40 -76.8 -55.74 5.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -131.09 155.59 46.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.824 ' O ' HG23 ' A' ' 257' ' ' VAL . 38.7 p -47.99 -32.18 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.66 -67.08 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.45 -43.33 75.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.54 -49.72 67.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 253' ' ' SER . 62.6 t -57.26 -53.15 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -48.24 -44.63 33.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.51 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -66.77 -62.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.649 HD11 HG12 ' A' ' 205' ' ' VAL . 78.2 mt -40.8 -39.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.7 t -78.97 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 34.9 mtp -49.93 -21.39 1.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.543 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 41.9 m-85 -103.89 -21.97 13.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -55.58 111.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.72 18.21 71.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.496 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -78.39 125.16 28.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.8 mt -83.46 101.66 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.455 HD22 ' SD ' ' A' ' 273' ' ' MET . 11.6 tp -111.12 124.88 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 59.42 31.74 21.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 73.46 28.36 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -144.9 126.84 7.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 117.26 4.98 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 0.0 112.317 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.455 ' SD ' HD22 ' A' ' 268' ' ' LEU . 47.3 mtm -78.07 150.72 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 14.6 t-160 -117.33 104.37 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.53 HG21 ' HB3' ' A' ' 263' ' ' PHE . 1.6 t -114.29 119.9 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.1 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 277' ' ' MET . 11.4 ttmt -136.55 157.22 47.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.457 ' HG2' HD13 ' A' ' 260' ' ' ILE . 3.9 mtt -64.68 132.34 49.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.46 165.76 15.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.68 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.418 ' HD3' ' C ' ' A' ' 280' ' ' ARG . 0.0 OUTLIER -95.23 136.39 35.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.835 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -106.43 79.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.584 HD12 ' HD2' ' A' ' 283' ' ' PRO . 6.4 tp -58.67 140.43 85.4 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.584 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.6 Cg_endo -69.71 88.69 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 0.0 112.313 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -91.57 94.83 9.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -138.43 81.22 0.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -107.82 132.83 53.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.789 0.328 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.457 ' O ' ' CG ' ' A' ' 287' ' ' PHE . 9.6 p90 -170.64 121.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -113.24 143.91 30.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.683 0.754 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 148.16 64.28 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.711 2.274 . . . . 0.0 112.313 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 5.38 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.698 2.265 . . . . 0.0 112.356 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -97.07 158.13 15.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -124.88 80.94 62.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 126.29 13.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.641 2.227 . . . . 0.0 112.309 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -127.52 112.68 15.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -124.73 146.97 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 t -165.41 129.13 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.63 83.43 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 171.26 14.8 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 0.0 112.332 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 92.0 p -149.59 176.49 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.851 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 66.3 m -134.92 148.85 50.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.806 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.9 p -169.99 163.06 9.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.883 0.373 . . . . 0.0 110.897 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.9 t -57.7 89.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -100.77 55.15 0.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.3 m -115.72 -60.3 1.89 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.7 m -65.39 100.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -153.1 152.53 24.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -171.47 175.16 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 111.107 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 37.7 mt -117.16 171.98 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -96.35 -50.82 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -128.56 126.86 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -85.56 40.51 3.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -74.97 177.79 6.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 0.0 110.849 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 201' ' ' LEU . 0.2 OUTLIER -127.64 110.98 13.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -161.17 -162.34 12.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 33.9 m -86.02 37.97 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 90.0 m -79.77 131.44 35.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.527 HG12 HD11 ' A' ' 260' ' ' ILE . 35.4 m -108.0 138.05 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.185 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.435 ' CZ ' ' CG2' ' A' ' 245' ' ' ILE . 83.0 t80 -105.6 123.42 47.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.674 HG22 HG13 ' A' ' 275' ' ' VAL . 58.5 t -110.64 141.83 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 167.63 21.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 272' ' ' PRO . 62.7 t30 62.81 50.54 3.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 207' ' ' VAL . 83.7 mt -104.16 158.51 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -77.16 133.65 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -50.61 -34.59 26.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.925 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -64.75 -35.86 82.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.59 139.68 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -129.51 166.16 21.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.432 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 1.9 p-90 -44.54 -39.59 5.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 57.6 mttt -60.42 -55.56 32.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.826 ' NZ ' HD11 ' A' ' 268' ' ' LEU . 1.8 tmtt? -56.85 -57.69 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.4 tp -48.36 -52.58 21.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.532 ' HG2' HG11 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -57.5 -59.95 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -43.35 -44.96 5.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 218' ' ' LYS . 16.9 t -64.57 -52.53 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.585 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.7 m-85 -56.08 -18.51 9.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -52.19 -20.3 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 15.7 mtp -61.61 -62.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 255' ' ' GLU . . . -50.78 -35.84 33.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 170.93 -144.99 8.64 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.64 130.07 48.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 111.15 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.993 HG11 ' HB2' ' A' ' 232' ' ' ALA . 33.2 t -84.84 97.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.79 -42.78 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -153.7 116.99 4.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.993 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -118.4 141.22 48.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -164.59 171.69 14.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 16.7 mm -127.23 135.68 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 88.3 mt -76.03 126.02 30.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.415 ' HB3' ' N ' ' A' ' 241' ' ' LYS . 20.9 mt-10 -134.63 168.36 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.418 ' CB ' ' HE3' ' A' ' 241' ' ' LYS . 21.8 t0 -73.86 175.57 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -38.66 -43.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.02 -60.7 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 138.48 40.86 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.418 ' HE3' ' CB ' ' A' ' 237' ' ' ASP . 14.2 pttp -100.84 117.25 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.2 t -53.87 119.72 5.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -99.79 29.59 4.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 70.18 23.05 77.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.435 ' CG2' ' CZ ' ' A' ' 206' ' ' PHE . 32.7 mt -135.25 125.41 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.848 0.356 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.49 176.3 19.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 71.0 p -148.56 141.97 25.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 0.0 111.166 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 249' ' ' THR . 45.4 t -132.49 156.03 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.453 ' N ' HG12 ' A' ' 248' ' ' VAL . 92.0 m -128.73 109.76 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.116 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.454 ' CZ ' ' CB ' ' A' ' 259' ' ' ALA . 64.8 m-85 -83.85 -178.37 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -82.87 -51.22 7.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.14 158.16 44.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 96.8 p -44.83 -50.99 9.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -38.79 -67.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.639 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 5.7 mm-40 -50.27 -43.71 53.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -55.84 -62.72 1.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 44.4 t -43.31 -49.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.22 -41.12 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.62 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -71.51 -55.38 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 205' ' ' VAL . 65.2 mt -50.13 -38.54 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 36.6 m -79.62 -53.81 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 15.1 mmt -58.78 -22.1 57.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.0 m-85 -103.69 -23.19 13.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 1.5 t30 -58.81 110.5 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 81.43 7.59 88.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.13 131.31 42.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.08 100.03 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.826 HD11 ' NZ ' ' A' ' 218' ' ' LYS . 9.1 tp -106.77 121.84 45.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 57.78 43.67 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 22.9 t70 62.53 26.39 15.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -146.98 126.98 6.72 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.642 0.734 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 209' ' ' ASN . 53.7 Cg_endo -69.66 131.8 22.15 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.335 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.801 ' SD ' HD22 ' A' ' 268' ' ' LEU . 19.2 mtm -95.43 143.19 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -107.36 100.25 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 207' ' ' VAL . 1.9 t -109.06 124.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -146.93 127.5 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 1.7 ptp -61.89 138.27 58.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.35 162.85 1.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.845 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.52 82.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -106.11 86.69 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -102.9 85.08 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.08 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.768 HD12 ' HD2' ' A' ' 283' ' ' PRO . 3.0 tp -132.7 138.63 32.42 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.768 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.77 157.1 61.51 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.733 2.289 . . . . 0.0 112.286 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.97 146.49 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -123.34 125.28 5.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -124.05 133.91 53.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.83 0.347 . . . . 0.0 110.887 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -174.83 136.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -121.97 143.98 40.04 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.652 0.739 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 147.2 62.73 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.703 2.269 . . . . 0.0 112.368 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 5.36 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.673 2.249 . . . . 0.0 112.364 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 292' ' ' ARG . 0.2 OUTLIER -59.17 131.11 50.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.456 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 9.6 ttt85 -138.35 143.21 37.81 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.7 Cg_endo -69.8 115.48 4.12 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.637 2.225 . . . . 0.0 112.376 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -101.94 115.63 30.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.936 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -101.79 151.87 21.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 90.3 p -153.81 169.69 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -168.94 65.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -35.71 12.12 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.68 2.253 . . . . 0.0 112.337 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 37.6 m 40.91 42.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 93.5 p -67.01 160.32 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 -179.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 39.7 p -124.5 -47.85 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 0.0 110.879 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.5 t -57.58 120.95 9.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -90.09 -131.09 4.47 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.478 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.4 t -135.06 171.27 14.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.876 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.2 m -85.82 -52.99 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 63.57 148.34 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 197' ' ' GLN . . . -132.76 79.02 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 111.109 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 197' ' ' GLN . 1.2 pp -37.56 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.637 ' N ' HD12 ' A' ' 196' ' ' LEU . 9.4 tp-100 -64.67 143.52 57.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.77 127.84 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 84.18 97.36 0.63 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -91.06 43.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.04 151.16 39.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -178.48 -153.91 12.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.452 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 21.7 p -124.38 -41.71 2.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.937 0.399 . . . . 0.0 110.855 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 34.5 m -55.64 144.71 25.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.151 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.575 HG12 HD11 ' A' ' 260' ' ' ILE . 10.7 m -127.21 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.138 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -97.34 117.32 31.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.6 t -108.02 132.31 56.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.146 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.91 167.31 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.12 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 71.46 32.6 2.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.85 156.81 19.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' A' ' 214' ' ' VAL . 6.9 t70 -71.67 176.23 5.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -85.03 -30.23 24.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.74 33.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 211' ' ' ASP . 81.4 t -107.27 128.83 61.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -126.26 152.91 18.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -40.3 -33.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -60.1 -53.37 58.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.575 ' O ' HG23 ' A' ' 222' ' ' VAL . 0.0 OUTLIER -63.71 -50.41 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.648 HD22 ' CD1' ' A' ' 234' ' ' ILE . 17.9 tp -51.25 -56.43 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 232' ' ' ALA . 22.8 ttmt -60.57 -55.8 29.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 224' ' ' SER . 26.9 mm-40 -46.95 -59.97 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 218' ' ' LYS . 51.1 t -56.13 -51.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.571 ' CD2' HG21 ' A' ' 248' ' ' VAL . 4.2 m-85 -59.61 -13.98 11.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 5.4 t -58.53 -22.15 54.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.3 mtm -55.4 -62.07 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -49.59 -55.96 11.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.62 -150.43 6.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.1 t -96.01 96.6 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.993 HG11 ' HB2' ' A' ' 232' ' ' ALA . 87.6 t -50.48 96.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 249' ' ' THR . 55.6 t -52.79 -50.77 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -139.62 119.82 13.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.993 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -126.64 133.19 51.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.437 ' CG ' ' C ' ' A' ' 232' ' ' ALA . 0.4 OUTLIER -163.14 165.3 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.648 ' CD1' HD22 ' A' ' 219' ' ' LEU . 4.6 mm -124.39 151.33 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 70.3 mt -100.58 142.38 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -117.51 178.64 4.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -130.1 179.04 6.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -50.54 -22.89 2.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -80.45 -30.15 37.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.48 -34.41 4.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -70.15 144.26 52.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.779 0.323 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.0 t -51.56 134.32 29.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -26.13 16.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.67 29.49 2.64 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 83.5 mt -137.52 132.91 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.79 171.65 24.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.544 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.4 p -134.37 139.97 45.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.781 HG13 HG13 ' A' ' 229' ' ' VAL . 72.3 t -138.6 128.29 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.13 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 230' ' ' VAL . 94.0 m -111.79 123.11 49.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 226' ' ' ALA . 66.4 m-85 -96.7 175.51 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -69.96 -57.29 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.98 162.67 27.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.963 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.591 ' O ' HG23 ' A' ' 257' ' ' VAL . 0.9 OUTLIER -52.57 -38.42 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.6 mm -47.24 -66.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.087 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.49 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 4.9 mm-40 -54.79 -43.56 72.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -52.77 -47.38 67.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 253' ' ' SER . 65.5 t -60.34 -50.13 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.156 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -48.96 -43.88 40.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.626 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -68.36 -59.67 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.076 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 275' ' ' VAL . 33.4 mt -43.99 -42.7 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 34.4 m -76.27 -60.66 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -50.14 -23.36 2.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.886 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 3.6 m-85 -102.46 -22.8 13.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -52.63 111.38 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.95 17.87 71.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.474 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -77.21 122.5 25.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.93 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.5 mt -81.21 99.98 8.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.545 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -108.55 122.01 46.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 58.21 43.6 20.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 24.0 t0 63.24 25.45 14.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.74 125.22 8.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.591 0.71 . . . . 0.0 110.867 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 126.55 13.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.545 ' SD ' HD22 ' A' ' 268' ' ' LEU . 46.0 mtm -85.54 155.93 20.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -121.14 101.12 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 260' ' ' ILE . 2.7 t -111.56 117.8 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.405 ' CG ' ' N ' ' A' ' 277' ' ' MET . 17.7 tttm -136.81 157.6 46.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.447 ' CE ' HG22 ' A' ' 257' ' ' VAL . 14.0 mtt -65.61 136.83 56.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -84.7 177.7 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.76 79.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -95.87 107.56 19.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -89.48 78.42 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 5.8 tp -112.53 137.03 21.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 113.62 3.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.66 2.24 . . . . 0.0 112.352 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -100.97 145.43 28.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.07 83.61 0.22 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.441 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -125.54 82.08 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.42 149.07 22.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -100.83 143.88 27.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.477 ' HA ' ' HD2' ' A' ' 290' ' ' PRO . 53.8 Cg_endo -69.77 110.32 2.53 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.734 2.289 . . . . 0.0 112.311 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.477 ' HD2' ' HA ' ' A' ' 289' ' ' PRO . 53.7 Cg_endo -69.74 112.75 3.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.664 2.242 . . . . 0.0 112.359 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.3 130.96 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -128.26 143.83 49.54 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 159.15 54.48 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -139.49 146.68 40.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -113.12 136.51 52.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.0 t -140.97 144.97 35.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.853 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 174.81 84.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -177.11 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.754 2.303 . . . . 0.0 112.336 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 89.5 p -146.38 128.12 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.2 m -146.3 172.17 13.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.7 m -165.1 129.17 2.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.869 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 83.9 p -160.96 118.15 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -151.75 96.38 0.17 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.487 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 79.7 p -174.05 112.7 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.806 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.0 p -56.81 -29.54 62.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 47.08 49.82 17.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -99.53 91.25 4.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.58 124.92 26.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -96.04 113.65 25.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -116.39 162.38 17.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.053 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 100.99 64.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -61.06 -14.75 25.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.01 114.21 3.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 168.43 141.73 3.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 204' ' ' THR . 59.5 m -81.38 -43.88 18.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.955 0.407 . . . . 0.0 110.909 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 203' ' ' SER . 10.5 m -35.19 121.7 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.158 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 260' ' ' ILE . 24.2 m -111.97 142.65 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.204 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -99.06 117.19 33.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 245' ' ' ILE . 33.1 t -107.89 130.16 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -135.23 170.87 15.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.5 m120 62.19 50.06 4.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 51.4 mt -101.41 158.78 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' A' ' 214' ' ' VAL . 18.1 t0 -67.88 174.42 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -92.46 -6.22 50.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.58 ' HD2' ' CE1' ' A' ' 269' ' ' PHE . 10.1 ptpt -111.51 31.58 6.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 211' ' ' ASP . 14.9 t -108.5 132.25 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -120.62 158.53 15.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.418 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 35.1 p-90 -45.82 -31.39 2.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 32.3 mtpt -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.937 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.804 ' O ' HG23 ' A' ' 222' ' ' VAL . 2.5 tmtp? -63.13 -50.84 68.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.8 tp -59.39 -38.99 81.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -69.35 -64.18 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 222' ' ' VAL . 12.0 pt-20 -44.32 -40.91 5.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 218' ' ' LYS . 89.6 t -66.89 -52.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.538 ' CD1' ' CE2' ' A' ' 263' ' ' PHE . 3.2 m-85 -61.64 -14.01 27.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.5 t -52.03 -25.06 7.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 14.0 mtm -57.62 -64.25 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -47.76 -48.16 30.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -179.3 -154.65 13.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.482 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.2 t -90.81 127.05 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.38 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.958 HG11 ' HB2' ' A' ' 232' ' ' ALA . 73.5 t -84.54 99.51 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.101 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -148.54 118.97 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.958 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -119.83 142.24 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.057 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -165.88 169.36 14.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 219' ' ' LEU . 44.3 mm -129.53 132.91 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.132 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 71.3 mt -73.69 126.98 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.972 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -114.71 178.46 4.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -94.41 178.71 5.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -40.62 -54.48 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -66.32 -57.62 7.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 146.78 33.5 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.439 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -103.39 149.61 24.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 82.7 p -76.61 118.47 19.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -87.92 16.99 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.32 24.03 64.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 207' ' ' VAL . 44.4 mt -135.78 126.27 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.381 . . . . 0.0 111.133 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.19 168.65 20.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.52 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 73.5 p -138.32 145.49 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 t -139.1 155.25 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.1 m -129.76 115.48 17.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.136 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 60.2 m-85 -89.01 -177.62 5.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.89 -55.68 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -129.29 158.58 38.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 257' ' ' VAL . 14.8 p -51.08 -34.14 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 46.4 mm -49.37 -68.82 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.137 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -55.37 -43.39 75.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.25 -46.6 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 253' ' ' SER . 76.2 t -63.26 -48.67 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -47.96 -49.49 30.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.4 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -64.32 -60.06 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.677 HD11 HG12 ' A' ' 205' ' ' VAL . 74.8 mt -39.9 -38.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.092 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.3 m -82.0 -64.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 10.6 mmt -48.46 -19.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.538 ' CE2' ' CD1' ' A' ' 223' ' ' PHE . 4.9 m-85 -104.81 -25.33 12.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.05 112.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 83.48 11.97 79.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.44 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.39 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.927 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.1 mt -79.91 99.87 7.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.758 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.1 tp -106.72 123.25 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . 0.58 ' CE1' ' HD2' ' A' ' 213' ' ' LYS . 9.2 m-85 60.03 37.43 21.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 68.79 24.97 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.94 127.13 8.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 120.29 7.09 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.758 ' SD ' HD22 ' A' ' 268' ' ' LEU . 35.3 mtm -80.88 151.91 28.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -115.89 105.73 13.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.817 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.3 t -113.71 125.73 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.159 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -144.7 157.33 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.415 ' HG2' HD13 ' A' ' 260' ' ' ILE . 7.9 mmt -63.05 137.88 58.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.01 147.24 43.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -100.14 79.64 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 13.4 ttt-85 -93.79 170.56 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -135.02 103.21 5.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.612 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.2 tp -160.56 140.64 8.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.575 0.703 . . . . 0.0 110.953 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.612 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.78 139.02 39.15 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 0.0 112.337 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -71.57 -56.15 6.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.899 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.55 61.64 1.61 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.534 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -74.6 150.77 39.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -154.45 129.04 9.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.59 143.08 31.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.629 0.728 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 151.0 69.38 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.4 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 146.13 59.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -99.34 166.07 11.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 293' ' ' PRO . 0.0 OUTLIER -111.6 105.51 56.71 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.586 0.707 . . . . 0.0 110.872 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 292' ' ' ARG . 53.7 Cg_endo -69.74 142.83 49.1 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.351 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -114.87 92.26 3.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -41.59 141.09 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.5 m -160.23 153.82 22.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 145.24 -84.71 0.19 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 1.85 4.08 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.704 2.269 . . . . 0.0 112.334 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 29.7 t -40.67 -49.4 3.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 93.6 p -63.73 132.84 52.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.505 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 m -115.28 83.57 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.837 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.5 t -86.15 98.09 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.823 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.53 109.0 2.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 91.3 p -101.16 161.62 13.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.829 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 5.0 t -111.21 150.27 29.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.852 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -88.54 70.21 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.462 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -61.89 154.49 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 111.089 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -133.45 133.59 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -137.79 145.75 42.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.11 139.99 51.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -164.19 -167.01 24.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.456 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -93.79 -179.24 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.89 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 201' ' ' LEU . 6.7 tt -116.24 138.12 51.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -178.05 -123.82 0.82 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.476 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 26.0 m -109.01 53.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.928 0.394 . . . . 0.0 110.853 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 205' ' ' VAL . 30.4 m -87.0 159.04 19.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.69 HG12 HD11 ' A' ' 260' ' ' ILE . 22.3 m -132.49 143.08 40.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -100.37 113.26 25.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 245' ' ' ILE . 3.7 t -101.33 135.04 39.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -139.88 165.46 27.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.088 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.6 t30 63.29 49.99 3.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 42.1 mt -100.85 162.91 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 214' ' ' VAL . 0.6 OUTLIER -83.11 132.57 35.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -44.06 -44.3 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.862 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -56.42 -40.17 74.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 211' ' ' ASP . 74.2 t -51.91 123.58 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 218' ' ' LYS . . . -121.5 158.39 16.24 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.487 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.48 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 25.1 p-90 -38.89 -32.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.48 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 22.5 mtpp -72.35 -47.85 46.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.745 ' O ' HG23 ' A' ' 222' ' ' VAL . 3.1 tmtt? -66.2 -49.64 66.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.427 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.3 tp -56.38 -50.84 70.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' A' ' 232' ' ' ALA . 26.5 tttm -66.55 -35.04 79.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.66 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 218' ' ' LYS . 38.4 t -83.79 -49.13 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.134 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -59.1 -26.38 64.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 3.5 t -46.01 -24.38 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 24.1 mtm -57.91 -65.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -45.27 -42.34 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 175.92 -160.74 28.99 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.456 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.7 t -84.9 123.53 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 111.088 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 232' ' ' ALA . 47.0 t -83.66 98.76 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 76.1 t -54.6 -48.07 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -136.55 123.28 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.892 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -126.28 128.98 47.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -163.56 163.87 24.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.427 ' CD1' HD22 ' A' ' 219' ' ' LEU . 19.3 mm -122.73 148.1 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.123 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 76.2 mt -88.65 125.08 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' A' ' 236' ' ' GLU . 26.5 mp0 -132.57 167.96 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -61.04 173.56 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -50.86 -23.41 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -95.16 -55.48 3.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.6 37.22 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -88.75 144.41 26.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.3 m -83.43 120.6 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.838 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.31 -16.36 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 100.65 22.49 11.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 207' ' ' VAL . 28.6 mt -132.01 123.08 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 111.123 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.46 169.5 15.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 72.1 p -135.33 135.47 40.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.81 143.48 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.158 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 24.5 m -126.54 117.6 23.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.167 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 226' ' ' ALA . 67.7 m-85 -88.08 -177.91 5.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -82.47 -48.39 11.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -132.92 155.7 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.3 p -49.14 -46.0 44.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 23.8 mm -41.02 -60.47 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.43 -42.02 90.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.0 -54.2 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.09 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.74 -49.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.147 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -47.92 -48.29 31.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -67.93 -58.28 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.69 HD11 HG12 ' A' ' 205' ' ' VAL . 80.3 mt -41.36 -46.1 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 6.2 m -77.09 -62.22 1.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 49.7 mmm -47.62 -21.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.416 ' CB ' HG21 ' A' ' 275' ' ' VAL . 4.6 m-85 -104.58 -30.64 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -50.52 115.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.98 16.56 76.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -81.58 121.28 26.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.8 100.63 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.571 HD21 ' HZ1' ' A' ' 218' ' ' LYS . 13.6 tp -108.87 123.14 48.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 59.23 31.56 21.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 74.08 28.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -145.19 121.78 6.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.583 0.706 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 115.43 4.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.7 2.267 . . . . 0.0 112.354 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 58.8 mtm -73.95 153.53 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 18.2 t-160 -118.01 100.3 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 260' ' ' ILE . 2.2 t -109.96 113.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 277' ' ' MET . 1.8 tppp? -124.1 157.6 34.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.643 ' HG2' HD13 ' A' ' 260' ' ' ILE . 24.0 mtp -67.45 127.57 33.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -93.76 43.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 280' ' ' ARG . 15.7 tp10 -92.4 101.78 14.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 279' ' ' GLU . 17.4 tpt180 -35.42 138.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -74.03 81.05 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 5.5 tp -146.22 133.95 10.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.591 0.71 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 160.17 50.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.643 2.229 . . . . 0.0 112.382 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -99.01 -48.85 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.45 43.77 1.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.446 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -68.57 134.36 49.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.511 ' C ' ' CD1' ' A' ' 287' ' ' PHE . 3.3 p90 -123.12 148.92 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.841 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -128.5 129.48 23.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 148.18 64.78 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 0.0 112.342 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -177.89 2.09 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.737 2.291 . . . . 0.0 112.342 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -139.57 161.55 37.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -117.82 143.83 33.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 0.0 110.819 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.8 23.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.322 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -105.28 118.24 36.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -105.45 134.26 48.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 30.5 t -68.99 150.79 47.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -116.95 83.59 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.443 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 161.28 46.52 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.333 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 1.1 t -83.7 159.63 21.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 80.4 p -150.65 177.47 10.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.531 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -157.89 118.72 3.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.5 m -152.83 153.63 33.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.85 -179.76 43.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.473 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.6 p -174.3 150.56 1.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 110.868 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.9 t -169.06 173.47 6.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.28 35.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.459 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -118.19 144.24 45.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 0.0 111.1 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.28 168.11 19.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.86 111.26 8.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.21 -45.91 65.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.098 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 100.64 96.66 2.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.51 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -82.41 -41.92 19.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 19.4 tp -86.99 151.44 23.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.64 150.27 13.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 20.2 m -133.4 41.48 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.986 0.422 . . . . 0.0 110.872 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.8 m -89.09 130.6 35.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.142 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.531 HG12 HD11 ' A' ' 260' ' ' ILE . 34.4 m -111.06 130.38 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.114 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -95.32 118.58 32.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 275' ' ' VAL . 80.8 t -106.31 140.98 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.82 163.51 32.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 65.66 43.37 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.548 HD11 ' CG1' ' A' ' 207' ' ' VAL . 45.2 mt -92.77 149.01 21.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 3.3 t70 -60.12 162.89 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.415 ' N ' ' CG ' ' A' ' 211' ' ' ASP . 19.1 m-85 -79.12 -34.32 43.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.479 ' N ' ' OD2' ' A' ' 211' ' ' ASP . 20.8 mtpp -82.99 37.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 215' ' ' GLY . 47.6 t -110.02 157.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.131 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 214' ' ' VAL . . . -150.53 155.98 26.47 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -46.99 -33.43 4.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -67.4 -44.83 77.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -56.49 12.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 234' ' ' ILE . 12.4 tp -49.94 -61.25 2.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.544 ' HG3' HG11 ' A' ' 229' ' ' VAL . 35.9 tttm -50.25 -58.19 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -44.12 -39.89 4.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.647 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 20.0 t -73.73 -46.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.65 -20.05 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.3 t -53.22 -22.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.846 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 11.0 mtm -62.93 -61.64 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -50.85 -52.98 36.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.082 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -176.2 -160.26 23.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 67.9 t -79.32 124.84 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 0.0 111.1 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 232' ' ' ALA . 79.6 t -87.47 96.0 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.082 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.79 -45.57 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -139.84 121.26 15.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.952 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -125.92 124.12 40.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.97 165.16 37.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.551 ' CD1' HD22 ' A' ' 219' ' ' LEU . 35.5 mm -124.17 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 245' ' ' ILE . 86.6 mt -76.64 135.9 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -129.96 175.92 8.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 15.2 t0 -83.81 176.21 9.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' ASP . 3.4 mptt -37.06 -62.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 239' ' ' ASP . 1.9 t0 -55.79 -58.02 9.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 142.43 42.07 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -106.35 132.96 51.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.8 m -56.27 113.04 1.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -87.51 27.68 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 64.06 21.28 65.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 207' ' ' VAL . 48.5 mt -132.81 132.13 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -130.69 176.99 18.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p -151.82 127.26 10.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.649 ' CG1' HG13 ' A' ' 229' ' ' VAL . 33.0 t -130.16 154.67 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.157 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 248' ' ' VAL . 79.3 m -131.17 120.49 23.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 76.9 m-85 -87.55 -177.77 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -90.28 -55.03 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -111.35 143.55 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.8 p -48.31 -43.81 33.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.812 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.23 -60.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.03 -48.22 67.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -48.87 -53.34 19.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.153 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.508 ' HA ' HD12 ' A' ' 260' ' ' ILE . 85.8 t -54.33 -55.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -41.39 -56.99 2.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.509 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -57.08 -47.03 82.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.593 HD13 ' HG2' ' A' ' 277' ' ' MET . 73.1 mt -53.69 -56.83 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.8 t -64.68 -58.98 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 262' ' ' MET . 0.0 OUTLIER -47.0 -57.96 4.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.647 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 23.4 m-85 -65.66 -40.35 92.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 260' ' ' ILE . 0.5 OUTLIER -45.04 114.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.938 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.43 19.93 67.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -87.9 124.73 33.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.2 mt -79.4 99.99 7.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.466 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.7 tp -108.75 120.68 43.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 60.11 35.03 21.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 72.04 25.04 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -144.56 122.48 6.64 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.633 0.73 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 125.62 12.37 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.698 2.265 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.466 ' SD ' HD22 ' A' ' 268' ' ' LEU . 58.7 mtm -85.31 151.88 23.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -119.04 101.01 7.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 207' ' ' VAL . 14.3 t -114.01 127.2 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' A' ' 277' ' ' MET . 7.5 ttmm -143.32 159.98 41.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.593 ' HG2' HD13 ' A' ' 260' ' ' ILE . 8.9 mtp -66.5 117.04 8.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.8 110.37 2.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -74.15 -40.25 62.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -50.98 107.06 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -105.07 80.68 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.873 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.4 tp -69.7 135.68 88.04 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.603 0.716 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.873 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.3 Cg_endo -69.81 123.32 9.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.658 2.239 . . . . 0.0 112.341 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -126.77 113.97 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 152.43 136.66 2.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.02 175.85 9.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -146.44 148.42 32.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 289' ' ' PRO . 48.5 t80 -96.95 123.38 53.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.844 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.486 ' O ' ' CE2' ' A' ' 288' ' ' PHE . 54.3 Cg_endo -69.73 159.48 53.29 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.749 2.299 . . . . 0.0 112.346 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 121.52 8.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.243 . . . . 0.0 112.315 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -138.36 134.95 34.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 292' ' ' ARG . 3.6 ptm85 -139.24 146.0 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 110.915 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 130.54 19.46 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.231 . . . . 0.0 112.345 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -129.78 138.92 51.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -106.94 146.53 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.4 t -156.84 160.72 39.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 172.36 82.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -176.41 1.49 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.707 2.272 . . . . 0.0 112.347 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 4.0 t -162.32 173.9 13.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 2.0 t -156.88 177.96 10.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 179.973 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.0 p -88.79 127.36 35.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 86.1 p -88.82 164.9 15.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 113.73 140.49 7.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.462 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 99.6 p -109.62 129.5 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 8.3 t -77.71 136.83 38.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 44.34 -122.52 4.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 55.96 54.62 7.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.106 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 196' ' ' LEU . 5.7 mp -72.41 112.45 8.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -111.36 100.87 9.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -112.2 111.98 23.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.056 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 61.36 73.85 0.45 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.516 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -53.38 109.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.889 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.544 ' C ' HD12 ' A' ' 201' ' ' LEU . 0.9 OUTLIER -93.63 147.96 22.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 141.59 103.61 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 204' ' ' THR . 15.1 m -75.56 -38.95 58.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 203' ' ' SER . 6.8 m -35.82 139.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 260' ' ' ILE . 11.8 m -125.72 144.06 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -101.05 125.31 47.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.437 ' CG1' HD11 ' A' ' 210' ' ' LEU . 9.1 t -115.85 127.04 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -134.73 171.68 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.0 36.37 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.437 HD11 ' CG1' ' A' ' 207' ' ' VAL . 44.3 mt -89.16 144.94 25.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 214' ' ' VAL . 30.2 t0 -63.44 142.28 58.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -57.49 -27.28 62.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -74.03 -34.57 64.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 211' ' ' ASP . 54.4 t -59.55 133.32 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.14 158.17 22.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.504 ' CZ2' ' HG2' ' A' ' 217' ' ' LYS . 46.3 p-90 -36.35 -33.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.504 ' HG2' ' CZ2' ' A' ' 216' ' ' TRP . 24.9 mtpt -62.51 -53.15 58.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -67.06 -52.64 39.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 234' ' ' ILE . 12.6 tp -46.92 -40.52 14.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.572 ' HE3' ' HB3' ' A' ' 232' ' ' ALA . 32.4 ttmt -76.0 -58.84 3.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -46.07 -33.88 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.19 -58.72 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.543 ' HD2' HG11 ' A' ' 248' ' ' VAL . 3.2 m-85 -52.06 -19.48 1.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 30.1 t -53.55 -15.74 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 30.6 mtm -65.53 -63.19 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.92 -46.95 32.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.066 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -174.37 -136.28 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.437 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.99 117.67 54.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.932 HG11 ' HB2' ' A' ' 232' ' ' ALA . 77.5 t -72.34 97.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.165 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 249' ' ' THR . 92.9 t -53.66 -52.85 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.096 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -142.66 117.86 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.932 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -118.65 143.13 47.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.097 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.89 158.0 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.831 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 219' ' ' LEU . 26.7 mm -119.59 127.39 75.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.7 mt -70.0 127.04 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -130.2 176.98 7.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.0 173.15 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -39.85 -58.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -70.89 -58.34 3.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.36 44.73 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.85 114.64 27.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 69.1 m -52.3 117.75 3.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -94.38 -20.0 20.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.46 24.55 21.08 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 91.9 mt -136.0 131.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.87 0.367 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.607 ' HA3' HD13 ' A' ' 234' ' ' ILE . . . -138.33 175.44 21.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.3 p -138.39 145.6 41.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.799 0.333 . . . . 0.0 111.156 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.638 HG13 HG13 ' A' ' 229' ' ' VAL . 82.9 t -135.91 137.17 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 230' ' ' VAL . 77.4 m -115.24 114.06 24.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.131 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 256' ' ' ALA . 73.6 m-85 -88.2 169.78 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.409 ' HG2' ' CG2' ' A' ' 230' ' ' VAL . 14.6 mm-40 -75.74 -55.41 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -123.61 154.5 39.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 257' ' ' VAL . 68.5 p -49.72 -47.69 50.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 35.1 mm -41.2 -63.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.116 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -54.33 -45.67 72.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 250' ' ' PHE . . . -52.63 -49.82 64.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 253' ' ' SER . 42.1 t -56.19 -60.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -39.96 -50.54 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -61.63 -59.37 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.481 HD11 HG12 ' A' ' 205' ' ' VAL . 35.8 mt -42.49 -48.35 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 264' ' ' ASN . 7.0 m -73.36 -65.24 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 3.3 mmt -45.39 -22.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.425 ' HB3' HG21 ' A' ' 275' ' ' VAL . 25.7 m-85 -103.82 -21.47 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 261' ' ' SER . 5.9 t30 -61.78 111.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.52 8.53 86.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -76.39 130.68 38.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.928 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.3 mt -88.23 107.92 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.517 HD22 ' SD ' ' A' ' 273' ' ' MET . 13.8 tp -114.37 123.58 49.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 60.3 32.28 20.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 74.18 25.94 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -147.07 127.8 7.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.865 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 130.57 19.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.648 2.232 . . . . 0.0 112.328 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.517 ' SD ' HD22 ' A' ' 268' ' ' LEU . 48.3 mtm -91.46 132.82 35.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -96.76 105.31 17.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' A' ' 263' ' ' PHE . 2.6 t -120.69 127.33 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -149.54 150.87 32.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.465 ' HG3' HD13 ' A' ' 260' ' ' ILE . 28.8 mtt -57.88 139.06 55.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -52.95 137.82 31.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -83.32 -48.71 10.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -73.81 130.16 39.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.875 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -124.41 93.14 3.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.129 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.584 HD12 ' HD2' ' A' ' 283' ' ' PRO . 6.4 tp -85.51 140.46 36.06 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.584 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.5 Cg_endo -69.75 163.69 37.32 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.742 2.294 . . . . 0.0 112.325 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -98.82 -37.78 9.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.53 46.56 2.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.0 85.07 7.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -115.84 153.43 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.551 ' CD1' ' HD2' ' A' ' 289' ' ' PRO . 36.7 t80 -130.73 139.42 35.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.641 0.734 . . . . 0.0 110.89 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.551 ' HD2' ' CD1' ' A' ' 288' ' ' PHE . 53.3 Cg_endo -69.74 110.54 2.58 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.629 2.22 . . . . 0.0 112.394 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 289' ' ' PRO . 53.9 Cg_endo -69.78 175.13 8.53 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.379 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.38 169.29 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.482 ' CD ' ' HD2' ' A' ' 293' ' ' PRO . 9.5 tpp180 -129.34 138.88 34.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.679 0.752 . . . . 0.0 110.854 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.482 ' HD2' ' CD ' ' A' ' 292' ' ' ARG . 54.3 Cg_endo -69.73 164.89 32.83 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.67 2.247 . . . . 0.0 112.329 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -133.15 87.18 2.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -119.59 177.19 5.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.1 t -173.84 140.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 157.8 82.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.48 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 168.68 20.78 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 0.0 112.372 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 44.1 m -154.47 154.58 33.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.845 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 54.9 m -129.3 146.53 51.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 65.9 m -133.44 158.88 41.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.845 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.3 m -138.97 160.79 38.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.97 82.72 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.8 t -133.1 133.99 43.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.3 m -65.9 156.32 33.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.807 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 145.47 66.59 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.83 117.74 23.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.468 HD23 ' H ' ' A' ' 196' ' ' LEU . 2.5 pt? -75.78 133.53 40.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.7 162.03 13.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -127.58 80.54 1.96 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 102.48 139.49 10.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.499 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -124.9 -42.59 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.69 105.06 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 174.24 162.56 26.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.4 p -132.76 -33.6 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.984 0.421 . . . . 0.0 110.877 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 65.6 m -55.65 134.93 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.0 m -120.15 134.99 61.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 245' ' ' ILE . 74.7 t80 -95.42 118.26 31.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 275' ' ' VAL . 92.6 t -105.38 138.65 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.142 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.64 155.99 46.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 74.85 45.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.466 HD11 ' CG1' ' A' ' 207' ' ' VAL . 76.2 mt -99.56 134.82 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -57.57 162.51 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -72.05 -25.3 61.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -70.58 -42.88 70.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.43 139.48 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -141.3 159.9 26.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.529 ' CE2' ' HG3' ' A' ' 217' ' ' LYS . 16.6 p-90 -36.61 -33.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.359 . . . . 0.0 110.917 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.529 ' HG3' ' CE2' ' A' ' 216' ' ' TRP . 9.9 mtpm? -68.23 -61.06 2.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.466 ' HD3' HG23 ' A' ' 222' ' ' VAL . 4.3 tmtm? -56.19 -54.24 47.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.9 tp -47.29 -58.07 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.942 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -49.96 -63.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -41.94 -42.86 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.62 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 69.8 t -67.61 -51.17 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 248' ' ' VAL . 5.0 m-85 -59.73 -28.19 67.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 48.3 t -45.46 -28.39 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.832 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 34.5 mtp -51.99 -68.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -42.67 -56.46 3.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.91 -170.95 31.51 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.46 104.03 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.14 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 232' ' ' ALA . 78.4 t -62.45 99.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.108 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.675 HG22 ' OE2' ' A' ' 251' ' ' GLU . 83.1 t -50.09 -50.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.445 ' CG ' ' HB ' ' A' ' 249' ' ' THR . 14.1 ptm180 -153.45 117.44 4.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.808 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -108.53 146.32 33.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -165.04 172.09 13.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 49.2 mm -125.25 136.61 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.667 HD12 HG22 ' A' ' 245' ' ' ILE . 70.5 mt -77.48 136.45 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -130.9 178.16 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.09 177.28 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.409 ' HD3' ' C ' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -38.72 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.08 -53.63 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.69 37.51 0.23 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.502 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -105.11 135.95 45.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 51.4 m -69.09 121.33 16.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -93.21 26.61 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 69.68 21.29 76.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.504 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.667 HG22 HD12 ' A' ' 235' ' ' LEU . 46.9 mt -124.99 138.08 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -135.98 166.79 24.55 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 30.6 p -136.24 143.84 44.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 223' ' ' PHE . 85.3 t -140.47 134.56 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.445 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 22.3 m -114.19 111.72 22.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.479 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 57.1 m-85 -87.39 174.87 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.675 ' OE2' HG22 ' A' ' 230' ' ' VAL . 42.1 mm-40 -68.6 -60.01 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -127.2 162.67 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.7 p -51.77 -46.6 64.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.8 mm -40.34 -68.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.127 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.494 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 5.4 mm-40 -52.31 -44.83 65.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -51.21 -56.9 10.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.608 HG22 ' CE ' ' A' ' 277' ' ' MET . 60.0 t -52.29 -45.58 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -52.74 -42.58 65.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -72.78 -50.27 25.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 257' ' ' VAL . 72.0 mt -44.7 -52.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 5.3 m -72.22 -62.69 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 18.6 mmt -44.79 -23.55 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.62 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 22.9 m-85 -102.72 -28.02 12.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.921 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.44 ' C ' ' OD1' ' A' ' 264' ' ' ASN . 19.7 t-20 -56.42 111.05 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.57 11.49 84.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -74.53 128.31 35.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.787 0.327 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 267' ' ' LEU . 11.8 mt -81.42 102.38 10.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.577 HD22 ' SD ' ' A' ' 273' ' ' MET . 14.2 tp -112.02 121.64 45.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 56.77 41.66 27.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 270' ' ' ASP . 28.8 t70 63.26 29.51 15.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -147.02 121.46 5.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.601 0.715 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 123.78 10.43 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.73 2.287 . . . . 0.0 112.289 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.577 ' SD ' HD22 ' A' ' 268' ' ' LEU . 46.1 mtm -85.47 158.2 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -121.68 100.57 7.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 207' ' ' VAL . 1.7 t -112.84 128.67 69.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -144.31 154.97 43.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.608 ' CE ' HG22 ' A' ' 257' ' ' VAL . 13.9 mmt -55.34 132.88 49.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -96.7 102.36 14.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.11 88.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -72.39 143.41 48.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -128.73 89.61 2.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.8 tp -123.26 139.8 32.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.615 0.721 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.525 ' HD2' HD12 ' A' ' 282' ' ' LEU . 52.9 Cg_endo -69.85 157.14 61.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.663 2.242 . . . . 0.0 112.308 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -123.36 131.58 53.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.63 147.78 5.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.504 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.21 141.37 41.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.843 0.354 . . . . 0.0 110.863 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.62 129.45 22.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -101.64 144.54 28.77 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.656 0.741 . . . . 0.0 110.882 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 116.92 4.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 0.0 112.316 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 155.77 65.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.232 . . . . 0.0 112.338 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 292' ' ' ARG . 6.6 tp10 -126.48 136.57 52.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.46 ' CG ' ' HD2' ' A' ' 293' ' ' PRO . 26.3 ttm180 -38.21 139.73 0.63 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 292' ' ' ARG . 53.5 Cg_endo -69.82 -164.94 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -119.74 177.4 4.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -139.38 113.89 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 91.2 p -101.55 173.62 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -158.08 83.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.492 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.92 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.667 2.244 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 5.0 t -168.35 146.11 4.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.7 m -141.43 177.37 8.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.474 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.9 m -116.45 97.4 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.9 p -80.03 102.99 9.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -90.28 40.35 3.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 m -110.3 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 26.3 t -124.59 -36.73 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 67.33 57.01 9.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -84.79 110.37 18.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.9 mp -125.58 -53.16 1.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.8 134.48 54.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.4 -51.67 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 46.02 61.25 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.471 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -63.7 80.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.829 0.347 . . . . 0.0 110.891 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.6 mt -130.99 157.29 43.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.404 ' N ' ' NH2' ' A' ' 280' ' ' ARG . . . -112.63 -87.13 1.63 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.423 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 204' ' ' THR . 13.1 m -40.14 -45.63 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.835 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 203' ' ' SER . 42.1 m -36.56 128.97 0.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.689 HG12 HD11 ' A' ' 260' ' ' ILE . 20.1 m -109.4 139.99 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -99.73 117.05 33.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.7 t -105.65 135.44 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 274' ' ' HIS . . . -139.86 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.117 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.5 m120 62.94 41.66 8.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 31.5 mt -89.25 166.61 13.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.691 ' HB2' HG23 ' A' ' 214' ' ' VAL . 1.1 m-20 -93.55 139.14 31.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -51.65 -41.68 61.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.02 -33.88 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.691 HG23 ' HB2' ' A' ' 211' ' ' ASP . 47.6 t -67.04 132.5 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 217' ' ' LYS . . . -132.68 164.75 23.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.492 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.417 ' C ' ' O ' ' A' ' 215' ' ' GLY . 37.6 p-90 -36.26 -31.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.38 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 215' ' ' GLY . 32.1 mttm -60.43 -69.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 219' ' ' LEU . 16.3 mmmt -54.11 -58.16 8.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 1.016 HD22 HD11 ' A' ' 234' ' ' ILE . 16.2 tp -36.94 -56.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 6.8 ttpt -61.1 -67.22 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 224' ' ' SER . 6.3 mm-40 -41.16 -67.22 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 25.0 t -43.84 -49.08 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.159 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 219' ' ' LEU . 3.8 m-85 -63.31 -26.14 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 221' ' ' GLU . 8.2 t -46.45 -23.23 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . . . . . . . . . 16.3 mtm -55.14 -66.53 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.83 ' CB ' ' HB2' ' A' ' 259' ' ' ALA . . . -38.39 -50.84 1.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.31 -112.94 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.8 t -129.78 110.45 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.151 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.733 HG11 ' HB2' ' A' ' 232' ' ' ALA . 49.1 t -70.92 96.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 251' ' ' GLU . 98.3 t -50.05 -49.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.102 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.47 HH11 HG21 ' A' ' 249' ' ' THR . 6.6 ptp85 -151.22 122.4 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.733 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -111.96 151.16 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -169.84 160.47 8.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 1.016 HD11 HD22 ' A' ' 219' ' ' LEU . 49.3 mm -120.01 128.59 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.112 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.0 114.98 6.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -128.13 174.21 9.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 238' ' ' LYS . 0.8 OUTLIER -85.91 174.69 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' ASP . 36.8 mtmt -37.36 -48.98 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.44 -64.15 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 149.47 36.25 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.95 122.24 33.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.2 m -70.62 120.36 16.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 15.1 ttm105 -92.24 24.54 3.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.834 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.31 12.77 73.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.4 mt -122.37 126.1 73.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.53 165.91 19.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.3 p -137.45 140.1 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 0.0 111.132 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.581 HG13 HG13 ' A' ' 229' ' ' VAL . 61.1 t -138.16 146.09 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.181 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.47 HG21 HH11 ' A' ' 231' ' ' ARG . 17.9 m -123.18 111.96 17.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 38.5 m-85 -86.17 165.88 16.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 230' ' ' VAL . 0.7 OUTLIER -52.79 -52.63 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -143.12 168.27 20.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.942 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 254' ' ' ILE . 8.9 t -48.23 -54.21 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 253' ' ' SER . 49.5 mm -35.98 -68.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.159 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.444 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 24.1 mp0 -48.71 -46.84 41.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.562 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -53.77 -60.86 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.401 HG22 ' CE ' ' A' ' 277' ' ' MET . 94.5 t -42.88 -53.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.138 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -47.92 -56.82 6.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.83 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -58.54 -55.4 35.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.689 HD11 HG12 ' A' ' 205' ' ' VAL . 91.7 mt -40.65 -58.1 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 264' ' ' ASN . 46.4 t -68.71 -61.66 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 2.8 mtt -44.42 -22.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -103.88 -26.71 12.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 264' ' ' ASN . 0.2 OUTLIER -52.34 116.73 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.832 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.51 82.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . 0.463 ' OE1' ' N ' ' A' ' 267' ' ' LEU . 6.3 tp-100 -78.24 130.15 35.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . 0.463 ' N ' ' OE1' ' A' ' 266' ' ' GLN . 13.0 mt -87.68 100.37 12.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.406 HD22 ' SD ' ' A' ' 273' ' ' MET . 22.0 tp -108.1 123.81 49.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 59.89 32.23 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 74.1 26.78 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -145.32 129.01 8.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 126.57 13.49 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.406 ' SD ' HD22 ' A' ' 268' ' ' LEU . 36.6 mtm -84.17 143.43 29.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 14.5 t-160 -109.87 99.26 8.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 260' ' ' ILE . 2.5 t -109.43 131.1 61.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -151.65 155.07 37.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . 0.401 ' CE ' HG22 ' A' ' 257' ' ' VAL . 9.1 mmt -61.54 138.18 58.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CG ' ' N ' ' A' ' 279' ' ' GLU . 1.9 t70 -53.71 166.56 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.442 ' N ' ' CG ' ' A' ' 278' ' ' ASP . 2.9 tp10 -85.69 100.45 12.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . 0.404 ' NH2' ' N ' ' A' ' 202' ' ' GLY . 19.0 tpp180 -98.96 142.82 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -96.49 92.57 6.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.587 HD12 ' HD2' ' A' ' 283' ' ' PRO . 7.1 tp -75.04 140.07 73.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.595 0.712 . . . . 0.0 110.948 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.587 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.8 Cg_endo -69.76 -173.22 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.346 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -112.07 -32.83 6.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 84.85 176.74 50.95 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -136.64 178.93 6.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 110.853 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -137.39 119.32 15.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -110.14 143.99 29.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.671 0.748 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 124.76 11.4 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.657 2.238 . . . . 0.0 112.4 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 106.63 1.7 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.656 2.237 . . . . 0.0 112.347 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.49 107.37 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.26 151.35 42.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.843 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 125.47 12.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.5 139.98 52.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -109.21 134.14 52.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 1.4 t -151.42 108.49 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -130.51 81.44 0.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 173.03 11.56 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.699 2.266 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 65.1 p -107.66 151.18 26.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 57.9 p -85.02 166.16 16.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.516 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.0 p -150.54 150.88 31.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.817 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.7 t -143.47 165.73 26.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -137.2 59.16 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 26.4 t -174.02 108.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.894 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 96.0 p -150.44 144.51 25.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 127.3 51.36 0.15 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.472 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -105.36 92.78 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.49 57.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -76.65 51.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.82 87.55 2.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.09 41.01 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -76.98 115.65 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.6 mp -137.43 148.28 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 148.75 168.39 14.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 204' ' ' THR . 34.1 p -106.44 -36.36 6.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.955 0.407 . . . . 0.0 110.851 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 203' ' ' SER . 62.3 m -34.25 126.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.15 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.81 134.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -94.35 120.82 35.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.787 HG11 HD21 ' A' ' 210' ' ' LEU . 49.1 t -109.93 139.72 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -139.09 165.23 27.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 38.5 t30 62.78 46.43 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.787 HD21 HG11 ' A' ' 207' ' ' VAL . 30.8 mt -95.74 149.09 21.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.609 ' HB2' HG23 ' A' ' 214' ' ' VAL . 1.2 m-20 -69.65 138.47 53.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -50.5 -39.96 49.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -61.26 -41.48 96.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 211' ' ' ASP . 59.9 t -50.93 131.48 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -131.93 161.88 23.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -43.36 -34.63 1.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -62.3 -59.44 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -60.37 -57.18 13.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 12.4 tp -44.67 -55.86 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -56.04 -52.11 65.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.16 -58.08 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.565 HG12 ' CZ ' ' A' ' 263' ' ' PHE . 71.2 t -52.89 -40.09 34.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.15 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 225' ' ' MET . 3.7 m-85 -69.04 -32.62 72.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.3 m -40.65 -25.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' MET . . . . . 0.458 ' N ' ' O ' ' A' ' 223' ' ' PHE . 51.8 mtp -54.77 -66.31 0.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 255' ' ' GLU . . . -47.4 -48.62 26.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -171.59 -165.14 28.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.04 107.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 111.14 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.87 HG11 ' HB2' ' A' ' 232' ' ' ALA . 77.4 t -63.83 104.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.156 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -42.74 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.072 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -144.42 120.31 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.87 ' HB2' HG11 ' A' ' 229' ' ' VAL . . . -122.65 133.4 54.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -164.68 167.69 18.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.82 142.57 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 86.0 mt -82.3 125.39 30.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -137.11 176.08 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 238' ' ' LYS . 2.5 m-20 -109.22 178.51 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 237' ' ' ASP . 58.7 mttp -37.87 -59.45 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 241' ' ' LYS . 0.2 OUTLIER -48.12 -48.02 34.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.429 ' N ' ' CG ' ' A' ' 239' ' ' ASP . . . 105.84 24.8 6.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.532 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 239' ' ' ASP . 0.0 OUTLIER -94.07 139.0 31.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.9 m -70.36 120.84 16.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 243' ' ' ARG . 5.4 mmm180 -96.85 27.44 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 64.7 28.11 72.88 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.532 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 75.7 mt -135.95 125.73 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 111.122 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -132.21 176.31 19.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.4 p -144.82 136.33 25.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.129 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' A' ' 223' ' ' PHE . 39.3 t -129.22 149.91 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.2 m -129.17 117.13 20.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.496 ' CD2' ' HA ' ' A' ' 256' ' ' ALA . 70.9 m-85 -91.22 -175.2 4.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -81.87 -54.78 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -129.37 163.63 25.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 92.5 p -53.91 -41.67 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 27.8 mm -46.13 -65.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.638 ' O ' ' HB1' ' A' ' 226' ' ' ALA . 42.0 mt-10 -53.11 -45.09 68.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.496 ' HA ' ' CD2' ' A' ' 250' ' ' PHE . . . -52.28 -59.17 4.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.058 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -48.24 -56.72 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.169 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -44.06 -45.92 8.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 226' ' ' ALA . . . -69.51 -48.36 60.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 95.3 mt -48.88 -52.82 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.1 m -69.75 -63.19 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' MET . . . . . . . . . . . . . 5.4 mmt -42.58 -38.39 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CZ ' HG12 ' A' ' 222' ' ' VAL . 19.4 m-85 -88.21 -26.81 22.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.874 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -55.2 109.94 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.62 14.63 75.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -77.06 131.27 38.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 13.4 mt -88.7 103.02 15.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.7 tp -110.3 122.21 47.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 59.25 34.07 22.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 71.53 27.49 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -144.48 117.74 5.65 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.722 . . . . 0.0 110.871 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 119.86 6.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 47.5 mtm -79.15 163.17 25.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -126.66 100.65 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.7 129.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -146.23 145.83 30.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' MET . . . . . . . . . . . . . 15.5 mtt -56.79 126.99 29.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -62.44 158.16 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -114.29 86.8 2.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -135.01 114.51 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -76.53 68.39 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.09 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 283' ' ' PRO . 5.3 tp -77.92 140.93 62.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 0.0 110.939 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 282' ' ' LEU . 53.9 Cg_endo -69.76 164.6 33.94 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.732 2.288 . . . . 0.0 112.323 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.6 -56.84 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 51.11 52.71 30.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.457 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -120.53 143.05 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -167.36 149.14 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -133.81 137.25 28.17 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.625 0.726 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 148.27 64.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.705 2.27 . . . . 0.0 112.345 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 101.02 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 0.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -83.33 96.36 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -114.56 82.33 7.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 121.64 8.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.615 2.21 . . . . 0.0 112.341 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -128.34 131.34 48.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -129.13 132.95 47.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 12.6 t -157.73 145.14 18.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 140.05 145.25 4.64 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.425 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -177.89 2.1 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 0.0 112.36 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 1.8 t -132.69 170.2 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -168.22 151.1 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 -179.998 . . . . . . . . 0 0 . 1 stop_ save_